<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" xml:lang="en"><front id="16432c25-0355-4bbc-8488-003db0cbd3cf"><journal-meta id="de49f547-645b-444b-b3e7-2a25e2315a68"><journal-id journal-id-type="hwp" id="4d615e46-f32a-46bd-b5e2-db741dce29da">bjophthalmol</journal-id><journal-id journal-id-type="publisher-id" id="ddf43123-4703-4dd6-be17-f2ce880151a8">bjophthalmol</journal-id><journal-title-group id="69e3578e-713c-4bcc-bd25-435db42d196d"><journal-title id="42fb9ebd-e9c1-4f87-86e9-2f4d138ae1dc">British Journal of Ophthalmology</journal-title><abbrev-journal-title id="12be5fc5-9e80-496b-9812-d98c89c25364">Br J Ophthalmol</abbrev-journal-title></journal-title-group><issn pub-type="ppub" id="a685f086-ef2e-4747-be8f-3183415ae635">0007-1161</issn><issn pub-type="epub" id="f8db3f4e-2e4b-4df1-9360-e5bfafb7e5db">1468-2079</issn><publisher id="1b88d32f-1ab7-4f20-a5de-8ff96e8c29cd"><publisher-name id="7eaa631b-0902-433b-86db-578e0d4627fa">British Journal of Ophthalmology</publisher-name><publisher-loc id="aa54f2a0-d858-42ee-8526-22f79816eba6">BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta id="e0adff48-ae59-488d-9396-af2d5cfe50fd"><article-id pub-id-type="publisher-id" id="67118f3d-1501-40fd-a395-0afbea2c7ac6">10.1136/bjophthalmol-2019-313991</article-id><article-id pub-id-type="doi" id="7a4586ef-acf9-4989-af86-bdf588569868">bjophthalmol-2019-313991</article-id><article-id pub-id-type="paw-acronomy" id="6443281a-6a7c-49b8-b21b-4b03df015f8e">BJO</article-id><article-categories id="000a7ac7-ef83-4b6d-becd-cecec14d7459"><subj-group subj-group-type="display-channel" id="39c0e7d8-66f5-4b91-97ba-f38117a0b4a3"><subject id="c1b1a284-9b62-4a38-9839-6488459452f0">Clinical science</subject></subj-group></article-categories><title-group id="abcc6a1d-8d8a-4936-b1c1-fb4f19bf5f78">  <article-title id="0f778114-1f88-4d45-b6db-065c3aa08802"><named-content rid="1553859621114" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" content-type="jrnlQueryRef" specific-use="start" id="ae905301-c267-469f-8218-b197a3f471a5" data-answered="true"/><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1553859938" id="f2be88c2-5516-4a55-aa7b-5cecb2064b24" content-type="del cts-2" specific-use="1553859943712" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:15pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553859943712">Title: </named-content>Safety of 6000 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1553859621000_s" id="e98a3baf-a04c-4e39-abcf-fc4acebd0b6e" content-type="del" specific-use="1553859621000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-type="s-case" data-userid="preediting" data-username="Exeter" data-time="1553859621000">Intravitreal</named-content><named-content xmlns:xlink="http://www.w3.org/1999/xlink" data-cid="1553859621000_s" id="bbf05ca8-0479-4cae-8a63-4ce5be557242" content-type="ins" specific-use="1553859621000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-type="s-case" data-userid="preediting" data-username="Exeter" data-time="1553859621000">intravitreal</named-content> <named-content data-class="jrnlQueryRef" rid="5ba0b675-4149-42d9-a8b8-605e6b61dbe0" data-query-ref="true" data-type="start" data-query-for="author" data-query-from="preeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" id="4c57eebe-ecab-4def-a011-0ff7a6d35de5" content-type="jrnlQueryRef" specific-use="start"/>dexamethasone<named-content data-class="jrnlQueryRef" rid="5ba0b675-4149-42d9-a8b8-605e6b61dbe0" data-type="end" id="b9585238-983a-4305-9d4e-65d34500a3c8" content-type="jrnlQueryRef" specific-use="end"/> implants</article-title></title-group><contrib-group section="front" node-xpath="article-meta" next-xpath="author-notes" data-group="author" id="f64eadac-e93c-487c-83b8-3d3a490e4d5d"><contrib contrib-type="author" id="author-67801079" data-id="author-67801079"><name id="93242cab-31cf-4d75-b831-c0fb5bab1a66"><surname id="7e3de73c-c767-4ca9-b0cd-cda31c5181ed">Rajesh</surname><given-names id="c8d3b845-784f-454a-8e6a-868100fed22b">Bindu</given-names><prefix id="e4eb441c-d2c2-4bb0-9901-32c385b00f5e">Dr</prefix></name><xref ref-type="aff" rid="aff1" id="64a50da0-4558-497a-95e3-e558532339f4">1</xref><email id="130a55c6-355f-4d90-aea5-9aa7979b58e7">docbindu@gmail.com</email></contrib><contrib contrib-type="author" id="author-34235351" data-id="author-34235351"><name id="be03c194-5db5-4294-9e0f-afaf0d2c11ae"><surname id="03461ecc-f100-4812-babf-9baeed6c9445">Zarranz-Ventura</surname><given-names id="cf5d4053-5334-44c5-bbd8-73ce9e2d912e">Javier</given-names><prefix id="03469587-2f53-43f3-a807-ecf25ce79fce">Dr</prefix></name><xref ref-type="aff" rid="aff2" id="2f2b6150-fc28-4c00-a991-50657bb9f3c3">2</xref><email id="79c90ac2-f34c-48ff-bab2-03db4e46ead5">jzarranz@hotmail.com</email><contrib-id contrib-id-type="orcid" data-retain="true" id="cc0afb5f-6fb2-458b-84a8-5db59cc4503f">http://orcid.org/0000-0003-2338-8143</contrib-id></contrib><contrib contrib-type="author" id="author-60090143" data-id="author-60090143" data-edited-node="true"><name id="0e43c9b5-5d9e-4b09-b17d-1f41be7b6663"><surname id="8487b50f-3667-4cf1-bdc5-75ff8581456a">Fung</surname><given-names id="070bbc36-43b2-42e9-8f08-68d8df2b7598">Adrian T</given-names><prefix id="317b2f4d-aec7-497a-bfb1-e887dd4919a7">Dr</prefix></name><xref id="fcb0b3ed-f846-4215-969b-bc93aefc7b2c" rid="aff3, aff4" ref-type="aff">3,4</xref><email id="0841f9a1-2d24-46f9-b5cb-cd340949c9ad">adrianfungi@yahoo.com.au</email></contrib><contrib contrib-type="author" id="author-56346326" data-id="author-56346326"><name id="5bc95a87-2619-49a7-926a-c3ab43bee176"><surname id="a8327e68-6f9c-417d-9d55-d67d8034ee61">Busch</surname><given-names id="36dd8951-eb71-4bf8-89ba-7e944d4a981f">Catharina</given-names><prefix id="141a8a7c-129c-4aef-967e-e65b8d2fddc1">Dr</prefix></name><xref ref-type="aff" rid="aff5" id="f38f8f18-2172-419d-9bd3-c00f5ba6e99f">5</xref><email id="410c6858-8f02-47c7-975b-e6c27d8e116e">busch.catharina@gmail.com</email><contrib-id contrib-id-type="orcid" data-retain="true" id="cb061d77-8ecc-4988-bac0-99a8299fdb08">http://orcid.org/0000-0002-6267-4663</contrib-id></contrib><contrib contrib-type="author" id="author-65975773" data-id="author-65975773"><name id="a89db268-4ea8-43e7-91e6-0f959f75339d"><surname id="60ba9a3e-3cbd-4778-b4f6-fa859973bc41">Sahoo</surname><given-names id="2260c2c5-7e62-4601-ac96-729da3ef517c">Niroj Kumar</given-names><prefix id="653b0c69-3983-46d4-b309-ee3c1ff739c7">Dr</prefix></name><xref ref-type="aff" rid="aff6" id="8b4562f9-c548-4739-a1bb-afcb66c91cc6">6</xref><email id="b4263536-77d2-4ff6-9f47-b3d03b49b617">nirojsahoo71@gmail.com</email></contrib><contrib contrib-type="author" id="author-60527574" data-id="author-60527574" data-edited-node="true"><name id="79f9a751-15b9-45c1-91a5-eb44b4d31f03"><surname id="d71e7568-b13e-4f6d-921e-c44824729401">Rodriguez-Valdes</surname><given-names id="746acc17-186b-4de2-be17-e68166defa5c">Patricio J</given-names><prefix id="1d13f92b-525b-4f75-8b89-c9754b533b27">Dr</prefix></name><xref id="de41a530-a470-48c7-85ef-0c8830700dce" rid="aff7" ref-type="aff">7</xref><email id="0a2a5a5f-948d-4211-a189-a3590a14ad1e">dr.patriciorodriguez@gmail.com</email><contrib-id contrib-id-type="orcid" data-retain="true" id="78cfcc55-46bf-4896-9afd-4815ba7bd072">http://orcid.org/0000-0002-6652-9631</contrib-id></contrib><contrib contrib-type="author" id="author-44083164" data-id="author-44083164"><name id="00161cde-28ba-4223-b077-fb8c6b4b3223"><surname id="293c4aeb-f452-4ad1-8d8e-1191eb466ce1">Sarao</surname><given-names id="dac6970e-15db-458b-bbe5-de594bf53210">Valentina</given-names></name><xref ref-type="aff" rid="aff8" id="a73033a5-6217-4091-bef7-673d890ef523">8</xref><email id="4a20f667-3aac-4dc0-8149-371a08b06900">sarao.valentina@gmail.com</email></contrib><contrib contrib-type="author" id="author-67801091" data-id="author-67801091"><name id="a0cd7bde-91d5-4412-a9a0-c5300df44f53"><surname id="8dc383bd-af21-46e1-a022-91c310702434">Mishra</surname><given-names id="1a2516ab-34c6-47ca-9c6e-2f27ed6cf4e0">Sanjay Kumar</given-names><prefix id="4671162e-8ffc-4d79-b815-678234684a43">Dr</prefix></name><xref ref-type="aff" rid="aff9" id="c4a68446-675a-40bc-930a-5a421534558e">9</xref><email id="52824f6a-d822-40fa-bb72-ceb102e48606">sanjusonu_2000@yahoo.com</email></contrib><contrib contrib-type="author" id="author-61729446" data-id="author-61729446" data-edited-node="true"><name id="86316f61-d3c1-4540-8c37-82002e61baab"><surname id="18b63b68-2d03-47c1-be69-284f88fe443b">Saatci</surname><given-names id="c3f0f7b5-722b-4ce4-9cc6-c66b0b9d0e82">A Osman</given-names><prefix id="ce7512e3-6280-41e5-bbba-39b4d4f5f7bd">Professor</prefix></name><xref id="7abd9eb1-dfc4-4f56-ae1b-d1881c4e130e" rid="aff10" ref-type="aff">10</xref><email id="b097687c-d700-44bb-91af-56b473758881">osman.saatci@gmail.com</email></contrib><contrib contrib-type="author" id="author-67801098" data-id="author-67801098"><name id="4ae17af2-ef7d-40fa-9882-bc50d03f4516"><surname id="c253cc25-34b5-4188-9a59-faf764e30835">Udaondo Mirete</surname><given-names id="5167ea6a-1f2d-4f17-89a1-626021ca2eba">Patricia</given-names><prefix id="f7bc0e3a-21d7-4c19-b07d-35dda4e24eb1">Dr</prefix></name><xref ref-type="aff" rid="aff11" id="10113168-bd5f-41f0-89c7-2ffe29c022a4">11</xref><email id="6804019d-547a-4377-a7a4-8cdcdcff67fb">draudaondo@gmail.com</email></contrib><contrib contrib-type="author" id="author-34477340" data-id="author-34477340"><name id="b9e452f8-eecd-4025-a06f-3e1c648efbdf"><surname id="5d37afb0-d59e-4493-8c83-33769430e890">Querques</surname><given-names id="d818889f-b616-431a-95c3-1f498307c029">Giuseppe</given-names><prefix id="e04a53d5-71b6-4de9-94a9-8645d499fee7">Professor</prefix></name><xref ref-type="aff" rid="aff12" id="4cdbaa12-1859-4e48-856e-275dae62e3df">12</xref><email id="94321af3-9e26-453e-876d-6d7b32cef92e">giuseppe.querques@hotmail.it</email><contrib-id contrib-id-type="orcid" data-retain="true" id="167a64ae-499c-4fbc-a70f-5745d28f659c">http://orcid.org/0000-0002-3292-9581</contrib-id></contrib><contrib contrib-type="author" id="author-31059460" data-id="author-31059460"><name id="93f71749-5054-4052-8eb3-80b289341ee3"><surname id="b5b2db13-372d-4bb4-8991-e4ef0005b0d7">Farah</surname><given-names id="02637e99-fe77-4f08-b39d-d5d6980045dc">Michel Eid</given-names><prefix id="283496d7-7dea-4900-800e-d3fa619728d4">Professor</prefix></name><xref ref-type="aff" rid="aff13" id="8751c4c7-d930-4052-aeaa-743c28217321">13</xref><email id="c2bebead-25ae-4de5-ab3e-7f7b1f4f4859">mefarah@uol.com.br</email></contrib><contrib contrib-type="author" id="author-21758950" data-id="author-21758950"><name id="b38cf4f1-52fd-49b6-932e-e7b0c60b2284"><surname id="32631623-3893-4814-93a5-588d8e632a65">Lanzetta</surname><given-names id="68ca7e3f-ca62-4448-a6a1-759c9a470449">Paolo</given-names><prefix id="13044131-4232-41eb-8b64-959c4f3f45e9">Professor</prefix></name><xref ref-type="aff" rid="aff14" id="6ea77371-2d2e-4bf0-994d-16aeee8bf0c1">14</xref><email id="77051aac-415d-49a6-bfba-60b3b7d9ed97">paolo.lanzetta@uniud.it</email></contrib><contrib contrib-type="author" id="author-21759086" data-id="author-21759086" data-edited-node="true"><name id="d28b8835-1fd4-4d29-a388-473962de8175"><surname id="a711f665-c390-4127-854b-7901bd53aa52">Arevalo</surname><given-names id="a0b3765e-0bf3-4248-a39e-0b9722c3ea61">J Fernando</given-names><prefix id="a1228041-d995-4142-84d4-645660a03fe3">Dr</prefix></name><xref id="42cfd97e-8160-43d7-8e6a-1de3bdbd133e" rid="aff15" ref-type="aff">15</xref><email id="f1f2816f-b9ca-417f-94e6-bf1a5904cf69">arevalojf@jhmi.edu</email></contrib><contrib contrib-type="author" id="author-36237025" data-id="author-36237025"><name id="d14ef4b0-e0f6-4978-b2ee-b988caaa367b"><surname id="3c7dbbc6-5fa8-4637-ac48-57bd413cd3b7">Kodjikian</surname><given-names id="a160d3d3-ce21-4654-92f6-4c69a608a833">Laurent</given-names><prefix id="13020dfb-496d-4b73-83aa-dfe2e48f41f3">Professor</prefix></name><xref ref-type="aff" rid="aff16, aff17" id="36d2f352-78d0-4ef9-8d45-1373c33dc279">16,17</xref><email id="1e9b4af2-a9ff-47f4-9932-f7a115391657">kodjikian.laurent@wanadoo.fr</email></contrib><contrib corresp="yes" contrib-type="author" id="author-26175961" data-id="author-26175961"><name id="c908664b-dc4c-4179-8c59-e238e9f1ccc1"><surname id="bdef5bc5-bbda-4381-a3c5-2c52e782cd9d">Chhablani</surname><given-names id="3eb1aef0-5a4b-4e33-99a4-60e0f86e3e96">Jay</given-names><prefix id="12e53e36-d37a-46ef-ab42-00eaea5b8e60">Dr</prefix></name><xref id="052015f4-7981-4863-ad52-38417b22c7ce" rid="aff6" ref-type="aff">6</xref><xref ref-type="corresp" rid="cor1" id="7534a733-d635-4f07-8642-1731d827766b"/><email id="f18ccfa7-94b9-4fad-ba23-dbe867a8c4af">jay.chhablani@gmail.com</email><contrib-id contrib-id-type="orcid" data-retain="true" id="3fd305cb-4936-4b46-a31b-07e3630a84a3">http://orcid.org/0000-0003-1772-3558</contrib-id></contrib><on-behalf-of id="37cfcb79-f6d9-41b7-a679-91ad792c3e68" data-track="ins" data-cid="1553925240782" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553925240782">for International Ozurdex Study Group</on-behalf-of><aff id="aff1" data-id="aff1" data-edited-node="true"><named-content data-class="jrnlQueryRef" rid="b38e040b-f359-4341-80e4-6096a35f6f55" data-query-ref="true" data-type="start" data-query-for="author" data-query-from="preeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="37a57153-cdba-4f2c-836a-232c79f4dc62" content-type="jrnlQueryRef" specific-use="start"/><label id="bc3d1759-0eae-41cd-af31-be096ad2d328">1</label><named-content content-type="institution" id="f15b17dd-13c0-4685-bc96-195a65333251">Khoo Teck Puat Hospital</named-content>, <named-content content-type="country" id="80e446ba-c452-45b7-910b-afebe12dc94b">Singapore</named-content></aff><aff id="aff2" data-id="aff2"><named-content data-class="jrnlQueryRef" rid="29c2ea1c-e813-4899-8b0e-a5580773b1ba" data-query-ref="true" data-type="start" data-query-for="publisher" data-query-from="preeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="0154fbac-e99e-4394-82ec-e80fd7b06af0" content-type="jrnlQueryRef" specific-use="start"/><label id="cc5332c0-8ce2-432e-8a85-5a29c11c7fd0">2</label><named-content content-type="dept" id="072ee8d6-a3b0-40de-aa97-5217010bd774">Hospital Clínic de Barcelona Insi</named-content>, <named-content content-type="institution" id="a90b35c0-8b2b-4010-9cbf-17fa2d08b5a5">Instituto Clinic de Barcelona, Instituto Clinic de Oftalmología (ICOF)</named-content>, <named-content content-type="city" id="88f68702-9b57-4cc4-a471-cdeb7b79f450">Barcelona</named-content>, <named-content content-type="country" id="a9abec11-6d9a-4b5e-9caa-8b3edb2a26a3">Spain</named-content></aff><aff id="aff3" data-id="aff3" data-edited-node="true"><named-content data-class="jrnlQueryRef" rid="679bcd7c-c4d5-4d63-ad2a-10828f446518" data-query-ref="true" data-type="start" data-query-for="typesetter" data-query-from="preeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="4e8362c4-9bef-4fe3-9a78-6d22e65e42d0" content-type="jrnlQueryRef" specific-use="start"/><label id="60c44811-49f5-4540-8e73-07a2f2b3aaaf">3</label><named-content content-type="dept" id="24c586ab-490a-4ad5-bcf8-34d889c0504a">Department of Ophthalmology</named-content>, <named-content content-type="institution" id="c1ab4487-e36e-431e-9caa-68e75f2600b6">Westmead Hospital</named-content>, <named-content content-type="city" id="ccbcb7cf-b507-40fa-ae1d-f08283fd076a">Sydney</named-content>, <named-content content-type="state" data-valid-state="true" id="e2295943-5a1c-4fb3-ba1b-e95e43576a4f">Australian Capital Territory</named-content>, <named-content content-type="country" id="7c37258f-63e6-413c-a4e5-fd1a4ddf1a38">Australia</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff4" data-id="aff4" data-edited-node="true"><label id="ea84d3aa-a91f-4051-971d-bb299e6d6748">4</label><named-content content-type="dept" id="ac147b83-e4dd-4ba6-bfba-4abc5d6872d9">Save Sight Institute</named-content>, <named-content content-type="institution" id="94ea1970-e362-474c-91a4-b948c77bb7a3">Sydney Eye Hospital, University of Sydney</named-content>, <named-content content-type="city" id="69e4aa71-8fb1-41fa-b275-7b7bacbcae11">Sydney</named-content>, <named-content content-type="state" id="54aa4e20-e4f3-400b-b0f7-0e2a8dd16a34">New South Wales</named-content>, <named-content content-type="country" id="7e9097d0-bbfb-49df-a4e4-34096ee02b60">Australia</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff5" data-id="aff5"><label id="99303c71-b61a-4d29-a02e-c5107ff3a3d4">5</label><named-content content-type="dept" id="2fabfc42-ee7d-438a-8afe-614fbf9d64c5">Department of Ophthalmology</named-content>, <named-content content-type="institution" id="87a035ba-3ad3-4b1e-a9f7-100b693e6cc5">Universitatsklinikum Leipzig</named-content>, <named-content content-type="city" id="5b9f7bf1-0220-4466-9f3f-b411dbd42e8e">Leipzig</named-content>, <named-content content-type="country" id="bec7272b-625f-4d92-9164-552ded304126">Germany</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff6" data-id="aff6" data-edited-node="true"><label id="f72eecf9-1af3-4746-848c-efb00269a5c1">6</label><named-content content-type="dept" id="f7eb9c91-781f-4ca6-ba07-60699b6144d2">Vitreo-retina</named-content>, <named-content content-type="institution" id="ee75f331-a3ce-45f6-8f03-0b5b99a0e7ee">L V Prasad Eye Institute</named-content>, <named-content content-type="city" id="01c9eaeb-aa71-498b-b2ca-f5216f66a302">Hyderabad</named-content>, <named-content content-type="state" data-valid-state="false" id="e8ab6a2a-1419-4e8a-bb35-3988ec688824">Andhra Pradesh</named-content>, <named-content content-type="country" id="1f1c3f08-3298-4e09-8041-fc368330bdbb">India</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff7" data-id="aff7" data-edited-node="true"><label id="e29abac2-57a9-4f07-ab4f-ac66466ccff4">7</label><named-content content-type="dept" id="a6dc429e-97d0-4fdd-a529-cacc9ea1c13a">Ophthalmology</named-content>, <named-content content-type="institution" id="c0710c1b-2b84-4999-a413-24850d6104db">Instituto de Oftalmología y Ciencias Visuales, Escuela de Medicina, Tecnológico de Monterrey</named-content>, <named-content content-type="city" id="9cdb392e-8ea3-4384-b2fd-171ba1b6b27f">San Pedro Garza García</named-content>, <named-content content-type="country" id="633eff57-898a-42b7-887d-7ccb357471dc">Mexico</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff8" data-id="aff8" data-element-added="true"><named-content rid="faaeb583-6ee3-4bb9-a7b3-603b5b1fdc90" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="preeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="13113327-de2f-4bc7-990d-833beb2c89b3" content-type="jrnlQueryRef" specific-use="start" data-answered="true"/><label id="4e92366a-10b1-4dd3-b29d-db664ea626c2">8</label><named-content content-type="dept" id="13074515-73bb-48be-b58c-28fe254416e6">Department of Medicine-Ophthalmology</named-content>, <named-content content-type="institution" id="f35be65d-1d1e-4b5f-a573-93946be161de">University of Udine</named-content>, <named-content content-type="city" id="172f85b8-5174-4978-828a-f5b72053762f">Udine</named-content>, <named-content content-type="country" id="166c805d-c05c-4ece-b091-a21716fb76d2">Italy</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff9" data-id="aff9" data-edited-node="true"><label id="918a1156-c3b3-48fa-bb35-0ab60eb1197b">9</label><named-content content-type="institution" id="c890f1c3-8da8-45a8-ac49-68130de75fa4">11 Department of Ophthalmology, Command Hospital</named-content>, <named-content content-type="city" id="331b3b3d-f741-4793-83f4-1c2e9ebe315e">Lucknow</named-content>, <named-content content-type="country" id="14e0a830-ed42-490e-a073-75903499ed8d">India</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff10" data-id="aff10"><label id="4cd444a9-c2d8-46d9-83ab-6e713531a6d6">10</label><named-content content-type="institution" id="56f60c9e-57db-44a9-ab82-0cd35c7c88ba">Dokuz Eylul University</named-content>, <named-content content-type="city" id="4d261306-aa60-4ec3-bb97-ba7ddd1be011">Izmir</named-content>, <named-content content-type="country" id="13b43d05-a625-451c-8b48-0a60eb595f2c">Turkey</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff11" data-id="aff11" data-edited-node="true"><label id="56e00c87-7018-4313-a65b-7dd3d3da5ef0">11</label><named-content content-type="dept" id="1d1129bb-ec1d-47a8-852f-0cc77d817133">13 Ophthalmology Department</named-content>, <named-content content-type="institution" id="60697f78-49d0-4249-9e17-3ea7d95944ec">Hospital Universitario La Fe</named-content>, <named-content content-type="city" id="3866e41f-695c-414b-88b9-a2188f2bda37">Valencia</named-content>, <named-content content-type="country" id="ed30cdcf-c381-4fa4-a1dc-af7941c6d707">Spain</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff12" data-id="aff12"><label id="93aeab89-ba83-440e-ba9a-99d4d779f3ed">12</label><named-content content-type="dept" id="08d9faa3-e83a-4241-abee-6c6583250d62">Ophthalmology</named-content>, <named-content content-type="institution" id="601ceb21-3c96-4cf0-84e4-c2baa79d11a2">Ospedale San Raffaele</named-content>, <named-content content-type="city" id="fc6d3cf8-a782-48a0-824e-cdc2d64b3f6f">Milano</named-content>, <named-content content-type="country" id="9d90eac3-2b8e-405b-946f-99774ed858ba">Italy</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff13" data-id="aff13" data-edited-node="true"><label id="4f8f2733-a440-41e8-8753-40a33bfb308d">13</label><named-content content-type="dept" id="2ed9d026-60d7-42cc-bc38-2a9549ff4677">Ophthalmology</named-content>, <named-content content-type="institution" id="cf083e9c-513a-4096-8bde-13c3af22f481">Federal University of Sao Paulo</named-content>, <named-content content-type="city" id="0d62c672-f6d4-402e-b6b2-cbaf9abca750">Sao Paulo</named-content>, <named-content content-type="country" id="52a3cfef-0408-4273-b960-4b3f2db81aa8">Brazil</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff14" data-id="aff14"><label id="f04e8357-2628-4055-807c-2673031b0e2b">14</label><named-content content-type="institution" id="dbf873af-0a22-4702-953e-aec7fdb6eac7">University of Udine</named-content>, <named-content content-type="city" id="e0fa5379-6ff3-4627-a7f9-f50f990359a5">Udine</named-content>, <named-content content-type="country" id="bc947442-fb91-4da0-85ff-0c2706fea994">Italy</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff15" data-id="aff15"><label id="7c8c4cde-a2f1-46ab-8acb-83e30d01c658">15</label><named-content content-type="dept" id="f14158e9-0c9f-40c4-ad0f-182e285a359e">Retina and Vitreous</named-content>, <named-content content-type="institution" id="82d46ccf-8960-4f35-9e22-e1b5386a085f">Clinica Oftalmologica Centro Caracas</named-content>, <named-content content-type="city" id="7a023e75-801b-4b2e-8c25-9efbcc497459">Caracas</named-content>, <named-content content-type="country" id="b3abf3e4-6988-4b21-97ed-d8b2d82c06e7">Venezuela</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff16" data-id="aff16" data-edited-node="true"><label id="bad8927a-05db-4f66-bc6c-cf378bbb9f4a">16</label><named-content content-type="dept" id="5dd50dd6-b30b-4952-8346-47e09704c27e">Ophthalmology</named-content>, <named-content content-type="institution" id="b7c96a78-6f9c-43b9-beec-4173f274c974">Croix-Rousse University Hospital, Hospices Civils de Lyon</named-content>, <named-content content-type="city" id="551e3f31-e664-4c88-bebc-28420b31f66e">Lyon</named-content>, <named-content content-type="country" id="6c7d1161-16d0-4962-9ef4-43d796bca6e6">France</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff17" data-id="aff17" data-edited-node="true"><label id="988fdf58-116f-4c02-b934-33685358fc13">17</label><named-content content-type="dept" id="7729e95e-81e4-4ecb-873e-9a21a895ce69">CNRS UMR 5510 Mateis</named-content>, <named-content content-type="institution" id="4e51dfa6-6ce4-4552-8f37-6f654ef8941c">University of Lyon</named-content>, <named-content content-type="city" id="3e278d35-5644-4f24-a6d4-4297259b743f">Lyon</named-content>, <named-content content-type="country" id="a03113d3-ded8-431f-8ec2-60c211a26e0a">France</named-content></aff></contrib-group><contrib-group content-type="section" id="7af70ef1-0aa9-411c-a9a8-9369401a3094"><contrib contrib-type="editor" id="author-21758538"><name id="3e490866-2094-4258-8865-c9bbc8220be8"><surname id="6167b9ac-12a1-4a12-a538-21c03f0ce3ae">Jonas</surname><given-names id="afd737d9-50a6-4c2d-99cc-40dbe7f93e3e">JostB.</given-names><prefix id="4cbe5982-c88a-42eb-b477-501d99516b24">Dr</prefix></name><xref ref-type="aff" rid="ae-aff1" id="32d603b6-b736-4974-9497-351e22a1f148"/></contrib><contrib contrib-type="editor" id="author-21759219"><name id="71d303f7-ce01-4570-8fcc-82bb9868b90a"><surname id="777eb1e7-e0a8-4e5d-b4a3-fd2604dba1a3">Sears</surname><given-names id="8f38086f-4b5a-4238-82b6-2b1a96cbd122">JonathanE</given-names><prefix id="b4895cb6-a4c3-4f6c-b7b6-079c2d1b5b77">Dr</prefix></name><xref ref-type="aff" rid="ae-aff2" id="a4a1909a-e9e3-4126-aa40-8acde2bfb78e"/></contrib><aff id="ae-aff1" data-id="ae-aff1"><department id="dada74b8-0240-4c4e-ac78-34bb79605822">Ruprecht-Karls-University Heidelberg, Seegartenklinik Heidelberg</department>, <institution id="86de67d0-bfb0-4ca6-b7d4-14f981e31eba">Department of Ophthalmology</institution>, <city id="fdefcb25-46f8-43ae-973e-a3aa836d0a49">Mannheim</city>, <country id="5046ca53-7c4b-4396-a841-3a04efabc6f2">Germany</country></aff><aff id="ae-aff2" data-id="ae-aff2"><department id="cdd65997-2030-4c4d-a3ae-4a2e9831a612">OphthalmologyCell Biology</department>, <institution id="2c19f918-282d-4399-b95c-71e021532c26">Cole Eye InstituteCleveland Clinic Foundation</institution>, <city id="a79afd63-5e32-4ce0-a02d-a33fc03f3d49">CLEVELAND</city>, <state id="2f599c22-0a26-4296-8a3a-a634a86d1c77">Ohio</state>, <country id="440319c3-68a3-41c5-893c-32659ef951d3">USA</country></aff></contrib-group><author-notes id="3dca0ed7-7df8-4b4b-8083-d9d8222ba0f2"><corresp section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" id="cor1" data-id="cor1"><name data-class="jrnlAuthor" id="67a5ff5a-9df5-4119-8d70-45431ea0380c"><prefix id="cca6b3f5-62ca-46a3-aa3a-90c196f0afc8">Dr</prefix> <given-names id="19b32888-10ab-463d-9876-7658057fd6f6">Jay</given-names> <surname id="2ac4539e-0b83-4f14-8767-3cd7afd69bc7">Chhablani</surname></name>,<fn fn-type="corresp-address" id="4f06e200-e6ff-42d4-8808-724a7a158556"><p id="f2c06283-18de-43e0-8cc9-0bb76c623c8d"><named-content content-type="dept" id="77d7de25-bc90-4de7-b638-b2e70b5c9f46">Vitreo-retina</named-content>, <named-content content-type="institution" id="d09592c3-e467-4984-9191-a774b8e31b73">L V Prasad Eye Institute</named-content>, <named-content content-type="city" id="9cf586e9-120f-4465-947f-1bbeba158f90">Hyderabad</named-content>, <named-content content-type="state" id="1e7592e3-a3ed-4cff-8338-56965e09048e">AP 500034</named-content>, <named-content content-type="country" id="d5f59afd-1dbb-42e8-841e-f1d09a453043">India</named-content></p></fn>; <email id="e020591d-d682-41f7-bf3f-c5c7e77b74ed">jay.chhablani@gmail.com</email></corresp><fn fn-type="con" section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-label="Contributors" id="fn1" data-id="fn1" data-edited-node="true"><label id="7c8c3d33-187b-4896-aad6-0d1e7186cada">Contributors</label><p id="e89df9a4-8509-4a7c-a535-2746389122ee">All persons designated as authors qualify for authorship, and all <span data-style="background-color: transparent;" id="decb5f13-0f68-4f31-af99-0a1f626e1d34">those who qualify are listed. Each author has participated sufficiently in the work to take </span><span data-style="background-color: transparent;" id="aedf08a6-0462-4af0-9080-691ef26a59c0">public responsibility for appropriate portions of the content. </span><span data-style="background-color: transparent;" id="ff4b0c05-1fff-4430-ac0c-aaec58a67cd4">Design: JC. Conduct of the study: JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC. Collection: JZV, AF, CB, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC. Management: BR, JC. Analysis: BR, NKS, JC. Interpretation of the data: BR, NKS, JC. Preparation: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC. Review: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC. Approval of the manuscript: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC.</span></p></fn><fn fn-type="conflict" section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-label="Competing interests" id="fn2" data-id="fn2" data-edited-node="true"><label id="a5798182-5ca7-4b2e-9677-2981cf58a066">Competing interests</label><p id="8ce3cb5d-1f96-425c-8847-51cfa0c8f4b7">BR: None <span data-style="background-color: transparent;" id="16c8749f-60e2-4234-b9f7-d7dc2a4038da">JZ-V: Allergan (Consultant); Bayer (Consultant); </span><span data-style="background-color: transparent;" id="722ca79f-81a9-48f3-90c5-945580826a9d">ATF: Allergan (Consultant); Bayer (Consultant); </span><span data-style="background-color: transparent;" id="a852abde-fc05-491a-9a8f-787ffa4118b6">CB: Allergan (Consultant); Bayer (Travel support); Novartis (Consultant) </span><span data-style="background-color: transparent;" id="8f179727-42ee-43e2-bc64-d348a786b158">NKS: None </span><span data-style="background-color: transparent;" id="94f47a96-c633-47bf-a3ff-2facb7c1584b">PJR-V: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia </span><span data-style="background-color: transparent;" id="67fe5421-8c83-4c6e-a886-69a61d16a053">VS: None </span><span data-style="background-color: transparent;" id="7e02f20a-8e9c-463e-8a27-9235c35ec65b">SKM: None A</span><span data-style="background-color: transparent;" id="c67f758d-3106-4e91-a39c-fe428a8debd1">OS: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant) </span><span data-style="background-color: transparent;" id="5cca05e9-192f-42a6-9362-09b1254103d2">PUM: Bayer (Consultant); Centervue (Consultant); Novartis (Consultant) </span><span data-style="background-color: transparent;" id="dab2d202-8432-45a5-a90a-71606a968fcb">GQ: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia. </span><span data-style="background-color: transparent;" id="014d1273-bebc-498a-92cf-56d3eb3d9388">MEF: None </span><span data-style="background-color: transparent;" id="a2501ee4-04a7-49fe-bb52-a8714f852970">PL: Alcon (Consultant); Alimera (Consultant); Allergan (Consultant); Bausch&amp;Lomb (Consultant); Bayer (Consultant); Boehringer (Consultant); CenterVue (Consultant); Genentech (Consultant); Lupin (Consultant); Lutronic (Consultant); Novartis Pharma AG (Consultant); Roche (Consultant); Teva (Consultant); Topcon (Consultant) </span><span data-style="background-color: transparent;" id="dc5eb36f-635e-4dc2-866d-00ad8751e461">JFA: TURING PHARMACEUTICALS LLC(Consultant); DORC International B.V. (Consultant); Allergan Inc. (Consultant); Bayer (Consultant); Mallinckrodt (Consultant); TOPCON (Grant Support) </span><span data-style="background-color: transparent;" id="f8698710-ad93-4210-922a-d58d830ef4c1">LK: Principal Investigator for trials sponsored by Novartis, Allergan, Bayer, Théa, Alcon; has sat on advisory boards for Alcon, Alimera, Allergan, Bayer, Roche, Novartis; lecture fees from Alcon, Alimera, Allergan, Bayer, Horus, Novartis, Théa. </span><span data-style="background-color: transparent;" id="a428bfc1-2d5b-469c-a508-898dd6cf0f49">JC: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant); OD-OS (Consultant).</span></p></fn><fn fn-type="provenance-and-peer-review" data-label="Provenance and peer review" id="fn3" data-id="fn3"><label id="a5dbd7ba-990f-465b-a2b0-acef8be050b2">Provenance and peer review</label><p id="514adedc-9beb-4ae5-9b92-63ca3fb91ed7">Not commissioned; externally peer reviewed.</p></fn><fn fn-type="ethics" data-label="Ethics approval" data-track="ins" data-cid="1553861131312" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553861131311" id="905b6f5c-e125-4af6-8e8f-3e63dad2ecf3"><label id="a386c35d-30f4-4bf8-aad2-d1c5165c2e81">Ethics approval</label><p id="5de15c50-477f-4d10-aee5-dd48a7d39b1a">Local Institutional ethics committee at all study sites.</p></fn><fn fn-type="consent" data-label="Patient consent" data-track="ins" data-cid="1553861957010" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553861957010" id="d72cde15-83ef-4f0d-8282-e098d2670e7e"><label id="0643a3c2-a2ef-42ee-aad1-432d79a76e65">Patient consent for publication</label><p id="8002b8c8-e178-4c1d-9328-3612b77a9be4">Obtained.</p></fn><fn fn-type="collaborators" section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-label="Collaborators" id="4de00338-df01-47f7-9668-b73e9dd3afdd" data-track="ins" data-cid="1553929391324" data-username="Gowtham Ram (PREEDITOR)" data-userid="preeditor gowthamram" data-time="1553929391324" data-edited-node="true"><label id="9b08c021-5da3-461d-a738-4efd41b50c34">Collaborators</label><p id="da34cfc8-5a24-4219-bc4e-6e8bffe5c3e8">collaborators test</p></fn></author-notes><pub-date pub-type="ppub" id="475726b0-977b-4600-841b-e8ff2fe296ee"/><pub-date pub-type="epub" id="d8fbf1e2-9d05-4502-96c6-42332aef4a73"/><volume section="front" node-xpath="article-meta" node-next-xpath="//history" id="204f9638-3e47-4001-84cf-240050080dd1">0</volume><issue section="front" node-xpath="article-meta" node-next-xpath="//history" id="87aa65d2-5808-4c1f-be5f-023c8c5ab60c"/><fpage id="9a136e46-953f-4f51-a79f-11f017aa1589">1</fpage><lpage id="0c79ae44-a2e4-47e2-85d5-43806c9b07a4">7</lpage><history id="797e1524-8698-48c3-80c4-af1d79e5faab"><date date-type="received" id="6b179630-057a-46ae-a9b4-1206b3aee658"><day id="d505ee62-5b36-413d-a6f4-0f47e3d7f0d6">28</day><month id="1bcc2294-e8ce-42e7-bd74-f771a0927880">01</month><year id="806d6863-0008-4f31-ad9c-cd958fd87a04">2019</year></date><date date-type="rev-recd" id="e648abd0-e92b-4f71-b584-c91e95c62d7e"><day id="994b8cb1-f4e1-4ba6-bfa4-98114d1ff039">25</day><month id="409640c1-1877-403c-9e37-aa3d988808a3">03</month><year id="b498e1b2-4fc1-4545-ba14-a107201c3837">2019</year></date><date date-type="accepted" id="83105529-cee7-49d0-bd6c-a39d0fbe7369"><day id="6abf7f61-ec39-47a5-a10d-67e9049caf0b">27</day><month id="9775e12c-0be4-4214-8bec-d9c79302a9c7">03</month><year id="b4ec95af-7d91-45ad-a008-fa6810babeac">2019</year></date></history><permissions data-type="nonOA" id="cfd19f7d-e273-4ae9-b506-310aab26442b"><copyright-statement data-statement="new" id="6111b1ca-ecc7-4d8b-80ef-b485a6439cfb">© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement><copyright-year id="90e9c84e-1f03-4fa1-a196-f6173cd5ac14">2018</copyright-year><license id="7450bd7a-a3ab-4723-b9b8-42e7e230af76"><license-p id="fd8d941e-d793-4c5e-92b4-91c04368930b"/></license></permissions><files id="43909d86-2b6f-414a-9c51-041197623388"><file file-type="Main Document" file_category="" file_name="bjophthalmol-2019-313991-File001.docx" submission_medium="online" id="413b7963-35ca-4042-b89c-ca99a638d2c0"><file_createddate id="1cbe9c95-12a8-4c43-b3c6-3bf8022ad148">2019-03-25 02:41:00.0</file_createddate><file-format id="0e24e45f-4fa0-4eac-b708-9337f26eff73">docx</file-format><file-extension id="2a2b0d47-7240-46d2-9766-df1b4857536d">docx</file-extension><file-name id="d5f66773-0967-4580-b7ad-6d11c1a5ff37">Final_final_Ozurdex_6k_21-3-19_CLEAN_COPY.docx</file-name><file-caption id="aa82c619-28e5-4faf-b397-4a703f11ca05"/><file_tag id="bdd3b35d-dcca-4f3f-97d4-cc1edfad7c5f"/><attribute attr_name="File Designation" id="06e8670b-4e69-4467-93bf-e6129079226c">Main Document</attribute></file></files><abstract id="6b225885-1b40-4b15-b3aa-146b6bfc0bc2"><title data-level="1" id="4e64d837-eeed-4005-a6f3-9873c4a5c659"><named-content data-cid="1553859945" id="58924d95-b5ba-4437-892c-99576a009a81" content-type="changeCase sty cts-2" specific-use="1553859956299" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Sentencecase Added by Pradheep (PREEDITOR) - 03/29/2019 5:15pm" data-track-detail="" data-track-hint="Sentencecase Added" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553859956299">Abstract<span data-class="hidden" hidden-track="track" id="99832968-21f4-4d7a-93cc-0d69cf47f541">ABSTRACT</span></named-content></title><title data-level="2" id="59357251-25e4-4e60-b021-f9ed54433ebf">Purpose<named-content data-cid="1553859621000" id="20af2f5c-9064-4186-976c-2085ceef35be" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">:</named-content></title><p id="32e71463-ea94-473e-98d5-154d2cadb4be">To evaluate the real-life safety profile of intravitreal dexamethasone implant injection for various retinal conditions.</p><title data-level="2" id="6c745f15-6a38-45c7-86e7-f0febe376f07">Methods<named-content data-cid="1553859621001" id="477391d6-8692-491b-9b40-64339daadd98" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">:</named-content></title><p id="73ced7ec-4d9c-4845-9943-625442767a8b">Retrospective multicenter analysis of intravitreal dexamethasone implant injections (<named-content id="1b816ba4-30a3-4b16-8313-591d7277b7ec" data-cid="1b816ba4-30a3-4b16-8313-591d7277b7ec" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="85" data-match="700µg" data-replace="700" data-pattern="$1" data-tag-index="3_1" data-time="" data-username="" data-userid="">700</named-content><named-content id="f1ef36da-4b64-4c54-86ee-21e497f3e49e" data-cid="f1ef36da-4b64-4c54-86ee-21e497f3e49e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'µg' to ' µg'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="88" data-match="700µg" data-replace=" &amp;#x00B5;g" data-pattern=" $2" data-tag-index="3_1" data-track-change="µg" data-time="" data-username="" data-userid=""> µg</named-content>) due to various retinal conditions including central retinal venous occlusion (<named-content id="b8d1418f-235e-48dc-86f3-d5085cbfc4bc" data-cid="b8d1418f-235e-48dc-86f3-d5085cbfc4bc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="171" data-match="1861" data-replace="1861" data-pattern="1861" data-tag-index="3_2" data-time="" data-username="" data-userid="">1861</named-content> injections), diabetic macular <named-content data-cid="1553859621052" id="51028e83-f73c-4d43-b4cc-8ae64397d6fe" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content data-cid="1553859621052" id="e72dc2ca-9ec5-4536-903a-256dab090af7" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="206" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="3_4" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> (<named-content id="51beae5e-286b-4ecb-bdb7-d3d941f6b954" data-cid="51beae5e-286b-4ecb-bdb7-d3d941f6b954" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="213" data-match="3104" data-replace="3104" data-pattern="3104" data-tag-index="3_3" data-time="" data-username="" data-userid="">3104</named-content> injections), post-surgical cystoid macular <named-content data-cid="1553859621053" id="4d4aac18-67cf-473e-b352-bb6c538cff83" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content data-cid="1553859621053" id="4c93d086-fddc-447f-87cd-244c1b7bff52" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="261" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="3_5" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> (305 injections) and uveitis (381 injections). The eyes were evaluated mainly for the occurrence of adverse events such as glaucoma, cataract, retinal detachment and endophthalmitis along during the follow-up period<named-content data-cid="1554366205" id="95a173f7-28c5-445e-95ff-59c36bc31b9c" content-type="del cts-3" specific-use="1554366561112" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 1:59pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554366561112"> </named-content>.</p><title data-level="2" id="5cf83af9-2b58-4763-8d93-c89b4354f2ca">Results<named-content data-cid="1553859621002" id="e8212c6d-9837-4b3f-b662-f4f0447891be" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">:</named-content></title><p id="3f32c671-a01c-453c-bc93-d0e8c7e9f929">A total of <named-content id="0c8e4266-33cf-4c98-80b1-3bb762ae18de" data-cid="0c8e4266-33cf-4c98-80b1-3bb762ae18de" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="11" data-match="6015" data-replace="6015" data-pattern="6015" data-tag-index="4_14" data-time="" data-username="" data-userid="">6015</named-content> injections in <named-content id="233f2bb6-e098-4bcc-995f-38e6ed89e97c" data-cid="233f2bb6-e098-4bcc-995f-38e6ed89e97c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="30" data-match="2736" data-replace="2736" data-pattern="2736" data-tag-index="4_15" data-time="" data-username="" data-userid="">2736</named-content> eyes of <named-content id="2db54e19-9c84-4646-a330-520b36194d75" data-cid="2db54e19-9c84-4646-a330-520b36194d75" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="43" data-match="1441" data-replace="1441" data-pattern="1441" data-tag-index="4_16" data-time="" data-username="" data-userid="">1441</named-content> <named-content id="22b27396-a651-4260-b35f-f67499d6678c" data-cid="22b27396-a651-4260-b35f-f67499d6678c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="48" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="4_17" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> (mean age of <named-content id="96fcf4e5-d213-4cc7-8dd7-441a9560d59d" data-cid="96fcf4e5-d213-4cc7-8dd7-441a9560d59d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="70" data-match="65.7 ± 12.9 years" data-replace="65.7" data-pattern="$1" data-tag-index="4_2" data-time="" data-username="" data-userid="">65.7</named-content><named-content data-cid="1554366210" id="07b43d38-28f8-4961-9dca-d14d3debed1f" content-type="del cts-3" specific-use="1554366873855" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554366873855"> </named-content><named-content id="c25151c3-d38e-462e-915c-1121cdc7e04f" data-cid="c25151c3-d38e-462e-915c-1121cdc7e04f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣±␣' to '±'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="74" data-match="65.7 ± 12.9 years" data-replace="±" data-pattern="$2" data-tag-index="4_2" data-track-change=" ± " data-time="" data-username="" data-userid="">±</named-content><named-content data-cid="1554366211" id="2b36be12-57fa-46cc-b35c-fd2ffd127aa0" content-type="del cts-3" specific-use="1554366876093" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554366876093"> </named-content><named-content id="07621bed-a962-463f-8001-ff115c63f213" data-cid="07621bed-a962-463f-8001-ff115c63f213" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="78" data-match="65.7 ± 12.9 years" data-replace="12.9" data-pattern="$1" data-tag-index="4_2" data-time="" data-username="" data-userid="">12.9</named-content> <named-content id="1e380b4f-d71d-4b53-b633-a966b35fe73d" data-cid="1e380b4f-d71d-4b53-b633-a966b35fe73d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="82" data-match="65.7 ± 12.9 years" data-replace=" years" data-pattern=" $2" data-tag-index="4_2" data-time="" data-username="" data-userid="">years</named-content>) were in total <named-content data-cid="1553859621054" id="703013f4-bc47-4aef-8cb0-af9f43b1399f" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">analyzed</named-content><named-content data-cid="1553859621054" id="a1fcbdd5-ba1c-432d-80d1-5527d5b18c6a" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'analyzed' to 'analysed'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="104" data-match="analyzed" data-replace="analysed" data-pattern="analysed" data-tag-index="4_19" data-function="addTrackChanges" data-track-change="analyzed" data-userid="preediting" data-username="Exeter" data-time="1553859621001">analysed</named-content> over an average period of <named-content id="32d27a2e-9350-41ad-92d3-6b89f1aa4ed0" data-cid="32d27a2e-9350-41ad-92d3-6b89f1aa4ed0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="139" data-match="18 months" data-replace="18" data-pattern="$1" data-tag-index="4_7" data-time="" data-username="" data-userid="">18</named-content> <named-content id="3646e588-1d84-4892-89bf-4cae4575d7d9" data-cid="3646e588-1d84-4892-89bf-4cae4575d7d9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="141" data-match="18 months" data-replace=" months" data-pattern=" $2" data-tag-index="4_7" data-time="" data-username="" data-userid="">months</named-content> (range <named-content id="fa89a886-3f39-4f73-b790-f43c8213c736" data-cid="fa89a886-3f39-4f73-b790-f43c8213c736" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT,OPR,VALS,UNTS" data-tag-type="VAL" data-offset="156" data-match="6 months to 102 months" data-pattern="" data-tag-index="4_1" data-time="" data-username="" data-userid="">6</named-content> <named-content id="73ada479-76c6-4d6a-9b95-b61fe49ebdf7" data-cid="73ada479-76c6-4d6a-9b95-b61fe49ebdf7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT,OPR,VALS,UNTS" data-tag-type="UNT" data-offset="157" data-match="6 months to 102 months" data-pattern="" data-tag-index="4_1" data-time="" data-username="" data-userid="">months</named-content> <named-content id="6e89edc7-b592-4a19-90ed-84988f80e3d9" data-cid="6e89edc7-b592-4a19-90ed-84988f80e3d9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAL,UNT,OPR,VALS,UNTS" data-tag-type="OPR" data-offset="164" data-match="6 months to 102 months" data-pattern="" data-tag-index="4_1" data-time="" data-username="" data-userid="">to </named-content><named-content id="84c79e74-d3ec-4545-b367-2fff6706ce0d" data-cid="84c79e74-d3ec-4545-b367-2fff6706ce0d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VALS" data-track-detail="" data-tag-desc="VAL,UNT,OPR,VALS,UNTS" data-tag-type="VALS" data-offset="168" data-match="6 months to 102 months" data-pattern="" data-tag-index="4_1" data-time="" data-username="" data-userid="">102</named-content> <named-content id="e6cc9a0d-8cae-4b8b-a7c9-65839fe2288f" data-cid="e6cc9a0d-8cae-4b8b-a7c9-65839fe2288f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNTS" data-track-detail="" data-tag-desc="VAL,UNT,OPR,VALS,UNTS" data-tag-type="UNTS" data-offset="171" data-match="6 months to 102 months" data-pattern="" data-tag-index="4_1" data-time="" data-username="" data-userid="">months</named-content>). A total of 576 eyes (<named-content id="4c7cdcab-edc2-4c67-a663-96d006d5eb1a" data-cid="4c7cdcab-edc2-4c67-a663-96d006d5eb1a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="202" data-match="32.5%" data-replace="32.5" data-pattern="$1" data-tag-index="4_10" data-time="" data-username="" data-userid="">32.5</named-content><named-content data-cid="1554366209" id="24820ebc-160f-4911-8527-01245961fb37" content-type="del cts-3" specific-use="1554366801168" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554366801168"> </named-content><named-content id="de40ca79-f1c6-46ad-865b-99161439ce68" data-cid="de40ca79-f1c6-46ad-865b-99161439ce68" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="206" data-match="32.5%" data-replace="%" data-pattern="%" data-tag-index="4_10" data-time="" data-username="" data-userid="">%</named-content> of the phakic eyes) developed cataract requiring surgical intervention. However, visually insignificant cataract progression was observed in another 259 phakic eyes (14.6%) which did not require surgical removal. A total of 727 eyes (26.5%) experienced an intraocular pressure (<named-content id="7eed4016-2147-46c9-b369-b0b1eff66c5f" data-cid="7eed4016-2147-46c9-b369-b0b1eff66c5f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="486" data-match=" (IOP)" data-pattern="" data-tag-index="4_13" data-time="" data-username="" data-userid="">IOP</named-content>) rise of<named-content id="a7997828-fe23-459a-a701-bdaf0c33e2a8" data-cid="a7997828-fe23-459a-a701-bdaf0c33e2a8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣&gt;' to '⍽&gt;'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="498" data-match="of &amp;gt;25 mmHg" data-replace=" &gt;" data-pattern=" $2" data-tag-index="4_3" data-track-change=" &amp;gt;" data-time="" data-username="" data-userid=""> &gt;</named-content><named-content data-cid="1554366206" id="8d9a0d81-7ce0-4b2e-b595-68ad3270b9aa" content-type="del cts-3" specific-use="1554366727375" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:02pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554366727375"> </named-content><named-content id="9925ac02-df46-4e0f-88bd-20006d30ba25" data-cid="9925ac02-df46-4e0f-88bd-20006d30ba25" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="500" data-match="of &amp;gt;25 mmHg" data-replace="25" data-pattern="$3" data-tag-index="4_3" data-time="" data-username="" data-userid="">25</named-content><named-content id="bc5a5379-0911-428a-b58a-e08c304f0ed2" data-cid="bc5a5379-0911-428a-b58a-e08c304f0ed2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmHg' to ' mmHg'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="502" data-match="of &amp;gt;25 mmHg" data-replace=" mmHg" data-pattern=" $6" data-tag-index="4_3" data-track-change=" mmHg" data-time="" data-username="" data-userid=""> mm<named-content data-cid="1554366207" id="f61d4336-75f8-44cd-b412-98e91dd20afa" content-type="ins cts-3" specific-use="1554366730292" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:02pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554366730292"> </named-content>Hg</named-content>, with 155 eyes (5.67%) having a prior history of glaucoma and 572 eyes (20.9%) having new onset IOP rise. Overall, more than <named-content id="23c2bbb7-699e-4926-aa0c-1152a302f75c" data-cid="23c2bbb7-699e-4926-aa0c-1152a302f75c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="633" data-match="90%" data-replace="90" data-pattern="$1" data-tag-index="4_11" data-time="" data-username="" data-userid="">90</named-content><named-content data-cid="1554366208" id="3f0e7eb9-3a51-467f-bd71-3ae6e8f6858b" content-type="del cts-3" specific-use="1554366764929" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:02pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554366764929"> </named-content><named-content id="bc536fbc-b6a7-4a66-aeca-2cba5fd899ad" data-cid="bc536fbc-b6a7-4a66-aeca-2cba5fd899ad" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="635" data-match="90%" data-replace="%" data-pattern="%" data-tag-index="4_11" data-time="" data-username="" data-userid="">%</named-content> of eyes with IOP rise were managed medically, and <named-content id="7a9062fc-680c-4723-a645-8f559bff809c" data-cid="7a9062fc-680c-4723-a645-8f559bff809c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="687" data-match="0.5%" data-replace="0.5" data-pattern="$1" data-tag-index="4_12" data-time="" data-username="" data-userid="">0.5</named-content><named-content data-cid="1554366212" id="e7bc5a9a-e58c-44a5-816a-b56c45e307d1" content-type="del cts-3" specific-use="1554366915215" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554366915215"> </named-content><named-content id="b894de09-b2b5-4d4f-84d9-c7c03dbeec65" data-cid="b894de09-b2b5-4d4f-84d9-c7c03dbeec65" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="690" data-match="0.5%" data-replace="%" data-pattern="%" data-tag-index="4_12" data-time="" data-username="" data-userid="">%</named-content> eyes required filtering surgery. Endophthalmitis (0.07%), retinal detachment (0.03%) and vitreous <named-content data-cid="1553859621055" id="a5b0dad5-c815-4c39-9f6b-85643ac37cd2" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">hemorrhage</named-content><named-content data-cid="1553859621055" id="9e9a33cb-58d6-4c65-9e5d-f7c3bb7c4aa3" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'hemorrhage' to 'haemorrhage'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="790" data-match="hemorrhage" data-replace="haemorrhage" data-pattern="haemorrhage" data-tag-index="4_20" data-function="addTrackChanges" data-track-change="hemorrhage" data-userid="preediting" data-username="Exeter" data-time="1553859621001">haemorrhage</named-content> (0.03%) were rare. There was no significant change in visual acuity (<named-content id="a6e0b640-b5d8-4e85-8703-0bbf0830d9a8" data-cid="a6e0b640-b5d8-4e85-8703-0bbf0830d9a8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="870" data-match="p=0.87" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="4_4" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content data-cid="1554366213" id="041ca86b-7ba7-4b3e-b0f1-2179d21c492b" content-type="del cts-3" specific-use="1554366992527" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554366992527"> </named-content><named-content id="59014af1-1bc3-4b94-b9be-cc6f303ba4f8" data-cid="59014af1-1bc3-4b94-b9be-cc6f303ba4f8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="871" data-match="p=0.87" data-replace="=" data-pattern="$2" data-tag-index="4_4" data-time="" data-username="" data-userid="">=</named-content><named-content data-cid="1554366214" id="5af6ff52-649e-49d9-9100-c108525ae077" content-type="del cts-3" specific-use="1554366993744" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554366993744"> </named-content><named-content id="fb175d04-e7f9-480c-a7c3-168f3b2a67c6" data-cid="fb175d04-e7f9-480c-a7c3-168f3b2a67c6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="872" data-match="p=0.87" data-replace="0.87" data-pattern="$3" data-tag-index="4_4" data-time="" data-username="" data-userid="">0.87</named-content>) and central macular thickness (<named-content id="49375071-63d2-4d27-b342-f190fe98272d" data-cid="49375071-63d2-4d27-b342-f190fe98272d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="909" data-match="p=0.12" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="4_5" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content data-cid="1554366215" id="261cb658-3410-4970-92d6-bfe085200779" content-type="del cts-3" specific-use="1554366998192" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554366998192"> </named-content><named-content id="9a6ce8aa-f03a-4c77-bf0b-61fa0f11dabe" data-cid="9a6ce8aa-f03a-4c77-bf0b-61fa0f11dabe" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="910" data-match="p=0.12" data-replace="=" data-pattern="$2" data-tag-index="4_5" data-time="" data-username="" data-userid="">=</named-content><named-content data-cid="1554366216" id="7a789490-b763-4125-8ca1-43bd88406acb" content-type="del cts-3" specific-use="1554366999887" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554366999887"> </named-content><named-content id="4864c00e-5728-4c4a-a457-58d963c8ab3f" data-cid="4864c00e-5728-4c4a-a457-58d963c8ab3f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="911" data-match="p=0.12" data-replace="0.12" data-pattern="$3" data-tag-index="4_5" data-time="" data-username="" data-userid="">0.12</named-content>) at the last <named-content data-cid="1553859621029" id="b56759f7-5004-42a5-8fa9-58a134766790" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow up</named-content><named-content data-cid="1553859621029" id="01ed5425-7f8c-429f-beb5-6ebba20d6288" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="929" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="4_18" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow-up</named-content>.</p><title data-level="2" id="dc2a0049-4c30-4af1-9ff7-744ee84111a5">Conclusion<named-content data-cid="1553859621003" id="a044e001-a127-410b-be52-539f9944df8c" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">:</named-content></title><p id="1201069f-6e6a-4231-b137-268193658ba1">This is the largest real-life study assessing the safety of intravitreal dexamethasone implant injections in various retinal conditions. Cataract progression and intraocular pressure rise are the most common side effects<named-content data-cid="1554366217" id="dca6c458-32be-44bc-ad2c-49124f8a8a7a" content-type="ins cts-3" specific-use="1554367030966" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554367030966">,</named-content> but are often rather easily manageable.</p> </abstract><kwd-group id="0925d23d-8cae-4783-9984-978122d8307d"><kwd id="ddb7c8e5-1088-4b6b-9c0f-d9e396420176">drugs</kwd><kwd id="083bc326-bc30-40ff-8632-af6224b0f24e">treatment medical</kwd><kwd id="d26208d4-9711-48ba-b8ef-9124225d20e1">vitreous</kwd><kwd id="e9623060-7248-4474-a008-221bd8301887">vision</kwd></kwd-group><funding-group id="7eaeb8d9-1aac-4729-b18d-ae02b0f4a79a"><funding-statement data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'addDataTempSelector', 'param' : {'component' : 'jrnlFN'}}" data-ele-type="funding-statement" fn-type="funding" data-label="Funding" data-track="ins" data-cid="1553861970864" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553861970864" data-title="Inserted by Pradheep (PREEDITOR) - Mar 29 2019 5:49pm" id="a60725ae-38a8-4574-8ec6-f35417e965c9">The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.</funding-statement></funding-group><custom-meta-group id="75b05ff6-f5f8-4a7d-813d-9cf2486b7184"><custom-meta id="48738e59-35cf-4e44-9e30-cd6705007002"><meta-name id="001f2b7b-572b-40ef-b3d9-9fc8ee956aaa">Copy editing requirement</meta-name><meta-value id="05975c54-0b35-4743-ab33-9dbfc481567d">2</meta-value></custom-meta><custom-meta id="bbd02364-a2c6-41d6-a4cf-38f6669a8e0a"><meta-name id="00ab2cd0-bc55-42b4-91b0-9858c9e91109">Author requirement</meta-name><meta-value id="cb571480-fc7e-4576-b613-0a7602e473b9">2</meta-value></custom-meta><custom-meta id="aeb05dbe-4d89-407d-8b67-81e79f56dada"><meta-name id="91a53254-3120-4ce6-bfa5-673cfa98c077">payment method</meta-name><meta-value holdtype="NoHold" id="15ee983e-84c6-4175-97c1-aeaa5846404d">No APC</meta-value></custom-meta><custom-meta id="b7cf41e5-baac-4082-ad02-1833592873aa"><meta-name id="4033dec8-7195-44dd-92b5-95d69b02216f">license type</meta-name><meta-value id="17a90e59-72f0-431a-8c62-692796e6c095">nonOA</meta-value></custom-meta><custom-meta id="10269bcb-7ffa-4171-866f-9f0402776541"><meta-name id="b91b320f-3212-437a-9d7f-18b3d6bcf781">Spelling language</meta-name><meta-value id="c33f50e1-fc50-4a9d-897f-df382de1bfef">en-GB</meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="1553859621114" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="Exeter Pre-editing" specific-use="Mar 29 2019 (17:10)" content-type="Author" alt="preeditor">Corrections at this stage should be limited to those that are essential. Extensive corrections will delay the time to publication and may also have to be approved by the Editor. Changes can not be made after the article has published online. Please acknowledge that you have read this message.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (10:44)" content-type="answered" alt="author" data-replied-stage="">yes</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="1553859621115" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="Exeter Pre-editing" specific-use="Mar 29 2019 (17:10)" content-type="Author" alt="preeditor">Please confirm that the section headings are correct.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (10:47)" content-type="answered" alt="author" data-replied-stage="">Yes<div id="40ded303-e3fe-4d58-b4c6-a1894e29b345"><break/></div></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="e9b27604-8f6f-43c8-939b-100be6518b4d" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 4 2019 2:37 PM" content-type="Author" alt="copyeditor">Please check if expansion for BCVA is correct.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (10:47)" content-type="answered" alt="author" data-replied-stage="">yes</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="90ef9aeb-207e-4033-9ffa-5af4cd076596" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 4 2019 2:53 PM" content-type="Author" alt="copyeditor">Please provide expansion for ERM.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (10:48)" content-type="answered" alt="author" data-replied-stage="">Epiretinal membrane</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="36c7736e-b528-44f1-a188-456ee0aa19d5" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 4 2019 2:55 PM" content-type="Author" alt="copyeditor">Please provide expansion for CNV.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (10:48)" content-type="answered" alt="author" data-replied-stage="">choroidal neovascularization</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="c9275d62-57bc-43f9-8340-8d0f83b5a792" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 4 2019 3:36 PM" content-type="Author" alt="copyeditor">Please check whether author name (ie Haller et al) should be included before GENEVA.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (10:49)" content-type="answered" alt="author" data-replied-stage="">This is okay</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="5f09a7f0-e5db-4ed9-9e5f-2b8fbeda4aa4" xlink:type="action" data-type="action" data-replied="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 4 2019 3:44 PM" content-type="Typesetter" alt="copyeditor">Reference citation does not match with the author name and reference for author name 'Li' also not found. Kindly check.</named-content><named-content xlink:title="Gowtham Ram (TYPESETTER)" specific-use="Apr 6 2019 (11:31)" content-type="reply" alt="typesetter" data-replied-stage="">ok</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="88c9a2a3-a5e6-4f9e-8a5c-a27bf6a8aaff" xlink:type="action" data-type="action" data-replied="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 4 2019 3:44 PM" content-type="Typesetter" alt="copyeditor">Reference citation does not match with the author name and reference forauthor name ‘Eter’ also not found. Kindly check.</named-content><named-content xlink:title="Gowtham Ram (TYPESETTER)" specific-use="Apr 6 2019 (11:31)" content-type="reply" alt="typesetter" data-replied-stage="">ok</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="0f811813-c9a9-4802-ab00-ba8b546daa37" xlink:type="action" data-type="action" data-replied="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 4 2019 3:47 PM" content-type="Typesetter" alt="copyeditor">Reference citation is incorrect. Please check.</named-content><named-content xlink:title="Gowtham Ram (TYPESETTER)" specific-use="Apr 6 2019 (11:31)" content-type="reply" alt="typesetter" data-replied-stage="">ok</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="d7a6b4ba-c006-4fec-885c-138133f61121" xlink:type="action" data-type="action" data-replied="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 4 2019 3:48 PM" content-type="Typesetter" alt="copyeditor">Reference citation is incorrect. Please check.</named-content><named-content xlink:title="Gowtham Ram (TYPESETTER)" specific-use="Apr 6 2019 (11:32)" content-type="reply" alt="typesetter" data-replied-stage="">ok</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="734d202f-3f65-4af2-828e-95beaa6f1a82" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 4 2019 3:54 PM" content-type="Author" alt="copyeditor">Please check expansion for DME, RVO, RD, BRVO and CRVO are correct.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (10:48)" content-type="answered" alt="author" data-replied-stage="">yes</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="25610cd7-15ef-4687-b4ee-31f17f10dbd3" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 4 2019 3:54 PM" content-type="Author" alt="copyeditor">Please provide expansion for SLT.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (10:48)" content-type="answered" alt="author" data-replied-stage=""><a href="https://www.glaucoma.org/treatment/selective-laser-trabeculoplasty-10-commonly-asked-questions.php" ping="/url?sa=t&amp;source=web&amp;rct=j&amp;url=https://www.glaucoma.org/treatment/selective-laser-trabeculoplasty-10-commonly-asked-questions.php&amp;ved=2ahUKEwjBmufE37_hAhV563MBHaZZCTgQFjAAegQIAxAB" id="dbdf3337-0e23-458c-8651-f3b5dd63fcbe">Selective Laser Trabeculoplasty</a></named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="bd72e454-f2e1-424f-9267-51cbbc24b27b" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 4 2019 4:01 PM" content-type="Author" alt="copyeditor">Please provide expansion for IVD and RBZ.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (10:50)" content-type="answered" alt="author" data-replied-stage="">intravitreal dexamethasone and ranibizumab</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="4cc3abd0-588f-490e-9c92-7c2bd4663d20" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 4 2019 4:17 PM" content-type="Author" alt="copyeditor">Please check author name. No reference available for 'Li'.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (11:54)" content-type="answered" alt="author" data-replied-stage="">Reference 27 has been replaced, so this is correct now. </named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="5ba0b675-4149-42d9-a8b8-605e6b61dbe0" xlink:type="action" data-type="action"><meta-value><named-content xlink:title="Sabari (PREEDITOR)" specific-use="Sep 19 2019 10:03 AM" content-type="Author" alt="preeditor">Need to delete this query in automation</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="679bcd7c-c4d5-4d63-ad2a-10828f446518" xlink:type="action" data-type="action"><meta-value><named-content xlink:title="Sabari (PREEDITOR)" specific-use="Sep 17 2019 2:42 PM" content-type="Typesetter" alt="preeditor">Query to TS</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="b38e040b-f359-4341-80e4-6096a35f6f55" xlink:type="action" data-type="action"><meta-value><named-content xlink:title="Sabari (PREEDITOR)" specific-use="Sep 17 2019 2:40 PM" content-type="Author" alt="preeditor">query to author</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="29c2ea1c-e813-4899-8b0e-a5580773b1ba" xlink:type="action" data-type="action"><meta-value><named-content xlink:title="Sabari (PREEDITOR)" specific-use="Sep 17 2019 2:40 PM" content-type="Publisher" alt="preeditor">Query to publisher</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="b12f3f73-8c91-4a70-a92b-d6d6ba29d106" xlink:type="action" data-type="action" data-replied="true"><meta-value><named-content xlink:title="Eleanor (BMJ)" specific-use="Apr 17 2019 3:19 PM" content-type="Typesetter" alt="publisher">Exeter the formatting of SLT in the PDF verison is incorrect. I cannot fix this in Kriya.</named-content><named-content xlink:title="Anushya (TYPESETTER)" specific-use="Apr 18 2019 (10:53)" content-type="reply" alt="typesetter" data-replied-stage="">Done</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="0971378c-b413-427b-9dbc-7ce1501848d9" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="Gowtham Ram (TYPESETTER)" specific-use="Apr 6 2019 11:32 AM" content-type="Author" alt="typesetter">Reference citation does not match with the author name in the reference list for these names 'Li and Eter N' also not found. Kindly check.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (11:59)" content-type="answered" alt="author" data-replied-stage="">Reference 27 has been replaced, so this is correct now. </named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="2dbaf59a-17f0-4046-9ac6-422722a9f598" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 5 2019 8:18 AM" content-type="Author" alt="copyeditor">Kindly check if journal names and years mentioned with reference could be removed to avoid repetition.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (10:49)" content-type="answered" alt="author" data-replied-stage="">Okay</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="5ef9e0f2-4347-4005-871c-12bd052e446c" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="B020-Baburaj (COPYEDITOR)" specific-use="Apr 5 2019 8:23 AM" content-type="Author" alt="copyeditor">Please check if the expansion is correct.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (10:47)" content-type="answered" alt="author" data-replied-stage="">yes</named-content></meta-value></custom-meta><custom-meta xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="query" id="faaeb583-6ee3-4bb9-a7b3-603b5b1fdc90" xlink:type="action" data-type="action" data-answered="true"><meta-value><named-content xlink:title="Pradheep (PREEDITOR)" specific-use="Mar 29 2019 5:21 PM" content-type="Author" alt="preeditor">Please provide Department, Institution For this affiliation 8.</named-content><named-content xlink:title="Jay Chhablani (AUTHOR)" specific-use="Apr 8 2019 (10:47)" content-type="answered" alt="author" data-replied-stage="">This is correct, please accept</named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="c307ee8f-6a07-44e6-a909-cdaad9f68c33" xlink:title="R28" xlink:actuate="3056793852" xlink:role="author" xlink:href="dba106dd-3b91-4ff4-baef-507c8af57241"><meta-value id="bfb2e345-7840-4d18-9e73-8d120b71f3ed"><named-content specific-use="historyContent" data-title="" id="72a0a871-0761-42c2-9bae-67bab89d2c2c"><named-content specific-use="change-person" data-title="" id="aba2a001-218a-4c3e-ae19-dc66fa64c468">Jay Chhablani</named-content> <named-content specific-use="" data-title="" id="ff0ba405-478d-450c-b4fa-f9e787eeaa30">changed</named-content> <named-content specific-use="oldVal" data-title="10.1007/s00417-016-3559-8" id="28b85e4f-89f6-4fce-be81-c77092701e6c">10.1007/s00417-016-3559-8</named-content> <named-content specific-use="" data-title="" id="99367228-d538-4488-8484-00428f0d1c0c">to</named-content> <named-content specific-use="newVal" data-title="10.1007/s00417-016-3431-x" id="20fe6071-6990-4a72-8500-dcec34436234">10.1007/s00417-016-3431-x</named-content> <named-content specific-use="" data-title="" id="f7101b83-acac-42c3-898d-d483752c0dbb"> in DOI field on</named-content> <named-content specific-use="change-time" data-title="" id="799caa2b-68f2-44af-b81c-b553ae4b86dc">8 Apr 2019 12:02 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="3df26d77-b3b6-415c-b542-69db3bf77a9e" xlink:title="R28" xlink:actuate="3056793852" xlink:role="author" xlink:href="3fe39dea-a69c-4a4d-851c-a91a7c943305"><meta-value id="5f3d267d-db0c-45af-95f9-01c1f4441554"><named-content specific-use="historyContent" data-title="" id="9da62b4f-91f2-4d80-a904-ffe1453df39a"><named-content specific-use="change-person" data-title="" id="4715edd1-d177-4655-af22-d8699b0a3a9b">Jay Chhablani</named-content> <named-content specific-use="" data-title="" id="472572fd-acc7-4577-91d1-fcda1df9ff7b">changed</named-content> <named-content specific-use="oldVal" data-title="" id="e91705ca-14bd-4249-971f-7b8e76b362c7">8</named-content> <named-content specific-use="" data-title="" id="848b4f14-5520-458b-85bc-7ad3d0f774a5">to</named-content> <named-content specific-use="newVal" data-title="" id="b743dadd-22f7-4bdc-aafe-9a300e3e1806">87</named-content> <named-content specific-use="" data-title="" id="8da76b77-3173-4ae9-a25b-4670176e66ee"> in Last page field on</named-content> <named-content specific-use="change-time" data-title="" id="7b2cc833-1740-4519-b94b-7623cbf8cb78">8 Apr 2019 12:02 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="b9a48e2a-db7e-49f2-80f5-843202415d3d" xlink:title="R28" xlink:actuate="3056793852" xlink:role="author" xlink:href="5a706cd0-3e53-45b2-902a-c8900a3c0c60"><meta-value id="d6d40dcc-1368-4f95-8afa-7c566efa5e1f"><named-content specific-use="historyContent" data-title="" id="21209369-fe9e-49ba-bbcd-52d0855d9e2d"><named-content specific-use="change-person" data-title="" id="8d139eba-7555-4952-86ff-52f5cd9f8507">Jay Chhablani</named-content> <named-content specific-use="" data-title="" id="35f0681b-3f56-46ca-b6bc-f3ae44f650da">changed</named-content> <named-content specific-use="oldVal" data-title="" id="319b7811-5a4e-4c6a-813b-16edcbb2923f">427</named-content> <named-content specific-use="" data-title="" id="4f49c654-8867-4361-87af-85121f4234f8">to</named-content> <named-content specific-use="newVal" data-title="" id="e6f3181c-dd7e-48fd-8db9-3161220e9eb7">77</named-content> <named-content specific-use="" data-title="" id="b11dc1c3-d82f-4bc8-a6f9-80099cf039c8"> in First Page field on</named-content> <named-content specific-use="change-time" data-title="" id="cdbead13-158e-4732-9b4c-44936bb521b1">8 Apr 2019 12:02 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="51ec9da0-75f3-4885-8fda-d277fce0701a" xlink:title="R27" xlink:actuate="3056793852" xlink:role="author" xlink:href="d24c55a8-cb78-446a-a01e-d5d42165c419"><meta-value id="e23e80a8-b0e9-4fa6-9d3e-6488aedcc767"><named-content specific-use="historyContent" data-title="" id="6810dc92-7866-4303-a079-5c8a59a1b101"><named-content specific-use="change-person" data-title="" id="69e70d20-c979-4a55-a063-67aa964ccca7">Jay Chhablani</named-content> <named-content specific-use="" data-title="" id="4b1821b0-e4e5-4fb7-9abe-55f9d28cdd65">changed</named-content> <named-content specific-use="oldVal" data-title="10.1007/s00417-018-3918-8" id="ac717686-3264-409d-b487-7e78a390062e">10.1007/s00417-018-3918-8</named-content> <named-content specific-use="" data-title="" id="39ca7f74-224b-4604-a0fb-c7fe2081a6d5">to</named-content> <named-content specific-use="newVal" data-title="10.1007/s00417-017-3831-6" id="16baa171-e760-4aa4-bd36-b589a2de8057">10.1007/s00417-017-3831-6</named-content> <named-content specific-use="" data-title="" id="851698b3-35f7-412f-9e94-bc812fec8ff2"> in DOI field on</named-content> <named-content specific-use="change-time" data-title="" id="c21bfbe3-54ed-488e-9bd1-475f17204937">8 Apr 2019 11:59 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="36fd07c3-543b-4323-8f60-63a1c84ae273" xlink:title="R27" xlink:actuate="3056793852" xlink:role="author" xlink:href="8aa8b432-2757-4491-913c-219b033265de"><meta-value id="ceddf346-f868-487c-9033-e6f852b4d470"><named-content specific-use="historyContent" data-title="" id="f5ca89c2-d9a9-4402-8fc2-bbf686ddac3d"><named-content specific-use="change-person" data-title="" id="8b5dd4d4-d9c8-4856-8878-3382279c2867">Jay Chhablani</named-content> <named-content specific-use="" data-title="" id="5b8dcbfc-a8ad-4275-8158-6198612755d0">changed</named-content> <named-content specific-use="oldVal" data-title="" id="9e80bd89-c9b2-4bc5-9407-e16b47c2e2ec">10</named-content> <named-content specific-use="" data-title="" id="3fbfef98-15ab-4226-bd11-8294236c5a86">to</named-content> <named-content specific-use="newVal" data-title="" id="c8e17a7b-0e94-4b53-ba5c-0b31ab1a6819">69</named-content> <named-content specific-use="" data-title="" id="265e3830-d6ab-437e-ab55-093a05c8aa48"> in Last page field on</named-content> <named-content specific-use="change-time" data-title="" id="9bde6140-6fd3-4586-8d5f-96e4b9d34668">8 Apr 2019 11:59 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="ea25d31c-e61f-49d5-a2d3-4c046d406af6" xlink:title="R27" xlink:actuate="3056793852" xlink:role="author" xlink:href="088023e5-03bc-49ce-95f8-cb91ea395d25"><meta-value id="2cfd100c-000d-40bd-947b-2c8657a04386"><named-content specific-use="historyContent" data-title="" id="2414e216-9be1-4d93-959e-a0e27dcc96ea"><named-content specific-use="change-person" data-title="" id="5104fbb4-7744-418d-8cfe-000a8be970fd">Jay Chhablani</named-content> <named-content specific-use="" data-title="" id="d3e92dce-d711-47f6-902c-b061618dae19">changed</named-content> <named-content specific-use="oldVal" data-title="" id="592206ed-615f-4e17-8f6c-99add0e7c7a7">1209</named-content> <named-content specific-use="" data-title="" id="058bd6d2-03dd-431b-ae88-8291c51a5106">to</named-content> <named-content specific-use="newVal" data-title="" id="46717983-8c26-4a46-85d2-dfc7c97009c7">59</named-content> <named-content specific-use="" data-title="" id="3406af4e-2b7f-424d-b7df-2af42b393107"> in First Page field on</named-content> <named-content specific-use="change-time" data-title="" id="3f496ab1-7c10-40f7-958a-2ce9bfa37bec">8 Apr 2019 11:59 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="d1b05038-d509-4d97-becc-98d4215fc1e3" xlink:title="aff8" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="f35be65d-1d1e-4b5f-a573-93946be161de"><meta-value id="9661979c-4e6e-4599-aff3-6a9bc68373ec"><named-content specific-use="historyContent" data-title="" id="c59e65f2-df41-4f1f-bf31-b3fd11536aed"><named-content specific-use="change-person" data-title="" id="941a6ac9-33c3-42a2-8e17-cbc537398f5d">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="ed9a823a-db50-4141-80da-a5b34a125b36">inserted</named-content> <named-content specific-use="newVal" data-title="University of Udine" id="76919625-bdfe-412a-9416-ebd8af46fa8f">University of Udine</named-content> <named-content specific-use="" data-title="" id="f18c1ae4-2aa9-46c5-9953-a269a521d83b"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="7ef53167-d1fe-438f-844e-4562d06c2b95">6 Apr 2019 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="eefab13c-972b-4655-abab-2000f2a56f22" xlink:title="aff8" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="13074515-73bb-48be-b58c-28fe254416e6"><meta-value id="2167e963-6341-4113-b3b0-e4329c7bdb36"><named-content specific-use="historyContent" data-title="" id="a3a15321-c611-4ea5-aa71-04650025ec3a"><named-content specific-use="change-person" data-title="" id="32d7e750-b2a0-4159-b8bf-8e5af586a902">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="7b29271d-8eab-41f8-88d5-7f7a05b12cb0">inserted</named-content> <named-content specific-use="newVal" data-title="Department of Medicine-Ophthalmology" id="514445dd-3a43-4263-8b9b-f5ef0f78200b">Department of Medicine-Ophthalmology</named-content> <named-content specific-use="" data-title="" id="31887210-263b-4adb-a44c-ababa8543ec5"> in Department field on</named-content> <named-content specific-use="change-time" data-title="" id="a3b9eec5-b130-42c6-a8e6-945c9ea17180">6 Apr 2019 11:42 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="c44a8112-8e24-4d9d-8ff6-d29763fb1dd3" xlink:title="aff16" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="b7c96a78-6f9c-43b9-beec-4173f274c974"><meta-value id="26335f28-4a89-4a4e-91bc-2b42416e7052"><named-content specific-use="historyContent" data-title="" id="7b330a1d-ff7e-47d2-85c1-b7e2a8019a42"><named-content specific-use="change-person" data-title="" id="92ac6f3f-a290-4ab3-8b98-33a8993065ee">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="938d3c94-7873-4381-86f0-98ef09981bca">changed</named-content> <named-content specific-use="oldVal" data-title="Croix-Rousse UNIVERSITY HOSPITAL, Hospices Civils de Lyon" id="ce7b73f1-2af9-488a-a67f-954461aa9787">Croix-Rousse UNIVERSITY HOSPITAL, Hospices Civils de Lyon</named-content> <named-content specific-use="" data-title="" id="029b25cf-f2c8-455a-a6fb-65b14bc12fa2">to</named-content> <named-content specific-use="newVal" data-title="Croix-Rousse University Hospital, Hospices Civils de Lyon" id="e41dfa0b-1f3b-44b5-b1f8-a8dd96af3bf4">Croix-Rousse University Hospital, Hospices Civils de Lyon</named-content> <named-content specific-use="" data-title="" id="fd7cedcb-6b96-4ac9-9986-ae50b6e4323e"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="cb654ace-bc6a-4693-a3b7-316ce4cc78c1">6 Apr 2019 11:41 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="36c10218-bfcc-4d10-aaf5-926fbe596620" xlink:title="aff1" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="f15b17dd-13c0-4685-bc96-195a65333251"><meta-value id="da10e561-0afd-4d81-ab3f-3d1e12ca5ea1"><named-content specific-use="historyContent" data-title="" id="12939d80-bd81-4a6c-813d-4a223b4745f7"><named-content specific-use="change-person" data-title="" id="f5441201-402b-482a-98f2-edfc60429ff1">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="e89c95c9-57f7-463f-8c83-b125aada6612">changed</named-content> <named-content specific-use="oldVal" data-title="1 Khoo Teck Puat Hospital, 90 Yishun Central, Singapore 768828" id="effa5469-c7f3-4957-a02e-af2bf9a74550">1 Khoo Teck Puat Hospital, 90 Yishun Central, Singapore 768828</named-content> <named-content specific-use="" data-title="" id="7ad9c6c6-fb16-4115-95e8-34826f9d8d51">to</named-content> <named-content specific-use="newVal" data-title="Khoo Teck Puat Hospital" id="8f5c3344-e9b7-4f1d-ae56-8153655fde0e">Khoo Teck Puat Hospital</named-content> <named-content specific-use="" data-title="" id="83077b13-71fb-4199-b640-28f5ed5471b7"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="9783f886-47b7-45e9-b295-fe0aa2724516">6 Apr 2019 11:41 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="bd0cbcf9-acf0-42c7-b801-01ec1a77e0a6" xlink:title="pubData" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="204f9638-3e47-4001-84cf-240050080dd1"><meta-value id="611115ac-7f47-4593-b7a9-b8fd67a3d5f4"><named-content specific-use="historyContent" data-title="" id="833b890a-a49e-4e8c-a883-71e7edb5c3f9"><named-content specific-use="change-person" data-title="" id="b6fb6066-a710-49e8-9bd6-939beb9f0106">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="ac1de6af-70b6-4f5c-aaeb-b553739d5d35">inserted</named-content> <named-content specific-use="newVal" data-title="" id="8b8b6936-71e6-42f1-a0f1-31a06b7581d6">0</named-content> <named-content specific-use="" data-title="" id="ac19c451-2725-4e36-b5f7-51480ca647e3"> in Volume field on</named-content> <named-content specific-use="change-time" data-title="" id="1e968467-837f-490d-8b72-61acc98d3af9">6 Apr 2019 11:10 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="41d072ca-48be-4497-887e-c634763c6e4e" xlink:title="fn1" xlink:actuate="8576948431" xlink:role="copyeditor" xlink:href="fn1"><meta-value id="731d7bd4-b352-4f40-991b-4b86236e4d13"><named-content specific-use="historyContent" data-title="" id="ea591799-4929-4a14-bc61-05e5159fd07b"><named-content specific-use="change-person" data-title="" id="940f146a-b088-4776-a5ec-2fddb34d850e">B020-Baburaj</named-content> <named-content specific-use="" data-title="" id="6ef19fa6-9ef2-4e23-819e-7a1e244caa6c">changed</named-content> <named-content specific-use="oldVal" data-title="All persons designated as authors qualify for authorship, and all those who qualify are listed. Each author has participated sufficiently in the work to take public responsibility for appropriate portions of the content. Design: JC Conduct of the study: JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC." id="1c11726d-0047-41e4-a509-216473daa3a4">All persons designated as authors qualify for authorship, and all those who qualify are listed. Each author has participated sufficiently in the work to take public responsibility for appropriate portions of the content. Design: JC Conduct of the study: JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC.</named-content> <named-content specific-use="" data-title="" id="779b0e65-2df6-4926-933f-d7b299cc231e">to</named-content> <named-content specific-use="newVal" data-title="All persons designated as authors qualify for authorship, and all those who qualify are listed. Each author has participated sufficiently in the work to take public responsibility for appropriate portions of the content. Design: JC. Conduct of the study: JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC. Collection: JZV, AF, CB, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC. Management: BR, JC. Analysis: BR, NKS, JC. Interpretation of the data: BR, NKS, JC. Preparation: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC. Review: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC. Approval of the manuscript: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC." id="e40034a3-8ebc-4776-b257-73c6d6401234">All persons designated as authors qualify for authorship, and all those who qualify are listed. Each author has participated sufficiently in the work to take public responsibility for appropriate portions of the content. Design: JC. Conduct of the study: JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC. Collection: JZV, AF, CB, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC. Management: BR, JC. Analysis: BR, NKS, JC. Interpretation of the data: BR, NKS, JC. Preparation: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC. Review: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC. Approval of the manuscript: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC.</named-content> <named-content specific-use="" data-title="" id="9c6096dd-ca06-4e75-91d6-95e6ce0f6579"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="077bd636-54d9-4b81-a7cc-0437bf50e8f8">4 Apr 2019 4:22 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="f5e608d0-ee4e-4837-8855-5f941a3c7880" xlink:title="aff9" xlink:actuate="8576948431" xlink:role="copyeditor" xlink:href="c890f1c3-8da8-45a8-ac49-68130de75fa4"><meta-value id="599c967d-6e5d-431a-b071-a601f365cf18"><named-content specific-use="historyContent" data-title="" id="08e5d02f-8759-45da-87a9-f2c2a81434c0"><named-content specific-use="change-person" data-title="" id="fc835e96-121a-4f5a-8719-71a3aabde4dd">B020-Baburaj</named-content> <named-content specific-use="" data-title="" id="4579c96d-95b0-4f80-b706-1797141e77f4">changed</named-content> <named-content specific-use="oldVal" data-title="11 Department of Ophthalmology Command hospital" id="334fe8a6-5008-41fa-9a11-9474a2eed41f">11 Department of Ophthalmology Command hospital</named-content> <named-content specific-use="" data-title="" id="bf28f8ba-b534-4cf6-9089-e6e314d210cc">to</named-content> <named-content specific-use="newVal" data-title="11 Department of Ophthalmology, Command Hospital" id="71106dc4-88fa-45e9-ba19-762cf0c49c18">11 Department of Ophthalmology, Command Hospital</named-content> <named-content specific-use="" data-title="" id="ce034090-b101-4a48-98c0-a57f59bc5793"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="d3011cb8-d62b-4f87-9897-2dcf2917fb80">4 Apr 2019 1:56 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="9979a02a-48bd-47a4-9419-a0bdd44a2b99" xlink:title="aff1" xlink:actuate="8576948431" xlink:role="copyeditor" xlink:href="f15b17dd-13c0-4685-bc96-195a65333251"><meta-value id="ba7eb268-aa85-4a8d-86fd-2e0e5b51ca0e"><named-content specific-use="historyContent" data-title="" id="5bfe68de-1050-4d7c-8ce6-d9ed21ca43c1"><named-content specific-use="change-person" data-title="" id="88859be4-470f-4af4-9cd8-1256128f9392">B020-Baburaj</named-content> <named-content specific-use="" data-title="" id="ab8d6db2-66a3-494f-9100-4669cda9fbb1">changed</named-content> <named-content specific-use="oldVal" data-title="1 Khoo Teck Puat Hospital, 90 Yishun central, Singapore 768828" id="8f80ec9b-aed3-458d-a550-54e0e6e0b86e">1 Khoo Teck Puat Hospital, 90 Yishun central, Singapore 768828</named-content> <named-content specific-use="" data-title="" id="c899575e-d474-41a1-a471-1216997e0348">to</named-content> <named-content specific-use="newVal" data-title="1 Khoo Teck Puat Hospital, 90 Yishun Central, Singapore 768828" id="f039a4ab-9ff1-443f-a4f3-820fd768a836">1 Khoo Teck Puat Hospital, 90 Yishun Central, Singapore 768828</named-content> <named-content specific-use="" data-title="" id="8092ab3f-dc8d-40e3-af91-367592c1dfb7"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="763c4802-03b0-4a62-9799-d04aa3da6c72">4 Apr 2019 1:55 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="9b368e13-29dc-425e-aa4c-d2d0d50e50bf" xlink:title="fn1" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="fn1"><meta-value id="f48cff25-724a-4627-ac82-66ef1d6a5e65"><named-content specific-use="historyContent" data-title="" id="b3571430-c7ae-4066-a4cb-72fd2ae9ef74"><named-content specific-use="change-person" data-title="" id="594b45f1-1402-4aa5-bfdc-4d6ccd6fff13">Pradheep</named-content> <named-content specific-use="" data-title="" id="7228427e-2aa4-4c98-bfba-b4a0b69fac0f">changed</named-content> <named-content specific-use="oldVal" data-title="Design: JC Conduct of the study: JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC." id="10fd3187-3fdc-4197-b9c8-da3d071be9d8">Design: JC Conduct of the study: JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC.</named-content> <named-content specific-use="" data-title="" id="5185d933-5c67-48b5-8b49-bf7a81de9303">to</named-content> <named-content specific-use="newVal" data-title="All persons designated as authors qualify for authorship, and all those who qualify are listed. Each author has participated sufficiently in the work to take public responsibility for appropriate portions of the content. Design: JC Conduct of the study: JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC." id="1788a2ee-9d3f-40a8-a35b-2269c3db9cc4">All persons designated as authors qualify for authorship, and all those who qualify are listed. Each author has participated sufficiently in the work to take public responsibility for appropriate portions of the content. Design: JC Conduct of the study: JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC.</named-content> <named-content specific-use="" data-title="" id="0b7a4ec6-1d3d-453e-a035-9005263c7d3d"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="275606c8-65c5-4d0b-830e-ca7b4b9969ec">30 Mar 2019 2:32 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="58af13e0-d454-4858-94c4-6789bb74578f" xlink:title="fn2" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="fn2"><meta-value id="df3b3d37-e5e9-4931-b082-8681fd5549a7"><named-content specific-use="historyContent" data-title="" id="df3c2e29-5813-4213-9678-7d45f859bdc9"><named-content specific-use="change-person" data-title="" id="1901cb06-535a-4220-8da0-d514c37e738a">Pradheep</named-content> <named-content specific-use="" data-title="" id="fe7f4bdc-7cd0-4fea-a129-8825940a5bed">changed</named-content> <named-content specific-use="oldVal" data-title="Bindu Rajesh: None Javier Zarranz-Ventura: Allergan (Consultant); Bayer (Consultant); Adrian Fung: Allergan (Consultant); Bayer (Consultant); Catharina Busch: Allergan (Consultant); Bayer (Travel support); Novartis (Consultant) Niroj Kumar Sahoo: None Patricio J. Rodríguez-Valdés: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia Valentina Sarao: None S. K. Mishra: None Osman Saatci: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant) Patricia Udaondo Mirete: Bayer (Consultant); Centervue (Consultant); Novartis (Consultant) Giuseppe Querques: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia. Michel Eid Farah: None Paolo Lanzetta: Alcon (Consultant); Alimera (Consultant); Allergan (Consultant); Bausch&amp;Lomb (Consultant); Bayer (Consultant); Boehringer (Consultant); CenterVue (Consultant); Genentech (Consultant); Lupin (Consultant); Lutronic (Consultant); Novartis Pharma AG (Consultant); Roche (Consultant); Teva (Consultant); Topcon (Consultant) J. Fernando Arevalo: TURING PHARMACEUTICALS LLC(Consultant); DORC International B.V. (Consultant); Allergan Inc. (Consultant); Bayer (Consultant); Mallinckrodt (Consultant); TOPCON (Grant Support) Laurent Kodjikian: Principal Investigator for trials sponsored by Novartis, Allergan, Bayer, Théa, Alcon; has sat on advisory boards for Alcon, Alimera, Allergan, Bayer, Roche, Novartis; lecture fees from Alcon, Alimera, Allergan, Bayer, Horus, Novartis, Théa. Jay Chhablani: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant); OD-OS (Consultant)." id="bfd533e7-39b8-464b-80f6-8541b331490d">Bindu Rajesh: None Javier Zarranz-Ventura: Allergan (Consultant); Bayer (Consultant); Adrian Fung: Allergan (Consultant); Bayer (Consultant); Catharina Busch: Allergan (Consultant); Bayer (Travel support); Novartis (Consultant) Niroj Kumar Sahoo: None Patricio J. Rodríguez-Valdés: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia Valentina Sarao: None S. K. Mishra: None Osman Saatci: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant) Patricia Udaondo Mirete: Bayer (Consultant); Centervue (Consultant); Novartis (Consultant) Giuseppe Querques: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia. Michel Eid Farah: None Paolo Lanzetta: Alcon (Consultant); Alimera (Consultant); Allergan (Consultant); Bausch&amp;Lomb (Consultant); Bayer (Consultant); Boehringer (Consultant); CenterVue (Consultant); Genentech (Consultant); Lupin (Consultant); Lutronic (Consultant); Novartis Pharma AG (Consultant); Roche (Consultant); Teva (Consultant); Topcon (Consultant) J. Fernando Arevalo: TURING PHARMACEUTICALS LLC(Consultant); DORC International B.V. (Consultant); Allergan Inc. (Consultant); Bayer (Consultant); Mallinckrodt (Consultant); TOPCON (Grant Support) Laurent Kodjikian: Principal Investigator for trials sponsored by Novartis, Allergan, Bayer, Théa, Alcon; has sat on advisory boards for Alcon, Alimera, Allergan, Bayer, Roche, Novartis; lecture fees from Alcon, Alimera, Allergan, Bayer, Horus, Novartis, Théa. Jay Chhablani: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant); OD-OS (Consultant).</named-content> <named-content specific-use="" data-title="" id="56a76be2-5418-46e8-8e63-417191c9cde8">to</named-content> <named-content specific-use="newVal" data-title="BR: None JZ-V: Allergan (Consultant); Bayer (Consultant); ATF: Allergan (Consultant); Bayer (Consultant); CB: Allergan (Consultant); Bayer (Travel support); Novartis (Consultant) NKS: None PJR-V: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia VS: None SKM: None AOS: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant) PUM: Bayer (Consultant); Centervue (Consultant); Novartis (Consultant) GQ: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia. MEF: None PL: Alcon (Consultant); Alimera (Consultant); Allergan (Consultant); Bausch&amp;Lomb (Consultant); Bayer (Consultant); Boehringer (Consultant); CenterVue (Consultant); Genentech (Consultant); Lupin (Consultant); Lutronic (Consultant); Novartis Pharma AG (Consultant); Roche (Consultant); Teva (Consultant); Topcon (Consultant) JFA: TURING PHARMACEUTICALS LLC(Consultant); DORC International B.V. (Consultant); Allergan Inc. (Consultant); Bayer (Consultant); Mallinckrodt (Consultant); TOPCON (Grant Support) LK: Principal Investigator for trials sponsored by Novartis, Allergan, Bayer, Théa, Alcon; has sat on advisory boards for Alcon, Alimera, Allergan, Bayer, Roche, Novartis; lecture fees from Alcon, Alimera, Allergan, Bayer, Horus, Novartis, Théa. JC: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant); OD-OS (Consultant)." id="9199b8b9-b849-499a-8d02-3eae0079c35d">BR: None JZ-V: Allergan (Consultant); Bayer (Consultant); ATF: Allergan (Consultant); Bayer (Consultant); CB: Allergan (Consultant); Bayer (Travel support); Novartis (Consultant) NKS: None PJR-V: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia VS: None SKM: None AOS: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant) PUM: Bayer (Consultant); Centervue (Consultant); Novartis (Consultant) GQ: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia. MEF: None PL: Alcon (Consultant); Alimera (Consultant); Allergan (Consultant); Bausch&amp;Lomb (Consultant); Bayer (Consultant); Boehringer (Consultant); CenterVue (Consultant); Genentech (Consultant); Lupin (Consultant); Lutronic (Consultant); Novartis Pharma AG (Consultant); Roche (Consultant); Teva (Consultant); Topcon (Consultant) JFA: TURING PHARMACEUTICALS LLC(Consultant); DORC International B.V. (Consultant); Allergan Inc. (Consultant); Bayer (Consultant); Mallinckrodt (Consultant); TOPCON (Grant Support) LK: Principal Investigator for trials sponsored by Novartis, Allergan, Bayer, Théa, Alcon; has sat on advisory boards for Alcon, Alimera, Allergan, Bayer, Roche, Novartis; lecture fees from Alcon, Alimera, Allergan, Bayer, Horus, Novartis, Théa. JC: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant); OD-OS (Consultant).</named-content> <named-content specific-use="" data-title="" id="b807de11-5f62-4202-bb4a-261f9ed2a3ba"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="ef72f1ed-4f86-4fd1-8701-eeaf2d436a59">30 Mar 2019 11:21 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="1786a7f9-d022-4dd2-a56e-3500f65ecec0" xlink:title="fn1" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="fn1"><meta-value id="d287b531-7720-4e15-9e5f-6a3efaaef95b"><named-content specific-use="historyContent" data-title="" id="b764688d-c972-4b71-99d0-fc0c39ba4079"><named-content specific-use="change-person" data-title="" id="e20ea1dc-3049-4e9e-a5be-e45318e45553">Pradheep</named-content> <named-content specific-use="" data-title="" id="c90a3ab0-885a-41e9-8549-bc8fca1e2b07">changed</named-content> <named-content specific-use="oldVal" data-title="Design: JC Conduct of the study: JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC." id="0f2a049b-7e89-4129-b0d0-cad0202277fe">Design: JC Conduct of the study: JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC.</named-content> <named-content specific-use="" data-title="" id="ceb8d164-b900-42be-b7f9-d4526aa04364">to</named-content> <named-content specific-use="newVal" data-title="Design: JC Conduct of the study: JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC." id="f11584c2-b3e0-4da5-a344-11bd3bc49589">Design: JC Conduct of the study: JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, ATF, CB, NKS, PJRV, VS, SKM, AOS, PUM, GQ, MEF, PL, JFA, LK, JC.</named-content> <named-content specific-use="" data-title="" id="ddd4fd98-f5cb-4c04-82f7-9999fa4db977"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="5d99f872-2a58-4a52-9843-6263e7ace035">30 Mar 2019 11:16 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="64dfe0a5-7934-4792-b098-803d3a016c45" xlink:title="aff4" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="54aa4e20-e4f3-400b-b0f7-0e2a8dd16a34"><meta-value id="2ab6a899-7ca5-4a2a-b441-03dc99ba9511"><named-content specific-use="historyContent" data-title="" id="b2a69b69-3ed7-4813-bd59-70af86b728fd"><named-content specific-use="change-person" data-title="" id="c3ebf292-998d-405e-8a0c-fb907ce99c92">Pradheep</named-content> <named-content specific-use="" data-title="" id="ee0b4239-80d1-4c8d-b331-edd6447a5ee8">inserted</named-content> <named-content specific-use="newVal" data-title="New South Wales" id="ddc7a87a-3b2a-45c9-8c73-d4453c322a99">New South Wales</named-content> <named-content specific-use="" data-title="" id="4945d293-77ed-4225-b799-c450e9c4097f"> in State field on</named-content> <named-content specific-use="change-time" data-title="" id="f92003bc-a8b9-4816-b53a-17baff224c6a">29 Mar 2019 5:57 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="dd00435b-5e42-4160-a38d-131b514f7ed7" xlink:title="aff1" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="f15b17dd-13c0-4685-bc96-195a65333251"><meta-value id="42783e8b-c0bc-40b9-b90b-88565050fee2"><named-content specific-use="historyContent" data-title="" id="d9d8f7af-af2c-4e4a-8774-87fd19aa99fd"><named-content specific-use="change-person" data-title="" id="22d2c5b2-1a94-4420-8065-64cef99f832e">Pradheep</named-content> <named-content specific-use="" data-title="" id="85701a85-d32f-466a-b9ef-d2452b51d335">changed</named-content> <named-content specific-use="oldVal" data-title="1 Khoo Teck Puat Hospital, 90 Yishun central ,Singapore 768828" id="3729953c-3ef9-484e-a190-e6cc1518b735">1 Khoo Teck Puat Hospital, 90 Yishun central ,Singapore 768828</named-content> <named-content specific-use="" data-title="" id="73c3004f-744b-4b5f-8813-d3d71fd561a8">to</named-content> <named-content specific-use="newVal" data-title="1 Khoo Teck Puat Hospital, 90 Yishun central, Singapore 768828" id="32e90953-8abf-41b0-a135-e0ba9c67ca76">1 Khoo Teck Puat Hospital, 90 Yishun central, Singapore 768828</named-content> <named-content specific-use="" data-title="" id="146ef458-4240-40cb-b0fb-45ec59215df4"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="0a0714f3-b7f0-4047-817a-7b9dd2673fe4">29 Mar 2019 5:55 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="cf356fd8-5dd7-4187-879e-36191390f8d0" xlink:title="fn1" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="fn1"><meta-value id="d46ebcfb-8be1-4af1-b0b3-1d788ca6bd0a"><named-content specific-use="historyContent" data-title="" id="af8c9225-bad8-4134-b23e-90cda46f5051"><named-content specific-use="change-person" data-title="" id="1315f77e-873d-4032-9afc-14cfd2ddd9d2">Pradheep</named-content> <named-content specific-use="" data-title="" id="49cc53ad-c4c1-46d1-8096-b7af68bef062">changed</named-content> <named-content specific-use="oldVal" data-title="Design: JC Conduct of the study: JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC." id="772a7212-1f39-443a-b7c0-e3930920faf2">Design: JC Conduct of the study: JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC.</named-content> <named-content specific-use="" data-title="" id="70891ea2-bd63-4c81-92f4-af946befa1a7">to</named-content> <named-content specific-use="newVal" data-title="Design: JC Conduct of the study: JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC." id="dddd4a20-dc56-4e6e-bd02-2c0e1bcc95e5">Design: JC Conduct of the study: JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC.</named-content> <named-content specific-use="" data-title="" id="a3bdec4c-f00c-4214-9eb9-6de35fd46a82"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="31fc7f48-0e2a-44de-b69d-07910dde3e58">29 Mar 2019 5:50 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="35140810-00b1-4f47-b179-488137ae551f" xlink:title="fn1" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="fn1"><meta-value id="d368fa56-b9fb-4cf9-b95c-8b65c1740c5a"><named-content specific-use="historyContent" data-title="" id="dda143b7-c5cb-4e07-9abe-42d480122c4b"><named-content specific-use="change-person" data-title="" id="25fe1357-da67-4666-9d67-dd22988935b1">Pradheep</named-content> <named-content specific-use="" data-title="" id="ea5d0df3-6daf-4c15-98c8-df17e961c716">changed</named-content> <named-content specific-use="oldVal" data-title=" Design: JC Conduct of the study: JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC  Preparation: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC" id="00b92644-9e7a-45ca-a0c4-da0f0fde565c"> Design: JC Conduct of the study: JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC  Preparation: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC</named-content> <named-content specific-use="" data-title="" id="0f39e40d-cda1-40fa-bf64-ada87b551993">to</named-content> <named-content specific-use="newVal" data-title="Design: JC Conduct of the study: JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC." id="8ff29fbd-9f5a-4826-ba5d-9f69fc15f83a">Design: JC Conduct of the study: JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Collection: JZV, AF, CB, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Management: BR, JC Analysis: BR, NKS, JC Interpretation of the data: BR, NKS, JC Preparation: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Review: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC Approval of the manuscript: BR, JZV, AF, CB, NKS, PRV, VS, SKM, OS, PUM, GQ, MEF, PL, JFA, LK, JC.</named-content> <named-content specific-use="" data-title="" id="0d96251f-5a9d-4918-b1c1-3bd1f2828bb8"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="1aec5f35-6951-4fb6-97c6-72042ab2f3bb">29 Mar 2019 5:48 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="dae011e0-5662-4926-b3ff-1d81a91f3371" xlink:title="fn2" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="fn2"><meta-value id="40aed788-b4a7-49bc-9b9d-1c81ff68877a"><named-content specific-use="historyContent" data-title="" id="5c33dc89-0b33-42d4-ba8a-70928570fd08"><named-content specific-use="change-person" data-title="" id="75220d6f-a33d-4cc3-805d-8b90fa33b368">Pradheep</named-content> <named-content specific-use="" data-title="" id="a4b3ceb2-e2f9-405a-bba6-44255cd883d0">changed</named-content> <named-content specific-use="oldVal" data-title="Bindu Rajesh: None Javier Zarranz-Ventura: Allergan (Consultant); Bayer (Consultant); Adrian Fung: Allergan (Consultant); Bayer (Consultant); Catharina Busch: Allergan (Consultant); Bayer (Travel support); Novartis (Consultant)Niroj Kumar Sahoo: NonePatricio J. Rodríguez-Valdés: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia Valentina Sarao: NoneS. K. Mishra: NoneOsman Saatci: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant)Patricia Udaondo Mirete: Bayer (Consultant); Centervue (Consultant); Novartis (Consultant)Giuseppe Querques: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia.Michel Eid Farah: NonePaolo Lanzetta: Alcon (Consultant); Alimera (Consultant); Allergan (Consultant); Bausch&amp;Lomb (Consultant); Bayer (Consultant); Boehringer (Consultant); CenterVue (Consultant); Genentech (Consultant); Lupin (Consultant); Lutronic (Consultant); Novartis Pharma AG (Consultant); Roche (Consultant); Teva (Consultant); Topcon (Consultant)J. Fernando Arevalo: TURING PHARMACEUTICALS LLC(Consultant); DORC International B.V. (Consultant); Allergan Inc. (Consultant); Bayer (Consultant); Mallinckrodt (Consultant); TOPCON (Grant Support)Laurent Kodjikian: Principal Investigator for trials sponsored by Novartis, Allergan, Bayer, Théa, Alcon; has sat on advisory boards for Alcon, Alimera, Allergan, Bayer, Roche, Novartis; lecture fees from Alcon, Alimera, Allergan, Bayer, Horus, Novartis, Théa.Jay Chhablani: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant); OD-OS (Consultant)" id="255de241-ddde-4c7e-a4b1-3572eb1a996a">Bindu Rajesh: None Javier Zarranz-Ventura: Allergan (Consultant); Bayer (Consultant); Adrian Fung: Allergan (Consultant); Bayer (Consultant); Catharina Busch: Allergan (Consultant); Bayer (Travel support); Novartis (Consultant)Niroj Kumar Sahoo: NonePatricio J. Rodríguez-Valdés: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia Valentina Sarao: NoneS. K. Mishra: NoneOsman Saatci: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant)Patricia Udaondo Mirete: Bayer (Consultant); Centervue (Consultant); Novartis (Consultant)Giuseppe Querques: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia.Michel Eid Farah: NonePaolo Lanzetta: Alcon (Consultant); Alimera (Consultant); Allergan (Consultant); Bausch&amp;Lomb (Consultant); Bayer (Consultant); Boehringer (Consultant); CenterVue (Consultant); Genentech (Consultant); Lupin (Consultant); Lutronic (Consultant); Novartis Pharma AG (Consultant); Roche (Consultant); Teva (Consultant); Topcon (Consultant)J. Fernando Arevalo: TURING PHARMACEUTICALS LLC(Consultant); DORC International B.V. (Consultant); Allergan Inc. (Consultant); Bayer (Consultant); Mallinckrodt (Consultant); TOPCON (Grant Support)Laurent Kodjikian: Principal Investigator for trials sponsored by Novartis, Allergan, Bayer, Théa, Alcon; has sat on advisory boards for Alcon, Alimera, Allergan, Bayer, Roche, Novartis; lecture fees from Alcon, Alimera, Allergan, Bayer, Horus, Novartis, Théa.Jay Chhablani: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant); OD-OS (Consultant)</named-content> <named-content specific-use="" data-title="" id="10547a03-0d51-4eab-a3a9-b21eecbb9f34">to</named-content> <named-content specific-use="newVal" data-title="Bindu Rajesh: None Javier Zarranz-Ventura: Allergan (Consultant); Bayer (Consultant); Adrian Fung: Allergan (Consultant); Bayer (Consultant); Catharina Busch: Allergan (Consultant); Bayer (Travel support); Novartis (Consultant) Niroj Kumar Sahoo: None Patricio J. Rodríguez-Valdés: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia Valentina Sarao: None S. K. Mishra: None Osman Saatci: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant) Patricia Udaondo Mirete: Bayer (Consultant); Centervue (Consultant); Novartis (Consultant) Giuseppe Querques: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia. Michel Eid Farah: None Paolo Lanzetta: Alcon (Consultant); Alimera (Consultant); Allergan (Consultant); Bausch&amp;Lomb (Consultant); Bayer (Consultant); Boehringer (Consultant); CenterVue (Consultant); Genentech (Consultant); Lupin (Consultant); Lutronic (Consultant); Novartis Pharma AG (Consultant); Roche (Consultant); Teva (Consultant); Topcon (Consultant) J. Fernando Arevalo: TURING PHARMACEUTICALS LLC(Consultant); DORC International B.V. (Consultant); Allergan Inc. (Consultant); Bayer (Consultant); Mallinckrodt (Consultant); TOPCON (Grant Support) Laurent Kodjikian: Principal Investigator for trials sponsored by Novartis, Allergan, Bayer, Théa, Alcon; has sat on advisory boards for Alcon, Alimera, Allergan, Bayer, Roche, Novartis; lecture fees from Alcon, Alimera, Allergan, Bayer, Horus, Novartis, Théa. Jay Chhablani: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant); OD-OS (Consultant)." id="f90bf3a8-698a-4106-912b-1626dfbac0b5">Bindu Rajesh: None Javier Zarranz-Ventura: Allergan (Consultant); Bayer (Consultant); Adrian Fung: Allergan (Consultant); Bayer (Consultant); Catharina Busch: Allergan (Consultant); Bayer (Travel support); Novartis (Consultant) Niroj Kumar Sahoo: None Patricio J. Rodríguez-Valdés: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia Valentina Sarao: None S. K. Mishra: None Osman Saatci: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant) Patricia Udaondo Mirete: Bayer (Consultant); Centervue (Consultant); Novartis (Consultant) Giuseppe Querques: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia. Michel Eid Farah: None Paolo Lanzetta: Alcon (Consultant); Alimera (Consultant); Allergan (Consultant); Bausch&amp;Lomb (Consultant); Bayer (Consultant); Boehringer (Consultant); CenterVue (Consultant); Genentech (Consultant); Lupin (Consultant); Lutronic (Consultant); Novartis Pharma AG (Consultant); Roche (Consultant); Teva (Consultant); Topcon (Consultant) J. Fernando Arevalo: TURING PHARMACEUTICALS LLC(Consultant); DORC International B.V. (Consultant); Allergan Inc. (Consultant); Bayer (Consultant); Mallinckrodt (Consultant); TOPCON (Grant Support) Laurent Kodjikian: Principal Investigator for trials sponsored by Novartis, Allergan, Bayer, Théa, Alcon; has sat on advisory boards for Alcon, Alimera, Allergan, Bayer, Roche, Novartis; lecture fees from Alcon, Alimera, Allergan, Bayer, Horus, Novartis, Théa. Jay Chhablani: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant); OD-OS (Consultant).</named-content> <named-content specific-use="" data-title="" id="8dbae7aa-de5b-4a0a-8dde-9cbf063cdba9"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="cdb4e488-7fb1-4ce1-aa0a-2a3524060451">29 Mar 2019 5:37 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="14a67f3f-a3b9-4000-8a29-ee4ce010992d" xlink:title="fn2" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="fn2"><meta-value id="669c07dc-3470-48a5-985a-1e98bc0c392b"><named-content specific-use="historyContent" data-title="" id="33934d59-db57-4a7f-b898-8f2c930c510d"><named-content specific-use="change-person" data-title="" id="ccf6074d-907f-44aa-97d7-ce3b51bd16b0">Pradheep</named-content> <named-content specific-use="" data-title="" id="bf295ccf-7ffb-4fff-a466-dd52c44ac3c4">changed</named-content> <named-content specific-use="oldVal" data-title="" id="a654e3f2-74ee-4294-aa62-341992823403">None declared.</named-content> <named-content specific-use="" data-title="" id="732afe6e-0d59-4d7b-a4d3-3f3745ef0934">to</named-content> <named-content specific-use="newVal" data-title="Bindu Rajesh: None Javier Zarranz-Ventura: Allergan (Consultant); Bayer (Consultant); Adrian Fung: Allergan (Consultant); Bayer (Consultant); Catharina Busch: Allergan (Consultant); Bayer (Travel support); Novartis (Consultant)Niroj Kumar Sahoo: NonePatricio J. Rodríguez-Valdés: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia Valentina Sarao: NoneS. K. Mishra: NoneOsman Saatci: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant)Patricia Udaondo Mirete: Bayer (Consultant); Centervue (Consultant); Novartis (Consultant)Giuseppe Querques: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia.Michel Eid Farah: NonePaolo Lanzetta: Alcon (Consultant); Alimera (Consultant); Allergan (Consultant); Bausch&amp;Lomb (Consultant); Bayer (Consultant); Boehringer (Consultant); CenterVue (Consultant); Genentech (Consultant); Lupin (Consultant); Lutronic (Consultant); Novartis Pharma AG (Consultant); Roche (Consultant); Teva (Consultant); Topcon (Consultant)J. Fernando Arevalo: TURING PHARMACEUTICALS LLC(Consultant); DORC International B.V. (Consultant); Allergan Inc. (Consultant); Bayer (Consultant); Mallinckrodt (Consultant); TOPCON (Grant Support)Laurent Kodjikian: Principal Investigator for trials sponsored by Novartis, Allergan, Bayer, Théa, Alcon; has sat on advisory boards for Alcon, Alimera, Allergan, Bayer, Roche, Novartis; lecture fees from Alcon, Alimera, Allergan, Bayer, Horus, Novartis, Théa.Jay Chhablani: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant); OD-OS (Consultant)" id="26f31351-203d-4aea-b5b2-b2f01f900a7a">Bindu Rajesh: None Javier Zarranz-Ventura: Allergan (Consultant); Bayer (Consultant); Adrian Fung: Allergan (Consultant); Bayer (Consultant); Catharina Busch: Allergan (Consultant); Bayer (Travel support); Novartis (Consultant)Niroj Kumar Sahoo: NonePatricio J. Rodríguez-Valdés: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia Valentina Sarao: NoneS. K. Mishra: NoneOsman Saatci: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant)Patricia Udaondo Mirete: Bayer (Consultant); Centervue (Consultant); Novartis (Consultant)Giuseppe Querques: Allergan, Alcon, Novartis, Bayer, Industrial Organica, SA de CV, Laboratorios Sophia.Michel Eid Farah: NonePaolo Lanzetta: Alcon (Consultant); Alimera (Consultant); Allergan (Consultant); Bausch&amp;Lomb (Consultant); Bayer (Consultant); Boehringer (Consultant); CenterVue (Consultant); Genentech (Consultant); Lupin (Consultant); Lutronic (Consultant); Novartis Pharma AG (Consultant); Roche (Consultant); Teva (Consultant); Topcon (Consultant)J. Fernando Arevalo: TURING PHARMACEUTICALS LLC(Consultant); DORC International B.V. (Consultant); Allergan Inc. (Consultant); Bayer (Consultant); Mallinckrodt (Consultant); TOPCON (Grant Support)Laurent Kodjikian: Principal Investigator for trials sponsored by Novartis, Allergan, Bayer, Théa, Alcon; has sat on advisory boards for Alcon, Alimera, Allergan, Bayer, Roche, Novartis; lecture fees from Alcon, Alimera, Allergan, Bayer, Horus, Novartis, Théa.Jay Chhablani: Allergan (Consultant); Bayer (Consultant); Novartis (Consultant); OD-OS (Consultant)</named-content> <named-content specific-use="" data-title="" id="2e4bbd70-cd5f-4d30-99d5-a30644ce1f3f"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="fc5228d8-d5f7-412e-87d5-fcccdfb036a6">29 Mar 2019 5:36 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="301b1358-6137-4506-9689-c2d19483a21e" xlink:title="4f06e200-e6ff-42d4-8808-724a7a158556" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="1e7592e3-a3ed-4cff-8338-56965e09048e"><meta-value id="0c493b1e-4e90-467c-a00f-8a1998456864"><named-content specific-use="historyContent" data-title="" id="f6a324bb-57c0-418b-b9eb-849ea6b8088e"><named-content specific-use="change-person" data-title="" id="a9008f03-72b0-4e71-9b07-228f94872c43">Pradheep</named-content> <named-content specific-use="" data-title="" id="ab811197-0f7a-452b-ad28-5de932de691f">changed</named-content> <named-content specific-use="oldVal" data-title="" id="ad22e29d-3761-4c0c-becc-e4a430ca1d2e">AP</named-content> <named-content specific-use="" data-title="" id="011450fe-3344-466d-a77c-39672a7846a5">to</named-content> <named-content specific-use="newVal" data-title="" id="01625169-9a16-4c21-b994-5016ce3411a6">AP 500034</named-content> <named-content specific-use="" data-title="" id="6d4a359e-75b9-4529-a02b-a2ba085e3af0"> in State field on</named-content> <named-content specific-use="change-time" data-title="" id="6a666342-069a-4518-ae69-f1c67e544e47">29 Mar 2019 5:26 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="26054075-eb65-4d00-8411-69f1d09d3da4" xlink:title="aff17" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="3e278d35-5644-4f24-a6d4-4297259b743f"><meta-value id="e9120db0-9c6b-4b40-8791-c46b177d44b5"><named-content specific-use="historyContent" data-title="" id="ca7b36bc-e418-4d35-a769-4d9eb59ad96a"><named-content specific-use="change-person" data-title="" id="b3512f79-7d99-46fd-ac72-f61091d54fd4">Pradheep</named-content> <named-content specific-use="" data-title="" id="a5cc54bd-5d8a-4310-8046-4c3171c7ff00">changed</named-content> <named-content specific-use="oldVal" data-title="" id="4a51dd9d-e8a1-4a9f-a69d-868459c1b170">LYON</named-content> <named-content specific-use="" data-title="" id="79f0a7d4-76a5-4cdd-a966-347961868810">to</named-content> <named-content specific-use="newVal" data-title="" id="b3eb5504-9cae-4b3f-b97d-f9ffbdc640c2">Lyon</named-content> <named-content specific-use="" data-title="" id="ba5588dd-9264-48ac-8ffd-7c154d604057"> in City field on</named-content> <named-content specific-use="change-time" data-title="" id="dd7f93b9-8106-4f65-b336-7d411e45186f">29 Mar 2019 5:25 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="5ccd0126-ae43-483d-a1d7-72c26923ffd1" xlink:title="aff16" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="551e3f31-e664-4c88-bebc-28420b31f66e"><meta-value id="474e7a08-0715-4f72-be03-aacb207fdde8"><named-content specific-use="historyContent" data-title="" id="3f873348-17d2-42ce-9648-ea2d1fd32290"><named-content specific-use="change-person" data-title="" id="b7c276e6-de40-4405-82bf-f7362a518731">Pradheep</named-content> <named-content specific-use="" data-title="" id="351e57aa-4571-4bf8-82b3-a64397a2b22b">changed</named-content> <named-content specific-use="oldVal" data-title="" id="7522a6a6-a138-400d-b174-5d646aa9c977">LYON</named-content> <named-content specific-use="" data-title="" id="0ec5d2fc-0e2d-4754-84db-64b86c4a856b">to</named-content> <named-content specific-use="newVal" data-title="" id="248abca0-b3dc-4d28-80da-ccb6511fd7af">Lyon</named-content> <named-content specific-use="" data-title="" id="ec12b2a9-ea05-4943-bae0-8d755e74a00e"> in City field on</named-content> <named-content specific-use="change-time" data-title="" id="19ffd663-b7db-4f40-b037-9838fde2a6a6">29 Mar 2019 5:24 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="20a2f414-d725-4a68-a319-583ce298a5c4" xlink:title="author-21759086" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="a0b3765e-0bf3-4248-a39e-0b9722c3ea61"><meta-value id="7bd97b98-63a4-4d81-a458-2434505b08a0"><named-content specific-use="historyContent" data-title="" id="9210d6ad-8bdb-47e4-96bb-0498616d7de3"><named-content specific-use="change-person" data-title="" id="4d1876a7-5016-43e3-bc09-200771723ca3">Pradheep</named-content> <named-content specific-use="" data-title="" id="ad26a038-ec75-43c2-8b72-1ea009f60e26">changed</named-content> <named-content specific-use="oldVal" data-title="" id="ff7940c5-8fc4-4e3d-ab16-937da38971b6">J. Fernando</named-content> <named-content specific-use="" data-title="" id="ea5e2e33-bf9a-4f8a-9604-0cffb3b4ee66">to</named-content> <named-content specific-use="newVal" data-title="" id="71849675-5a3a-4806-81b3-34466d7f8dfd">J Fernando</named-content> <named-content specific-use="" data-title="" id="30efc05a-36ef-4149-be1e-3ec163785c45"> in Given name field on</named-content> <named-content specific-use="change-time" data-title="" id="2372c16e-e9c6-4dc8-8242-981615230c16">29 Mar 2019 5:24 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="eeac8498-c561-4e0d-b89c-53a5962a3c4f" xlink:title="aff13" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="6c5fccb4-6461-4523-a580-a8d4499414c6"><meta-value id="7c8dfda0-d111-41df-8015-deb8f38a994b"><named-content specific-use="historyContent" data-title="" id="27760596-ec76-4c82-a63b-651f912536fc"><named-content specific-use="change-person" data-title="" id="8d89e230-1edf-42fb-9fe4-3ea5b697bbf2">Pradheep</named-content> <named-content specific-use="" data-title="" id="28a4c644-1cc3-4500-9087-88b0957fe522">deleted</named-content> <named-content specific-use="oldVal" data-title="" id="22256d6c-ad2f-45d6-8974-f687b6353c49">Sao Paulo</named-content> <named-content specific-use="" data-title="" id="97aa19de-08c3-45df-bc3a-425f964bc075"> in State field on</named-content> <named-content specific-use="change-time" data-title="" id="38d15551-7971-49bf-8bc9-1095b07b6841">29 Mar 2019 5:23 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="c540bb1a-3e43-42a8-a033-8c09ce43bd04" xlink:title="aff11" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="60697f78-49d0-4249-9e17-3ea7d95944ec"><meta-value id="ee736d69-3150-4694-b397-fbabcbcf115d"><named-content specific-use="historyContent" data-title="" id="3695d5f6-5d0c-40a3-a1e5-b4e317fb0190"><named-content specific-use="change-person" data-title="" id="2b1280d3-17b5-4228-8f79-62753b2a444d">Pradheep</named-content> <named-content specific-use="" data-title="" id="f2dfca6d-2c38-45d5-a88f-f3c908ad8c15">changed</named-content> <named-content specific-use="oldVal" data-title="13. Ophthalmology Department, Hospital Universitario La Fe, Valencia, Spain." id="dd4bec13-152c-4f01-a860-bb2d3fe38918">13. Ophthalmology Department, Hospital Universitario La Fe, Valencia, Spain.</named-content> <named-content specific-use="" data-title="" id="19a7d51b-7990-4349-9c9c-021feb1285e0">to</named-content> <named-content specific-use="newVal" data-title="Hospital Universitario La Fe" id="9bab1cb8-105f-4447-927c-1dd6bd22a4c9">Hospital Universitario La Fe</named-content> <named-content specific-use="" data-title="" id="69fb2656-d45b-4c1d-8efa-cc9967e0f3fa"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="561a4d81-d0e1-4d24-b4bb-6c090924e0c9">29 Mar 2019 5:23 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="74ba0155-838a-46be-af1c-7f9ddd912a40" xlink:title="aff11" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="1d1129bb-ec1d-47a8-852f-0cc77d817133"><meta-value id="7aceb6b6-970d-4e14-b055-9c92b89bb6f2"><named-content specific-use="historyContent" data-title="" id="89da4b22-4caa-4039-8be1-184ad5ef21a5"><named-content specific-use="change-person" data-title="" id="90bbbef0-1689-4d0e-afc6-a88c0d88462b">Pradheep</named-content> <named-content specific-use="" data-title="" id="0e3e693a-1988-49fa-8fdf-be8b2eb89d8a">inserted</named-content> <named-content specific-use="newVal" data-title="13 Ophthalmology Department" id="7db0a04f-7dd5-4889-8137-e1815e80d6f0">13 Ophthalmology Department</named-content> <named-content specific-use="" data-title="" id="5293e02d-80a9-48c1-8f40-69e351d45a5e"> in Department field on</named-content> <named-content specific-use="change-time" data-title="" id="ed504157-b3d4-4585-a897-8776dc2efb63">29 Mar 2019 5:23 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="b2d56c93-3ed3-4d95-9ce4-16207d176fb8" xlink:title="author-61729446" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="c3f0f7b5-722b-4ce4-9cc6-c66b0b9d0e82"><meta-value id="b7c6449c-b5fb-4838-9706-ff6a2ceac43b"><named-content specific-use="historyContent" data-title="" id="bc0a0bfb-209f-49c7-b3fd-5e9c27e1279f"><named-content specific-use="change-person" data-title="" id="9fbb840f-5594-44d6-8f82-71fcc69c3b25">Pradheep</named-content> <named-content specific-use="" data-title="" id="14ffb17b-30a4-4afb-acd6-e34beac6eecd">changed</named-content> <named-content specific-use="oldVal" data-title="" id="3b1a533a-ca32-4242-af89-d012f0bede19">A. Osman</named-content> <named-content specific-use="" data-title="" id="d741b4b2-a436-4a50-822c-c363197ee6ab">to</named-content> <named-content specific-use="newVal" data-title="" id="dca2181a-3835-4a0f-8a62-de6f9224a10a">A Osman</named-content> <named-content specific-use="" data-title="" id="92c962eb-633b-4fce-abc1-a9a8f9f0e758"> in Given name field on</named-content> <named-content specific-use="change-time" data-title="" id="c14e9505-2689-47e0-a538-c18ede51d3b0">29 Mar 2019 5:22 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="dd39f251-8d99-42e8-9168-2f5f55051c40" xlink:title="aff9" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="c890f1c3-8da8-45a8-ac49-68130de75fa4"><meta-value id="a81c093d-a7a0-4ca6-a6f2-7dcd8b8aa6da"><named-content specific-use="historyContent" data-title="" id="0fda7036-83b3-4a6a-a0a1-149e93e62ec5"><named-content specific-use="change-person" data-title="" id="4579801d-bff3-4a39-a112-437c2e652453">Pradheep</named-content> <named-content specific-use="" data-title="" id="b8722919-7edb-4c21-92f3-81eff7fb2f26">changed</named-content> <named-content specific-use="oldVal" data-title="11. Department of Ophthalmology Command hospital, Lucknow cantt 226002, India" id="9fae9d0f-698e-4378-ac6e-13d2634bcc6e">11. Department of Ophthalmology Command hospital, Lucknow cantt 226002, India</named-content> <named-content specific-use="" data-title="" id="30a5a0f6-0583-4236-a61e-2c997dd5d330">to</named-content> <named-content specific-use="newVal" data-title="11 Department of Ophthalmology Command hospital" id="7b87eac3-a5c0-43fd-8bb3-a40b1e6ce382">11 Department of Ophthalmology Command hospital</named-content> <named-content specific-use="" data-title="" id="33fd711f-358c-40a7-baf0-ae5bb38415e8"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="0ad2247c-30f0-4b79-bca7-f4a6eb79cd2a">29 Mar 2019 5:22 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="99ffe377-206e-4cc0-9d5c-c97e22964093" xlink:title="aff7" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="c8d28089-addc-4ba6-b9ff-3eb30cf5673d"><meta-value id="d8a8db29-f49a-4ae9-a812-4ca8afb38464"><named-content specific-use="historyContent" data-title="" id="98c91e6d-ee0e-411c-ad88-5a6711966a95"><named-content specific-use="change-person" data-title="" id="a3989702-e54f-49ab-a733-fe197ee5f765">Pradheep</named-content> <named-content specific-use="" data-title="" id="b8097f9d-bf4a-407b-9046-1f2a2e729481">deleted</named-content> <named-content specific-use="oldVal" data-title="" id="c910150d-b14e-4d39-9614-2a7c93cb67a8">Nuevo Leon</named-content> <named-content specific-use="" data-title="" id="e93bce62-0e78-4758-8951-a2da962aa713"> in State field on</named-content> <named-content specific-use="change-time" data-title="" id="ddf97dcc-5758-4813-aefa-9becabfa3c59">29 Mar 2019 5:20 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="2917c661-4a96-4153-8834-f73910a8371e" xlink:title="author-60527574" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="746acc17-186b-4de2-be17-e68166defa5c"><meta-value id="f8875e62-8581-4181-842b-0b112aa7feb8"><named-content specific-use="historyContent" data-title="" id="261dc054-7fd4-4dfe-a53f-7e6999399e00"><named-content specific-use="change-person" data-title="" id="d8d9df05-73c1-4b6b-8977-4c85aab79b28">Pradheep</named-content> <named-content specific-use="" data-title="" id="44a7381a-00f1-4a8e-a6d6-643b1db24fef">changed</named-content> <named-content specific-use="oldVal" data-title="" id="9c2523bb-31a8-4934-859f-6187eddecbc6">Patricio J.</named-content> <named-content specific-use="" data-title="" id="ec04af4c-f144-44ef-a968-be5e085d4e4b">to</named-content> <named-content specific-use="newVal" data-title="" id="a6c1840f-dbb1-4104-8e80-170f6cd604fa">Patricio J</named-content> <named-content specific-use="" data-title="" id="95200954-77c9-4454-96cd-80415926555f"> in Given name field on</named-content> <named-content specific-use="change-time" data-title="" id="63f29f5f-9d66-4baa-b4f7-6bf25dc8a171">29 Mar 2019 5:20 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="184c92f2-8f5d-4cb1-9e3e-f54cf7c5f2cd" xlink:title="aff6" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="e8ab6a2a-1419-4e8a-bb35-3988ec688824"><meta-value id="b4da0863-b730-4ef1-8b21-91e166ffff52"><named-content specific-use="historyContent" data-title="" id="c312c45b-5ec8-48a2-8425-f3198c462db1"><named-content specific-use="change-person" data-title="" id="d2a37416-e726-4aab-8ee9-e6d494a2cf6d">Pradheep</named-content> <named-content specific-use="" data-title="" id="649016b6-a577-4941-a8c2-2aa3471ee68e">changed</named-content> <named-content specific-use="oldVal" data-title="" id="b8d79066-e742-4dfc-a0fc-5594f23e02c7">AP</named-content> <named-content specific-use="" data-title="" id="519de38e-1a3d-461c-ad14-e793e0acb5e2">to</named-content> <named-content specific-use="newVal" data-title="" id="a1c023f5-8bf3-4095-a2c9-e7fbb85b2815">Andhra Pradesh</named-content> <named-content specific-use="" data-title="" id="d6eff23d-cb78-4e1b-b9da-473400420ed5"> in State field on</named-content> <named-content specific-use="change-time" data-title="" id="2dbf5083-48d2-4a49-b1e7-2d5068d4e9ce">29 Mar 2019 5:20 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="2c9988e6-cd1e-49bd-ab3d-6e93a257785d" xlink:title="aff4" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="94ea1970-e362-474c-91a4-b948c77bb7a3"><meta-value id="82126273-cf05-4fbc-b3d2-15678eafafde"><named-content specific-use="historyContent" data-title="" id="3455f64a-ca74-4a0a-949e-e183f82eb927"><named-content specific-use="change-person" data-title="" id="5b2bdc04-5575-4844-913b-8b206b0e27cd">Pradheep</named-content> <named-content specific-use="" data-title="" id="f244410d-a9e0-4c46-9dc0-2261de87ec54">changed</named-content> <named-content specific-use="oldVal" data-title="Save Sight Institute, Sydney Eye Hospital, University of Sydney, Sydney, Australia" id="a98bd28e-ca4b-47c5-80c1-9b4fee38b160">Save Sight Institute, Sydney Eye Hospital, University of Sydney, Sydney, Australia</named-content> <named-content specific-use="" data-title="" id="697baf35-0db1-44eb-b0cc-656cc1e5265a">to</named-content> <named-content specific-use="newVal" data-title="Sydney Eye Hospital, University of Sydney" id="c3f9d320-f822-435d-853a-421592c86e33">Sydney Eye Hospital, University of Sydney</named-content> <named-content specific-use="" data-title="" id="d5882f52-9101-4ec7-acba-d0f9ffafbb0a"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="b556c7ec-19df-4fe1-8d64-e9984d697492">29 Mar 2019 5:19 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="46dae629-427f-4e5c-b444-900bb6be003d" xlink:title="aff4" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="ac147b83-e4dd-4ba6-bfba-4abc5d6872d9"><meta-value id="02820e6e-4422-4b42-ba2d-7de6a34baba8"><named-content specific-use="historyContent" data-title="" id="5220309a-35d4-403b-9446-cb26cebb3fa3"><named-content specific-use="change-person" data-title="" id="25486d36-80eb-4867-a0f2-19795ced6bda">Pradheep</named-content> <named-content specific-use="" data-title="" id="d207b9c0-d8b7-4578-9668-386d719a9f2b">changed</named-content> <named-content specific-use="oldVal" data-title="Save Sight Institute, Sydney Eye Hospital, University of Sydney, Sydney, Australia" id="45e8fbae-954e-47ea-a3c0-1eda78be7a1e">Save Sight Institute, Sydney Eye Hospital, University of Sydney, Sydney, Australia</named-content> <named-content specific-use="" data-title="" id="673f7e82-f25f-4662-a78b-4445aa886ee4">to</named-content> <named-content specific-use="newVal" data-title="Save Sight Institute" id="cc68b98d-4bb4-46ec-a84e-679d42e7a82c">Save Sight Institute</named-content> <named-content specific-use="" data-title="" id="6c451794-801f-4eee-ba82-4d247cac94d8"> in Department field on</named-content> <named-content specific-use="change-time" data-title="" id="27d8d227-e00c-4dfc-86b6-c48a103d4914">29 Mar 2019 5:19 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="331ef981-72d8-47d4-adf6-5fe00933216e" xlink:title="aff3" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="c1ab4487-e36e-431e-9caa-68e75f2600b6"><meta-value id="fe52d23f-0bcc-45cb-8476-3a700919005c"><named-content specific-use="historyContent" data-title="" id="881a0714-a75b-43d6-abef-669646dee6ad"><named-content specific-use="change-person" data-title="" id="3934adc4-53fe-4a5a-95a6-daad2c8484fb">Pradheep</named-content> <named-content specific-use="" data-title="" id="5b12ab92-d20f-4002-b5f0-9a9d5bfaf5bb">changed</named-content> <named-content specific-use="oldVal" data-title="Department of Ophthalmology, Westmead Hospital, Sydney, NSW, Australia" id="b28870b0-9666-4aaa-b431-f98ba1a43ed2">Department of Ophthalmology, Westmead Hospital, Sydney, NSW, Australia</named-content> <named-content specific-use="" data-title="" id="746d0218-97d9-44a4-af2a-e3f8dfa94109">to</named-content> <named-content specific-use="newVal" data-title="Westmead Hospital" id="3ede0e4e-74fe-4cfb-8aa3-e8e4b74979a4">Westmead Hospital</named-content> <named-content specific-use="" data-title="" id="58d1ac3d-29e7-44fb-8d47-6900d8d3a276"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="e2e36b44-68c8-4bff-a3b4-1f24e290e541">29 Mar 2019 5:18 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="a4b8e83a-1a92-4732-8433-4c19f90a16a1" xlink:title="aff3" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="24c586ab-490a-4ad5-bcf8-34d889c0504a"><meta-value id="06d7f236-2cdc-44a2-a3cd-32a6185d9822"><named-content specific-use="historyContent" data-title="" id="b4d0a73c-2627-42b9-aac8-b15aac2fc86c"><named-content specific-use="change-person" data-title="" id="72ef99a8-ff2d-4a38-a941-059e4992644a">Pradheep</named-content> <named-content specific-use="" data-title="" id="d26f033b-20c7-4319-af82-338d7f8f81de">changed</named-content> <named-content specific-use="oldVal" data-title="Department of Ophthalmology, Westmead Hospital, Sydney, NSW, Australia" id="182b9819-5693-420c-8b47-e2938d6efcaf">Department of Ophthalmology, Westmead Hospital, Sydney, NSW, Australia</named-content> <named-content specific-use="" data-title="" id="3706b800-cfcc-4f88-9b67-a9ca52c2f570">to</named-content> <named-content specific-use="newVal" data-title="Department of Ophthalmology" id="4b707165-3dbc-4e9b-b5b9-4647bb9f711b">Department of Ophthalmology</named-content> <named-content specific-use="" data-title="" id="9f2700c4-8bd1-4659-9604-701f2e82693c"> in Department field on</named-content> <named-content specific-use="change-time" data-title="" id="1c410703-2f47-4dce-b23d-0f8f089ea484">29 Mar 2019 5:18 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="e2ed9ae9-6a40-4511-972c-c987f88c3833" xlink:title="author-60090143" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="070bbc36-43b2-42e9-8f08-68d8df2b7598"><meta-value id="cb4d7db1-3cdd-4156-9506-ea3fe66fc6c3"><named-content specific-use="historyContent" data-title="" id="b205e1e9-6a95-4117-b88e-4a24e4ae914f"><named-content specific-use="change-person" data-title="" id="b3327028-3e2c-44ba-9bce-fe03f6faa5da">Pradheep</named-content> <named-content specific-use="" data-title="" id="d400aed9-8cab-4054-8b35-804ae0f05066">changed</named-content> <named-content specific-use="oldVal" data-title="" id="93932a20-5cdf-4ac7-a9ec-62ab3a922a2f">Adrian T.</named-content> <named-content specific-use="" data-title="" id="bb122b70-3fc0-48cd-9cab-294ad93b82eb">to</named-content> <named-content specific-use="newVal" data-title="" id="dff38250-347b-4c8a-8052-445a3b5b0a0b">Adrian T</named-content> <named-content specific-use="" data-title="" id="65a1579e-80d3-47a7-a191-0987a6c2eeb4"> in Given name field on</named-content> <named-content specific-use="change-time" data-title="" id="d1160058-439d-425e-8c11-e7f368e0f709">29 Mar 2019 5:18 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" id="edb40b50-4985-4696-90ea-d83da2ef2168" xlink:title="aff1" xlink:actuate="e08e910d-c111-44ed-9f81-d3874d44cbda" xlink:role="preeditor" xlink:href="f15b17dd-13c0-4685-bc96-195a65333251"><meta-value id="5c8ccc6e-0cf5-4b24-b436-c6baca548d72"><named-content specific-use="historyContent" data-title="" id="e0667560-65d3-4b2f-a263-932540f6e6d2"><named-content specific-use="change-person" data-title="" id="efa3a166-0206-49a6-be74-c5147375ebf1">Pradheep</named-content> <named-content specific-use="" data-title="" id="08f0aaf2-551a-41a6-9f18-00a7e351fe7e">changed</named-content> <named-content specific-use="oldVal" data-title="1. Khoo Teck Puat Hospital, 90 Yishun central ,Singapore 768828" id="ab792d9f-43aa-4d0c-af71-376bd45d1431">1. Khoo Teck Puat Hospital, 90 Yishun central ,Singapore 768828</named-content> <named-content specific-use="" data-title="" id="a4e84f9c-96eb-42e9-9c95-e8b4b38c6b80">to</named-content> <named-content specific-use="newVal" data-title="1 Khoo Teck Puat Hospital, 90 Yishun central ,Singapore 768828" id="18dc7ed8-60b1-4b8e-bafd-6fca94507cfe">1 Khoo Teck Puat Hospital, 90 Yishun central ,Singapore 768828</named-content> <named-content specific-use="" data-title="" id="d4a6879a-cb7b-40fa-8982-e1f49df3bbca"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="4e1be1c1-39c2-4e00-8574-52ab45db4f60">29 Mar 2019 5:17 PM</named-content></named-content></meta-value></custom-meta></custom-meta-group><counts id="58df1a04-21fc-4b70-a325-941b4d7d5923"><page-count count="6.6" id="7d20b3cd-fc24-4389-92a2-b7302fa1b53a"/><word-count count="8289"/><fig-count count="0"/><table-count count="5"/><equation-count count="0"/><ref-count count="38"/></counts></article-meta></front><body id="a6fbe2a3-7a55-4c2c-bbab-55720d868f82"><p data-class="jrnlDeleted" id="6bf52696-bbb4-4ae6-9904-53b80c22bd1a">Short title: Safety of 6000 dex implants</p><p data-class="jrnlDeleted" data-authors="true" id="e93e7dfe-cffa-42e0-b5e0-438cc3c9abd4">Bindu Rajesh;<sup id="e108a346-5ede-4668-b163-e654e814eaa3">1</sup> Javier Zarranz-Ventura;<sup id="998061c3-d355-4db8-a770-0994cf50aacf"> 2</sup> Adrian Fung;<sup id="b0d619e5-8a05-4916-8376-1240b0b97ec4"> 3,4,5</sup> Catharina Busch;<sup id="d9603c4f-fb81-4713-aa52-269cb5e667ab"> 6</sup> Niroj Kumar Sahoo;<sup id="d104128c-1933-42ce-995f-d6655eb21df5"> 7</sup> Patricio J. Rodríguez-Valdés;<sup id="e862f401-4f0c-456b-92bb-9703c09929e1"> 8</sup> Valentina Sarao;<sup id="bdc8ab19-fa0a-426f-8623-3dec673bc6f9"> 9,10</sup> S. K. Mishra;<sup id="ffc8deeb-ad22-4ccd-b605-144060021973"> 11</sup> Osman Saatci;<sup id="57705b97-522c-46ea-b92a-e3e860e795fd"> 12</sup> Patricia Udaondo Mirete;<sup id="36a072c6-570c-4a9b-89a5-7c4d321ae55a"> 13</sup> Giuseppe Querques;<sup id="70ab3a0b-73d5-486a-b0f4-3bc91e53332f"> 14</sup> Michel Eid Farah;<sup id="2f34fb49-08d8-48ab-91d4-be8a12398bdf"> 15</sup> Paolo Lanzetta;<sup id="f0f3a6b1-e8ca-4597-b478-5ad5f5cc44ed"> 9,10</sup> J. Fernando Arevalo;<sup id="da63979b-d052-41a7-95b9-3cc6963f400e"> 16</sup> Laurent Kodjikian;<sup id="951701e8-36da-4a46-a09c-cece64e46691"> 17</sup> Jay Chhablani;<sup id="c4e8c181-cd75-4abc-9544-ff34ab6f40c2"> 7</sup> for International Ozurdex Study Group</p><p data-class="jrnlDeleted" data-affs="true" id="cf68556e-0e49-4c10-a337-52ff5ab8d387">1. Khoo Teck Puat Hospital, 90 Yishun central, Singapore 768828</p><p data-class="jrnlDeleted" data-affs="true" id="2370e795-e649-4b9b-a259-1c2f9d17c4d3">2. Vitreo-Retinal Unit, Institut Clínic d´Oftalmologia (ICOF), Hospital Clínic, Barcelona</p><p data-class="jrnlDeleted" data-affs="true" id="fe4831c2-d04b-49de-9b79-15ab1294f787">3. Westmead Hospital, Sydney, New South Wales, Australia</p><p data-class="jrnlDeleted" data-affs="true" id="2640fdbb-a99d-4540-a512-e26a68c71df4">4. Faculty of Medicine and Health Sciences, Macquarie University, New South Wales, Australia</p><p data-class="jrnlDeleted" data-affs="true" id="68d80a7a-c0e4-4cb4-9fb6-61e0e2fff3e2">5. Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia</p><p data-class="jrnlDeleted" data-affs="true" id="c0a190a8-19b5-482f-b28c-07e09bcd9eb8">6. Department of Ophthalmology, University of Leipzig, Leipzig, Germany</p><p data-class="jrnlDeleted" data-affs="true" id="1b1b0c1c-1b21-4feb-8767-092f344b21d7">7. L.V. Prasad Eye Institute, Kallam Anji Reddy Campus, Banjara Hills, HYDERABAD - 500 034</p><p data-class="jrnlDeleted" data-affs="true" id="ed4a4a19-5e02-4549-b4fe-5ba000883c6d">8. Instituto de Oftalmología y Ciencias Visuales. Escuela de Medicina. TECNOLÓGICO DE MONTERREY Monterrey, Mexico</p><p data-class="jrnlDeleted" data-affs="true" id="90647e91-5945-4520-97e3-747db860d570">9. istituto Europeo di Microchirurgia Oculare-IEMO, Udine, Italy</p><p data-class="jrnlDeleted" data-affs="true" id="b17ab974-26a4-4fe9-a023-339a9f2d8095">10. Department of Medicine-Ophthalmology, University of Udine, Udine, Italy</p><p data-class="jrnlDeleted" data-affs="true" id="2d1c70b9-29b4-4d45-b6b6-d5ec329eb78b">11. Department of Ophthalmology Command hospital, Lucknow cantt 226002, India</p><p data-class="jrnlDeleted" data-affs="true" id="51cf2098-954c-4e73-bd15-526385904f41">12. Dokuz Eylul University, İzmir,Turkey</p><p data-class="jrnlDeleted" data-affs="true" id="0b4f365e-9355-44eb-992f-95f51c0260ef">13. Ophthalmology Department, Hospital Universitario La Fe, Valencia, Spain.</p><p data-class="jrnlDeleted" data-affs="true" id="01ec36a0-2e05-465c-85f1-8a4be8ceb998">14. Department of Ophthalmology, University Vita Salute, IRCCS Ospedale San Raffaele, Via Olgettina, 60, 20132 Milan, Italy</p><p data-class="jrnlDeleted" data-affs="true" id="cdc82e1e-4eb7-40e6-aa15-c529efd4cd62">15. Departamento de Oftalmologia Escola Paulista de Medicina, UNIFESP, Diretor do Centro Oftalmológico São Paulo</p><p data-class="jrnlDeleted" data-affs="true" id="3c1fdb43-00e8-41a1-bf35-1b4696dc6a7e">16. Johns Hopkins Bayview Medical Center, Retina Division, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA</p><p data-class="jrnlDeleted" data-affs="true" id="dd2e8762-69a3-424e-b704-5e83af40a05e">17. Service d'Ophtalmologie de l'Hôpital de la Croix-Rousse CHU de LYON, Hospices Civils de Lyon &amp; Université de Lyon</p><p data-class="jrnlDeleted" id="ee1a73cb-b5fe-4f99-99fa-eee497726089">Corresponding Author:</p><p data-class="jrnlDeleted" data-style="font-family: 'Times New Roman',serif; font-size: 12.0pt; line-height: 150%; margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" fontsize="12.0" id="256e9628-bb23-4c9b-97eb-8dd07edfcf4f">Jay Chhablani, Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L V Prasad Eye Institute, Banjara Hills, Hyderabad – 34, India.</p><p data-class="jrnlDeleted" data-style="font-family: 'Times New Roman',serif; font-size: 12.0pt; line-height: 150%; margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" fontsize="12.0" id="47613f4a-1637-4e4c-ac57-1aa0326a06c0">Contact number +91-40-30612618</p><p data-class="jrnlDeleted" id="06e1e626-4455-4647-ae64-dc9a2452f119">Email: jay.chhablani@gmail.com</p><p data-class="jrnlDeleted" id="faf918ab-99de-4358-9635-cc4c87aa383d">Conflict of Interest: None</p><p data-class="jrnlDeleted" id="6997a9d2-3cd9-465f-9442-c06bf1e0c9ff">Sources of support: None</p><p data-class="jrnlDeleted" id="5d957894-7c31-4ec0-abc7-79090d3720e2">Author’s Contribution: All persons designated as authors qualify for authorship, and all those who qualify are listed. Each author has participated sufficiently in the work to take public responsibility for appropriate portions of the content.</p><p data-class="jrnlDeleted" id="f7ad0a4c-a899-4f86-8872-82d4dee64353"><span data-class="Del cts-1" id="7ae19485-a766-4a12-9bee-2d18cc2dfb69">Word Count</span></p><p data-class="jrnlDeleted" id="12bc5ff9-a73f-4be7-ae07-b6d4928758e9"><span data-class="Del cts-1" id="5c744717-5eac-4cfe-b154-99f117eb8963">Abstract: 245</span></p><p data-class="jrnlDeleted" id="71d7b974-30e6-4f99-91fb-8b0163122cb8"><span data-class="Del cts-1" id="788107bc-9331-4fcf-89ed-43f5e58d9c70">Main text: 2404</span></p><p data-class="jrnlDeleted" headweightage="47" id="536b7ba4-b2fc-4158-9ba2-011e1accf20c">SYNOPSIS</p><p data-class="jrnlDeleted" id="6327c447-662f-493d-b504-53b62a634575">This study reports the safety of <named-content id="810d88f5-bc7a-4aee-83b9-7e3b5f79404e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="33" data-match="6015" data-replace="6015" data-pattern="6015" data-tag-index="6_3">6015</named-content> injections in <named-content id="88ac0136-d8bf-4857-b7c5-f4821ed5e5e9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="52" data-match="2736" data-replace="2736" data-pattern="2736" data-tag-index="6_4">2736</named-content> eyes in real life situation. Most common side effects were cataract progression (32.5%) and intraocular pressure rise of<named-content id="162561ac-e1e7-4aa7-b2af-6b7092b19e5d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣&gt;' to '⍽&gt;'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="177" data-match="of &amp;gt;25 mmHg" data-replace=" &gt;" data-pattern=" $2" data-tag-index="6_1" data-track-change=" &amp;gt;"> &gt;</named-content><named-content id="9f27f484-6add-4464-9ea1-4788d97188aa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="179" data-match="of &amp;gt;25 mmHg" data-replace="25" data-pattern="$3" data-tag-index="6_1">25</named-content><named-content id="43c3d8b6-df73-4371-9996-eff74b495c3c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmHg' to ' mmHg'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="181" data-match="of &amp;gt;25 mmHg" data-replace=" mmHg" data-pattern=" $6" data-tag-index="6_1" data-track-change=" mmHg"> mmHg</named-content> (26.5%), with only <named-content id="4d26768a-8dfa-42f6-951f-062204cd14ec" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="206" data-match="0.5%" data-replace="0.5" data-pattern="$1" data-tag-index="6_2">0.5</named-content><named-content id="2e39ac10-5232-4e4a-ad6e-38771a416ce9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="209" data-match="0.5%" data-replace="%" data-pattern="%" data-tag-index="6_2">%</named-content> eyes required filtering surgery.</p><title data-level="1" data-class="jrnlHead1" id="fe93af67-43d2-4b49-9fec-629eee50e811"><named-content rid="1553859621115" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" content-type="jrnlQueryRef" specific-use="start" id="1e666cca-3353-46e7-8b55-7142d7c4aef1" data-answered="true"/><named-content data-cid="1553859621103" id="bbeb52e0-e675-4542-b437-1531eb8e3083" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase">INTRODUCTION</named-content><named-content data-cid="1553859621103" id="f91004ca-dae8-40ba-bf68-aefe71830692" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase">Introduction</named-content></title><p data-class="jrnlSecPara" id="ca5f7f1a-049d-4fd2-b6e2-1f357bd308cd">Intravitreal therapy has been a major milestone in ophthalmology and become one of the most commonly performed ocular procedures.<xref id="48cd025c-a0dd-4185-9e2b-b9dbd2b2d7fb" ref-type="bibr" rid="R1 R2" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="130" data-match="1 2" data-pattern="" data-tag-index="7_1" data-citation-string=" R1 R2 " data-track-change="1 2"><sup id="5496312f-101d-4539-b105-5f5139c123bc">1 2</sup></xref> Macular <named-content data-cid="1553859621056" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" id="65741bb8-7978-4925-8e74-950060542799">edema</named-content><named-content id="3564c1cd-4dce-4a5a-8d48-92a30fdfc115" data-cid="1553859621056" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="143" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="7_4" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> is one the most common vision threatening complications of various retinal diseases including diabetic retinopathy, retinal vascular occlusion, uveitis and pseudophakic cystoid macular <named-content data-cid="1553859621057" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" id="e803194d-ca2b-4f31-a8a2-c2a5838047c5">edema</named-content><named-content id="bf751db4-2ded-42ab-ac74-3e97babaf6bd" data-cid="1553859621057" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="334" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="7_5" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content>. Occurrence of macular <named-content data-cid="1553859621058" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" id="8fbbac7c-99e2-400d-8dee-9fbbd2accef2">edema</named-content><named-content id="8cfce1da-2128-4b5e-9d5d-cfed9d448fd5" data-cid="1553859621058" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="363" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="7_6" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> in these conditions is thought to be of multifactorial cause with inflammatory cytokines and <named-content id="b390783a-bcfa-4fba-8c7b-cabff71f767b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="462" data-match="vascular endothelial growth factor" data-pattern="" data-tag-index="" data-abbr="VEGF">vascular endothelial growth factor</named-content> (<named-content id="efb60947-63a2-400e-94d2-5b3e6d5d4a6b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="498" data-match=" (VEGF)" data-pattern="" data-tag-index="7_3">VEGF</named-content>) playing an important role.<xref id="a3efcbe9-1ba7-4f49-9009-5a5719281111" ref-type="bibr" rid="R3" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="531" data-match="3" data-pattern="" data-tag-index="7_2" data-citation-string=" R3 " data-track-change="3"><sup id="f3ac4c73-4d5f-4385-a979-538162d307dd">3</sup></xref></p><p data-class="jrnlSecPara" id="8c644aca-38d4-474e-8485-38cc41b0e2c5">Corticosteroids have been used to treat macular <named-content data-cid="1553859621059" id="8d57422b-7d81-47f6-9da9-4f8173edf680" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="ce9e03bd-5d0e-4877-b5fd-f0cc0bd7b9cf" data-cid="1553859621059" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="48" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="8_18" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> given its multifactorial <named-content data-cid="1553859621060" id="149e3e28-bcc2-43d6-a698-8dce34ac8108" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">etiology</named-content><named-content id="36422645-160b-47e5-b34f-23e6f9aac77d" data-cid="1553859621060" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'etiology' to 'aetiology'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="79" data-match="etiology" data-replace="aetiology" data-pattern="aetiology" data-tag-index="8_19" data-function="addTrackChanges" data-track-change="etiology" data-userid="preediting" data-username="Exeter" data-time="1553859621001">aetiology</named-content> including inflammation.<xref id="8e05117e-f68a-46ee-9a92-8721c4fbc819" ref-type="bibr" rid="R4 R5 R6 R7 R8 R9" data-citation-string=" R4 R5 R6 R7 R8 R9 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="112" data-match="4-9" data-pattern="" data-tag-index="8_1" data-track-change="4-9"><sup id="a85d0f18-c32f-46d7-b94d-711af6985c1c">4–9</sup></xref> Intravitreal triamcinolone acetonide<named-content data-cid="1554366271" id="816d349b-515f-4fb0-a086-3b4c6395b6c8" content-type="del cts-3" specific-use="1554368934717" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:38pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368934717"> (</named-content><named-content id="3df83464-64ce-4cfe-b9d6-71c9bf1deca5" data-cid="3df83464-64ce-4cfe-b9d6-71c9bf1deca5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="155" data-match=" (IVTA)" data-pattern="" data-tag-index="8_13" data-time="" data-username="" data-userid=""><named-content data-cid="1554366271" id="41ecb3ed-a402-4d1e-a5c5-515d681cc6b0" content-type="del cts-3" specific-use="1554368934717" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:38pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368934717">IVTA</named-content></named-content><named-content data-cid="1554366271" id="48f235ba-c0ed-4f89-80f5-c37487d69b45" content-type="del cts-3" specific-use="1554368934717" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:38pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368934717">)</named-content> was initially used but has a high incidence of intraocular pressure rise and cataract progression, especially in younger <named-content id="4912b3d9-2bbd-47d9-a272-6cdf35f3e883" data-cid="4912b3d9-2bbd-47d9-a272-6cdf35f3e883" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="282" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="8_16" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>.<xref id="e019c9fd-6de9-4ab7-8dd4-1d1c470fb0b8" ref-type="bibr" rid="R6 R7 R8" data-citation-string=" R6 R7 R8 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="292" data-match="6-8" data-pattern="" data-tag-index="8_2" data-track-change="6-8"><sup id="1b123fcf-22d5-4b97-93ad-9ce916b18a4c">6–8</sup></xref> The necessity of repeated monthly intravitreal anti-VEGF injections for retinal conditions paved the way for development of sustained release implants, which slowly released the drug over a <named-content id="ed0c9a59-f8e4-4786-b931-fb5bf38829ed" data-cid="ed0c9a59-f8e4-4786-b931-fb5bf38829ed" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="487" data-match="3-6-month" data-replace="3" data-pattern="$2" data-tag-index="8_9" data-time="" data-username="" data-userid="">3</named-content><named-content id="cf4753f1-dd89-4012-98c9-f7df8c1e8329" data-cid="cf4753f1-dd89-4012-98c9-f7df8c1e8329" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="488" data-match="3-6-month" data-replace="–" data-pattern="–" data-tag-index="8_9" data-track-change="-" data-time="" data-username="" data-userid=""><named-content data-cid="1554366218" id="499be8ca-a1c4-4245-a210-a91f3a4e0785" content-type="del cts-3" specific-use="1554367317496" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554367317496">–</named-content></named-content><named-content id="9955f788-3c13-4147-88c6-ff959639eaac" data-cid="9955f788-3c13-4147-88c6-ff959639eaac" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="489" data-match="3-6-month" data-replace="6" data-pattern="$4" data-tag-index="8_9" data-time="" data-username="" data-userid=""><named-content data-cid="1554366219" id="219edbb1-740a-41ce-ac34-299027a5dff3" content-type="ins cts-3" specific-use="1554367317635" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554367317635"> to </named-content>6</named-content><named-content id="f82703e8-05b4-4e95-83d5-3622a6b9dd58" data-cid="f82703e8-05b4-4e95-83d5-3622a6b9dd58" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-month' to ' month'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="490" data-match="3-6-month" data-replace=" month" data-pattern=" $5" data-tag-index="8_9" data-track-change="-month" data-time="" data-username="" data-userid=""> month</named-content> period. <named-content data-cid="1553859621030" id="05de9179-1304-4b90-8f4a-b77551556a21" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">Amongst</named-content><named-content id="cc2b5358-b93a-4740-9c41-171ffe84232c" data-cid="1553859621030" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'Amongst' to 'Among'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="505" data-match="Amongst" data-replace="Among" data-pattern="Among" data-tag-index="8_17" data-function="addTrackChanges" data-track-change="Amongst" data-userid="preediting" data-username="Exeter" data-time="1553859621001">Among</named-content> the sustained release steroid devices, dexamethasone implant (300 or 700 mcg) (Ozurdex<named-content id="70ee5e86-98cb-416d-8c34-ab7d1c8c4be0" data-cid="70ee5e86-98cb-416d-8c34-ab7d1c8c4be0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="SYM" data-track-detail="" data-tag-desc="SYM" data-tag-type="SYM" data-offset="599" data-match="®" data-replace="delete" data-pattern="delete" data-tag-index="8_14" data-time="" data-username="" data-userid=""><named-content id="71d2f881-047b-453b-9418-3bcc47bae7d7" data-cid="71d2f881-047b-453b-9418-3bcc47bae7d7" content-type="del cts-1" specific-use="1553859621001 data-cid=" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001 data-cid=">®</named-content></named-content>, Allergan Inc<named-content data-cid="1554366223" id="5d276bb2-fd7e-492a-ad52-b69f85631eb8" content-type="ins cts-3" specific-use="1554367388064" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:13pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554367388064">.</named-content>, Irvine, <named-content data-cid="1554366224" id="31a481a3-ac91-44c8-8f58-0a2ee4fd833d" content-type="del cts-3" specific-use="1554367469199" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:14pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554367469199">CA</named-content><icepaste id="8b198a4a-9b5f-49ac-8732-6af3fa00c6e3"/><named-content data-cid="1554366225" id="2d4d71b3-2f2f-42ba-b8fd-e70cce85783e" content-type="ins cts-3" specific-use="1554367476510" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:14pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554367476510">California</named-content>) is the most widely used treatment modality.<xref id="a1692195-a390-4923-b1a8-274f267e6dd0" ref-type="bibr" rid="R10 R11 R12 R13" data-citation-string=" R10 R11 R12 R13 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="677" data-match="11-13" data-pattern="" data-tag-index="8_4" data-track-change="10 11-13"><sup id="ff58e156-5705-40cd-9b98-0f061be1126d">10–13</sup></xref> Following <named-content data-cid="1554366226" id="dbe48f51-9512-4e75-9d00-e78f33ef558f" content-type="del cts-3" specific-use="1554367579581" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:16pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554367579581">FDA</named-content><icepaste id="7407118b-7cf4-4787-baec-b180394a8d35"/><named-content data-cid="1554366227" id="a1b8cf2c-9883-4fbd-9f72-ed725399c57c" content-type="ins cts-3" specific-use="1554367584597" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:16pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554367584597">Food and Drug Administration</named-content> approval in June 2014, along with macular <named-content data-cid="1553859621061" id="6b4cc804-21e7-4c60-a4b2-907ec5ca67e7" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="7c945da7-181b-432f-a250-43d86bfd607e" data-cid="1553859621061" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="740" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="8_20" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> due to retinal vascular occlusions, the use of dexamethasone implant has been extended to treat conditions such as diabetic macular <named-content data-cid="1553859621062" id="c941c8e9-0edc-46c5-96b8-0b35f17a8421" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="031f8c70-ff8d-4b50-b857-6d3d3659dd12" data-cid="1553859621062" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="878" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="8_21" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content>, non-infectious posterior uveitis pseudophakic cystoid macular <named-content data-cid="1553859621063" id="0386b965-5902-4275-97a0-637bbece54cb" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="e4e7c851-0be7-4540-95c3-92c9c2fc0a0e" data-cid="1553859621063" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="947" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="8_22" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content>.<xref id="84bc6a26-30ef-4350-82ac-069225f0329d" ref-type="bibr" rid="R6 R7 R8 R9 R14 R15 R16 R17 R18" data-citation-string=" R6 R7 R8 R9 R14 R15 R16 R17 R18 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="954" data-match="6-9 14-18" data-pattern="" data-tag-index="8_5" data-track-change="6-9 14-18"><sup id="0859fe89-82e8-49ea-9234-d251d592ef24">6–9 14–18</sup></xref></p><p data-class="jrnlSecPara" id="eb245699-388c-4f0e-b3d5-3fbb81bba14f">Efficacy and safety of dexamethasone implant in various retinal diseases has been proved in various clinical trials all over the world.<xref id="0b5cabe7-e02d-414d-9079-5dcb33b68316" ref-type="bibr" rid="R18 R19 R20 R21 R22" data-citation-string=" R18 R19 R20 R21 R22 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="136" data-match="18-22" data-pattern="" data-tag-index="9_1" data-track-change="18-22"><sup id="3b9420d8-392b-40de-b1a3-915f8a19274d">18–22</sup></xref> Clinical trials are of a stringent inclusion criteria, <named-content data-cid="1553859621031" id="b398dd60-10fa-4f68-8d7f-88ec83e77978" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow up</named-content><named-content id="aa633d96-54ca-46c3-aece-fda9d0aeeb4d" data-cid="1553859621031" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="198" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="9_19" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow-up</named-content> schedules and retreatment protocols, however, in real life, the treatment is usually <named-content data-cid="1553859621064" id="40790e48-a83e-4101-908f-17affddcb0f2" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">individualized</named-content><named-content id="221889d1-e80a-4dad-b8e2-996be6d4b798" data-cid="1553859621064" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'individualized' to 'individualised'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="293" data-match="individualized" data-replace="individualised" data-pattern="individualised" data-tag-index="9_21" data-function="addTrackChanges" data-track-change="individualized" data-userid="preediting" data-username="Exeter" data-time="1553859621001">individualised</named-content> with the need for multiple treatments in few <named-content id="689eb451-58d4-47d5-bafc-5d8838f95622" data-cid="689eb451-58d4-47d5-bafc-5d8838f95622" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="353" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="9_20" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>, longer or shorter treatment-free intervals depending on the disease <named-content data-cid="1553859621065" id="95c8dcd0-b8ab-42e4-ab92-a907ecd62eb3" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">etiology</named-content><named-content id="cb4a3b04-951b-43b1-842f-0e752f14daca" data-cid="1553859621065" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'etiology' to 'aetiology'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="431" data-match="etiology" data-replace="aetiology" data-pattern="aetiology" data-tag-index="9_22" data-function="addTrackChanges" data-track-change="etiology" data-userid="preediting" data-username="Exeter" data-time="1553859621001">aetiology</named-content> and recurrence. Increase in intraocular pressure<named-content data-cid="1554366228" id="9189250f-098a-446b-a62d-9ccab92f2a72" content-type="ins cts-3" specific-use="1554367703156" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:18pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554367703156"> (IOP)</named-content> and cataract progression are the major concerns with dexamethasone implant. Clinical trials such as ZERO and MEAD reported IOP rise of <named-content id="78aa2254-d8b1-4c25-ad77-23cfc326d418" data-cid="78aa2254-d8b1-4c25-ad77-23cfc326d418" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '20' to '20%'" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="PRE" data-offset="624" data-match="20-32% and" data-replace="20%" data-pattern="$2$6" data-tag-index="9_6" data-track-change="20" data-time="" data-username="" data-userid="">20%</named-content><named-content id="e158b78f-8d6f-4b20-aae6-a5dd14561566" data-cid="e158b78f-8d6f-4b20-aae6-a5dd14561566" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="RNG" data-offset="626" data-match="20-32% and" data-replace="–" data-pattern="–" data-tag-index="9_6" data-track-change="-" data-time="" data-username="" data-userid=""><named-content data-cid="1554366234" id="2a4184bc-f943-4ca4-953b-db93efe55e86" content-type="del cts-3" specific-use="1554367920453" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:22pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554367920453">–</named-content></named-content><named-content id="23c882c9-2b22-4bf1-9251-32fd3de3982d" data-cid="23c882c9-2b22-4bf1-9251-32fd3de3982d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="SUF" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="SUF" data-offset="627" data-match="20-32% and" data-replace="32" data-pattern="$5" data-tag-index="9_6" data-time="" data-username="" data-userid=""><named-content data-cid="1554366235" id="a7099131-96f5-41e3-9beb-f0827ee9e9e4" content-type="ins cts-3" specific-use="1554367920595" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:22pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554367920595"> to </named-content>32</named-content><named-content id="0101084a-d5f9-48c4-b147-bcc90997c95f" data-cid="0101084a-d5f9-48c4-b147-bcc90997c95f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="SREP" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="SREP" data-offset="629" data-match="20-32% and" data-replace="%" data-pattern="$6" data-tag-index="9_6" data-time="" data-username="" data-userid="">%</named-content><named-content id="66b88bbd-2b1b-45d5-a83b-4a1d6705d76f" data-cid="66b88bbd-2b1b-45d5-a83b-4a1d6705d76f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣and' to ' and'" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="UNT" data-offset="630" data-match="20-32% and" data-replace=" and" data-pattern=" $7" data-tag-index="9_6" data-track-change=" and" data-time="" data-username="" data-userid=""> and</named-content> cataract progression in <named-content id="7335f5ff-95df-4f6c-871e-4c1ac57e1f3d" data-cid="7335f5ff-95df-4f6c-871e-4c1ac57e1f3d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '64' to '64%'" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="PRE" data-offset="659" data-match="64-67% eyes" data-replace="64%" data-pattern="$2$6" data-tag-index="9_7" data-track-change="64" data-time="" data-username="" data-userid="">64%</named-content><named-content id="f5795eb7-44ea-4749-9d83-1666674af40f" data-cid="f5795eb7-44ea-4749-9d83-1666674af40f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="RNG" data-offset="661" data-match="64-67% eyes" data-replace="–" data-pattern="–" data-tag-index="9_7" data-track-change="-" data-time="" data-username="" data-userid=""><named-content data-cid="1554366239" id="c783c3bf-beef-499b-8f1e-613f899c5e20" content-type="del cts-3" specific-use="1554367926029" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:22pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554367926029">–</named-content></named-content><named-content id="f08cea58-3366-4e07-b4de-a9275132253d" data-cid="f08cea58-3366-4e07-b4de-a9275132253d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="SUF" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="SUF" data-offset="662" data-match="64-67% eyes" data-replace="67" data-pattern="$5" data-tag-index="9_7" data-time="" data-username="" data-userid=""><named-content data-cid="1554366240" id="75764e32-04bd-4137-846c-8be572bee1b8" content-type="ins cts-3" specific-use="1554367926170" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:22pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554367926170"> to </named-content>67</named-content><named-content id="9f051c6c-21f0-45ac-84e3-5da510e2fc35" data-cid="9f051c6c-21f0-45ac-84e3-5da510e2fc35" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="SREP" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="SREP" data-offset="664" data-match="64-67% eyes" data-replace="%" data-pattern="$6" data-tag-index="9_7" data-time="" data-username="" data-userid="">%</named-content><named-content id="163f5bf7-6727-4a72-a514-5eefa94661b6" data-cid="163f5bf7-6727-4a72-a514-5eefa94661b6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="UNT" data-offset="665" data-match="64-67% eyes" data-replace=" eyes" data-pattern=" $7" data-tag-index="9_7" data-time="" data-username="" data-userid=""> eyes</named-content>.<xref id="56780038-0c0b-4561-8c93-3564ebacf96c" ref-type="bibr" rid="R19 R20" data-citation-string=" R19 R20 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="672" data-match="19 20" data-pattern="" data-tag-index="9_2" data-track-change="19 20"><sup id="be635762-9582-43f8-9258-185ef2d34670">19 20</sup></xref> Real<named-content data-cid="1554366245" id="d9955281-52cb-42fa-b2e7-8bba782665f9" content-type="del cts-3" specific-use="1554368041840" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:24pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368041840"> </named-content><named-content data-cid="1554366246" id="6756bc2d-61ba-48c7-bc29-5e762976249f" content-type="ins cts-3" specific-use="1554368041986" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:24pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368041986">-</named-content>life studies by Blanc <named-content id="aaeb3788-9a92-48ee-8ab5-f1fb0d569fc5" data-cid="aaeb3788-9a92-48ee-8ab5-f1fb0d569fc5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="706" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="9_15" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="000f2543-b15d-4631-8a0c-2dfc16a37bcf">et al</italic></named-content><named-content id="847793cc-5c94-4280-bda7-803cebab309b" data-cid="847793cc-5c94-4280-bda7-803cebab309b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ETLDOT" data-track-detail="" data-tag-desc="ETLDOT" data-tag-type="ETLDOT" data-offset="711" data-match="." data-replace="delete" data-pattern="delete" data-tag-index="9_17" data-time="" data-username="" data-userid=""><named-content id="07780311-ca7b-4722-9bd6-2bb6ca536730" data-cid="07780311-ca7b-4722-9bd6-2bb6ca536730" content-type="del cts-1" specific-use="1553859621001 data-cid=" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001 data-cid=">.</named-content></named-content> and Meyer<named-content data-cid="1554366244" id="d17ac1b7-d05f-47de-a4db-42d650836c20" content-type="del cts-3" specific-use="1554368012021" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:23pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368012021"> </named-content><named-content id="b12d1723-11c6-4dfd-ab48-dae93f85f2b0" data-cid="b12d1723-11c6-4dfd-ab48-dae93f85f2b0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="723" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="9_16" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="0507abe7-b323-4e8d-a197-76816b8b2348"><named-content data-cid="1554366244" id="16aa4ae3-4ca7-4944-a529-7919af20ba28" content-type="del cts-3" specific-use="1554368012021" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:23pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368012021">et al</named-content></italic></named-content><named-content id="83be6859-23e2-4a88-993f-525a6c594491" data-cid="83be6859-23e2-4a88-993f-525a6c594491" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ETLDOT" data-track-detail="" data-tag-desc="ETLDOT" data-tag-type="ETLDOT" data-offset="728" data-match="." data-replace="delete" data-pattern="delete" data-tag-index="9_18" data-time="" data-username="" data-userid=""><named-content id="9fb85f1e-af7f-466d-907b-ce387af0feb6" data-cid="9fb85f1e-af7f-466d-907b-ce387af0feb6" content-type="del cts-1" specific-use="1553859621001 data-cid=" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001 data-cid=">.</named-content></named-content> reported <named-content id="a14875ae-a7e6-4f61-a211-4b0629cbea30" data-cid="a14875ae-a7e6-4f61-a211-4b0629cbea30" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PRE" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="PRE" data-offset="739" data-match="70.4% and 40%" data-replace="70.4" data-pattern="$2" data-tag-index="9_4" data-time="" data-username="" data-userid="">70.4</named-content><named-content id="800ec306-c0fb-415e-b339-c55276a77a35" data-cid="800ec306-c0fb-415e-b339-c55276a77a35" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PREP" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="PREP" data-offset="743" data-match="70.4% and 40%" data-replace="%" data-pattern="$3" data-tag-index="9_4" data-time="" data-username="" data-userid="">%</named-content><named-content id="7482dc42-514e-44d5-874b-e75164eeaf31" data-cid="7482dc42-514e-44d5-874b-e75164eeaf31" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNG" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="RNG" data-offset="744" data-match="70.4% and 40%" data-replace=" and " data-pattern=" $4 " data-tag-index="9_4" data-time="" data-username="" data-userid=""> and </named-content><named-content id="d0666708-eb83-4b24-840f-ad9866f44e72" data-cid="d0666708-eb83-4b24-840f-ad9866f44e72" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="VAL" data-offset="749" data-match="70.4% and 40%" data-replace="40" data-pattern="$1" data-tag-index="9_4" data-time="" data-username="" data-userid="">40</named-content><named-content id="a665b41f-4235-4a80-98fa-1eaa2f2d685d" data-cid="a665b41f-4235-4a80-98fa-1eaa2f2d685d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="UNT" data-offset="751" data-match="70.4% and 40%" data-replace="%" data-pattern="%" data-tag-index="9_4" data-time="" data-username="" data-userid="">%</named-content> of IOP rise with <named-content id="3ba77d6f-4916-491e-9dc4-19ad07d5163e" data-cid="3ba77d6f-4916-491e-9dc4-19ad07d5163e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PRE" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="PRE" data-offset="770" data-match="50% and 54.5% cataract" data-replace="50" data-pattern="$2" data-tag-index="9_5" data-time="" data-username="" data-userid="">50</named-content><named-content id="ace0b90f-09a2-4ca8-9170-162a71a7562d" data-cid="ace0b90f-09a2-4ca8-9170-162a71a7562d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PREP" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="PREP" data-offset="772" data-match="50% and 54.5% cataract" data-replace="%" data-pattern="$3" data-tag-index="9_5" data-time="" data-username="" data-userid="">%</named-content><named-content id="9af1c660-cf8d-41c6-b34f-a3f08cb321ec" data-cid="9af1c660-cf8d-41c6-b34f-a3f08cb321ec" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNG" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="RNG" data-offset="773" data-match="50% and 54.5% cataract" data-replace=" and " data-pattern=" $4 " data-tag-index="9_5" data-time="" data-username="" data-userid=""> and </named-content><named-content id="f2338b9b-dd6a-46e3-894b-e91b4d8987a7" data-cid="f2338b9b-dd6a-46e3-894b-e91b4d8987a7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="VAL" data-offset="778" data-match="50% and 54.5% cataract" data-replace="54.5" data-pattern="$1" data-tag-index="9_5" data-time="" data-username="" data-userid="">54.5</named-content><named-content id="2732b2ee-16f8-47dc-808c-320a0dbe1380" data-cid="2732b2ee-16f8-47dc-808c-320a0dbe1380" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="UNT" data-offset="782" data-match="50% and 54.5% cataract" data-replace="%" data-pattern="%" data-tag-index="9_5" data-time="" data-username="" data-userid="">%</named-content><named-content id="50ab5a18-b9b5-4e66-94f8-dd4d2023785d" data-cid="50ab5a18-b9b5-4e66-94f8-dd4d2023785d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="UNT" data-offset="783" data-match="50% and 54.5% cataract" data-replace=" cataract" data-pattern=" $7" data-tag-index="9_5" data-time="" data-username="" data-userid=""> cataract</named-content> progression respectively.<xref id="f4c2230e-f2a6-4d35-ba6d-11eb6a880ffc" ref-type="bibr" rid="R21 R22" data-citation-string=" R21 R22 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="819" data-match="21 22" data-pattern="" data-tag-index="9_3" data-track-change="21 22"><sup id="c55c42ef-e5a3-4454-b1b4-4eb0c1f707c7">21 22</sup></xref></p><p data-class="jrnlSecPara" id="a8ed14a2-0328-4c66-92be-59d68b0411e9">However, so far safety data is reported from rather small cohorts. Hence, we aimed, to evaluate the safety profile of dexamethasone implants in real-life situations in a variety of retinal conditions by pooling data from multiple <named-content data-cid="1553859621066" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" id="e263fef0-3965-4b3b-a9c6-b35c7b628e1a">centers</named-content><named-content id="ffdbc5d7-71fc-44ed-a311-16e159431bf2" data-cid="1553859621066" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'centers' to 'centres'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="230" data-match="centers" data-replace="centres" data-pattern="centres" data-tag-index="10_1" data-function="addTrackChanges" data-track-change="centers" data-userid="preediting" data-username="Exeter" data-time="1553859621001">centres</named-content> across the world.</p><title data-level="1" data-class="jrnlHead1" id="b1a1da13-24cc-4b5d-a33a-4e1de49e21e1"><named-content data-cid="1553859621104" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="3d75deae-70f1-41f8-865d-d1706677b403">METHODS</named-content><named-content data-cid="1553859621104" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="5dd70c56-43e1-4842-b806-79f51327a716">Methods</named-content></title><p data-class="jrnlSecPara" id="730f275f-75e2-4f47-95f4-c82c9068cdd0">A retrospective analysis of cases from 25 <named-content data-cid="1553859621067" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" id="f68e6068-f78f-49d8-bbc1-8ea62317138e">centers</named-content><named-content id="c3a58fa3-ba81-4fdb-89d7-8c372af66507" data-cid="1553859621067" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'centers' to 'centres'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="42" data-match="centers" data-replace="centres" data-pattern="centres" data-tag-index="11_10" data-function="addTrackChanges" data-track-change="centers" data-userid="preediting" data-username="Exeter" data-time="1553859621001">centres</named-content> across the world was carried out. <named-content id="d99efb65-2c83-4b44-bd33-920f704f7efc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'Patients' to 'Patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="84" data-match="Patients" data-replace="Patients" data-pattern="$1" data-tag-index="11_7" data-function="addTrackChanges">Patients</named-content> treated within the period of January 2012 to December 2017 were included in the study. The study adhered to the tenets of the <named-content id="a18fe6a1-9285-412c-9c88-bccfb518c45b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'Declaration of Helsinki' to 'Declaration of Helsinki'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="219" data-match="Declaration of Helsinki" data-replace="Declaration of Helsinki" data-pattern="$1" data-tag-index="11_8" data-function="addTrackChanges">Declaration of Helsinki</named-content>. Institutional review boards at each study sites approved this study. Data was collected from <named-content id="94116b00-4c3f-4849-9043-65f14bbc862f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="337" data-match="2736" data-replace="2736" data-pattern="2736" data-tag-index="11_6">2736</named-content> <named-content id="d15738ae-5ceb-464c-aef7-1669aab37c58" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="342" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="11_9" data-function="addTrackChanges">patients</named-content> who underwent intravitreal dexamethasone implant (<named-content id="a70ffd30-8576-47e2-9276-f913d3dd27f9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="401" data-match="700µg" data-replace="700" data-pattern="$1" data-tag-index="11_3">700</named-content><named-content id="066bafac-7255-43c2-a211-f2d883e71d99" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'µg' to ' µg'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="404" data-match="700µg" data-replace=" &amp;#x00B5;g" data-pattern=" $2" data-tag-index="11_3" data-track-change="µg"> µg</named-content>) for macular <named-content data-cid="1553859621068" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" id="339a8701-2bfd-48c1-8f36-48b447148616">edema</named-content><named-content id="53974d41-0d03-411e-8ca5-06f8642e4440" data-cid="1553859621068" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="421" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="11_11" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> due to various retinal pathologies including diabetic retinopathy, retinal vascular occlusion, non-infectious posterior uveitis and pseudophakic cystoid macular <named-content data-cid="1553859621069" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" id="105597a2-97d1-4526-b930-355d2c79f018">edema</named-content><named-content id="6faab4fc-3820-469b-be7f-593ad9e86b58" data-cid="1553859621069" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="588" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="11_12" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content>.</p><p data-class="jrnlSecPara" id="c8f451ff-63a1-4cb6-8de5-7e75e003829d">Inclusion criteria included eyes which underwent dexamethasone implant for any indication with at least <named-content id="413a2ad9-b56e-4896-b49d-4f0c1b4e09f4" data-cid="413a2ad9-b56e-4896-b49d-4f0c1b4e09f4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="104" data-match="6 months" data-replace="6" data-pattern="$1" data-tag-index="12_1" data-time="" data-username="" data-userid="">6</named-content><named-content id="df5fd04e-89ea-499c-81ad-565c367cef68" data-cid="df5fd04e-89ea-499c-81ad-565c367cef68" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="105" data-match="6 months" data-replace=" months" data-pattern=" $2" data-tag-index="12_1" data-time="" data-username="" data-userid=""> months</named-content> <named-content data-cid="1553859621032" id="dd5a133c-295b-410b-9813-b38979d2417c" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow up</named-content><named-content id="afc25a41-0bca-42ae-ad93-87535492f3f8" data-cid="1553859621032" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="113" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="12_3" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow-up</named-content> after the last dexamethasone implant injection. Previously treated (anti<named-content data-cid="1554366247" id="6cc16c04-1bda-43ad-b039-d1f30e44fe62" content-type="del cts-3" specific-use="1554368167806" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:26pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368167806"> </named-content><named-content data-cid="1554366248" id="c7c0d458-b56e-428f-8d9d-d26d4748f252" content-type="ins cts-3" specific-use="1554368167951" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:26pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368167951">-</named-content>VEGF<named-content data-cid="1554366249" id="1728903d-aede-4533-aef0-03aac6bc6998" content-type="del cts-3" specific-use="1554368325632" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:28pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368325632">,</named-content><named-content data-cid="1554366250" id="6f7279a3-b9bd-47ee-a2b3-edfd250f96ba" content-type="ins cts-3" specific-use="1554368325777" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:28pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368325777"> or </named-content>laser) eyes were included in the study, however, none of the study eyes were concomitantly treated with anti<named-content data-cid="1554366254" id="7cab928f-58c7-4cce-a52d-3106a7680b86" content-type="del cts-3" specific-use="1554368337319" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:28pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368337319"> </named-content><named-content data-cid="1554366255" id="64ee0e46-7bea-47f5-a59f-997f885f3783" content-type="ins cts-3" specific-use="1554368337468" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:28pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368337468">-</named-content>VEGF or laser during the study period. Eyes with concomitant treatment were not included in the study. Exclusion criteria included eyes with less than <named-content id="5a9025d2-aa14-46f0-b7e2-4dd7f551ba59" data-cid="5a9025d2-aa14-46f0-b7e2-4dd7f551ba59" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="463" data-match="6 months" data-replace="6" data-pattern="$1" data-tag-index="12_2" data-time="" data-username="" data-userid="">6</named-content><named-content id="4cf56a0b-e9f2-4a62-b022-03b6120bc8ab" data-cid="4cf56a0b-e9f2-4a62-b022-03b6120bc8ab" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="464" data-match="6 months" data-replace=" months" data-pattern=" $2" data-tag-index="12_2" data-time="" data-username="" data-userid=""> months</named-content> <named-content data-cid="1553859621033" id="ff6f22ad-989b-474f-a886-0368ff64d8b4" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow up</named-content><named-content id="2b45a47e-aedf-4ecb-8693-97d567337edb" data-cid="1553859621033" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="472" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="12_4" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow-up</named-content> and lack of data about comprehensive ophthalmic examination<named-content data-cid="1554366256" id="1faf494c-a63c-4142-a06b-ae7047cec55c" content-type="ins cts-3" specific-use="1554368356231" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:29pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368356231">.</named-content></p><p data-class="jrnlSecPara" id="86ec5ff0-bfed-4904-a9a2-2da7c447367d">The <named-content id="950c4f71-003e-4d3c-9e66-d049906ec829" data-cid="950c4f71-003e-4d3c-9e66-d049906ec829" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="4" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="13_1" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content> demographics; systemic history; previous treatment history; laterality; comprehensive ophthalmic examination details including best corrected visual acuity, phakic status, intraocular pressure recording at baseline and at the last <named-content data-cid="1553859621034" id="be646807-1cfd-4631-bc9f-9ede9a2e5639" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow up</named-content><named-content id="f73bc2e0-98fc-4d27-9cc2-debc5fc435f8" data-cid="1553859621034" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="243" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="13_2" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow-up</named-content><named-content data-cid="1554366257" id="b6173afe-5eb4-4c55-b9f2-3c5138c629de" content-type="del cts-3" specific-use="1554368426105" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:30pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368426105">;</named-content> and occurrence of any ocular or systemic adverse events during the <named-content data-cid="1553859621035" id="63508a1a-ce4a-44a4-a315-0242c358241f" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow up</named-content><named-content id="acfe451b-aa77-49ec-8025-8ceb023f963f" data-cid="1553859621035" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="321" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="13_3" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow-up</named-content> period were recorded. Details about the management of adverse event, number of injections needed and occurrence of side effects was also <named-content data-cid="1553859621070" id="e9a25344-5fa7-4d0d-b5f9-abde7e6409f0" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">analyzed</named-content><named-content id="1042c85b-fc78-4bfc-a907-971a9a85796d" data-cid="1553859621070" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'analyzed' to 'analysed'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="468" data-match="analyzed" data-replace="analysed" data-pattern="analysed" data-tag-index="13_4" data-function="addTrackChanges" data-track-change="analyzed" data-userid="preediting" data-username="Exeter" data-time="1553859621001">analysed</named-content>. The study eyes were also divided into previously treated and treatment naïve groups and a comparison between the occurrence of adverse events in these two groups was also carried out<named-content data-cid="1553860015" id="276cd19d-335b-480c-9b5f-07ccc3e3a871" content-type="del cts-2" specific-use="1553861979337" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:49pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553861979337">.</named-content><named-content data-cid="1554366259" id="c510db36-5887-40f8-82b2-05e8d6695149" content-type="del cts-3" specific-use="1554368536788" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:32pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368536788">.</named-content><named-content data-cid="1554366261" id="603d9b29-c9e4-44ef-8e80-cd42fa59b70e" content-type="ins cts-3" specific-use="1554368543084" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:32pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368543084">.</named-content></p><p data-class="jrnlSecPara" id="2b840861-fdd7-4ecc-9f61-311f9641a0fe">Intraocular pressure was recorded by the Goldman<named-content data-cid="1554366262" id="762632ea-15cd-4739-aa70-9dd4d7869476" content-type="ins cts-3" specific-use="1554368608769" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:33pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368608769">n</named-content>’s applanation tonometry and an IOP of<named-content id="6c4d7867-25be-44db-848d-e52cfd4cc6f3" data-cid="6c4d7867-25be-44db-848d-e52cfd4cc6f3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣&gt;␣' to '⍽&gt;'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="88" data-match="of &amp;gt; 25 mmHg" data-replace=" &gt;" data-pattern=" $2" data-tag-index="14_2" data-track-change=" &amp;gt; " data-time="" data-username="" data-userid=""> &gt;</named-content><named-content id="e9dd2bc3-34f2-4726-8d96-c004fe9c6285" data-cid="e9dd2bc3-34f2-4726-8d96-c004fe9c6285" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="91" data-match="of &amp;gt; 25 mmHg" data-replace="25" data-pattern="$1" data-tag-index="14_2" data-time="" data-username="" data-userid="">25</named-content><named-content id="444f947e-8c2c-4d47-af18-a03aabc0d34d" data-cid="444f947e-8c2c-4d47-af18-a03aabc0d34d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmHg' to ' mmHg'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="93" data-match="of &amp;gt; 25 mmHg" data-replace=" mmHg" data-pattern=" $2" data-tag-index="14_2" data-track-change=" mmHg" data-time="" data-username="" data-userid=""> mm<named-content data-cid="1554366263" id="a6d97962-ded4-4fdd-a78c-ed91d7cac0f6" content-type="ins cts-3" specific-use="1554368614146" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:33pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368614146"> </named-content>Hg</named-content> was considered as significant ocular hypertension.<xref id="99a06643-3b72-4b10-bd6b-aa38be59fd52" ref-type="bibr" rid="R23" data-citation-string=" R23 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="150" data-match="23" data-pattern="" data-tag-index="14_1" data-track-change="23"><sup id="3efb61da-9c8b-4ae4-aaf1-a377c0ae9a51">23</sup></xref> Best corrected visual acuity was measured in Snellen’s and was converted into logMAR for the purpose of analysis. The baseline and <named-content id="90e23f5c-a6a8-4b97-bc2b-1d4395565b40" data-cid="90e23f5c-a6a8-4b97-bc2b-1d4395565b40" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HYPPRE" data-track-detail="" data-tag-desc="HYPPRE" data-tag-type="HYPPRE" data-offset="287" data-match="post " data-pattern="" data-tag-index="14_4" data-time="" data-username="" data-userid="">post </named-content>treatment <named-content data-cid="1554366264" id="54f5a5f1-6903-4f49-a90d-69adabbd72b5" content-type="ins cts-3" specific-use="1554368824959" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:37pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368824959"><span id="e5cd71bd-80c7-442a-9578-2443d17fff54"><named-content rid="e9b27604-8f6f-43c8-939b-100be6518b4d" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="f4ea94a5-b465-4530-9d20-f9ba2cb7181a" content-type="jrnlQueryRef" specific-use="start" data-answered="true"/>best corrected visual acuity<named-content rid="e9b27604-8f6f-43c8-939b-100be6518b4d" data-class="jrnlQueryRef" data-type="end" id="9564beaf-a7d9-49d0-917f-84160352d3a8" content-type="jrnlQueryRef" specific-use="end" data-answered="true"/></span> (</named-content>BCVA<named-content data-cid="1554366267" id="e82ea404-5de6-4a51-8b14-b921f2672303" content-type="ins cts-3" specific-use="1554368829014" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:37pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368829014">)</named-content> were <named-content data-cid="1553859621071" id="9c4a27fd-85cb-4761-8cb4-2426fcf63acd" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">analyzed</named-content><named-content id="0edcd479-2e7b-45ca-9bd8-b8f981a261c1" data-cid="1553859621071" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'analyzed' to 'analysed'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="312" data-match="analyzed" data-replace="analysed" data-pattern="analysed" data-tag-index="14_5" data-function="addTrackChanges" data-track-change="analyzed" data-userid="preediting" data-username="Exeter" data-time="1553859621001">analysed</named-content> to look for statistical significance.</p><p data-class="jrnlSecPara" id="97a8afb4-b9b5-4a4e-baa1-62f61b44a9d7">Progression of cataract was determined and the number of eyes with cataract requiring surgery was also documented.<xref id="5a871a7b-e2fc-46ae-b1c2-7fc60826ba4f" ref-type="bibr" rid="R24" data-citation-string=" R24 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="115" data-match="24" data-pattern="" data-tag-index="15_1" data-track-change="24"><sup id="4a025aa0-009f-4ab0-a59e-f936e80b9bd5">24</sup></xref> Occurrence<named-content data-cid="1554366268" id="0d035993-0ca9-4731-bd21-1057403473ef" content-type="ins cts-3" specific-use="1554368897023" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:38pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554368897023"> of</named-content> other side effects like vitreous <named-content data-cid="1553859621072" id="bc1badd1-9a4e-4c09-8dff-47c23125e891" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">hemorrhage</named-content><named-content id="ddb77e6e-3668-4d72-9eaf-da9c02c2ee1a" data-cid="1553859621072" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'hemorrhage' to 'haemorrhage'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="163" data-match="hemorrhage" data-replace="haemorrhage" data-pattern="haemorrhage" data-tag-index="15_2" data-function="addTrackChanges" data-track-change="hemorrhage" data-userid="preediting" data-username="Exeter" data-time="1553859621001">haemorrhage</named-content>, retinal tears, retinal detachment, inflammation and endophthalmitis and were also recorded.</p><p data-class="jrnlSecPara" id="3dd8961c-997c-455b-83d0-839f2876d2ea">All the data was tabulated and <named-content data-cid="1553859621073" id="ffca0c39-d0ac-4bbc-9ab2-acc1fd4464e1" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">analyzed</named-content><named-content id="ac9f4318-736b-4d47-b1cc-6daf6509b1d5" data-cid="1553859621073" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'analyzed' to 'analysed'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="31" data-match="analyzed" data-replace="analysed" data-pattern="analysed" data-tag-index="16_2" data-function="addTrackChanges" data-track-change="analyzed" data-userid="preediting" data-username="Exeter" data-time="1553859621001">analysed</named-content> statistically by the statistical software using SPSS <named-content data-cid="1554366272" id="53b0cae7-ac04-43e4-9350-1930333049ab" content-type="del cts-3" specific-use="1554369000570" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:40pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369000570">v</named-content><named-content data-cid="1554366273" id="3c20be0e-a08a-4b68-ac5e-243fa05b2936" content-type="ins cts-3" specific-use="1554369000722" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:40pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369000722">V</named-content>.18.0<named-content data-cid="1554366275" id="427fe006-82a9-4d5f-95ae-599969c936a7" content-type="del cts-3" specific-use="1554369024126" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:40pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369024126"> </named-content><named-content data-cid="1554366274" id="062c209a-f507-4db2-b26a-5366a9f7c355" content-type="del cts-3" specific-use="1554369020687" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:40pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369020687">(IBM Corp., Armonk, NY, USA)</named-content>. Continuous variables were <named-content data-cid="1553859621074" id="46440af3-05d0-4a88-b476-f3dad66dd0ee" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">analyzed</named-content><named-content id="19c42bbc-afc3-4c3d-8187-f7a729ce0568" data-cid="1553859621074" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'analyzed' to 'analysed'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="156" data-match="analyzed" data-replace="analysed" data-pattern="analysed" data-tag-index="16_3" data-function="addTrackChanges" data-track-change="analyzed" data-userid="preediting" data-username="Exeter" data-time="1553859621001">analysed</named-content> using descriptive statistics while pre- and post-implantation parameters were <named-content data-cid="1553859621075" id="f2f94fa1-e8dc-4b5b-8b9e-b14f48b253f1" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">analyzed</named-content><named-content id="ae8afa52-f36a-4a13-8beb-98029dd5de65" data-cid="1553859621075" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'analyzed' to 'analysed'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="243" data-match="analyzed" data-replace="analysed" data-pattern="analysed" data-tag-index="16_4" data-function="addTrackChanges" data-track-change="analyzed" data-userid="preediting" data-username="Exeter" data-time="1553859621001">analysed</named-content> using Wilcoxon signed-rank test. <named-content data-cid="1553859621076" id="d5518045-54f1-4065-97ff-e683cc1112f2" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">Generalized</named-content><named-content id="82661a6a-f770-4c65-a34e-c12a2903a853" data-cid="1553859621076" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'Generalized' to 'Generalised'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="285" data-match="Generalized" data-replace="Generalised" data-pattern="Generalised" data-tag-index="16_5" data-function="addTrackChanges" data-track-change="Generalized" data-userid="preediting" data-username="Exeter" data-time="1553859621001">Generalised</named-content> estimated equation was used to account for correlation between eyes. Regression analysis was performed using <named-content data-cid="1554430588" id="eb3addc8-52b3-4b72-9493-009d9bff4637" content-type="ins cts-7" specific-use="1554432790982" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 2536700366" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 5 2019 8:23am" data-track-detail="" data-userid="copyeditor 2536700366" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554432790982"><span id="706af65c-db0e-40c2-93e5-d5d2f2c1864e"><named-content rid="5ef9e0f2-4347-4005-871c-12bd052e446c" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="3bc9de45-097b-4ee3-9f4c-d809e419a195" content-type="jrnlQueryRef" specific-use="start" data-answered="true"/>analysis of variance</span></named-content><named-content data-cid="1554430587" id="e070e7bc-444c-4470-b889-bc3c2217be08" content-type="del cts-7" specific-use="1554432784593" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 2536700366" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 5 2019 8:23am" data-track-detail="" data-userid="copyeditor 2536700366" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554432784593">ANOVA<named-content data-class="jrnlQueryRef" rid="5ef9e0f2-4347-4005-871c-12bd052e446c" data-type="end" id="57f7ee66-2ade-47a3-a446-df75504f2662" content-type="jrnlQueryRef" specific-use="end"/></named-content><icepaste id="a38387f1-fce5-4afb-a9e5-72704992f4b7"/> to correlate various independent variables with BCVA at final visit and cataract progression. A <named-content id="44d3e6ce-f276-4695-94a0-f478e63a0a7d" data-cid="44d3e6ce-f276-4695-94a0-f478e63a0a7d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="508" data-match="P-value &amp;lt; 0.05 was" data-replace="P-value" data-pattern="$1" data-tag-index="16_1" data-time="" data-username="" data-userid=""><named-content data-cid="1554366276" id="69a1a2bf-33bb-4344-b96e-7ac655d26ca0" content-type="del cts-3" specific-use="1554369161257" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:42pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369161257">P-</named-content><named-content data-cid="1554366277" id="be28de98-e380-47a9-a739-f747a16fa9d7" content-type="ins cts-3" specific-use="1554369161409" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:42pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369161409">p </named-content>value<named-content data-cid="1554366279" id="f9e23f34-ee83-465a-afd8-6c182965b046" content-type="ins cts-3" specific-use="1554369163621" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:42pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369163621"> </named-content></named-content><named-content id="722e49f8-a70e-4c83-8d6d-d4acb8b619c1" data-cid="722e49f8-a70e-4c83-8d6d-d4acb8b619c1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣&lt;␣' to '&lt;'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="515" data-match="P-value &amp;lt; 0.05 was" data-replace="&lt;" data-pattern="$2" data-tag-index="16_1" data-track-change=" &amp;lt; " data-time="" data-username="" data-userid="">&lt;</named-content><named-content id="a263ee64-c363-4827-a783-dc069199ac54" data-cid="a263ee64-c363-4827-a783-dc069199ac54" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="518" data-match="P-value &amp;lt; 0.05 was" data-replace="0.05" data-pattern="$3" data-tag-index="16_1" data-time="" data-username="" data-userid="">0.05</named-content> was considered statistically significant.</p><title data-level="1" data-class="jrnlHead1" id="4cc6edec-a816-41b7-bdbf-eafa6e0e56f4"><named-content data-cid="1553859621105" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="3f70dc35-f116-4b00-b003-5fea959335d2">RESULTS</named-content><named-content data-cid="1553859621105" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="494e3ab4-23b1-4ea4-9c13-c186f291b5f3">Results</named-content></title><p data-class="jrnlSecPara" id="269760f1-d769-4cf3-8ddc-ec2e2ddf4212">A total of <named-content id="9ff01fff-2e69-4d93-bf09-26a9da9244b0" data-cid="9ff01fff-2e69-4d93-bf09-26a9da9244b0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="11" data-match="2736" data-replace="2736" data-pattern="2736" data-tag-index="17_10" data-time="" data-username="" data-userid="">2736</named-content> eyes from <named-content id="443cfb12-7556-4d9c-b840-0e2754d3ea2e" data-cid="443cfb12-7556-4d9c-b840-0e2754d3ea2e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="26" data-match="1441" data-replace="1441" data-pattern="1441" data-tag-index="17_11" data-time="" data-username="" data-userid="">1441</named-content> subjects treated with <named-content id="dba21875-2e71-47de-bf82-99e69218f84c" data-cid="dba21875-2e71-47de-bf82-99e69218f84c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="53" data-match="6015" data-replace="6015" data-pattern="6015" data-tag-index="17_12" data-time="" data-username="" data-userid="">6015</named-content> dexamethasone implant injections were included. The mean age of the subjects was <named-content id="db83c79f-9261-4d61-86b1-4960e8bbad46" data-cid="db83c79f-9261-4d61-86b1-4960e8bbad46" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="139" data-match="65.7±12.9 years" data-replace="65.7" data-pattern="$1" data-tag-index="17_4" data-time="" data-username="" data-userid="">65.7</named-content><named-content id="c06c8108-bf77-4de4-9c0a-12b800e0896c" data-cid="c06c8108-bf77-4de4-9c0a-12b800e0896c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="143" data-match="65.7±12.9 years" data-replace="±" data-pattern="$2" data-tag-index="17_4" data-time="" data-username="" data-userid="">±</named-content><named-content id="540c0388-e09d-4783-bc74-75ace0589740" data-cid="540c0388-e09d-4783-bc74-75ace0589740" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="145" data-match="65.7±12.9 years" data-replace="12.9" data-pattern="$1" data-tag-index="17_4" data-time="" data-username="" data-userid="">12.9</named-content><named-content id="2875755e-7c29-4dfb-85c9-e342e593cb70" data-cid="2875755e-7c29-4dfb-85c9-e342e593cb70" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="149" data-match="65.7±12.9 years" data-replace=" years" data-pattern=" $2" data-tag-index="17_4" data-time="" data-username="" data-userid=""> years</named-content> with <named-content id="af8dfc0b-1caf-4a52-93e8-4f8891fb0fa4" data-cid="af8dfc0b-1caf-4a52-93e8-4f8891fb0fa4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="161" data-match="865 (60.64%)" data-replace="865" data-pattern="$1" data-tag-index="17_2" data-time="" data-username="" data-userid="">865</named-content><named-content id="89d49376-e065-451d-8de3-5d09bda61bcb" data-cid="89d49376-e065-451d-8de3-5d09bda61bcb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="164" data-match="865 (60.64%)" data-replace=" (60.64%)" data-pattern=" $2" data-tag-index="17_2" data-time="" data-username="" data-userid=""> (60.64%)</named-content> males and <named-content id="6e71ca91-ac8c-4534-bba0-8ac67580fbf4" data-cid="6e71ca91-ac8c-4534-bba0-8ac67580fbf4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="184" data-match="576 (39.36 %)" data-replace="576" data-pattern="$1" data-tag-index="17_3" data-time="" data-username="" data-userid="">576</named-content><named-content id="587dc9b6-48f7-4321-a952-24f1faae3596" data-cid="587dc9b6-48f7-4321-a952-24f1faae3596" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="187" data-match="576 (39.36 %)" data-replace=" (39.36 %)" data-pattern=" $2" data-tag-index="17_3" data-time="" data-username="" data-userid=""> (39.36 %)</named-content> females. The demographics of the group at baseline are described in <xref id="62819b2a-97f8-4722-bbd0-e109797223b4" ref-type="table" rid="T1" data-citation-string=" T1 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="266" data-match="Table 1" data-pattern="" data-tag-index="17_1" data-anchor="true"><named-content data-cid="1556001224045" id="4d11d752-27bd-4df8-8624-6e65e4fd99ae" content-type="del cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">Table 1</named-content><named-content data-cid="1556001224045" id="ce28060f-453e-4d2d-bc55-de4cf55c704a" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">table 1</named-content></xref>. The mean duration of follow-up was <named-content id="7a8c07cf-8807-4033-8f61-9ed1a210755f" data-cid="7a8c07cf-8807-4033-8f61-9ed1a210755f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="310" data-match="18.9±16.1 months" data-replace="18.9" data-pattern="$1" data-tag-index="17_5" data-time="" data-username="" data-userid="">18.9</named-content><named-content id="5d762080-3096-432b-b3f4-7e62502c6622" data-cid="5d762080-3096-432b-b3f4-7e62502c6622" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="314" data-match="18.9±16.1 months" data-replace="±" data-pattern="$2" data-tag-index="17_5" data-time="" data-username="" data-userid="">±</named-content><named-content id="d8ef9a50-9338-4050-bec3-e692255d8ec4" data-cid="d8ef9a50-9338-4050-bec3-e692255d8ec4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="316" data-match="18.9±16.1 months" data-replace="16.1" data-pattern="$1" data-tag-index="17_5" data-time="" data-username="" data-userid="">16.1</named-content><named-content id="d4722032-be38-4571-a43c-928b43587514" data-cid="d4722032-be38-4571-a43c-928b43587514" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="320" data-match="18.9±16.1 months" data-replace=" months" data-pattern=" $2" data-tag-index="17_5" data-time="" data-username="" data-userid=""> months</named-content> (range: <named-content id="c5a8f95d-61de-4461-89fd-203ece7d34eb" data-cid="c5a8f95d-61de-4461-89fd-203ece7d34eb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="336" data-match="6 - 102 months" data-replace="6" data-pattern="$2" data-tag-index="17_6" data-time="" data-username="" data-userid="">6</named-content><named-content id="302ea028-7f56-4fcf-9734-f40e436ea8a7" data-cid="302ea028-7f56-4fcf-9734-f40e436ea8a7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣-␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="337" data-match="6 - 102 months" data-replace="–" data-pattern="–" data-tag-index="17_6" data-track-change=" - " data-time="" data-username="" data-userid=""><named-content data-cid="1554366280" id="b6d98260-a560-43c9-8cea-ed17bb404716" content-type="del cts-3" specific-use="1554369223115" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:43pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369223115">–</named-content></named-content><named-content id="5a1e48df-ef7a-4683-85c6-af70cb16e7c2" data-cid="5a1e48df-ef7a-4683-85c6-af70cb16e7c2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="340" data-match="6 - 102 months" data-replace="102" data-pattern="$1" data-tag-index="17_6" data-time="" data-username="" data-userid=""><named-content data-cid="1554366281" id="af46d0ac-cb2d-4d31-9ba0-34a7269f1862" content-type="ins cts-3" specific-use="1554369223269" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:43pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369223269"> to </named-content>102</named-content><named-content id="c7bbeffe-74a9-4be3-8277-dffa3de4d8bc" data-cid="c7bbeffe-74a9-4be3-8277-dffa3de4d8bc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="343" data-match="6 - 102 months" data-replace=" months" data-pattern=" $2" data-tag-index="17_6" data-time="" data-username="" data-userid=""> months</named-content>).</p><table-wrap id="BLK_T1" data-id="BLK_T1" data-stream-name="a_T1" position="float"><label id="b6c173a1-c31d-4912-a15c-f69ef833adcf">Table 1</label><caption id="9b4856f3-2867-46b6-a570-6a7af336fdfe"><title id="T1" data-id="T1">Demographics, baseline characteristics and outcome parameters in the overall cohort and subgroups<named-content data-cid="1553859946" id="3c3ecbec-5d0e-4f97-b751-cdcbe2508796" content-type="del cts-2" specific-use="1553859970771" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:16pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553859970771">.</named-content></title></caption><table data-col-count="5" data-caption-link="T1" id="7a09c882-2fa5-4812-9dfe-dea469db1683" data-col-widths-px="147,91.27539999999999,91,91,91" data-table-type="doubleColumn" data-old-attributes="&quot;data-col-widths-px&quot;:&quot;107.8552,100.8552,100.8552,100.8552,100.8552&quot;;" data-changed-attributes="data-col-widths-px"><thead id="a5d59b3c-00b0-4b23-b69b-7fc69a36e4c4"><tr data-col-count="5" id="f9ba3c0d-9198-4a43-9bd1-ae1792106281"><td width="28%" data-original-border="border:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="138f5349-886d-4af1-855f-ede706ff334b" valign="bottom" data-old-attributes=""><p id="64dfccb9-e438-47b0-9463-45d7136223e3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;" data-original-alignment=" text-align: center;">Demographics</p></td><td width="18%" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="bb53e3be-ef41-41e6-971f-5e677908a652" valign="bottom" data-old-attributes=""><p id="9d7efcfc-d390-4558-9ce2-0e2f0641a8f6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;" data-original-alignment=" text-align: center;">Entire series</p></td><td width="17%" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="ae10d774-b480-4a88-9efd-9abd87d574a6" valign="bottom" data-old-attributes=""><p id="2ce1363b-6774-4ebc-b057-e7d0459e0b00" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;" data-original-alignment=" text-align: center;">Retinal venous occlusion group</p></td><td width="18%" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="4cd9883c-b429-4e38-8d23-3e37ed956322" valign="bottom" data-old-attributes=""><p id="3edeba5a-d227-4e20-b122-badb83ffe3f9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;" data-original-alignment=" text-align: center;">Diabetic macular <named-content data-cid="1553859621077" id="0bd28972-86a3-4437-9c97-e1ec78241df2" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="cd692202-4d7a-4d5b-9832-1b3c9bd19298" data-cid="1553859621077" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="17" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="116_1" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> group</p></td><td width="17%" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="c3102d3b-8be5-4268-a109-4774c92bd7a1" valign="bottom" data-old-attributes=""><p id="9d50b75b-a9c3-4a39-b41d-041c01c89652" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;" data-original-alignment=" text-align: center;">Uveitis group</p></td></tr></thead><tbody id="90f5b40b-f1ec-4642-8f6d-6e846e8f7600"><tr data-col-count="5" id="21eeaec7-fdd7-49f4-bcd0-472268079e73" data-fill="true"><td width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="a673cdd8-cb3d-4863-9969-41cb942ee612" valign="top" data-old-attributes=""><p id="9c2e1d7a-81a5-42f9-8114-0ac988a49c77" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">No of eyes</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="6a814aab-3590-4936-a97a-2d36e89a18a5" valign="top" data-old-attributes=""><p id="31517e3e-f764-4a63-84aa-216c08d2ea60" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="37b47bdd-2202-4496-8f7e-dc71a266705b" data-cid="37b47bdd-2202-4496-8f7e-dc71a266705b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="2736" data-replace="2736" data-pattern="2736" data-tag-index="119_1" data-time="" data-username="" data-userid="">2736</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="58f2300b-acd1-4074-a1a6-680a3bc3adbe" valign="top" data-old-attributes=""><p id="e2d1b314-6ff3-4985-a4ac-30b836b457e8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">526</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="9531f9a3-70bf-4ed8-9627-de331a3ced6f" valign="top" data-old-attributes=""><p id="8066cb18-69d5-4e62-8fd2-00be5f259fe6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="2c4dabcc-95ae-4644-9827-63c300016110" data-cid="2c4dabcc-95ae-4644-9827-63c300016110" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1434" data-replace="1434" data-pattern="1434" data-tag-index="121_1" data-time="" data-username="" data-userid="">1434</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="2734d850-2ca5-43cf-983e-e9f558705a20" valign="top" data-old-attributes=""><p id="81a0ca71-f94c-4ff5-b54c-a7f723596bcd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">149</p></td></tr><tr data-col-count="5" id="25b0d46a-f38c-4d4f-ad3b-9272a504572f"><td width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="ce568c83-4db5-4ee7-9b1f-327f2d8fb282" valign="top" data-old-attributes=""><p id="3b12cf8a-84b3-4b5e-8752-5061635a1756" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">No of injections</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="93cc93df-90a9-4c1d-888e-ca64a8824d9e" valign="top" data-old-attributes=""><p id="2e1c3878-91ea-49ce-868c-7c9710fc0cb1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="e40b7bc1-eacd-475e-9d42-970b42779462" data-cid="e40b7bc1-eacd-475e-9d42-970b42779462" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="6015" data-replace="6015" data-pattern="6015" data-tag-index="124_1" data-time="" data-username="" data-userid="">6015</named-content></p></td><td data-class="" width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="51331b65-c974-46fd-b5f5-c5e69f2874f4" valign="top" data-old-attributes=""><p id="46c3bba7-a452-425c-a4ec-fc6f088e145b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="18a66e47-085b-4e56-9407-7f321069ce2c" data-cid="18a66e47-085b-4e56-9407-7f321069ce2c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1861" data-replace="1861" data-pattern="1861" data-tag-index="125_1" data-time="" data-username="" data-userid="">1861</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="40c04408-1bd5-4ee6-9380-dc8e6282df04" valign="top" data-old-attributes=""><p id="01c37e74-e59a-4ec2-9817-23c1d23f6efa" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="5cc467c2-a224-4377-a399-701dfec98215" data-cid="5cc467c2-a224-4377-a399-701dfec98215" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="3104" data-replace="3104" data-pattern="3104" data-tag-index="126_1" data-time="" data-username="" data-userid="">3104</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="91b1e361-ab3e-4ff8-b063-f1a1a620a314" valign="top" data-old-attributes=""><p id="f504562b-a769-4da6-baee-d51ff8e759db" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">381</p></td></tr><tr data-col-count="5" id="98fd5c27-47b9-498c-8409-e9b04447b138" data-fill="true"><td width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="afe052e2-7cd4-4c98-81c8-0484c5406d4a" valign="top" data-old-attributes=""><p id="65936ee7-abb1-48f8-855c-7b72390d7ec1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Mean age of <named-content id="07a6cce9-cd54-4d47-a059-071c8a7310b6" data-cid="07a6cce9-cd54-4d47-a059-071c8a7310b6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="12" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="128_3" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>, mean (<named-content id="75fb9357-e64b-4388-b358-de38b0cd1bc5" data-cid="75fb9357-e64b-4388-b358-de38b0cd1bc5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="28" data-match="±SD" data-replace="±" data-pattern="$2" data-tag-index="128_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="d3126c29-e809-4faf-982f-56992c34d825" data-cid="d3126c29-e809-4faf-982f-56992c34d825" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'SD' to 'SD'" data-track-detail="" data-tag-desc="ABBRV" data-tag-type="ABBRV" data-offset="30" data-match="SD" data-replace="SD" data-pattern="SD" data-tag-index="128_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">SD</named-content>), years</p></td><td data-class="" width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="108bbfa7-1648-41e6-952e-f863fd7fd772" valign="top" data-old-attributes=""><p id="45604f05-c774-45f5-ab4e-8041a8b056f0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="bd38becb-9146-4055-b2ae-0d863a92b81d" data-cid="bd38becb-9146-4055-b2ae-0d863a92b81d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="65.7±12.9" data-replace="65.7" data-pattern="$1" data-tag-index="129_1" data-time="" data-username="" data-userid="">65.7</named-content><named-content id="48be05ad-f78a-452c-9a6b-6da7a6e0fd2e" data-cid="48be05ad-f78a-452c-9a6b-6da7a6e0fd2e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="65.7±12.9" data-replace="±" data-pattern="$2" data-tag-index="129_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="de2875e6-a410-43f9-91e4-13dffd216e16" data-cid="de2875e6-a410-43f9-91e4-13dffd216e16" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="65.7±12.9" data-replace="12.9" data-pattern="$3" data-tag-index="129_1" data-time="" data-username="" data-userid="">12.9</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="f2a43ab6-9ee1-4113-8f40-08d9aa0e47f8" valign="top" data-old-attributes=""><p id="5f5a701c-84cd-4020-abb8-244046a111e5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="57e5369d-b455-4b7a-8a25-62475d04954b" data-cid="57e5369d-b455-4b7a-8a25-62475d04954b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="64.8±12.3" data-replace="64.8" data-pattern="$1" data-tag-index="130_1" data-time="" data-username="" data-userid="">64.8</named-content><named-content id="6d5bd3ef-bd49-4e3a-bf86-9bcdc86a66c0" data-cid="6d5bd3ef-bd49-4e3a-bf86-9bcdc86a66c0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="64.8±12.3" data-replace="±" data-pattern="$2" data-tag-index="130_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="8f0f10fb-273b-4d16-89be-636fb4e73037" data-cid="8f0f10fb-273b-4d16-89be-636fb4e73037" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="64.8±12.3" data-replace="12.3" data-pattern="$3" data-tag-index="130_1" data-time="" data-username="" data-userid="">12.3</named-content></p></td><td data-class="" width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="1c8740d8-e33b-40b3-aec2-414b8c09e46d" valign="top" data-old-attributes=""><p id="93ad8c05-5926-486e-8452-f597d2e056ef" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="e451f351-ac6e-44e2-ace7-68e156d3ca0d" data-cid="e451f351-ac6e-44e2-ace7-68e156d3ca0d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="65.6±10.7" data-replace="65.6" data-pattern="$1" data-tag-index="131_1" data-time="" data-username="" data-userid="">65.6</named-content><named-content id="c7f176b2-6462-45e1-aecc-6e0b5d6eb0e6" data-cid="c7f176b2-6462-45e1-aecc-6e0b5d6eb0e6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="65.6±10.7" data-replace="±" data-pattern="$2" data-tag-index="131_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="3de29569-9f37-45d6-bd80-a17beefdca9f" data-cid="3de29569-9f37-45d6-bd80-a17beefdca9f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="65.6±10.7" data-replace="10.7" data-pattern="$3" data-tag-index="131_1" data-time="" data-username="" data-userid="">10.7</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="6fbca09e-e096-4904-99ff-0a9c19c3618e" valign="top" data-old-attributes=""><p id="d9e6164d-0237-4f35-a848-85795fda1276" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="5dad2064-0826-4466-9acc-78e1d250a25f" data-cid="5dad2064-0826-4466-9acc-78e1d250a25f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="51.6±17.3" data-replace="51.6" data-pattern="$1" data-tag-index="132_1" data-time="" data-username="" data-userid="">51.6</named-content><named-content id="6bcb960b-515f-4f90-a98c-9e6fb8fcf706" data-cid="6bcb960b-515f-4f90-a98c-9e6fb8fcf706" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="51.6±17.3" data-replace="±" data-pattern="$2" data-tag-index="132_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="fb61d2a5-4a66-4d83-9028-5b6bb1de1c1d" data-cid="fb61d2a5-4a66-4d83-9028-5b6bb1de1c1d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="51.6±17.3" data-replace="17.3" data-pattern="$3" data-tag-index="132_1" data-time="" data-username="" data-userid="">17.3</named-content></p></td></tr><tr data-col-count="5" id="b22cc896-22f0-4eb8-bd7f-d1d3b79d0b02"><td data-class="" width="100%" colspan="5" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="2cd9f3eb-9791-4e46-a436-6891edbe42e8" valign="top" data-old-attributes=""><p id="76e92d4d-c826-4ac0-bffa-121c08938267" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1553859956" id="8a9ff1cb-2da3-4cfe-81b2-e8c4387ffff6" content-type="styrm cts-2" specific-use="1553860627629" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Bold Removed by Pradheep (PREEDITOR) - Mar 29 2019 5:27pm" data-track-detail="" data-format-command="bold" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860627629" data-track-hint="Bold Removed">Sex</named-content></p></td></tr><tr data-col-count="5" id="2cd9731e-d749-4bae-a333-15f21565832f" data-fill="true"><td width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="724685b7-47e5-4178-a2df-9567d3bd92c4" valign="top" data-old-attributes=""><p id="c6f8fcb8-d7d2-4748-b7d4-429ab7e073cd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Male</p><p id="94446c4a-d1eb-46b4-a67c-bf4d7a52c7a5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Female</p></td><td data-class="" width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="e667cf10-befa-4013-b148-c7af2349b198" valign="top" data-old-attributes=""><p id="cabc0ed9-c41b-41c9-861f-f5b86c0b3f7c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="36c2ae56-6134-419f-98c0-df25af3d97c3" data-cid="36c2ae56-6134-419f-98c0-df25af3d97c3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1659" data-replace="1659" data-pattern="1659" data-tag-index="136_2" data-time="" data-username="" data-userid="">1659</named-content><named-content id="f6423127-13e4-47c9-88fc-a2421110794f" data-cid="f6423127-13e4-47c9-88fc-a2421110794f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="1659 (60.64%)" data-replace=" (60.64%)" data-pattern=" $2" data-tag-index="136_1" data-time="" data-username="" data-userid=""> (60.64%)</named-content></p><p id="dff89989-e581-4daa-8a33-1e78dca33fac" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="da776149-f2a6-4edf-b0b5-f688f34c62c5" data-cid="da776149-f2a6-4edf-b0b5-f688f34c62c5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1077" data-replace="1077" data-pattern="1077" data-tag-index="137_2" data-time="" data-username="" data-userid="">1077</named-content><named-content id="01b9a5f9-e650-44d5-a7e5-f970a66d2597" data-cid="01b9a5f9-e650-44d5-a7e5-f970a66d2597" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="1077 (39.36 %)" data-replace=" (39.36 %)" data-pattern=" $2" data-tag-index="137_1" data-time="" data-username="" data-userid=""> (39.36<named-content data-cid="1554366285" id="ebe972cc-114d-424f-82a8-2829a479a56f" content-type="del cts-3" specific-use="1554369376759" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:46pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369376759"> </named-content>%)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="0c7de25a-76cf-4af2-a344-ac85c92e30b1" valign="top" data-old-attributes=""><p id="99bcc52c-baa5-46aa-83c4-6e389a754d5c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="dd50a58e-7d15-4d24-a167-4dc0259ae7aa" data-cid="dd50a58e-7d15-4d24-a167-4dc0259ae7aa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="277 (52.6%)" data-replace="277" data-pattern="$1" data-tag-index="138_1" data-time="" data-username="" data-userid="">277</named-content><named-content id="b9cde526-0f9c-46a2-81d7-91e7cac176dc" data-cid="b9cde526-0f9c-46a2-81d7-91e7cac176dc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="277 (52.6%)" data-replace=" (52.6%)" data-pattern=" $2" data-tag-index="138_1" data-time="" data-username="" data-userid=""> (52.6%)</named-content></p><p id="59a87a2b-82a8-491b-bad0-dd5c7f2090b2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="353a7cc0-4b4a-4aa0-a13c-58867ad2d254" data-cid="353a7cc0-4b4a-4aa0-a13c-58867ad2d254" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="249 (47.3%)" data-replace="249" data-pattern="$1" data-tag-index="139_1" data-time="" data-username="" data-userid="">249</named-content><named-content id="a8782fbd-6cc8-4ddd-9243-5dd4c63d0181" data-cid="a8782fbd-6cc8-4ddd-9243-5dd4c63d0181" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="249 (47.3%)" data-replace=" (47.3%)" data-pattern=" $2" data-tag-index="139_1" data-time="" data-username="" data-userid=""> (47.3%)</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="43c32786-517e-4131-8c9e-33f8613c267a" valign="top" data-old-attributes=""><p id="f13c5a4e-3e06-4aeb-95bd-71bee8e5ca36" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="63786111-c254-4e46-9414-d0d9d42c5fd6" data-cid="63786111-c254-4e46-9414-d0d9d42c5fd6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="928 (64.7%)" data-replace="928" data-pattern="$1" data-tag-index="140_1" data-time="" data-username="" data-userid="">928</named-content><named-content id="530d4e24-a4b8-45d1-a97c-4199f482815d" data-cid="530d4e24-a4b8-45d1-a97c-4199f482815d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="928 (64.7%)" data-replace=" (64.7%)" data-pattern=" $2" data-tag-index="140_1" data-time="" data-username="" data-userid=""> (64.7%)</named-content></p><p id="ee951f13-482b-40eb-a946-6b9809adc71b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="dfb47fa1-d1e8-46cc-94f2-9d3df004079e" data-cid="dfb47fa1-d1e8-46cc-94f2-9d3df004079e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="506 (35.29%)" data-replace="506" data-pattern="$1" data-tag-index="141_1" data-time="" data-username="" data-userid="">506</named-content><named-content id="cc808dc6-dc85-470e-ac1c-1ac7b2d8ec4a" data-cid="cc808dc6-dc85-470e-ac1c-1ac7b2d8ec4a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="506 (35.29%)" data-replace=" (35.29%)" data-pattern=" $2" data-tag-index="141_1" data-time="" data-username="" data-userid=""> (35.29%)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="58623828-1157-4946-8a54-a24748c06ba8" valign="top" data-old-attributes=""><p id="d38ebd0b-b8d6-448f-993b-ea8e4aab2b13" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="8a24c2dd-6829-43b3-b38d-585636cedcf5" data-cid="8a24c2dd-6829-43b3-b38d-585636cedcf5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="63 (42.28%)" data-replace="63" data-pattern="$1" data-tag-index="142_1" data-time="" data-username="" data-userid="">63</named-content><named-content id="3560cfd1-66f1-4d2d-9b80-3645d5b4bd1e" data-cid="3560cfd1-66f1-4d2d-9b80-3645d5b4bd1e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="63 (42.28%)" data-replace=" (42.28%)" data-pattern=" $2" data-tag-index="142_1" data-time="" data-username="" data-userid=""> (42.28%)</named-content></p><p id="585d8a17-fc1a-4b90-8a39-5c7b1aad7d21" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="faa6586b-f8e8-4468-91e7-b7e1e5cdb851" data-cid="faa6586b-f8e8-4468-91e7-b7e1e5cdb851" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="86 (57.71%)" data-replace="86" data-pattern="$1" data-tag-index="143_1" data-time="" data-username="" data-userid="">86</named-content><named-content id="14272f96-803c-4e37-95e3-6a67f991d531" data-cid="14272f96-803c-4e37-95e3-6a67f991d531" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="86 (57.71%)" data-replace=" (57.71%)" data-pattern=" $2" data-tag-index="143_1" data-time="" data-username="" data-userid=""> (57.71%)</named-content></p></td></tr><tr data-col-count="5" id="36a3d111-e5ef-42a4-8d27-43472d9543de"><td data-class="" width="100%" colspan="5" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="2305b6cb-fb36-493e-b6ee-c9fe81e16517" valign="top" data-old-attributes=""><p id="604fe16d-ca16-4c27-b26f-328046bf2cd6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1553859621036" id="d9dc4d23-aa1d-4f27-931d-412c62d06dcf" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">Follow up</named-content><named-content id="1ccbb70b-ada3-4b4f-967b-038983963b12" data-cid="1553859621036" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'Follow␣up' to 'Follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="0" data-match="Follow up" data-replace="Follow-up" data-pattern="Follow-up" data-tag-index="144_1" data-function="addTrackChanges" data-track-change="Follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">Follow-up</named-content></p></td></tr><tr data-col-count="5" id="4357bea5-95a1-4076-936d-306186dd293e" data-fill="true"><td data-class="" width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d80ace98-9f2a-44fa-a790-e0e7473b6354" valign="top" data-old-attributes=""><p id="1524ef64-1868-4a41-9a45-4c7f608da3a9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Mean duration (<named-content data-cid="1554366286" id="5bbe0fa9-c495-414d-939b-c8887d9faeeb" content-type="del cts-3" specific-use="1554369397104" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:46pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369397104">M</named-content><named-content data-cid="1554366287" id="246fe65e-e27a-4eb9-ba60-169949367335" content-type="ins cts-3" specific-use="1554369397267" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:46pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369397267">m</named-content>onths)</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="9b20818f-37c5-464d-bcae-68b3d18cbe26" valign="top" data-old-attributes=""><p id="71299bef-147d-4f23-9451-6bcc11df8fb1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="82e2bba0-f771-4765-8124-0843d676c7da" data-cid="82e2bba0-f771-4765-8124-0843d676c7da" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="18.9±16.1" data-replace="18.9" data-pattern="$1" data-tag-index="146_1" data-time="" data-username="" data-userid="">18.9</named-content><named-content id="34cfaac2-2078-4fd1-9bb4-f35f06bbc389" data-cid="34cfaac2-2078-4fd1-9bb4-f35f06bbc389" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="18.9±16.1" data-replace="±" data-pattern="$2" data-tag-index="146_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="dd86cb1d-2f9e-4760-9c10-d1374c6bedd0" data-cid="dd86cb1d-2f9e-4760-9c10-d1374c6bedd0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="18.9±16.1" data-replace="16.1" data-pattern="$3" data-tag-index="146_1" data-time="" data-username="" data-userid="">16.1</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="368a53c6-4721-44fc-8977-a6154aaedb25" valign="top" data-old-attributes=""><p id="87f6ee61-fc97-4da5-a45a-6c525335910d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="354b2504-8790-40ef-a596-dac8bc56d4c5" data-cid="354b2504-8790-40ef-a596-dac8bc56d4c5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="18.6±18" data-replace="18.6" data-pattern="$1" data-tag-index="147_1" data-time="" data-username="" data-userid="">18.6</named-content><named-content id="eaa0bf08-32d7-4f3a-aa83-5cdde1f3d442" data-cid="eaa0bf08-32d7-4f3a-aa83-5cdde1f3d442" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="18.6±18" data-replace="±" data-pattern="$2" data-tag-index="147_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="017af076-7ea8-4399-b0ee-77baf85b4bf1" data-cid="017af076-7ea8-4399-b0ee-77baf85b4bf1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="18.6±18" data-replace="18" data-pattern="$3" data-tag-index="147_1" data-time="" data-username="" data-userid="">18</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="eca31007-826c-4182-a68d-befaa51f5bff" valign="top" data-old-attributes=""><p id="7b594f76-02be-403f-b2f6-c4cf2c3b6833" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="1d460f2d-a812-4f96-b414-c3a1234aae9d" data-cid="1d460f2d-a812-4f96-b414-c3a1234aae9d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="18.05±14.9" data-replace="18.05" data-pattern="$1" data-tag-index="148_1" data-time="" data-username="" data-userid="">18.05</named-content><named-content id="991c2a96-769e-42b3-a05b-bda3f84be5f1" data-cid="991c2a96-769e-42b3-a05b-bda3f84be5f1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="5" data-match="18.05±14.9" data-replace="±" data-pattern="$2" data-tag-index="148_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="0be525d3-c405-47c8-b68b-2d5f3069887a" data-cid="0be525d3-c405-47c8-b68b-2d5f3069887a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="7" data-match="18.05±14.9" data-replace="14.9" data-pattern="$3" data-tag-index="148_1" data-time="" data-username="" data-userid="">14.9</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="71213858-5926-4228-bc19-1c5debbcabc7" valign="top" data-old-attributes=""><p id="a4e7d41f-e487-4d3f-a1bf-12a56d68c09f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="329b4d21-6487-418e-aab2-16f269047ba2" data-cid="329b4d21-6487-418e-aab2-16f269047ba2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="28.3±22.4" data-replace="28.3" data-pattern="$1" data-tag-index="149_1" data-time="" data-username="" data-userid="">28.3</named-content><named-content id="aeb5193d-246f-49ae-9479-241dac3da792" data-cid="aeb5193d-246f-49ae-9479-241dac3da792" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="28.3±22.4" data-replace="±" data-pattern="$2" data-tag-index="149_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="8bf71e20-d2e4-4770-b9ef-73c290b21119" data-cid="8bf71e20-d2e4-4770-b9ef-73c290b21119" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="28.3±22.4" data-replace="22.4" data-pattern="$3" data-tag-index="149_1" data-time="" data-username="" data-userid="">22.4</named-content></p></td></tr><tr data-col-count="5" id="28f85ecb-815a-428c-b3a6-8d72084a3c3c"><td data-class="" width="100%" colspan="5" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="10582efe-1ac4-4743-9325-e7f8b86c3bd7" valign="top" data-old-attributes=""><p id="a2032505-3561-452f-9db4-74c3d2860d38" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Phakic status at baseline, n (%)</p></td></tr><tr data-col-count="5" id="50f5590b-fd43-4fed-9163-1cf509546430" data-fill="true"><td data-class="" width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="73242eea-db8f-4c0f-a543-cc6b6d4713c8" valign="top" data-old-attributes=""><p id="16cfb5a8-01da-4e80-8639-bf036e7d0eda" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Phakic</p><p id="7aba0cd4-fcf3-45e8-9bec-c7989d276e3c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Cataract at baseline</p><p id="cb7c4138-263c-4605-b3f1-0d77863eedf0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pseudophakic</p></td><td data-class="" width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="528557e0-5375-4453-b894-c85e7af5e72d" valign="top" data-old-attributes=""><p id="bc8bf801-8ad8-43c0-a1d5-5b8f9d9f00aa" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="2a5d48c8-13ca-48f7-9c17-2de63bc7409a" data-cid="2a5d48c8-13ca-48f7-9c17-2de63bc7409a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1772" data-replace="1772" data-pattern="1772" data-tag-index="154_2" data-time="" data-username="" data-userid="">1772</named-content><named-content id="e82da71d-4802-4a55-a209-5b0eba1c0c77" data-cid="e82da71d-4802-4a55-a209-5b0eba1c0c77" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="1772 (64.8" data-replace=" (64.8" data-pattern=" $2" data-tag-index="154_1" data-time="" data-username="" data-userid=""> (64.8<named-content data-cid="1554366288" id="2e7e7495-b36c-4fdd-bde4-84855a69b001" content-type="ins cts-3" specific-use="1554369409429" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:46pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369409429">)</named-content></named-content></p><p id="2a8dff2e-5344-4c72-b064-2440ae7cf18e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="64da6a8b-8eed-4d53-8d62-60f740b5817a" data-cid="64da6a8b-8eed-4d53-8d62-60f740b5817a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="597 (21.8)" data-replace="597" data-pattern="$1" data-tag-index="155_1" data-time="" data-username="" data-userid="">597</named-content><named-content id="144cc6b2-b08e-4531-be38-55b95f3373ee" data-cid="144cc6b2-b08e-4531-be38-55b95f3373ee" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="597 (21.8)" data-replace=" (21.8)" data-pattern=" $2" data-tag-index="155_1" data-time="" data-username="" data-userid=""> (21.8)</named-content></p><p id="15e28bf2-8bcd-432a-b37d-76af08ca4417" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="93ec759f-5158-4aaa-a3de-6aa3f35388c3" data-cid="93ec759f-5158-4aaa-a3de-6aa3f35388c3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="964 (35.2)" data-replace="964" data-pattern="$1" data-tag-index="156_1" data-time="" data-username="" data-userid="">964</named-content><named-content id="d096da2d-5f84-47b5-afaa-249e019d5fb8" data-cid="d096da2d-5f84-47b5-afaa-249e019d5fb8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="964 (35.2)" data-replace=" (35.2)" data-pattern=" $2" data-tag-index="156_1" data-time="" data-username="" data-userid=""> (35.2)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="08a2e7a9-a909-4262-9ead-9e957491d3d8" valign="top" data-old-attributes=""><p id="534e3cc5-870e-4e8c-9318-cccf05d944cb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="337ebd80-60e3-4f40-a71c-420508356dec" data-cid="337ebd80-60e3-4f40-a71c-420508356dec" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="407 (77.4)" data-replace="407" data-pattern="$1" data-tag-index="157_1" data-time="" data-username="" data-userid="">407</named-content><named-content id="ed95e4f9-b96d-4105-a1dd-2eece909c47d" data-cid="ed95e4f9-b96d-4105-a1dd-2eece909c47d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="407 (77.4)" data-replace=" (77.4)" data-pattern=" $2" data-tag-index="157_1" data-time="" data-username="" data-userid=""> (77.4)</named-content></p><p id="19e2601d-0eb2-480e-aa9e-e90aae4e9224" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="d2ba4556-6ba5-4a4d-8307-b5fd83eeabe5" data-cid="d2ba4556-6ba5-4a4d-8307-b5fd83eeabe5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="145 (35.6)" data-replace="145" data-pattern="$1" data-tag-index="158_1" data-time="" data-username="" data-userid="">145</named-content><named-content id="037a0feb-48b4-447a-ab5e-a738b9135737" data-cid="037a0feb-48b4-447a-ab5e-a738b9135737" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="145 (35.6)" data-replace=" (35.6)" data-pattern=" $2" data-tag-index="158_1" data-time="" data-username="" data-userid=""> (35.6)</named-content></p><p id="91832a76-6af2-4c79-a3d4-586edf34602e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="4f09d3b8-c88b-40b7-8abd-9dc0855fe7ad" data-cid="4f09d3b8-c88b-40b7-8abd-9dc0855fe7ad" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="119 (22.6)" data-replace="119" data-pattern="$1" data-tag-index="159_1" data-time="" data-username="" data-userid="">119</named-content><named-content id="a1359476-8300-4e57-9fba-7adbc590dfc2" data-cid="a1359476-8300-4e57-9fba-7adbc590dfc2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="119 (22.6)" data-replace=" (22.6)" data-pattern=" $2" data-tag-index="159_1" data-time="" data-username="" data-userid=""> (22.6)</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="eabc7cd9-bf72-4923-934c-ab3a3e2473fc" valign="top" data-old-attributes=""><p id="190c7945-4334-4c08-9dde-cfcf6de8e82c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="46ccadf7-da85-437b-b7c2-60546dea530c" data-cid="46ccadf7-da85-437b-b7c2-60546dea530c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="874 (61.0)" data-replace="874" data-pattern="$1" data-tag-index="160_1" data-time="" data-username="" data-userid="">874</named-content><named-content id="5ad3dbbb-351e-4582-8fd0-22edf204537c" data-cid="5ad3dbbb-351e-4582-8fd0-22edf204537c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="874 (61.0)" data-replace=" (61.0)" data-pattern=" $2" data-tag-index="160_1" data-time="" data-username="" data-userid=""> (61.0)</named-content></p><p id="e81896a5-3e3c-40a4-a859-0e1c5daa9065" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="c912ff04-dadb-4959-a42e-e9ea0b87e16a" data-cid="c912ff04-dadb-4959-a42e-e9ea0b87e16a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="353 (24.6)" data-replace="353" data-pattern="$1" data-tag-index="161_1" data-time="" data-username="" data-userid="">353</named-content><named-content id="efbe0c52-69a6-486e-a2a4-22260adb9241" data-cid="efbe0c52-69a6-486e-a2a4-22260adb9241" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="353 (24.6)" data-replace=" (24.6)" data-pattern=" $2" data-tag-index="161_1" data-time="" data-username="" data-userid=""> (24.6)</named-content></p><p id="5d9cb7be-7bbd-4ade-998f-1714cf565f13" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="0f47bdd4-1830-41e1-a467-93d36e0d5d7d" data-cid="0f47bdd4-1830-41e1-a467-93d36e0d5d7d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="560 (39.1)" data-replace="560" data-pattern="$1" data-tag-index="162_1" data-time="" data-username="" data-userid="">560</named-content><named-content id="411b166c-879a-4041-b07c-28d7dd801f4a" data-cid="411b166c-879a-4041-b07c-28d7dd801f4a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="560 (39.1)" data-replace=" (39.1)" data-pattern=" $2" data-tag-index="162_1" data-time="" data-username="" data-userid=""> (39.1)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="6b2dc5f1-56c4-4217-9f45-5e2fff50bea1" valign="top" data-old-attributes=""><p id="34aad15c-9243-423a-8aba-1145c6563023" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="49f6300d-9c59-4cd0-935c-e2ef31be4bbc" data-cid="49f6300d-9c59-4cd0-935c-e2ef31be4bbc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="88 (59.1)" data-replace="88" data-pattern="$1" data-tag-index="163_1" data-time="" data-username="" data-userid="">88</named-content><named-content id="36354fde-fd8d-4036-b0fb-8c12eddbf93f" data-cid="36354fde-fd8d-4036-b0fb-8c12eddbf93f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="88 (59.1)" data-replace=" (59.1)" data-pattern=" $2" data-tag-index="163_1" data-time="" data-username="" data-userid=""> (59.1)</named-content></p><p id="6e159119-c5a7-4a84-9b26-ab9301bb72f8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="69d87be8-82bb-459a-b2b5-9ece1c882a62" data-cid="69d87be8-82bb-459a-b2b5-9ece1c882a62" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="33 (22.1)" data-replace="33" data-pattern="$1" data-tag-index="164_1" data-time="" data-username="" data-userid="">33</named-content><named-content id="f369e299-1055-4a42-b2e8-556a7514c9a2" data-cid="f369e299-1055-4a42-b2e8-556a7514c9a2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="33 (22.1)" data-replace=" (22.1)" data-pattern=" $2" data-tag-index="164_1" data-time="" data-username="" data-userid=""> (22.1)</named-content></p><p id="336dd031-8600-41ce-be86-73ee94fa02c1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="ae466439-fb11-4eb4-b0a9-f1bbde8196bd" data-cid="ae466439-fb11-4eb4-b0a9-f1bbde8196bd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="61 (40.9)" data-replace="61" data-pattern="$1" data-tag-index="165_1" data-time="" data-username="" data-userid="">61</named-content><named-content id="59f4caa9-f894-4a5f-88dc-abc1665f44bd" data-cid="59f4caa9-f894-4a5f-88dc-abc1665f44bd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="61 (40.9)" data-replace=" (40.9)" data-pattern=" $2" data-tag-index="165_1" data-time="" data-username="" data-userid=""> (40.9)</named-content></p></td></tr><tr data-col-count="5" id="838f79bc-9cf3-4ab3-93c2-f29dfe2dc93b"><td data-class="" width="100%" colspan="5" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="6d687bc6-4659-4baa-8d98-c19e5d42b985" valign="top" data-old-attributes=""><p id="74055912-4936-4d91-89ef-5f03d7801de0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Cataract and need for surgery, n (%)</p></td></tr><tr data-col-count="5" id="85ddbba1-9913-4393-8286-71d6b5de000b" data-fill="true"><td width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="baf11d1c-1402-4eb0-be9b-5237a763278b" valign="top" data-old-attributes=""><p id="6966cabb-17fa-4456-ab13-51e8bcb29750" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Cataract requiring surgery</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="75570ef8-be5b-40d8-ba7d-a93249450d78" valign="top" data-old-attributes=""><p id="4a2baff1-96e6-4031-a055-107abc58f0ba" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="37c357da-dee0-4d10-8a80-63b0776b4485" data-cid="37c357da-dee0-4d10-8a80-63b0776b4485" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="576 (32.5)" data-replace="576" data-pattern="$1" data-tag-index="168_1" data-time="" data-username="" data-userid="">576</named-content><named-content id="0a79a041-9232-49ff-b665-d1497a89a18d" data-cid="0a79a041-9232-49ff-b665-d1497a89a18d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="576 (32.5)" data-replace=" (32.5)" data-pattern=" $2" data-tag-index="168_1" data-time="" data-username="" data-userid=""> (32.5)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="8752f155-6705-4b1b-96f0-0f4c554d49bf" valign="top" data-old-attributes=""><p id="089196f8-940e-4d8e-b799-974eefa1dcad" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="8c07982e-c91b-4ff7-9f50-94c6d76a0880" data-cid="8c07982e-c91b-4ff7-9f50-94c6d76a0880" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="118 (28.9)" data-replace="118" data-pattern="$1" data-tag-index="169_1" data-time="" data-username="" data-userid="">118</named-content><named-content id="d805b5cf-ee9a-43f0-8ed3-ed20fb8f50dc" data-cid="d805b5cf-ee9a-43f0-8ed3-ed20fb8f50dc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="118 (28.9)" data-replace=" (28.9)" data-pattern=" $2" data-tag-index="169_1" data-time="" data-username="" data-userid=""> (28.9)</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="0ec496b5-76fb-4ae8-b8e2-3db40cc4ba67" valign="top" data-old-attributes=""><p id="3d17e2aa-5f85-4017-812d-d33bb3bdd5e9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="bf6d5eae-c46e-4354-87f6-7c38ed423069" data-cid="bf6d5eae-c46e-4354-87f6-7c38ed423069" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="271 (31.0)" data-replace="271" data-pattern="$1" data-tag-index="170_1" data-time="" data-username="" data-userid="">271</named-content><named-content id="a504bc9a-ad0b-46b7-8b8e-9a3315389fdd" data-cid="a504bc9a-ad0b-46b7-8b8e-9a3315389fdd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="271 (31.0)" data-replace=" (31.0)" data-pattern=" $2" data-tag-index="170_1" data-time="" data-username="" data-userid=""> (31.0)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="2554d09d-e979-4898-baf6-0652df8e494c" valign="top" data-old-attributes=""><p id="b43009a9-830d-46ae-bd15-15b95b7f7dc3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="38257400-8553-4dcc-8efa-9e17e4adad2e" data-cid="38257400-8553-4dcc-8efa-9e17e4adad2e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="35 (39.8)" data-replace="35" data-pattern="$1" data-tag-index="171_1" data-time="" data-username="" data-userid="">35</named-content><named-content id="a084e1ec-65bf-4440-a979-6fb02bdeb1c6" data-cid="a084e1ec-65bf-4440-a979-6fb02bdeb1c6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="35 (39.8)" data-replace=" (39.8)" data-pattern=" $2" data-tag-index="171_1" data-time="" data-username="" data-userid=""> (39.8)</named-content></p></td></tr><tr data-col-count="5" id="33583ede-60e9-4fb1-bd7f-2eb11e0ab575"><td data-class="" width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="afa6f039-5a8a-44b2-ac1f-2c47680a1354" valign="top" data-old-attributes=""><p id="469bd07b-07d4-4d67-a1ec-dc22aa574b8f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Progression of cataract not requiring surgery</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="f95ea8ed-dde3-4e57-9f93-2af7210dd6e3" valign="top" data-old-attributes=""><p id="914e47ac-badc-4d58-b910-1d81304b0cee" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="0bd90b60-1c96-4cd2-a35b-3fcd33e385b3" data-cid="0bd90b60-1c96-4cd2-a35b-3fcd33e385b3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="259 (14.6)" data-replace="259" data-pattern="$1" data-tag-index="173_1" data-time="" data-username="" data-userid="">259</named-content><named-content id="a9659034-130c-4734-9591-fe010910f82b" data-cid="a9659034-130c-4734-9591-fe010910f82b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="259 (14.6)" data-replace=" (14.6)" data-pattern=" $2" data-tag-index="173_1" data-time="" data-username="" data-userid=""> (14.6)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="23770107-de15-4bf2-8519-6389e0d77d0f" valign="top" data-old-attributes=""><p id="28ca349b-2d36-4976-9969-d4fb849548b2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="6de964d8-c772-40e7-abea-42e34b73dec9" data-cid="6de964d8-c772-40e7-abea-42e34b73dec9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="81 (19.9)" data-replace="81" data-pattern="$1" data-tag-index="174_1" data-time="" data-username="" data-userid="">81</named-content><named-content id="da481ee2-e59c-42f3-9ce2-446cb76eb784" data-cid="da481ee2-e59c-42f3-9ce2-446cb76eb784" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="81 (19.9)" data-replace=" (19.9)" data-pattern=" $2" data-tag-index="174_1" data-time="" data-username="" data-userid=""> (19.9)</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="5c979572-5ba1-4fe1-8805-77b2e63625cd" valign="top" data-old-attributes=""><p id="3482b58f-013c-4880-92f8-56c549136f84" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="f2c42009-4f75-4cb3-91a9-8f205193381e" data-cid="f2c42009-4f75-4cb3-91a9-8f205193381e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="125 (14.3)" data-replace="125" data-pattern="$1" data-tag-index="175_1" data-time="" data-username="" data-userid="">125</named-content><named-content id="8d26d679-a496-427e-b172-9ad0d1222106" data-cid="8d26d679-a496-427e-b172-9ad0d1222106" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="125 (14.3)" data-replace=" (14.3)" data-pattern=" $2" data-tag-index="175_1" data-time="" data-username="" data-userid=""> (14.3)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="1a561d29-35c7-4623-bae3-09c08d7def09" valign="top" data-old-attributes=""><p id="82cb7554-598f-42b8-b720-00460a6daff3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="2d2ddb2c-9c98-4667-b295-ac72b1c3317e" data-cid="2d2ddb2c-9c98-4667-b295-ac72b1c3317e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="15 (17.1)" data-replace="15" data-pattern="$1" data-tag-index="176_1" data-time="" data-username="" data-userid="">15</named-content><named-content id="e811e56b-6db2-4d2e-8e63-1eb89dc8f1fb" data-cid="e811e56b-6db2-4d2e-8e63-1eb89dc8f1fb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="15 (17.1)" data-replace=" (17.1)" data-pattern=" $2" data-tag-index="176_1" data-time="" data-username="" data-userid=""> (17.1)</named-content></p></td></tr><tr data-col-count="5" id="c9186926-421e-4945-8cb2-cf4f730d22d0" data-fill="true"><td data-class="" width="100%" colspan="5" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="abc5f6e5-29d2-4b66-9556-12cd12d5fd8f" valign="top" data-old-attributes=""><p id="5f795037-7855-4608-8015-aa904a6a3472" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Glaucoma, n (%)</p></td></tr><tr data-col-count="5" id="3c3cc5db-0042-4aa3-9f2a-bb62fd908b1b"><td data-class="" width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="b4eaeb33-701c-4334-9d0f-8d32df1d898d" valign="top" data-old-attributes=""><p id="b808e292-a684-4b16-a2ef-d13dc204088d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Prior history of glaucoma</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="a36d213f-20e1-4489-9b6b-02e895bdc122" valign="top" data-old-attributes=""><p id="3933a416-5966-4390-ab48-fba2d3eb51f9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="bce473a7-fd15-43b3-9946-305618adef10" data-cid="bce473a7-fd15-43b3-9946-305618adef10" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="155 (5.8)" data-replace="155" data-pattern="$1" data-tag-index="179_1" data-time="" data-username="" data-userid="">155</named-content><named-content id="2dc4d28e-58c3-453c-9334-4e7983cbedfa" data-cid="2dc4d28e-58c3-453c-9334-4e7983cbedfa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="155 (5.8)" data-replace=" (5.8)" data-pattern=" $2" data-tag-index="179_1" data-time="" data-username="" data-userid=""> (5.8)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="09aefb93-4cff-496d-8450-014037489392" valign="top" data-old-attributes=""><p id="8353eb3f-7a8d-4cea-9a56-cae632dfbf2c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="29d79fa1-75a4-4ba1-b422-b5a3c31e3314" data-cid="29d79fa1-75a4-4ba1-b422-b5a3c31e3314" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="27 (5.1)" data-replace="27" data-pattern="$1" data-tag-index="180_1" data-time="" data-username="" data-userid="">27</named-content><named-content id="87637440-49bb-4969-9d6c-5499013f4e59" data-cid="87637440-49bb-4969-9d6c-5499013f4e59" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="27 (5.1)" data-replace=" (5.1)" data-pattern=" $2" data-tag-index="180_1" data-time="" data-username="" data-userid=""> (5.1)</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="479c61c5-b18d-405b-a954-aebb62b3fcd2" valign="top" data-old-attributes=""><p id="92dc7dec-e35d-45b9-9766-340571c54276" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="a436ccf2-0f03-4269-b5ba-c5299525a21c" data-cid="a436ccf2-0f03-4269-b5ba-c5299525a21c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="77 (5.4)" data-replace="77" data-pattern="$1" data-tag-index="181_1" data-time="" data-username="" data-userid="">77</named-content><named-content id="1971fbd7-f90a-4744-93fc-5ff732d0b3de" data-cid="1971fbd7-f90a-4744-93fc-5ff732d0b3de" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="77 (5.4)" data-replace=" (5.4)" data-pattern=" $2" data-tag-index="181_1" data-time="" data-username="" data-userid=""> (5.4)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="e84d4d5c-b084-419e-8b09-f4c8d52f157f" valign="top" data-old-attributes=""><p id="21882e7b-d5fc-4522-a129-45469a0ef95b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="a23e885a-0768-4f47-bd37-c9555c196909" data-cid="a23e885a-0768-4f47-bd37-c9555c196909" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="16 (10.7)" data-replace="16" data-pattern="$1" data-tag-index="182_1" data-time="" data-username="" data-userid="">16</named-content><named-content id="f384310f-c33d-47d5-9577-940d4fa7dcca" data-cid="f384310f-c33d-47d5-9577-940d4fa7dcca" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="16 (10.7)" data-replace=" (10.7)" data-pattern=" $2" data-tag-index="182_1" data-time="" data-username="" data-userid=""> (10.7)</named-content></p></td></tr><tr data-col-count="5" id="550bfa5c-c919-425c-9f92-dac8760523a6" data-fill="true"><td data-class="" width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="bd4d04c9-ff77-4b2c-a38f-411f1dcbb56e" valign="top" data-old-attributes=""><p id="dfe9e1e4-c945-40e4-b951-8fa7bc81ea58" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Requiring surgery</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="e7c8c7b7-2ff2-4324-acf8-be5277747e0a" valign="top" data-old-attributes=""><p id="19f804a6-8e7b-4bec-9544-2eb2fb21fefb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="334f5506-15ca-4753-a70c-91c71bbf5726" data-cid="334f5506-15ca-4753-a70c-91c71bbf5726" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="7 (4.5)" data-replace="7" data-pattern="$1" data-tag-index="184_1" data-time="" data-username="" data-userid="">7</named-content><named-content id="7e408057-4779-4568-9f7a-b4f387c1d478" data-cid="7e408057-4779-4568-9f7a-b4f387c1d478" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="7 (4.5)" data-replace=" (4.5)" data-pattern=" $2" data-tag-index="184_1" data-time="" data-username="" data-userid=""> (4.5)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="43d12c9e-835c-487b-b3d5-92cccec78208" valign="top" data-old-attributes=""><p id="4f16502a-dfdd-4643-b8cd-b6943afa4a53" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="646e1479-7012-4515-9e0e-b1447238fe00" data-cid="646e1479-7012-4515-9e0e-b1447238fe00" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (7.4)" data-replace="2" data-pattern="$1" data-tag-index="185_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="c03abe7f-ab11-4a74-b116-bb3549a4b87e" data-cid="c03abe7f-ab11-4a74-b116-bb3549a4b87e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (7.4)" data-replace=" (7.4)" data-pattern=" $2" data-tag-index="185_1" data-time="" data-username="" data-userid=""> (7.4)</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="bee1184b-877e-4841-8946-27df35f87be5" valign="top" data-old-attributes=""><p id="6bdc6320-7230-44f8-9c04-33131c9714b9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="01f728d0-76d1-48bc-8609-965d7a29f411" data-cid="01f728d0-76d1-48bc-8609-965d7a29f411" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="3 (3.9)" data-replace="3" data-pattern="$1" data-tag-index="186_1" data-time="" data-username="" data-userid="">3</named-content><named-content id="35b688cb-a78e-4dcf-826b-f3ea300105f9" data-cid="35b688cb-a78e-4dcf-826b-f3ea300105f9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="3 (3.9)" data-replace=" (3.9)" data-pattern=" $2" data-tag-index="186_1" data-time="" data-username="" data-userid=""> (3.9)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="6890ffc3-5ffe-4382-8fa2-823b918262db" valign="top" data-old-attributes=""><p id="d06580f1-5708-4bb8-b88a-8ec81552aace" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="fb1fc12a-00d6-4d90-bea7-ac7f3e2606c2" data-cid="fb1fc12a-00d6-4d90-bea7-ac7f3e2606c2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (0.1)" data-replace="2" data-pattern="$1" data-tag-index="187_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="7fc913b8-a004-47ef-8a32-51cfe7394fd9" data-cid="7fc913b8-a004-47ef-8a32-51cfe7394fd9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (0.1)" data-replace=" (0.1)" data-pattern=" $2" data-tag-index="187_1" data-time="" data-username="" data-userid=""> (0.1)</named-content></p></td></tr><tr data-col-count="5" id="5c20ff1b-61e6-4e13-9bb8-220aab068dea"><td data-class="" width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="506730bd-3ec1-44e6-8f93-f4320ae06d20" valign="top" data-old-attributes=""><p id="8a210ffd-5d02-4e98-9012-021c4a976e31" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Post injection intraocular pressure rise<named-content data-cid="1554366289" id="753ae8b3-70dc-4f54-b828-28bdadd10d12" content-type="ins cts-3" specific-use="1554369460122" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:47pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369460122"> </named-content>(new)</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="bf75b7a0-6c42-432d-8cdb-dd0c57b5aaf5" valign="top" data-old-attributes=""><p id="ce6766ca-e1ef-4ed4-bc23-1eb2a6fcacb0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="4cc367f5-d723-4eb6-a363-4b185ef0b195" data-cid="4cc367f5-d723-4eb6-a363-4b185ef0b195" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="572 (20.9)" data-replace="572" data-pattern="$1" data-tag-index="189_1" data-time="" data-username="" data-userid="">572</named-content><named-content id="cfc31efc-d183-4efe-8df2-409e27fba689" data-cid="cfc31efc-d183-4efe-8df2-409e27fba689" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="572 (20.9)" data-replace=" (20.9)" data-pattern=" $2" data-tag-index="189_1" data-time="" data-username="" data-userid=""> (20.9)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="78423e86-41b4-439c-9ea4-8bc23a504a04" valign="top" data-old-attributes=""><p id="33468bee-2a6e-4e53-946d-cc49bb5af855" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="9f450d52-0941-4553-8992-599477bf41a1" data-cid="9f450d52-0941-4553-8992-599477bf41a1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="52 (9.9)" data-replace="52" data-pattern="$1" data-tag-index="190_1" data-time="" data-username="" data-userid="">52</named-content><named-content id="90ba81fa-be7b-4eaf-9494-4505c2743940" data-cid="90ba81fa-be7b-4eaf-9494-4505c2743940" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="52 (9.9)" data-replace=" (9.9)" data-pattern=" $2" data-tag-index="190_1" data-time="" data-username="" data-userid=""> (9.9)</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="20e0a7ed-780d-4fa5-8437-d510796ff596" valign="top" data-old-attributes=""><p id="87b94b86-ee4e-4af7-93ac-8ff0edcb35c9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="e0484756-8202-4bee-9e44-b0c7e2eb42e1" data-cid="e0484756-8202-4bee-9e44-b0c7e2eb42e1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="285 (19.9)" data-replace="285" data-pattern="$1" data-tag-index="191_1" data-time="" data-username="" data-userid="">285</named-content><named-content id="52c9417b-ec4b-4bd7-83a5-18f16aa0940a" data-cid="52c9417b-ec4b-4bd7-83a5-18f16aa0940a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="285 (19.9)" data-replace=" (19.9)" data-pattern=" $2" data-tag-index="191_1" data-time="" data-username="" data-userid=""> (19.9)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="0b161b10-d576-48fb-b9be-6b99ea3e4a47" valign="top" data-old-attributes=""><p id="74303d8f-fc1d-4399-8058-be9fc45f4cc9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="7217ddbd-0994-4a63-a476-1d7a7a92bc56" data-cid="7217ddbd-0994-4a63-a476-1d7a7a92bc56" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="51 (34.2)" data-replace="51" data-pattern="$1" data-tag-index="192_1" data-time="" data-username="" data-userid="">51</named-content><named-content id="2d832e7a-cbdb-4844-a635-8135cac3b7a4" data-cid="2d832e7a-cbdb-4844-a635-8135cac3b7a4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="51 (34.2)" data-replace=" (34.2)" data-pattern=" $2" data-tag-index="192_1" data-time="" data-username="" data-userid=""> (34.2)</named-content></p></td></tr><tr data-col-count="5" id="47868142-63fc-4998-84e8-aed02925b951" data-fill="true"><td width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="5f735df8-638b-4bde-8140-fe5e0989162a" valign="top" data-old-attributes=""><p id="4136f321-cdca-4111-aeda-2aeea49991b8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not requiring treatment</p></td><td data-class="" width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="82e89a69-991f-4562-b7b9-5555dd7e7232" valign="top" data-old-attributes=""><p id="5afe2d95-b0d4-437b-b964-3a1eab66604b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="136ca980-b865-4e12-8f92-c09c3492a989" data-cid="136ca980-b865-4e12-8f92-c09c3492a989" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '27' to '27'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="27" data-pattern="" data-tag-index="194_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">27</named-content><named-content data-cid="1554366290" id="bf9cbb5b-d4f4-4ed1-a08f-a853b9faaecd" content-type="del cts-3" specific-use="1554369500549" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:48pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369500549"> eyes</named-content> (4.7)</p></td><td data-class="" width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="c6d87c60-5a91-494a-b0f8-100783a42943" valign="top" data-old-attributes=""><p id="4f5928d6-dd90-4b9a-8b9f-799571405bf7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="b2d70fad-6528-4c60-8885-571bfc387e6f" data-cid="b2d70fad-6528-4c60-8885-571bfc387e6f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="8 (15.4)" data-replace="8" data-pattern="$1" data-tag-index="195_1" data-time="" data-username="" data-userid="">8</named-content><named-content id="a6feca3e-9366-444c-8bf3-dc4539afc430" data-cid="a6feca3e-9366-444c-8bf3-dc4539afc430" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="8 (15.4)" data-replace=" (15.4)" data-pattern=" $2" data-tag-index="195_1" data-time="" data-username="" data-userid=""> (15.4)</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="5a73dfd4-92fc-4d2e-91f3-2ff53e7f2419" valign="top" data-old-attributes=""><p id="7e65df6e-cf8c-4bed-830d-79664047b7b7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="863cfa48-59b4-4ea4-8958-79e21e573f48" data-cid="863cfa48-59b4-4ea4-8958-79e21e573f48" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="15 (5.3)" data-replace="15" data-pattern="$1" data-tag-index="196_1" data-time="" data-username="" data-userid="">15</named-content><named-content id="4409286a-72da-4f72-99c1-481b821b3379" data-cid="4409286a-72da-4f72-99c1-481b821b3379" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="15 (5.3)" data-replace=" (5.3)" data-pattern=" $2" data-tag-index="196_1" data-time="" data-username="" data-userid=""> (5.3)</named-content></p></td><td data-class="" width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="71a70499-623c-4be5-9f7e-63c6ad993247" valign="top" data-old-attributes=""><p id="8da976d0-7953-42fb-8b40-061fd69fe5d1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1553859621004" id="129b6e0a-21f0-4fab-b36c-4e59e7e7f5ca" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">2</named-content><named-content id="87c4ca66-3968-4f7b-9c7b-6f0c1234aeae" data-cid="1553859621004" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="2" data-pattern="" data-tag-index="197_1" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1553859621001"><named-content data-cid="1554366291" id="dd1ff5a3-cbec-4905-94b6-d1758f0cad9f" content-type="del cts-3" specific-use="1554369506423" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:48pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369506423">two</named-content></named-content><named-content data-cid="1554366291" id="667fa5f4-8673-46a9-9242-f21b74f0cbf6" content-type="del cts-3" specific-use="1554369506423" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:48pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369506423"> eyes</named-content><named-content data-cid="1554366292" id="9b479546-8ecb-422f-9abb-d4af1498fbc2" content-type="ins cts-3" specific-use="1554369506630" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:48pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369506630">2</named-content> (3.9)</p></td></tr><tr data-col-count="5" id="2cc368a9-cbc9-4255-b060-5b6ba4ab42d0"><td data-class="" width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="546d0ac9-ae7e-426f-bc03-7cf00bc3fcc1" valign="top" data-old-attributes=""><p id="f7b62b87-5c73-4c74-8bd0-95b34c088098" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Requiring anti-glaucoma medication</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="6820dfc3-7550-45f7-86d6-b7e9a718e657" valign="top" data-old-attributes=""><p id="e0690329-d6dd-4570-8609-475729a3e666" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="b0e45168-50e8-4ade-ae3f-46cece58f251" data-cid="b0e45168-50e8-4ade-ae3f-46cece58f251" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="525 (91.8)" data-replace="525" data-pattern="$1" data-tag-index="199_1" data-time="" data-username="" data-userid="">525</named-content><named-content id="38539444-3aba-4392-8a86-0c980e80fb29" data-cid="38539444-3aba-4392-8a86-0c980e80fb29" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="525 (91.8)" data-replace=" (91.8)" data-pattern=" $2" data-tag-index="199_1" data-time="" data-username="" data-userid=""> (91.8)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="29645bab-4004-499f-8830-4fae5f56ea76" valign="top" data-old-attributes=""><p id="6c4174fe-2296-4bd5-aaa9-68290bcb2840" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="938f6dc1-d50a-42af-ac78-217ffaed2cb1" data-cid="938f6dc1-d50a-42af-ac78-217ffaed2cb1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="42 (80.8)" data-replace="42" data-pattern="$1" data-tag-index="200_1" data-time="" data-username="" data-userid="">42</named-content><named-content id="26da8f7c-9540-4b19-b029-1a496dbc6727" data-cid="26da8f7c-9540-4b19-b029-1a496dbc6727" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="42 (80.8)" data-replace=" (80.8)" data-pattern=" $2" data-tag-index="200_1" data-time="" data-username="" data-userid=""> (80.8)</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="7d162754-a254-4f3c-b688-771eb57df6bc" valign="top" data-old-attributes=""><p id="6272ea1b-b54c-45ef-a393-e8528d9a9977" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="a2856ebc-8f1b-4275-b039-83a31f147581" data-cid="a2856ebc-8f1b-4275-b039-83a31f147581" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="260 (91.2)" data-replace="260" data-pattern="$1" data-tag-index="201_1" data-time="" data-username="" data-userid="">260</named-content><named-content id="8f7eba90-8679-4ec9-b2d7-d20fb1625b22" data-cid="8f7eba90-8679-4ec9-b2d7-d20fb1625b22" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="260 (91.2)" data-replace=" (91.2)" data-pattern=" $2" data-tag-index="201_1" data-time="" data-username="" data-userid=""> (91.2)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="9072ce8d-2aee-4fb8-835f-c5ea72a8c9f1" valign="top" data-old-attributes=""><p id="d136b467-bb99-42f6-9d39-4f57cbc3c72b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="62a4d9eb-bfb3-4dcc-930d-f3c964d3e5f1" data-cid="62a4d9eb-bfb3-4dcc-930d-f3c964d3e5f1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="48 (94.1)" data-replace="48" data-pattern="$1" data-tag-index="202_1" data-time="" data-username="" data-userid="">48</named-content><named-content id="12b77d8f-3b8b-4a2d-9024-113806585928" data-cid="12b77d8f-3b8b-4a2d-9024-113806585928" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="48 (94.1)" data-replace=" (94.1)" data-pattern=" $2" data-tag-index="202_1" data-time="" data-username="" data-userid=""> (94.1)</named-content></p></td></tr><tr data-col-count="5" id="3faf9448-3e26-44fb-914f-5cd923d7b649" data-fill="true"><td width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="35e93365-062d-472f-82ea-083af26e67b1" valign="top" data-old-attributes=""><p id="194c78df-9f67-499d-bd63-7723d6324853" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Requiring surgery</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="98faffbf-91aa-46dc-b601-44386d908ec1" valign="top" data-old-attributes=""><p id="587c360e-b4f3-45ce-9a0d-fe4cb7042d86" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="66d2e157-61b8-49fc-810d-0c4e9ad7a886" data-cid="66d2e157-61b8-49fc-810d-0c4e9ad7a886" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="18 (3.1)" data-replace="18" data-pattern="$1" data-tag-index="204_1" data-time="" data-username="" data-userid="">18</named-content><named-content id="7ff94ca1-d44f-44b2-8b99-094b107c3ae2" data-cid="7ff94ca1-d44f-44b2-8b99-094b107c3ae2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="18 (3.1)" data-replace=" (3.1)" data-pattern=" $2" data-tag-index="204_1" data-time="" data-username="" data-userid=""> (3.1)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="11463244-4835-4dde-95ef-bb64ab9bbbf1" valign="top" data-old-attributes=""><p id="5f32bf4c-7753-4426-a57f-fdea4aa99de3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="380a9fd4-884c-420e-98e0-a9caf05bba6d" data-cid="380a9fd4-884c-420e-98e0-a9caf05bba6d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (3.8)" data-replace="2" data-pattern="$1" data-tag-index="205_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="aa06a227-b9c7-45de-8deb-1e07e73b0a4d" data-cid="aa06a227-b9c7-45de-8deb-1e07e73b0a4d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (3.8)" data-replace=" (3.8)" data-pattern=" $2" data-tag-index="205_1" data-time="" data-username="" data-userid=""> (3.8)</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="a74d0345-5a0c-4c3b-8cba-dc61fccf2c99" valign="top" data-old-attributes=""><p id="b8fe905e-3311-4b99-b1d4-7b4e1f39db1e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="9be49f03-01a3-40c5-8f5a-22b35e7f72c9" data-cid="9be49f03-01a3-40c5-8f5a-22b35e7f72c9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="9 (3.2)" data-replace="9" data-pattern="$1" data-tag-index="206_1" data-time="" data-username="" data-userid="">9</named-content><named-content id="6417dcb5-0b84-48a5-b0d9-c5fb5e53c21f" data-cid="6417dcb5-0b84-48a5-b0d9-c5fb5e53c21f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="9 (3.2)" data-replace=" (3.2)" data-pattern=" $2" data-tag-index="206_1" data-time="" data-username="" data-userid=""> (3.2)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="8533efd2-04e1-43c1-85a8-09c70d17325a" valign="top" data-old-attributes=""><p id="96128970-001c-41a6-bbb0-d662a00288b5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="3f6fb20d-9dc1-48ee-9525-2fb2abd7b8f5" data-cid="3f6fb20d-9dc1-48ee-9525-2fb2abd7b8f5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (1.9)" data-replace="1" data-pattern="$1" data-tag-index="207_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="93d2b1f4-2433-4246-ac62-b0a9644c3efb" data-cid="93d2b1f4-2433-4246-ac62-b0a9644c3efb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (1.9)" data-replace=" (1.9)" data-pattern=" $2" data-tag-index="207_1" data-time="" data-username="" data-userid=""> (1.9)</named-content></p></td></tr><tr data-col-count="5" id="d44f04ae-948d-4f56-a38f-b0f27f930497"><td width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="89e62181-3032-475c-9751-20dca017eabb" valign="top" data-old-attributes=""><p id="351d60cf-024e-4b34-894c-7df0f93c3652" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Requiring laser trabeculoplasty</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="9e3f81ee-f28d-4b94-9717-c7a062c65a8a" valign="top" data-old-attributes=""><p id="12661dbf-ddaf-41af-83a1-fa7d8dff6874" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="985efe0a-74f5-46a6-9c78-e974275c183d" data-cid="985efe0a-74f5-46a6-9c78-e974275c183d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (0.4)" data-replace="2" data-pattern="$1" data-tag-index="209_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="4a86788c-4ba3-4b9e-9515-f9d79023238d" data-cid="4a86788c-4ba3-4b9e-9515-f9d79023238d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (0.4)" data-replace=" (0.4)" data-pattern=" $2" data-tag-index="209_1" data-time="" data-username="" data-userid=""> (0.4)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="6a8846ca-2eac-4b42-b569-30d0a6213c4c" valign="top" data-old-attributes=""><p id="61cdd06f-4a93-48a5-ae7c-7577b4c82d61" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="80db43fe-60b6-400a-a9c7-000e58b1025b" data-cid="80db43fe-60b6-400a-a9c7-000e58b1025b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="0 (0)" data-replace="0" data-pattern="$1" data-tag-index="210_1" data-time="" data-username="" data-userid="">0</named-content><named-content id="f2ba43be-576e-417d-bf2c-23afa3fd76c9" data-cid="f2ba43be-576e-417d-bf2c-23afa3fd76c9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="0 (0)" data-replace=" (0)" data-pattern=" $2" data-tag-index="210_1" data-time="" data-username="" data-userid=""> (0)</named-content></p></td><td data-class="" width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="dc5b27e8-08de-4ad4-bf13-b1947d8ccef6" valign="top" data-old-attributes=""><p id="627fee6a-05c3-461a-adc8-08e6ddd3754f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="48b202f5-a0dd-4065-b375-ebfe224cf563" data-cid="48b202f5-a0dd-4065-b375-ebfe224cf563" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (0.3%)" data-replace="1" data-pattern="$1" data-tag-index="211_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="52fde5c9-6e7b-4b76-8cb8-c4b76ce4a87f" data-cid="52fde5c9-6e7b-4b76-8cb8-c4b76ce4a87f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (0.3%)" data-replace=" (0.3%)" data-pattern=" $2" data-tag-index="211_1" data-time="" data-username="" data-userid=""> (0.3<named-content data-cid="1554366293" id="f9e79777-41e9-4567-8846-1a76c03e4fea" content-type="del cts-3" specific-use="1554369534429" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:48pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369534429">%</named-content>)</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="a2116bf8-61dd-4114-8f17-84fd4956718e" valign="top" data-old-attributes=""><p id="c2d0f2a7-dd0d-4528-9dd3-018b493636f6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="0feb7e27-342e-409c-9b13-8fdd4e0f0299" data-cid="0feb7e27-342e-409c-9b13-8fdd4e0f0299" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="0 (0)" data-replace="0" data-pattern="$1" data-tag-index="212_1" data-time="" data-username="" data-userid="">0</named-content><named-content id="171c7536-59e1-4420-a7b8-f4b75473932c" data-cid="171c7536-59e1-4420-a7b8-f4b75473932c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="0 (0)" data-replace=" (0)" data-pattern=" $2" data-tag-index="212_1" data-time="" data-username="" data-userid=""> (0)</named-content></p></td></tr><tr data-col-count="5" id="28e90200-796a-47dd-b8e2-13dccd18b15c" data-fill="true"><td data-class="" width="100%" colspan="5" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="4e2309df-647f-4aae-bcf9-11bab5d2fd9b" valign="top" data-old-attributes=""><p id="50e34867-47a4-4bf2-ab9b-d31d02c7b90f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1553859960" id="f0883fb5-1443-404a-b1d9-48171538d3f8" content-type="styrm cts-2" specific-use="1553860646896" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Bold Removed by Pradheep (PREEDITOR) - Mar 29 2019 5:27pm" data-track-detail="" data-format-command="bold" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860646896" data-track-hint="Bold Removed">BCVA, </named-content><named-content id="419df805-7d5a-4235-9f5a-2f5ce94bdb4e" data-cid="419df805-7d5a-4235-9f5a-2f5ce94bdb4e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="6" data-match="mean ± SD" data-replace="mean" data-pattern="$1" data-tag-index="213_1" data-time="" data-username="" data-userid=""><named-content data-cid="1553859960" id="296bdf7e-cee2-4860-8f08-da0242c6bae1" content-type="styrm cts-2" specific-use="1553860646896" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Bold Removed by Pradheep (PREEDITOR) - Mar 29 2019 5:27pm" data-track-detail="" data-format-command="Bold" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860646896" data-track-hint="Bold Removed">mean</named-content></named-content><named-content id="16e42dbc-1a2f-498b-ad5d-0084458d6c76" data-cid="16e42dbc-1a2f-498b-ad5d-0084458d6c76" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣±␣' to '±'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="10" data-match="mean ± SD" data-replace="±" data-pattern="$2" data-tag-index="213_1" data-track-change=" ± " data-time="" data-username="" data-userid=""><named-content data-cid="1553859960" id="c1d246f6-7941-4f64-bf71-b3846488122f" content-type="styrm cts-2" specific-use="1553860646896" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Bold Removed by Pradheep (PREEDITOR) - Mar 29 2019 5:27pm" data-track-detail="" data-format-command="Bold" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860646896" data-track-hint="Bold Removed">±</named-content></named-content><named-content id="b078864b-2bdf-469d-8770-5454d03bcb37" data-cid="b078864b-2bdf-469d-8770-5454d03bcb37" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'SD' to 'SD'" data-track-detail="" data-tag-desc="ABBRV" data-tag-type="ABBRV" data-offset="14" data-match="SD" data-replace="SD" data-pattern="SD" data-tag-index="213_2" data-function="addTrackChanges" data-time="" data-username="" data-userid=""><named-content data-cid="1553859960" id="6eb9640f-344b-4b9e-a64d-067bac3bca2a" content-type="styrm cts-2" specific-use="1553860646896" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Bold Removed by Pradheep (PREEDITOR) - Mar 29 2019 5:27pm" data-track-detail="" data-format-command="Bold" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860646896" data-track-hint="Bold Removed">SD</named-content></named-content><named-content data-cid="1553859960" id="325d5dea-ca7f-459e-b424-340b6d62f324" content-type="styrm cts-2" specific-use="1553860646896" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Bold Removed by Pradheep (PREEDITOR) - Mar 29 2019 5:27pm" data-track-detail="" data-format-command="Bold" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860646896" data-track-hint="Bold Removed">, logMAR</named-content></p></td></tr><tr data-col-count="5" id="fceba1ed-9658-472c-8cd3-a9ff933a5997"><td data-class="" width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="2d10e95b-98f0-4421-bff1-1f45f21e46ea" valign="top" data-old-attributes=""><p id="3c301427-d8bb-4ece-9d70-23f084a56fa5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Mean <named-content data-cid="1554366294" id="20349037-9a18-45c9-b3c8-1a568d739f94" content-type="del cts-3" specific-use="1554369566658" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:49pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369566658">B</named-content><named-content data-cid="1554366295" id="e51c116e-52c7-40ae-a06f-842b243a4666" content-type="ins cts-3" specific-use="1554369566832" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:49pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369566832">b</named-content>aseline BCVA</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="5e03a866-3959-45e7-a904-2a075ae7af8d" valign="top" data-old-attributes=""><p id="8d9964a2-94dc-48cc-a165-be86486c8f51" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="4abcc191-d3b0-4c81-9577-cb76bb11725b" data-cid="4abcc191-d3b0-4c81-9577-cb76bb11725b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="0.55±0.44" data-replace="0.55" data-pattern="$1" data-tag-index="215_1" data-time="" data-username="" data-userid="">0.55</named-content><named-content id="22d1b5a4-5a85-40bb-bdaa-363e95afa706" data-cid="22d1b5a4-5a85-40bb-bdaa-363e95afa706" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="0.55±0.44" data-replace="±" data-pattern="$2" data-tag-index="215_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="50ebc4e2-32ab-4d06-857b-2a6c47acd478" data-cid="50ebc4e2-32ab-4d06-857b-2a6c47acd478" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="0.55±0.44" data-replace="0.44" data-pattern="$3" data-tag-index="215_1" data-time="" data-username="" data-userid="">0.44</named-content></p></td><td data-class="" width="17%" data-original-space="1" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="d8fec043-fc15-4dae-b055-49f9d1981716" data-emspace="1" valign="top" data-old-attributes=""><p id="5b5fad0b-e148-4561-a48f-87feee090284" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> <named-content id="cf72c6c8-aef1-4899-91c3-876ad293e883" data-cid="cf72c6c8-aef1-4899-91c3-876ad293e883" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="1" data-match="0.69±0.50" data-replace="0.69" data-pattern="$1" data-tag-index="216_1" data-time="" data-username="" data-userid="">0.69</named-content><named-content id="9d9a4e5d-da63-44c6-a1a8-85d20a174e6a" data-cid="9d9a4e5d-da63-44c6-a1a8-85d20a174e6a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="5" data-match="0.69±0.50" data-replace="±" data-pattern="$2" data-tag-index="216_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="f47ddc8d-6032-4138-93a4-90fe5d6a4043" data-cid="f47ddc8d-6032-4138-93a4-90fe5d6a4043" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="7" data-match="0.69±0.50" data-replace="0.50" data-pattern="$3" data-tag-index="216_1" data-time="" data-username="" data-userid="">0.50</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="350ded76-6a20-44cf-9d65-d90c2ce70814" valign="top" data-old-attributes=""><p id="9a6fc71e-4d4b-41b8-a592-681d1e22dd94" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="b3bb3bf1-f119-4aa4-9657-9528cd425e3e" data-cid="b3bb3bf1-f119-4aa4-9657-9528cd425e3e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="0.53±0.39" data-replace="0.53" data-pattern="$1" data-tag-index="217_1" data-time="" data-username="" data-userid="">0.53</named-content><named-content id="e96e627c-170e-49eb-a811-3ef781330570" data-cid="e96e627c-170e-49eb-a811-3ef781330570" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="0.53±0.39" data-replace="±" data-pattern="$2" data-tag-index="217_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="4d21c9ec-f74f-4d8c-a376-0fe10c430820" data-cid="4d21c9ec-f74f-4d8c-a376-0fe10c430820" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="0.53±0.39" data-replace="0.39" data-pattern="$3" data-tag-index="217_1" data-time="" data-username="" data-userid="">0.39</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="a8c7018b-a887-40d7-9abb-616ca1d2d7e5" valign="top" data-old-attributes=""><p id="0dff5bf4-4977-4c5c-8771-c0d6dda34ea1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="0444d465-bf6f-45a5-8829-b317089c419b" data-cid="0444d465-bf6f-45a5-8829-b317089c419b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="0.49±0.39" data-replace="0.49" data-pattern="$1" data-tag-index="218_1" data-time="" data-username="" data-userid="">0.49</named-content><named-content id="b102ca71-e7e6-4f8a-b4b6-f9d86c6dd34c" data-cid="b102ca71-e7e6-4f8a-b4b6-f9d86c6dd34c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="0.49±0.39" data-replace="±" data-pattern="$2" data-tag-index="218_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="8d1a091f-d766-41e4-982c-348b2c33e68f" data-cid="8d1a091f-d766-41e4-982c-348b2c33e68f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="0.49±0.39" data-replace="0.39" data-pattern="$3" data-tag-index="218_1" data-time="" data-username="" data-userid="">0.39</named-content></p></td></tr><tr data-col-count="5" id="912324a0-23e8-47f2-ac67-091a82cbac49" data-fill="true"><td width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="f9c44ed4-d855-433e-92ee-6476111d1a67" valign="top" data-old-attributes=""><p id="c43910ae-08a5-4586-b230-a28e103f7915" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Mean BCVA at last <named-content data-cid="1553859621037" id="d5e1b7e1-3100-4246-ab07-2341215f3d05" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow up</named-content><named-content id="a392cdbe-ad6b-4757-9cf0-f878e106efdb" data-cid="1553859621037" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="18" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="219_1" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow-up</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="97d07bee-2e06-4a57-bf83-4a140431da65" valign="top" data-old-attributes=""><p id="3a41d2a5-b1b5-4c56-9349-af9998796dbe" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="5988314d-2e3c-4e5f-8815-907f79514699" data-cid="5988314d-2e3c-4e5f-8815-907f79514699" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="0.55±0.44" data-replace="0.55" data-pattern="$1" data-tag-index="220_1" data-time="" data-username="" data-userid="">0.55</named-content><named-content id="db8bf39c-b05a-4168-8fe4-652f07d51ce2" data-cid="db8bf39c-b05a-4168-8fe4-652f07d51ce2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="0.55±0.44" data-replace="±" data-pattern="$2" data-tag-index="220_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="ae575b62-683e-4e04-94ab-933d2a14ca28" data-cid="ae575b62-683e-4e04-94ab-933d2a14ca28" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="0.55±0.44" data-replace="0.44" data-pattern="$3" data-tag-index="220_1" data-time="" data-username="" data-userid="">0.44</named-content></p></td><td width="17%" data-original-space="1" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="bd6fc39f-cf6f-4fcf-aead-434bea77a803" data-emspace="1" valign="top" data-old-attributes=""><p id="58a870fc-0303-4f5e-a527-22b0f82719f5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> <named-content id="160a29aa-7dd6-4f5a-94aa-76dd92c079cd" data-cid="160a29aa-7dd6-4f5a-94aa-76dd92c079cd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="1" data-match="0.61±0.51" data-replace="0.61" data-pattern="$1" data-tag-index="221_1" data-time="" data-username="" data-userid="">0.61</named-content><named-content id="83dc3c47-1843-4286-8870-5e20e0f5c2ff" data-cid="83dc3c47-1843-4286-8870-5e20e0f5c2ff" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="5" data-match="0.61±0.51" data-replace="±" data-pattern="$2" data-tag-index="221_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="d33a36b5-db81-4e07-8157-7dd8ea09254b" data-cid="d33a36b5-db81-4e07-8157-7dd8ea09254b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="7" data-match="0.61±0.51" data-replace="0.51" data-pattern="$3" data-tag-index="221_1" data-time="" data-username="" data-userid="">0.51</named-content></p></td><td data-class="" width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="ce4c36ce-0267-4fe8-8c39-7bd3571ee073" valign="top" data-old-attributes=""><p id="93817ab7-b215-49be-9bc2-0360ff2abf5f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="cddaca98-beef-4523-8ecc-702b5674c863" data-cid="cddaca98-beef-4523-8ecc-702b5674c863" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="0.51±0.376" data-replace="0.51" data-pattern="$1" data-tag-index="222_1" data-time="" data-username="" data-userid="">0.51</named-content><named-content id="c626f7f1-d738-48f1-82a0-1dcdbc945130" data-cid="c626f7f1-d738-48f1-82a0-1dcdbc945130" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="0.51±0.376" data-replace="±" data-pattern="$2" data-tag-index="222_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="99c7799c-856d-485f-8b42-220b55c020f7" data-cid="99c7799c-856d-485f-8b42-220b55c020f7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="0.51±0.376" data-replace="0.376" data-pattern="$3" data-tag-index="222_1" data-time="" data-username="" data-userid="">0.376</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="66b6b072-e263-4e5b-aacf-c79d2a96356d" valign="top" data-old-attributes=""><p id="f4d4f72a-be44-4b71-8dd9-4c9feb598750" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="61070170-fc22-46bd-9f72-00faf1abff42" data-cid="61070170-fc22-46bd-9f72-00faf1abff42" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="0.53±0.40" data-replace="0.53" data-pattern="$1" data-tag-index="223_1" data-time="" data-username="" data-userid="">0.53</named-content><named-content id="4bd34faa-4ec1-401c-b1da-9816203c0a48" data-cid="4bd34faa-4ec1-401c-b1da-9816203c0a48" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="0.53±0.40" data-replace="±" data-pattern="$2" data-tag-index="223_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="8220627d-1bb8-4fe5-91c7-e21d8581b783" data-cid="8220627d-1bb8-4fe5-91c7-e21d8581b783" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="0.53±0.40" data-replace="0.40" data-pattern="$3" data-tag-index="223_1" data-time="" data-username="" data-userid="">0.40</named-content></p></td></tr><tr data-col-count="5" id="5e3750d3-d4b6-4873-a87b-d717ec505606"><td width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="8f511446-d041-45b1-91ac-c6ecafb169a8" valign="top" data-old-attributes=""><p id="f1141aa4-8be2-4667-a95e-788d6ac5e23f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Mean BCVA change</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="2f83ebb1-5f99-42d1-944b-1286e3cf1758" valign="top" data-old-attributes=""><p id="a2b1e776-3336-41bc-a190-f79f62124105" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="a2b45f23-b4bb-4c92-a9aa-24872d8120ea" data-cid="a2b45f23-b4bb-4c92-a9aa-24872d8120ea" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="0.007±0.46" data-replace="0.007" data-pattern="$1" data-tag-index="225_1" data-time="" data-username="" data-userid="">0.007</named-content><named-content id="1920d66c-0b26-43b8-a4ae-d5b53b220e2b" data-cid="1920d66c-0b26-43b8-a4ae-d5b53b220e2b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="5" data-match="0.007±0.46" data-replace="±" data-pattern="$2" data-tag-index="225_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="6a75b020-21be-4b12-b862-505746cb9403" data-cid="6a75b020-21be-4b12-b862-505746cb9403" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="7" data-match="0.007±0.46" data-replace="0.46" data-pattern="$3" data-tag-index="225_1" data-time="" data-username="" data-userid="">0.46</named-content></p></td><td width="17%" data-original-space="1" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="b5e10585-5bfb-4f57-b563-aaee5cdc3d37" data-emspace="1" valign="top" data-old-attributes=""><p id="18a3c172-74de-41a4-9dc5-5ea1c1ec778b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> <named-content id="6c941df5-8d55-40a9-9df6-ca9539683f8f" data-cid="6c941df5-8d55-40a9-9df6-ca9539683f8f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="1" data-match="0.09±0.53" data-replace="0.09" data-pattern="$1" data-tag-index="226_1" data-time="" data-username="" data-userid="">0.09</named-content><named-content id="bc099288-e804-473d-8a62-79faa553d5ba" data-cid="bc099288-e804-473d-8a62-79faa553d5ba" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="5" data-match="0.09±0.53" data-replace="±" data-pattern="$2" data-tag-index="226_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="dc7cc681-b5c4-4276-9d87-62481e4fea51" data-cid="dc7cc681-b5c4-4276-9d87-62481e4fea51" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="7" data-match="0.09±0.53" data-replace="0.53" data-pattern="$3" data-tag-index="226_1" data-time="" data-username="" data-userid="">0.53</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="42c1039c-dc39-4d95-a010-2558585f0fff" valign="top" data-old-attributes=""><p id="c52e6806-ae54-41ea-96f1-3e26157fedba" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="11766486-b0c4-4580-aa7f-921a71cfd2b9" data-cid="11766486-b0c4-4580-aa7f-921a71cfd2b9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="0.02±0.388" data-replace="0.02" data-pattern="$1" data-tag-index="227_1" data-time="" data-username="" data-userid="">0.02</named-content><named-content id="758a8848-001d-409d-9c3a-e2cc830c438d" data-cid="758a8848-001d-409d-9c3a-e2cc830c438d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="0.02±0.388" data-replace="±" data-pattern="$2" data-tag-index="227_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="0bf6dbc7-b7cd-4af4-be40-ac015a3dd691" data-cid="0bf6dbc7-b7cd-4af4-be40-ac015a3dd691" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="0.02±0.388" data-replace="0.388" data-pattern="$3" data-tag-index="227_1" data-time="" data-username="" data-userid="">0.388</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="d968b3b8-fb79-4cd1-a94e-99d92032e129" valign="top" data-old-attributes=""><p id="cbf7fdad-06b7-4bbb-9581-ade7600cf125" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="8e6f96a8-73d2-45aa-9611-2a5542866e8f" data-cid="8e6f96a8-73d2-45aa-9611-2a5542866e8f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="0.01±0.45" data-replace="0.01" data-pattern="$1" data-tag-index="228_1" data-time="" data-username="" data-userid="">0.01</named-content><named-content id="870cf34b-3039-46a6-af58-8566897be568" data-cid="870cf34b-3039-46a6-af58-8566897be568" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="0.01±0.45" data-replace="±" data-pattern="$2" data-tag-index="228_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="587e3843-c346-4a97-97e7-f30f63d47257" data-cid="587e3843-c346-4a97-97e7-f30f63d47257" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="0.01±0.45" data-replace="0.45" data-pattern="$3" data-tag-index="228_1" data-time="" data-username="" data-userid="">0.45</named-content></p></td></tr><tr data-col-count="5" id="c14d9e0b-82cc-4acb-b7c2-2f4046d639f4" data-fill="true"><td width="28%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d47b3e62-448a-41e5-b35a-2cc1c6e25cea" valign="top" data-old-attributes=""><p id="47d2397a-36e7-46d2-afc8-26ce6b9d4163" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">P value* (<named-content data-cid="1553859621038" id="18b486d2-c79b-483e-9bda-e9d15ccadab7" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">compared to</named-content><named-content id="4e551899-1083-4770-b8e4-43bb903d27cc" data-cid="1553859621038" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="10" data-match="compared to" data-replace="compared with" data-pattern="compared with" data-tag-index="229_1" data-function="addTrackChanges" data-track-change="compared to" data-userid="preediting" data-username="Exeter" data-time="1553859621001">compared with</named-content> baseline)</p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="9695c94e-fdd6-48d3-bcfd-26c8aa81bcac" valign="top" data-old-attributes=""><p id="4d16abc4-7d42-48fa-9d41-045232a8b6c5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="9951a0e0-8dd0-4c96-b1e2-00dda327b888" data-cid="9951a0e0-8dd0-4c96-b1e2-00dda327b888" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="p=0.87" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="230_1" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="13325f67-8fef-449d-ac41-212b3cd2f115" data-cid="13325f67-8fef-449d-ac41-212b3cd2f115" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="1" data-match="p=0.87" data-replace="=" data-pattern="$2" data-tag-index="230_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="44fb9f88-487a-46fe-b00f-4a8f2a20c76b" data-cid="44fb9f88-487a-46fe-b00f-4a8f2a20c76b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="2" data-match="p=0.87" data-replace="0.87" data-pattern="$3" data-tag-index="230_1" data-time="" data-username="" data-userid="">0.87</named-content></p></td><td data-class="" width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="2767465d-882f-4421-b0b2-9f0c0d971327" valign="top" data-old-attributes=""><p id="995ffef6-2b83-40ea-9fc1-6e46574f3d34" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="ce53e42c-e789-41a7-8278-99355d775830" data-cid="ce53e42c-e789-41a7-8278-99355d775830" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="p&amp;lt;0.001" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="231_1" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="32adb694-ca80-4096-8a47-8ee8104a5ef8" data-cid="32adb694-ca80-4096-8a47-8ee8104a5ef8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="1" data-match="p&amp;lt;0.001" data-replace="&lt;" data-pattern="$2" data-tag-index="231_1" data-time="" data-username="" data-userid="">&lt;</named-content><named-content id="040d6d98-bb2e-4836-804a-7e3468e72fec" data-cid="040d6d98-bb2e-4836-804a-7e3468e72fec" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="2" data-match="p&amp;lt;0.001" data-replace="0.001" data-pattern="$3" data-tag-index="231_1" data-time="" data-username="" data-userid="">0.001</named-content></p></td><td width="18%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="1bf6068d-6452-4da3-9283-a68f6853754a" valign="top" data-old-attributes=""><p id="ba6a9206-c29a-4f0b-853d-40ff0c413182" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="47fece02-5f33-42d9-b4ce-9df5c51bc9b6" data-cid="47fece02-5f33-42d9-b4ce-9df5c51bc9b6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="p=0.047" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="232_1" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="c0f207ba-b75c-4bf5-942c-0d3c02aa7da8" data-cid="c0f207ba-b75c-4bf5-942c-0d3c02aa7da8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="1" data-match="p=0.047" data-replace="=" data-pattern="$2" data-tag-index="232_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="26bf2f3c-6f3f-4047-a1bf-0397d6aae8fd" data-cid="26bf2f3c-6f3f-4047-a1bf-0397d6aae8fd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="2" data-match="p=0.047" data-replace="0.047" data-pattern="$3" data-tag-index="232_1" data-time="" data-username="" data-userid="">0.047</named-content></p></td><td width="17%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="828bbdbc-f7c4-4d4b-99a3-1ffcf75194f0" valign="top" data-old-attributes=""><p id="44c82892-12b0-4daa-93c0-ae4966e40c1f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="52a52d3d-ead5-4e30-b30d-907cdd7dbdbe" data-cid="52a52d3d-ead5-4e30-b30d-907cdd7dbdbe" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="p=0.36" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="233_1" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="2eeb50d1-569b-4ed8-8f76-f338a7d18770" data-cid="2eeb50d1-569b-4ed8-8f76-f338a7d18770" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="1" data-match="p=0.36" data-replace="=" data-pattern="$2" data-tag-index="233_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="407c2537-ebed-401b-9025-f3943fb3d3e6" data-cid="407c2537-ebed-401b-9025-f3943fb3d3e6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="2" data-match="p=0.36" data-replace="0.36" data-pattern="$3" data-tag-index="233_1" data-time="" data-username="" data-userid="">0.36</named-content></p></td></tr></tbody></table><table-wrap-foot id="5c9a028d-916b-4359-a5f0-128851628e59"><fn data-class="jrnlTblFoot" fn-type="abbrev" data-def-list="true" id="dae42be5-9221-4ec8-b7ba-1ebc62a63610"><p id="ff734b3f-7741-46a5-94f5-b964566f173c"><def-list id="13f2991e-1941-499d-9a74-75035c3579d1"><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="ec432728-8b55-4eee-a772-88e71379e396" fn-type="abbrev" data-id="T1_FN1"><term data-class="jrnlAbbrevTerm" id="98c5d2ef-1bcc-4ba5-a212-c794a7d5f728">BCVA</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="d7977e5e-5497-4a06-bfd0-c17eda8f5ebb"><p id="e7ac6a97-3624-42be-a4b2-ad01eb571a83">best corrected visual acuity</p></def>.</def-item></def-list></p></fn></table-wrap-foot></table-wrap><title data-level="2" data-class="jrnlHead2" id="247454c1-4965-4da1-b489-5a143d35ab74"><named-content data-cid="1553859621106" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="5e14e80b-6dd7-4c2e-9d44-c1a698fee107">Indications of Dexamethasone implant</named-content><named-content data-cid="1553859621106" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="49d0bf01-fe48-475a-84e5-9076092e70b7">Indications of dexamethasone implant</named-content></title><p data-class="jrnlSecPara" id="335db1c6-31c9-48ae-8be7-772e7a049b62">Subjects in our series were treated with intravitreal dexamethasone implants for various indications as stated in <xref id="aba0f38c-14cc-44ef-a6c2-63a299427d17" ref-type="table" rid="T2" data-citation-string=" T2 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="114" data-match="table 2" data-pattern="" data-tag-index="18_1" data-anchor="true">table 2</xref> with diabetic macular <named-content data-cid="1553859621078" id="e3e2b2fb-78b6-467f-a3b2-2880de2ef348" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="24baecd4-fcfa-4edd-aef2-88e6fd939ad9" data-cid="1553859621078" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="144" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="18_6" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> (<named-content id="a79a8648-79d4-419b-a0b7-4cd251096e4d" data-cid="a79a8648-79d4-419b-a0b7-4cd251096e4d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="151" data-match="3104" data-replace="3104" data-pattern="3104" data-tag-index="18_3" data-time="" data-username="" data-userid="">3104</named-content> injections), retinal venous occlusions (<named-content id="abbb0c3b-3945-4065-8322-7a2ba2ec92c6" data-cid="abbb0c3b-3945-4065-8322-7a2ba2ec92c6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="196" data-match="1861" data-replace="1861" data-pattern="1861" data-tag-index="18_4" data-time="" data-username="" data-userid="">1861</named-content> injections), uveitis (381 injections)<named-content data-cid="1554366296" id="b6a128be-677b-4c44-9932-584ada3e87ac" content-type="del cts-3" specific-use="1554369662412" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:51pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369662412">,</named-content> and post-surgical macular <named-content data-cid="1553859621079" id="20e308b8-9687-4c06-befe-f54a3b67579a" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="b858e9d9-952d-43a5-9456-5aef13f6deef" data-cid="1553859621079" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="266" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="18_7" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> (305 injections) being the major indications (<xref id="1573b344-d042-42dc-844f-950364effb76" ref-type="table" rid="T2" data-citation-string=" T2 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="318" data-match="Table 2" data-pattern="" data-tag-index="18_2"><named-content data-cid="1556001224047" id="04868ee1-3ba2-4232-b319-5ad813ab6fe5" content-type="del cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">Table 2</named-content><named-content data-cid="1556001224047" id="36f704e7-2ff9-47ec-903f-d0b2a931406a" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">table 2</named-content></xref>).</p><table-wrap id="BLK_T2" data-id="BLK_T2" data-stream-name="a_T2" position="float"><label id="920b67dc-3824-479e-a608-f923876b6d77">Table 2</label><caption id="ff85eb70-6ee9-43aa-8253-638f20cf83b8"><title id="T2" data-id="T2">Indications<named-content data-cid="1553859621107" id="a3c6dd03-3dec-4b5f-a45d-c5b437626a2f" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase"> for intravitreal dexamethasone implant<named-content data-cid="1553859947" id="c698719c-ed7c-4ad8-bc33-c7318bd1fd2d" content-type="del cts-2" specific-use="1553859974232" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:16pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553859974232">.</named-content></named-content></title></caption><table data-col-count="2" data-caption-link="T2" id="5b3e180e-bcaa-4bd3-ade3-b52d662f8c35" data-col-widths-px="190,56.587" data-table-type="singleColumn" data-old-attributes="&quot;data-col-widths-px&quot;:&quot;205.587,41&quot;;" data-changed-attributes="data-col-widths-px"><thead id="2d8f8a9d-073a-4ebb-8b6e-95f87c45faa9"><tr data-col-count="2" id="50514b71-e468-49c9-b372-a9a6cba2e1f2"><td data-class="" width="73%" data-original-border="border:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="80347b29-0ebd-460c-8509-9beb1f6e6957" valign="bottom" data-old-attributes=""><p id="5eb36f21-8806-452c-ba68-76929653218b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;">Indication</p></td><td width="26%" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="fc0b1eeb-fe0b-4200-bd3c-7b99029a0606" valign="bottom" data-old-attributes=""><p id="1916d859-3770-44c1-a7ba-240c31853c6d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;">No of eyes, n (%)</p></td></tr></thead><tbody id="28583ddb-0e48-4c13-beb7-941a3af2ad3b"><tr data-col-count="2" id="06508ec5-c017-45cd-899d-cf35201e6c62" data-fill="true"><td data-class="" width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="64f73acd-55b7-4f8b-837f-fe60fe1fb1fa" valign="top" data-old-attributes=""><p id="4666bebf-25d9-4107-add0-ec5883b5f98c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Diabetic macular <named-content data-cid="1553859621080" id="c0d2e14b-d4b5-4535-a4bb-37471864ac42" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="1e9aa356-267a-49a2-8952-b2fad5518587" data-cid="1553859621080" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="17" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="238_1" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content></p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="053eb5e8-d459-43ed-a526-8d6abfd2f829" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="0cecc7b2-be3c-4128-8207-5bf55b353d73" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="4ec6bf9d-7054-498b-99cf-618c6438c162" data-cid="4ec6bf9d-7054-498b-99cf-618c6438c162" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1434" data-replace="1434" data-pattern="1434" data-tag-index="239_2" data-time="" data-username="" data-userid="">1434</named-content><named-content id="3a918485-cf5c-43de-bbf8-0b1baa514df6" data-cid="3a918485-cf5c-43de-bbf8-0b1baa514df6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="1434 (52.4)" data-replace=" (52.4)" data-pattern=" $2" data-tag-index="239_1" data-time="" data-username="" data-userid=""> (52.4)</named-content></p></td></tr><tr data-col-count="2" id="8accdb94-4a0a-4072-9969-93506fc47f8d"><td data-class="" width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="4efa995a-b217-4fec-8cb7-7a74ee925c6a" valign="top" data-old-attributes=""><p id="f7b0f00c-aba4-4970-bf03-7efab61532ea" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Branch retinal vein occlusion</p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="9da53a2d-379a-4f9b-9f18-5d6e6fa448ec" data-auto-align="true" data-left-indent="3.59375" data-align="decimal" valign="top" data-old-attributes=""><p id="66ba9182-d5b1-42ec-b248-d4443091a6ff" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="9c006d4b-4a03-4b03-b1ac-57d15ee13743" data-cid="9c006d4b-4a03-4b03-b1ac-57d15ee13743" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="281 (10.2)" data-replace="281" data-pattern="$1" data-tag-index="241_1" data-time="" data-username="" data-userid="">281</named-content><named-content id="f4462542-e203-42b0-bb5e-f192d370e448" data-cid="f4462542-e203-42b0-bb5e-f192d370e448" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="281 (10.2)" data-replace=" (10.2)" data-pattern=" $2" data-tag-index="241_1" data-time="" data-username="" data-userid=""> (10.2)</named-content></p></td></tr><tr data-col-count="2" id="23cb33be-3d68-4e91-9c67-528923b137cb" data-fill="true"><td width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="df817cc3-3624-4fc7-b4a9-7036d730e3c9" valign="top" data-old-attributes=""><p id="61397f81-639a-4e4b-975e-2ee2750ca729" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Central retinal vein occlusion</p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="440814ec-e89e-4c9e-a459-b08966b839a7" data-auto-align="true" data-left-indent="3.59375" data-align="decimal" valign="top" data-old-attributes=""><p id="be6de826-08f4-4f0f-ab14-b3fe72b04c03" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="4581f4b7-76d3-4dae-a078-f3bf44592619" data-cid="4581f4b7-76d3-4dae-a078-f3bf44592619" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="245 (17.1)" data-replace="245" data-pattern="$1" data-tag-index="243_1" data-time="" data-username="" data-userid="">245</named-content><named-content id="786238c2-9c6b-4c8e-867f-31fb8cab012c" data-cid="786238c2-9c6b-4c8e-867f-31fb8cab012c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="245 (17.1)" data-replace=" (17.1)" data-pattern=" $2" data-tag-index="243_1" data-time="" data-username="" data-userid=""> (17.1)</named-content></p></td></tr><tr data-col-count="2" id="b6a54255-55dd-4bbf-b4e2-13421673ca1c"><td data-class="" width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="1f187e57-2548-4037-a328-ef72b87ee0d2" valign="top" data-old-attributes=""><p id="d1c816d4-d924-4c06-99c5-b9f16ab81289" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Post surgical macular <named-content data-cid="1553859621081" id="b350d1e1-a04f-49a8-bfe2-ae67dcb0e6db" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="6bdddeeb-c32b-47ba-9e4e-4295dfa9824e" data-cid="1553859621081" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="22" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="244_1" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content></p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="908e7568-ed05-4c35-aaa0-79633709b0bf" data-auto-align="true" data-left-indent="3.59375" data-align="decimal" valign="top" data-old-attributes=""><p id="de80033d-a8b2-4c29-b6cb-582d347f91ef" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="28f9ffd2-c727-4f2a-aca9-c33ed84fac91" data-cid="28f9ffd2-c727-4f2a-aca9-c33ed84fac91" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="190 (6.9)" data-replace="190" data-pattern="$1" data-tag-index="245_1" data-time="" data-username="" data-userid="">190</named-content><named-content id="4967797b-3a6c-451b-9092-67da758d65ce" data-cid="4967797b-3a6c-451b-9092-67da758d65ce" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="190 (6.9)" data-replace=" (6.9)" data-pattern=" $2" data-tag-index="245_1" data-time="" data-username="" data-userid=""> (6.9)</named-content></p></td></tr><tr data-col-count="2" id="13f99b2f-ecdc-4be6-bbf7-cedec1a73f55" data-fill="true"><td data-class="" width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="b8f7a5b6-0860-4282-a83d-1deeca66a568" valign="top" data-old-attributes=""><p id="b13e2051-1c72-4444-8f32-3db48a836c42" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Uveitis</p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="e13be013-e30d-4e1c-99e0-41eef93ede3e" data-auto-align="true" data-left-indent="3.59375" data-align="decimal" valign="top" data-old-attributes=""><p id="9110129a-b9fb-4ede-bfd5-2b860ead19d9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="07f14d9f-e8b8-4c16-adff-42e0b9699d75" data-cid="07f14d9f-e8b8-4c16-adff-42e0b9699d75" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="149 (5.4)" data-replace="149" data-pattern="$1" data-tag-index="247_1" data-time="" data-username="" data-userid="">149</named-content><named-content id="50493ea2-540f-4312-a854-46962842ef6e" data-cid="50493ea2-540f-4312-a854-46962842ef6e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="149 (5.4)" data-replace=" (5.4)" data-pattern=" $2" data-tag-index="247_1" data-time="" data-username="" data-userid=""> (5.4)</named-content></p></td></tr><tr data-col-count="2" id="e3801435-5f37-4167-abce-f2a132051ee3"><td data-class="" width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="90ff699b-756e-4175-99be-d4bf2fd8cc3c" valign="top" data-old-attributes=""><p id="e6aed8a1-207a-4ad7-9798-a3c293937cd7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Post retinal detachment cystoid macular <named-content data-cid="1553859621082" id="c6a946d3-6991-4998-aac0-7b39cb01e613" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="d234a425-8caa-486b-9254-867ad2f9287d" data-cid="1553859621082" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="40" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="248_1" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content></p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="738855e1-8fd3-416a-814b-3203bf0cd61f" data-auto-align="true" data-left-indent="7.203125" data-align="decimal" valign="top" data-old-attributes=""><p id="1b90643c-6984-4e31-989f-1a0924e00e0e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="21da989f-c5c8-461c-abca-895992b4f74d" data-cid="21da989f-c5c8-461c-abca-895992b4f74d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="74 (2.7)" data-replace="74" data-pattern="$1" data-tag-index="249_1" data-time="" data-username="" data-userid="">74</named-content><named-content id="32c2d072-d70c-41e0-b609-3fc490675089" data-cid="32c2d072-d70c-41e0-b609-3fc490675089" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="74 (2.7)" data-replace=" (2.7)" data-pattern=" $2" data-tag-index="249_1" data-time="" data-username="" data-userid=""> (2.7)</named-content></p></td></tr><tr data-col-count="2" id="e53c5c0b-a92c-4f26-8ed0-74cc90e99eed" data-fill="true"><td data-class="" width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="a45fdac3-63e7-4616-8453-8cd91e062448" valign="top" data-old-attributes=""><p id="c6a16b31-edab-4ec8-8521-e28f49b75c81" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Macular oedema post-vitrectomy for <named-content rid="90ef9aeb-207e-4033-9ffa-5af4cd076596" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="fa7d7b8c-da1a-4048-8b91-0179e1939096" content-type="jrnlQueryRef" specific-use="start" data-answered="true"/>ERM <named-content rid="90ef9aeb-207e-4033-9ffa-5af4cd076596" data-class="jrnlQueryRef" data-type="end" id="e9fc65f3-98a0-46fa-aedf-154073439efd" content-type="jrnlQueryRef" specific-use="end" data-answered="true"/>peel</p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="aa0bc35d-b248-42c6-add3-b6451c4aa441" data-auto-align="true" data-left-indent="7.203125" data-align="decimal" valign="top" data-old-attributes=""><p id="a09f5e60-2e9f-4100-9f51-dd6a6f1c5a99" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="541660bf-16cd-4ef4-9d31-e7dc7179fa21" data-cid="541660bf-16cd-4ef4-9d31-e7dc7179fa21" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="47 (1.7)" data-replace="47" data-pattern="$1" data-tag-index="251_1" data-time="" data-username="" data-userid="">47</named-content><named-content id="021c70ff-e145-4869-9da4-52aedba7c9f0" data-cid="021c70ff-e145-4869-9da4-52aedba7c9f0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="47 (1.7)" data-replace=" (1.7)" data-pattern=" $2" data-tag-index="251_1" data-time="" data-username="" data-userid=""> (1.7)</named-content></p></td></tr><tr data-col-count="2" id="8845397c-a9f4-4d6c-8763-2f98984bfce3"><td data-class="" width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="f089a79b-d0da-4cb6-91d6-98b7ab8c3c43" valign="top" data-old-attributes=""><p id="3f0ee239-ddca-43fa-aa41-cd4b526981d9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Age<named-content data-cid="1554366297" id="47dbf9f9-6efa-4137-8e42-b8b5928b8c9e" content-type="del cts-3" specific-use="1554369844684" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:54pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369844684"> </named-content><named-content data-cid="1554366298" id="965fe01d-d4f0-47bb-903b-425144096d63" content-type="ins cts-3" specific-use="1554369844868" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:54pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369844868">-</named-content>related macular degeneration</p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="3fd5489d-ffa1-4707-b064-1a57098e2b56" data-auto-align="true" data-left-indent="7.203125" data-align="decimal" valign="top" data-old-attributes=""><p id="f2bfd902-3aba-462e-b5c9-e2c66543ca31" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="61f92d76-0172-496b-97eb-282c49704e1b" data-cid="61f92d76-0172-496b-97eb-282c49704e1b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="17 (0.6)" data-replace="17" data-pattern="$1" data-tag-index="253_1" data-time="" data-username="" data-userid="">17</named-content><named-content id="9e25fe65-70fe-44e6-bb99-d1f24fc9a84d" data-cid="9e25fe65-70fe-44e6-bb99-d1f24fc9a84d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="17 (0.6)" data-replace=" (0.6)" data-pattern=" $2" data-tag-index="253_1" data-time="" data-username="" data-userid=""> (0.6)</named-content></p></td></tr><tr data-col-count="2" id="52bb9831-3010-4ccf-866b-dd911388d1a4" data-fill="true"><td width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="da2dde6c-d4d6-471c-b0db-0b8438f097ad" valign="top" data-old-attributes=""><p id="34df4b8f-f92e-4146-a1b1-12ae0692ce9c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1553859621083" id="d0dc4f2c-3d1d-4c44-9d4d-71daccf4650b" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">Tumors</named-content><named-content id="b35c869a-6bae-4410-a19f-2d4b317eafb5" data-cid="1553859621083" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'Tumors' to 'Tumours'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="0" data-match="Tumors" data-replace="Tumours" data-pattern="Tumours" data-tag-index="254_2" data-function="addTrackChanges" data-track-change="Tumors" data-userid="preediting" data-username="Exeter" data-time="1553859621001">Tumours</named-content> with macular <named-content data-cid="1553859621084" id="510f2fcb-c8c3-4f52-8f23-000a28efcd20" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="cad022e6-6eba-4fdb-a994-9f2765dfcff3" data-cid="1553859621084" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="20" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="254_3" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> <named-content id="3cb986a2-e011-4de8-ada3-53a6ec2174af" data-cid="3cb986a2-e011-4de8-ada3-53a6ec2174af" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HYPPRE" data-track-detail="" data-tag-desc="HYPPRE" data-tag-type="HYPPRE" data-offset="26" data-match="post " data-pattern="" data-tag-index="254_1" data-time="" data-username="" data-userid="">post </named-content>treatment</p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="8d7c0af5-b886-465f-9525-2fe0845fbf39" data-auto-align="true" data-left-indent="7.203125" data-align="decimal" valign="top" data-old-attributes=""><p id="8f6d5ff2-bc82-4892-ae1f-177118d601b8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="b52ecf80-d4ab-411a-b2af-ecd04db9be8c" data-cid="b52ecf80-d4ab-411a-b2af-ecd04db9be8c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="17 (0.6)" data-replace="17" data-pattern="$1" data-tag-index="255_1" data-time="" data-username="" data-userid="">17</named-content><named-content id="c628e90e-9c42-4b33-898c-c6b74c775b3a" data-cid="c628e90e-9c42-4b33-898c-c6b74c775b3a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="17 (0.6)" data-replace=" (0.6)" data-pattern=" $2" data-tag-index="255_1" data-time="" data-username="" data-userid=""> (0.6)</named-content></p></td></tr><tr data-col-count="2" id="caafcc57-1443-411e-b0fa-5e8dc305a947"><td width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d2b5d83f-2740-40fa-a487-4cbe14beebd3" valign="top" data-old-attributes=""><p id="7b5b608f-7cbe-4a3e-a245-349692b3776a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Macular <named-content data-cid="1553859621085" id="9bdc0554-19dd-4318-b730-14b124a1857f" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="bb72445e-8ab2-4d32-a698-e9d6d76e57ba" data-cid="1553859621085" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="8" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="256_1" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> due to hereditary retinal disorders like retinitis pigmentosa</p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="d4d86090-0d38-4001-96ca-6cb79d26ddd2" data-auto-align="true" data-left-indent="7.203125" data-align="decimal" valign="top" data-old-attributes=""><p id="a1ccbd12-c418-4c32-b12d-bd3cd4c43230" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="08b49bbb-728a-4379-85e8-d22bfe8a84cc" data-cid="08b49bbb-728a-4379-85e8-d22bfe8a84cc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="13 (0.5)" data-replace="13" data-pattern="$1" data-tag-index="257_1" data-time="" data-username="" data-userid="">13</named-content><named-content id="16642f4f-e12a-4354-bca6-ac3499ffdbca" data-cid="16642f4f-e12a-4354-bca6-ac3499ffdbca" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="13 (0.5)" data-replace=" (0.5)" data-pattern=" $2" data-tag-index="257_1" data-time="" data-username="" data-userid=""> (0.5)</named-content></p></td></tr><tr data-col-count="2" id="258ae383-be7c-45a6-9ef5-51f293707d00" data-fill="true"><td width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="ae44c6f7-2e49-4587-aab9-cf1f791b4054" valign="top" data-old-attributes=""><p id="863949fd-9073-49bb-b2e5-bfee6cecf47b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Epiretinal membrane with cystoid macular <named-content data-cid="1553859621086" id="ba1fff34-bf55-4d8d-ac86-427004fadf0a" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="d34ab0b3-d458-43e5-bf16-4dc30602118c" data-cid="1553859621086" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="41" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="258_1" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content></p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="50c1d372-9a83-4e27-8eac-50ad1c6f4d70" data-auto-align="true" data-left-indent="10.796875" data-align="decimal" valign="top" data-old-attributes=""><p id="747a1e62-4615-4cf0-bfa2-d7f52920407d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="3f44a7f4-1dcb-43e9-bc6d-9a712c97fb0b" data-cid="3f44a7f4-1dcb-43e9-bc6d-9a712c97fb0b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="5 (0.2)" data-replace="5" data-pattern="$1" data-tag-index="259_1" data-time="" data-username="" data-userid="">5</named-content><named-content id="51161e07-a7a5-4653-9b36-398a1e5e57f2" data-cid="51161e07-a7a5-4653-9b36-398a1e5e57f2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="5 (0.2)" data-replace=" (0.2)" data-pattern=" $2" data-tag-index="259_1" data-time="" data-username="" data-userid=""> (0.2)</named-content></p></td></tr><tr data-col-count="2" id="34065645-1edb-461e-a62b-f416cd7bc61c"><td width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="84251fed-d934-4f80-b8f5-9df28a782d6d" valign="top" data-old-attributes=""><p id="7c8e5c06-d033-4a0b-8cde-ea7788801815" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Choroidal neovascular membrane associated to central serous retinopathy</p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="9d8232dc-514a-400a-a4a0-4c7cff0d7d9a" data-auto-align="true" data-left-indent="10.796875" data-align="decimal" valign="top" data-old-attributes=""><p id="b6c9babf-b29d-4948-8a87-ff417212eeba" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="ce5e275c-4a89-4762-b62d-09153d8a9fec" data-cid="ce5e275c-4a89-4762-b62d-09153d8a9fec" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="5 (0.2)" data-replace="5" data-pattern="$1" data-tag-index="261_1" data-time="" data-username="" data-userid="">5</named-content><named-content id="dc976efb-112d-4602-95c6-5d493437c0f7" data-cid="dc976efb-112d-4602-95c6-5d493437c0f7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="5 (0.2)" data-replace=" (0.2)" data-pattern=" $2" data-tag-index="261_1" data-time="" data-username="" data-userid=""> (0.2)</named-content></p></td></tr><tr data-col-count="2" id="d2e09774-178a-4c93-8e46-f60823c55beb" data-fill="true"><td data-class="" width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d763520f-6fa4-4721-9d35-4807bf7ac97e" valign="top" data-old-attributes=""><p id="5f959db0-0aab-453d-a869-0373998f71c0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Macular <named-content data-cid="1554366299" id="280c225a-e4b1-4635-a418-74bc4621a4e7" content-type="del cts-3" specific-use="1554369868932" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:54pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369868932">T</named-content><named-content data-cid="1554366300" id="ac70b5ab-5c9d-406c-b9d5-910bc1cbf78d" content-type="ins cts-3" specific-use="1554369869117" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:54pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369869117"><named-content data-cid="1554390501" id="ae1b5e55-c59f-4d2d-ba56-ffef3b0e8a4e" content-type="del cts-4" specific-use="1554390649392" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 5653473376" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 8:40pm" data-track-detail="" data-userid="copyeditor 5653473376" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554390649392">t</named-content></named-content><named-content data-cid="1554390501" id="2e936860-cd89-4af3-a788-4c6a614666af" content-type="del cts-4" specific-use="1554390649392" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 5653473376" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 8:40pm" data-track-detail="" data-userid="copyeditor 5653473376" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554390649392">eleangiectasia</named-content><icepaste id="14b70a7b-10fb-4966-a92d-58b3ef765a7b"/><named-content data-cid="1554390502" id="7a8eee46-d862-4f70-b208-db05da287019" content-type="ins cts-4" specific-use="1554390653697" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 5653473376" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 8:40pm" data-track-detail="" data-userid="copyeditor 5653473376" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554390653697">telangiectasia</named-content></p></td><td data-class="" width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="00095e6e-f80b-4265-aba2-aa651cb6569d" data-auto-align="true" data-left-indent="10.796875" data-align="decimal" valign="top" data-old-attributes=""><p id="f0214a55-24ed-4c85-8a04-25df5baa4f93" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="ca2ec46f-1ef9-400e-abd1-6713aa046d2f" data-cid="ca2ec46f-1ef9-400e-abd1-6713aa046d2f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="4 (0.1)" data-replace="4" data-pattern="$1" data-tag-index="263_1" data-time="" data-username="" data-userid="">4</named-content><named-content id="9c950490-a53d-4231-a1c5-ad75c41e51c8" data-cid="9c950490-a53d-4231-a1c5-ad75c41e51c8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="4 (0.1)" data-replace=" (0.1)" data-pattern=" $2" data-tag-index="263_1" data-time="" data-username="" data-userid=""> (0.1)</named-content></p></td></tr><tr data-col-count="2" id="e9eb96b4-71e6-4ccb-8d37-d3ef739f065c"><td data-class="" width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="2b708be0-1bf8-42b3-9581-6f9bd71f14a1" valign="top" data-old-attributes=""><p id="2517b464-ab66-469f-9ad7-77d94516fa0f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Coats disease with macular <named-content data-cid="1553859621087" id="cb862862-f384-4e90-8a64-b2d2fadeb81c" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="1d995e71-6791-4898-bccd-f5f19ea1914e" data-cid="1553859621087" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="27" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="264_1" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content></p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="fae46c83-968b-4aa0-b816-9dee5413fba5" data-auto-align="true" data-left-indent="10.796875" data-align="decimal" valign="top" data-old-attributes=""><p id="e0cf8a0e-43ec-433e-a9aa-d9ac9bda593b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="b8ddc673-8474-4897-a1b8-1127ac122a1f" data-cid="b8ddc673-8474-4897-a1b8-1127ac122a1f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (0.1)" data-replace="2" data-pattern="$1" data-tag-index="265_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="40d593c3-93f8-41bf-9fdc-9d906c5e5f06" data-cid="40d593c3-93f8-41bf-9fdc-9d906c5e5f06" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (0.1)" data-replace=" (0.1)" data-pattern=" $2" data-tag-index="265_1" data-time="" data-username="" data-userid=""> (0.1)</named-content></p></td></tr><tr data-col-count="2" id="81abc6f9-b936-4204-b47c-3da140c954f9" data-fill="true"><td data-class="" width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d9abcc0b-fcf0-4843-bcdd-2ff29cf0fd70" valign="top" data-old-attributes=""><p id="bf428c9f-bf2a-4811-a904-f6753eed5942" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Polypoidal choroidal vasculopathy</p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="fb921c34-5744-4240-a18b-1a86d565fa4b" data-auto-align="true" data-left-indent="10.796875" data-align="decimal" valign="top" data-old-attributes=""><p id="ec655ca8-846d-439c-a158-c8dbdab45c6c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="9360332b-1083-4942-937b-e06481a32b67" data-cid="9360332b-1083-4942-937b-e06481a32b67" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (0.1)" data-replace="2" data-pattern="$1" data-tag-index="267_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="e18d3e0e-99d4-4909-bab6-ea0cfd1cb195" data-cid="e18d3e0e-99d4-4909-bab6-ea0cfd1cb195" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (0.1)" data-replace=" (0.1)" data-pattern=" $2" data-tag-index="267_1" data-time="" data-username="" data-userid=""> (0.1)</named-content></p></td></tr><tr data-col-count="2" id="a0f04522-b4a5-420a-81ce-af57faf5e5a8"><td data-class="" width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="072c34ee-4b12-4d31-b6a2-e572642c097e" valign="top" data-old-attributes=""><p id="fa4cf401-c985-4129-b336-3c70a2b96aaa" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content rid="36c7736e-b528-44f1-a188-456ee0aa19d5" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="75ffadc8-a55d-40a7-a917-39c0bc2848b4" content-type="jrnlQueryRef" specific-use="start" data-answered="true"/>CNV <named-content rid="36c7736e-b528-44f1-a188-456ee0aa19d5" data-class="jrnlQueryRef" data-type="end" id="2334066a-9972-4584-ab9b-1ab0fdc19926" content-type="jrnlQueryRef" specific-use="end" data-answered="true"/>due to angoid streaks refractory to anti<named-content data-cid="1554366301" id="86038d8a-4872-425a-a62e-d8c253fc7ca7" content-type="del cts-3" specific-use="1554369877018" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:54pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369877018"> </named-content><named-content data-cid="1554366302" id="6f9ee37e-a8a4-4972-84c6-9af5a519eccf" content-type="ins cts-3" specific-use="1554369877206" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:54pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369877206">-</named-content>VEGF</p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="3ce2b7fd-6e52-4174-bbb1-11564c7ddbe2" data-auto-align="true" data-left-indent="10.796875" data-align="decimal" valign="top" data-old-attributes=""><p id="b7b0555a-723f-4a43-aa97-71dc1b0661bc" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="a3142231-7826-45d6-a807-9fbaf108fb3b" data-cid="a3142231-7826-45d6-a807-9fbaf108fb3b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (0.03)" data-replace="1" data-pattern="$1" data-tag-index="269_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="2a3edce6-57d1-4c24-baf0-fc1935ee113a" data-cid="2a3edce6-57d1-4c24-baf0-fc1935ee113a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (0.03)" data-replace=" (0.03)" data-pattern=" $2" data-tag-index="269_1" data-time="" data-username="" data-userid=""> (0.03)</named-content></p></td></tr><tr data-col-count="2" id="c86acc83-b082-4022-b71d-5dadd4d17725" data-fill="true"><td width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="26b562d3-1ba5-4511-a066-c7189557d72c" valign="top" data-old-attributes=""><p id="4b3d0c3b-8a80-474d-b0e9-fafccd9b7ded" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Radiation retinopathy</p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="c189b225-b578-48d7-8b92-482e444132b8" data-auto-align="true" data-left-indent="10.796875" data-align="decimal" valign="top" data-old-attributes=""><p id="2fe5a04b-3cfa-4476-80e4-0ade03a2aa6d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="03db4b84-4c82-48be-a19d-530ae40b5999" data-cid="03db4b84-4c82-48be-a19d-530ae40b5999" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (0.03)" data-replace="1" data-pattern="$1" data-tag-index="271_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="250445a8-204c-4afa-9a6e-253648f3be0c" data-cid="250445a8-204c-4afa-9a6e-253648f3be0c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (0.03)" data-replace=" (0.03)" data-pattern=" $2" data-tag-index="271_1" data-time="" data-username="" data-userid=""> (0.03)</named-content></p></td></tr><tr data-col-count="2" id="9129ef4e-ab41-48e3-9bbf-3373b106c23c"><td width="73%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="077e2273-78f8-47cd-9649-ae4e2581ba93" valign="top" data-old-attributes=""><p id="9cf5a4b4-9332-4d34-9606-298dafeada09" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Purtscher's retinopathy</p></td><td width="26%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="2d5ffdfb-d29e-429e-8935-115390336929" data-auto-align="true" data-left-indent="10.796875" data-align="decimal" valign="top" data-old-attributes=""><p id="8e203db7-5e48-4c53-a44e-7311edb58208" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"><named-content id="ce1b22cb-c2c0-433e-9a66-e4b09bad29a7" data-cid="ce1b22cb-c2c0-433e-9a66-e4b09bad29a7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (0.03)" data-replace="1" data-pattern="$1" data-tag-index="273_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="7fce7e7a-5ed0-418d-b7df-ea6d3d959ac3" data-cid="7fce7e7a-5ed0-418d-b7df-ea6d3d959ac3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (0.03)" data-replace=" (0.03)" data-pattern=" $2" data-tag-index="273_1" data-time="" data-username="" data-userid=""> (0.03)</named-content></p></td></tr></tbody></table><table-wrap-foot id="ac0bc4d0-265d-47bf-a9a1-36914e5ea69f"><fn data-class="jrnlTblFoot" fn-type="abbrev" data-def-list="true" id="02ac0345-2e9d-4413-93fc-737f59e48b83"><p id="d03cdd39-4676-4888-9bb4-51feb1feda8d"><def-list id="33b54cde-4284-4d12-b8c5-5886fabfc748"><def-item data-class="jrnlTblDefItem" alphabetical-order="true" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" id="ec6af389-f8fc-452b-9f48-163b1809e580" fn-type="abbrev" data-id="T2_FN1"><term data-class="jrnlAbbrevTerm" id="637e0e2a-c10e-4e7b-829b-6618645c6936">CNV</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="c6dd39b4-af6a-4be8-9848-574c424fcade"><p id="81f979a6-b845-49f6-b35e-3144583f6f2e">choroidal neovascularization</p></def>; </def-item><def-item data-class="jrnlTblDefItem" alphabetical-order="true" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" id="f67d6252-0cff-45b1-b420-bf512c2417e1" fn-type="abbrev" data-id="T2_FN1"><term data-class="jrnlAbbrevTerm" id="f77ade85-93f0-47f6-9248-42809bf048c3">ERM</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="8d732a56-1ced-4e5f-9035-74cedfb7fa72"><p id="49c0adb2-ceee-4b09-803b-e659c4e3fb0b">Epiretinal membrane</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="b3b05e1f-d61d-4d4c-b43c-44c11f202e76" fn-type="abbrev" data-id="T2_FN1"><term data-class="jrnlAbbrevTerm" id="5f5f49ff-eb63-44fa-8661-8e027c8cc2dc">VEGF</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="be48ff6c-7a3d-4021-a572-1d2965b04496"><p id="0469a3fd-9207-402c-8f8a-be80e93c5af2">vascular endothelial growth factor</p></def>.</def-item></def-list></p></fn></table-wrap-foot></table-wrap><title data-level="2" data-class="jrnlHead2" id="f58e7942-409c-4190-bf52-dcc5ab8f330f"><named-content data-cid="1553859621108" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="fa763956-551b-4e49-b0d0-46f8aed52805">Safety Results</named-content><named-content data-cid="1553859621108" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="96e8a82b-a3b4-4aba-b30b-e4fdfac080d7">Safety results</named-content></title><title data-level="3" data-class="jrnlHead3" id="4a565747-ec74-469b-b253-e117f360204d"><named-content data-cid="1553859621109" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="fb1b2272-4e67-44fd-af4a-7155bb4884a4">Cataract Progression</named-content><named-content data-cid="1553859621109" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="00c4828e-7d9d-4386-9a8e-0d65fbbfd403">Cataract progression</named-content></title><p data-class="jrnlSecPara" id="1b9ee3b3-84a8-4b4d-82b4-24729ce77ec2">Among all the study eyes, <named-content id="b57dfdcc-978c-4973-a900-a0bf2c54c07c" data-cid="b57dfdcc-978c-4973-a900-a0bf2c54c07c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="26" data-match="1772" data-replace="1772" data-pattern="1772" data-tag-index="19_3" data-time="" data-username="" data-userid="">1772</named-content> eyes (64.77%) were phakic at baseline<named-content data-cid="1554366303" id="b49baec4-cde5-4833-a175-4287dfe6e25c" content-type="del cts-3" specific-use="1554369997682" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:56pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554369997682">,</named-content> and rest were pseudophakic. Out of 1772 phakic eyes, 576 eyes (32.5%) underwent cataract surgery while <named-content id="e7790251-56cb-4050-ab7b-de5137540315" data-cid="e7790251-56cb-4050-ab7b-de5137540315" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="173" data-match="259 (14.6%)" data-replace="259" data-pattern="$1" data-tag-index="19_2" data-time="" data-username="" data-userid="">259</named-content><named-content id="78c1d072-75e8-4386-8665-390aa0e5d811" data-cid="78c1d072-75e8-4386-8665-390aa0e5d811" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="176" data-match="259 (14.6%)" data-replace=" (14.6%)" data-pattern=" $2" data-tag-index="19_2" data-time="" data-username="" data-userid=""> (14.6%)</named-content> had cataract progression from baseline but did not undergo surgery during the <named-content data-cid="1553859621039" id="0f42afb9-420b-4c4d-8efd-54e0bf874c5d" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow up</named-content><named-content id="92672f6f-f842-42eb-b228-b885c28c185c" data-cid="1553859621039" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="263" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="19_5" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow-up</named-content>.</p><p data-class="jrnlSecPara" id="94f09da8-693e-4d9a-8d70-6fd9405ae717">Although the percentage of eyes with baseline cataract was greater in the previously treated group <named-content data-cid="1553859621040" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" id="7aa618fb-d5a6-49cd-8108-7dba34516ef0">compared to</named-content><named-content id="3c522398-a7c3-4e5d-9047-40beb3507cc4" data-cid="1553859621040" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="99" data-match="compared to" data-replace="compared with" data-pattern="compared with" data-tag-index="20_10" data-function="addTrackChanges" data-track-change="compared to" data-userid="preediting" data-username="Exeter" data-time="1553859621001">compared with</named-content> the treatment naïve group <named-content id="69819354-603f-4361-9809-0f43ee0abe5f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="138" data-match="(42.6% vs. 27.8%" data-replace="(42.6%" data-pattern="$2" data-tag-index="20_6">(42.6%</named-content><named-content id="eb9a3cd2-3fcf-4736-8dc7-4e965c537d6e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣vs.␣' to '␣vs␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="144" data-match="(42.6% vs. 27.8%" data-replace=" vs " data-pattern=" vs " data-tag-index="20_6" data-track-change=" vs. "> vs </named-content><named-content id="974366f9-f187-4646-855a-90f69bf58feb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="149" data-match="(42.6% vs. 27.8%" data-replace="27.8%" data-pattern="$4" data-tag-index="20_6">27.8%</named-content>, <named-content id="ad184a59-6ae4-40df-8232-02889207adc5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="156" data-match="p=0.03" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="20_2" data-function="lowercase,removeItalics" data-track-change="p">p</named-content><named-content id="fdcce88e-23e3-4b3a-b435-1766517ba90c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="157" data-match="p=0.03" data-replace="=" data-pattern="$2" data-tag-index="20_2">=</named-content><named-content id="2be8e34a-e4e3-4e44-953e-84fdc9113643" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="158" data-match="p=0.03" data-replace="0.03" data-pattern="$3" data-tag-index="20_2">0.03</named-content>), the percentage of eyes requiring cataract surgery did not statistically differ between two groups <named-content id="0a39bafd-9117-4bed-8da5-d0c5705361bd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="263" data-match="(31.7% Vs 27.8%" data-replace="(31.7%" data-pattern="$2" data-tag-index="20_7">(31.7%</named-content><named-content id="9f5f3f72-6b57-4d48-a476-995b4722c089" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣Vs␣' to '␣vs␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="269" data-match="(31.7% Vs 27.8%" data-replace=" vs " data-pattern=" vs " data-tag-index="20_7" data-track-change=" Vs "> vs </named-content><named-content id="8d72f5b3-a1d5-4597-bc08-6c7300c4374e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="273" data-match="(31.7% Vs 27.8%" data-replace="27.8%" data-pattern="$4" data-tag-index="20_7">27.8%</named-content>, <named-content id="2d0be87c-74b9-42b4-923b-dea7ded59041" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="280" data-match="p=0.24" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="20_3" data-function="lowercase,removeItalics" data-track-change="p">p</named-content><named-content id="6d18ac95-0aa5-466e-b029-5393d975c0e0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="281" data-match="p=0.24" data-replace="=" data-pattern="$2" data-tag-index="20_3">=</named-content><named-content id="cd41941c-4880-4220-84eb-464ab17034b7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="282" data-match="p=0.24" data-replace="0.24" data-pattern="$3" data-tag-index="20_3">0.24</named-content>) (<xref id="2ee814d9-165e-42cd-9eec-3991cc756849" ref-type="table" rid="T3" data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="289" data-match="Table 3" data-pattern="" data-tag-index="20_1" data-citation-string=" T3 " data-anchor="true"><named-content data-cid="1556001224049" content-type="del cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000" id="e74ea4e0-d7cb-4d8a-8989-4f1f1043e7cd">Table 3</named-content><named-content data-cid="1556001224049" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000" id="b874484e-c6eb-4968-8ebc-b4a6c3133fb4">table 3</named-content></xref>). We found a statistically significant increase in cataract progression in eyes receiving more number of dexamethasone implant injections (<named-content id="4bc04f51-35e2-4cc8-b48e-bf6e50e04250" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="436" data-match="p= 0.004" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="20_4" data-function="lowercase,removeItalics" data-track-change="p">p</named-content><named-content id="328870c2-e7ae-4dfe-b342-6ba55ed763e6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '=␣' to '='" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="437" data-match="p= 0.004" data-replace="=" data-pattern="$2" data-tag-index="20_4" data-track-change="= ">=</named-content><named-content id="a91b71c3-7362-45f5-b4e0-d5b5af847132" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="439" data-match="p= 0.004" data-replace="0.004" data-pattern="$3" data-tag-index="20_4">0.004</named-content>), although the co-relation co-efficient was small (<named-content id="90938648-8d7e-4cc4-a6c7-efb6a57c142e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="496" data-match="r=0.057" data-replace="r" data-pattern="$1" data-tag-index="20_5">r</named-content><named-content id="5d3c9390-6ba7-438e-a2cf-ee60ca9ad914" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="497" data-match="r=0.057" data-replace="=" data-pattern="$2" data-tag-index="20_5">=</named-content><named-content id="53d5c2f2-7089-4e45-912f-c0003ad0eea1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="498" data-match="r=0.057" data-replace="0.057" data-pattern="$3" data-tag-index="20_5">0.057</named-content>).</p><table-wrap id="BLK_T3" data-id="BLK_T3" data-stream-name="a_T3" position="float"><label id="1fd7dc5a-7f2b-429e-8b95-ffd8320e6b74">Table 3</label><caption id="cf52d01b-30d2-4ea2-b83c-92c83781f496"><title id="T3" data-id="T3">Baseline parameters and side effects in the previously treated and treatment naïve <named-content id="f69a3d9a-6fac-45b8-9edc-990c5dedf308" data-cid="f69a3d9a-6fac-45b8-9edc-990c5dedf308" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="93" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="274_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content><named-content data-cid="1553859948" id="66253456-16e8-4dd9-b634-d0af911b9739" content-type="del cts-2" specific-use="1553859977711" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:16pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553859977711">.</named-content></title></caption><table data-col-count="3" id="a675168c-b0dc-457b-be30-e2a130af834e" data-col-widths-px="127,60,59.587" data-table-type="singleColumn" data-old-attributes="&quot;data-col-widths-px&quot;:&quot;92.529,75.529,78.529&quot;;" data-changed-attributes="data-col-widths-px"><thead id="13377a8e-7550-410d-ada1-3d0585a96825"><tr data-col-count="3" id="37cebff3-2eff-403a-b055-fd9139783b06"><td data-class="" width="55%" data-original-border="border:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="59e7a7aa-d2ab-4ce3-b940-d5f6445281ea" valign="bottom" data-old-attributes=""><p id="56776ab8-8c3c-4cbe-9364-2719ce574905" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;" data-original-alignment=" text-align: center;">Parameter</p></td><td data-class="" width="20%" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="2303acb2-f5a4-48ba-979d-8a95f43b91d8" valign="bottom" data-old-attributes=""><p id="766f678d-2169-4f20-837f-8f9d50a8f777" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;" data-original-alignment=" text-align: center;">Previous<named-content data-cid="1554366304" id="44ecc42e-3547-4f90-a2dd-e7a376f380ec" content-type="ins cts-3" specific-use="1554370069928" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:57pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370069928">ly</named-content> treated</p></td><td width="23%" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="0ec5602c-2184-4bc3-815c-53dcd5dae1b5" valign="bottom" data-old-attributes=""><p id="b2be19c6-9548-47ce-9a14-dda4cbe2ecfe" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;" data-original-alignment=" text-align: center;">Treatment naive</p></td></tr><tr data-col-count="3" id="69d89b4d-7c1d-4737-ad0a-eee0320318b9"><td data-class="" width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="2f1ced82-6890-44a4-9e2b-f9349b40e331" valign="top" data-old-attributes=""><p id="494c620a-1441-4751-8649-c21437f7ac80" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><bold id="354a3aa3-db87-43c6-a07b-7c8923e450b1">Entire group, n</bold></p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="ff844582-2cd7-4519-90a6-bd9ba31152b1" valign="top" data-old-attributes=""><p id="e697634b-4000-42d3-9f4f-1e74927a3322" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="8a83b0dd-e168-4cf2-976d-8f543e6dab5e" data-cid="8a83b0dd-e168-4cf2-976d-8f543e6dab5e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1181" data-replace="1181" data-pattern="1181" data-tag-index="279_1" data-time="" data-username="" data-userid=""><bold id="40eef7f7-b486-4b4b-8f47-c5135ab104ae">1181</bold></named-content></p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="2ca36b61-851c-41be-9599-e12c9253098b" valign="top" data-old-attributes=""><p id="e2e5c445-25a2-4860-84de-ed2f0efae0a9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="402fbde4-3d63-4e65-b16e-e300008367eb" data-cid="402fbde4-3d63-4e65-b16e-e300008367eb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1555" data-replace="1555" data-pattern="1555" data-tag-index="280_1" data-time="" data-username="" data-userid=""><bold id="66eebaea-c4f5-4bd1-a343-6ffc3e6ad16b">1555</bold></named-content></p></td></tr></thead><tbody id="854b78cb-fc23-4afe-aacc-8313a31f5a0d"><tr data-col-count="3" id="970a41d7-49ec-4a34-bd52-f8e24516d0d0" data-fill="true"><td data-class="" width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="555b7ff7-e920-4c19-a43d-ef9bd7c262c2" valign="top" data-old-attributes=""><p id="413bf4a4-26f0-4f7f-a686-ad1e39ea428f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Mean <named-content data-cid="1554366306" id="4d183da9-fdd5-4fa0-b1d5-b8afa9b331ee" content-type="del cts-3" specific-use="1554370090786" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:58pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370090786">B</named-content><named-content data-cid="1554366307" id="654870f3-f152-42f7-a625-68e17f80b860" content-type="ins cts-3" specific-use="1554370090983" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 2:58pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370090983">b</named-content>aseline BCVA, logMAR</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="c3c34499-79c1-443f-9ee0-ba58e6862268" valign="top" data-old-attributes=""><p id="e4a06e49-c05f-4904-9723-cd35efa12255" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="e4872ea4-a4c7-4db7-ae34-921c6ded067a" data-cid="e4872ea4-a4c7-4db7-ae34-921c6ded067a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="0.52±0.42" data-replace="0.52" data-pattern="$1" data-tag-index="282_1" data-time="" data-username="" data-userid="">0.52</named-content><named-content id="a8e8065a-b08e-4ae9-9aa5-5763cb8c73c3" data-cid="a8e8065a-b08e-4ae9-9aa5-5763cb8c73c3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="0.52±0.42" data-replace="±" data-pattern="$2" data-tag-index="282_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="a5b272dc-8837-482f-9df5-eee5b7cbfcd0" data-cid="a5b272dc-8837-482f-9df5-eee5b7cbfcd0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="0.52±0.42" data-replace="0.42" data-pattern="$3" data-tag-index="282_1" data-time="" data-username="" data-userid="">0.42</named-content></p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="0c7879a0-af4e-4d7c-89d9-3c836e499460" valign="top" data-old-attributes=""><p id="dbb4e93f-fb24-4163-98b7-1217a8742b28" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="51980665-5bce-48c7-95af-15d51fd13f02" data-cid="51980665-5bce-48c7-95af-15d51fd13f02" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="0.57±0.44" data-replace="0.57" data-pattern="$1" data-tag-index="283_1" data-time="" data-username="" data-userid="">0.57</named-content><named-content id="f638f852-4ada-4b16-8add-fe9252820b2f" data-cid="f638f852-4ada-4b16-8add-fe9252820b2f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="0.57±0.44" data-replace="±" data-pattern="$2" data-tag-index="283_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="b3c79ba9-b760-429d-8e99-3dec6613b984" data-cid="b3c79ba9-b760-429d-8e99-3dec6613b984" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="0.57±0.44" data-replace="0.44" data-pattern="$3" data-tag-index="283_1" data-time="" data-username="" data-userid="">0.44</named-content></p></td></tr><tr data-col-count="3" id="8ac15b3d-cb04-477c-bc23-c651002cf9c8"><td data-class="" width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="cebce84b-e394-4a98-9b06-9d0144c758e1" valign="top" data-old-attributes=""><p id="1d098589-a2fa-4b8a-aef6-846e3e03ee1d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Mean BCVA at <named-content data-cid="1553859621041" id="602995e8-a0ab-49f5-9c57-a117d22985b2" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow up</named-content><named-content id="596e6935-9fd1-492b-9e9e-7a92c6e9a553" data-cid="1553859621041" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="13" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="284_1" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow-up</named-content>, logMAR</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="1ae01674-3f8f-47a9-bc56-99acd9e3abb5" valign="top" data-old-attributes=""><p id="9dedbd72-cc10-479c-8f2b-8767ac9a0f1e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="51ba1db5-d153-4bf7-9f4f-6d969e6ba378" data-cid="51ba1db5-d153-4bf7-9f4f-6d969e6ba378" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="0.53±0.44" data-replace="0.53" data-pattern="$1" data-tag-index="285_1" data-time="" data-username="" data-userid="">0.53</named-content><named-content id="2f62ab1d-f41e-4e34-8b98-c4c9f4eb7361" data-cid="2f62ab1d-f41e-4e34-8b98-c4c9f4eb7361" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="0.53±0.44" data-replace="±" data-pattern="$2" data-tag-index="285_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="0afad371-720c-4c42-8b58-289162bd241b" data-cid="0afad371-720c-4c42-8b58-289162bd241b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="0.53±0.44" data-replace="0.44" data-pattern="$3" data-tag-index="285_1" data-time="" data-username="" data-userid="">0.44</named-content> (<named-content id="7d500148-bd2c-4eb7-9e3c-7932447c2070" data-cid="7d500148-bd2c-4eb7-9e3c-7932447c2070" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="12" data-match="p=0.14" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="285_2" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="6b437790-3ab0-47c0-9e70-c68348317680" data-cid="6b437790-3ab0-47c0-9e70-c68348317680" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="13" data-match="p=0.14" data-replace="=" data-pattern="$2" data-tag-index="285_2" data-time="" data-username="" data-userid="">=</named-content><named-content id="9d02eb05-50b2-4fa6-8cdc-b8b95776931a" data-cid="9d02eb05-50b2-4fa6-8cdc-b8b95776931a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="14" data-match="p=0.14" data-replace="0.14" data-pattern="$3" data-tag-index="285_2" data-time="" data-username="" data-userid="">0.14</named-content>)</p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="e818c76a-65f6-4637-a858-0bf57c7a93a3" valign="top" data-old-attributes=""><p id="f12b46fd-6f61-453f-9c07-4a3cc7475874" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="7e75fccd-c2da-43ea-a8d6-53c78b908646" data-cid="7e75fccd-c2da-43ea-a8d6-53c78b908646" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="0.56±0.43" data-replace="0.56" data-pattern="$1" data-tag-index="286_1" data-time="" data-username="" data-userid="">0.56</named-content><named-content id="cc704d70-19e0-42cf-9cd6-5ffc8ab54120" data-cid="cc704d70-19e0-42cf-9cd6-5ffc8ab54120" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="0.56±0.43" data-replace="±" data-pattern="$2" data-tag-index="286_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="852a888a-9cd2-4a2e-9636-d4095420104c" data-cid="852a888a-9cd2-4a2e-9636-d4095420104c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="0.56±0.43" data-replace="0.43" data-pattern="$3" data-tag-index="286_1" data-time="" data-username="" data-userid="">0.43</named-content> (<named-content id="a0d7d9db-e940-41f5-8895-7092c13d79f4" data-cid="a0d7d9db-e940-41f5-8895-7092c13d79f4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="12" data-match="p=0.18" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="286_2" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="e9c77248-c90e-44f8-9fae-a3706a5d6e8a" data-cid="e9c77248-c90e-44f8-9fae-a3706a5d6e8a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="13" data-match="p=0.18" data-replace="=" data-pattern="$2" data-tag-index="286_2" data-time="" data-username="" data-userid="">=</named-content><named-content id="2782c890-cf61-46e3-9f52-f8bc8455831c" data-cid="2782c890-cf61-46e3-9f52-f8bc8455831c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="14" data-match="p=0.18" data-replace="0.18" data-pattern="$3" data-tag-index="286_2" data-time="" data-username="" data-userid="">0.18</named-content>)</p></td></tr><tr data-col-count="3" id="7460840d-3add-4711-a0e0-d1d4489a031e" data-fill="true"><td width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="2297fb02-8368-4250-8833-562b894744ab" valign="top" data-old-attributes=""><p id="5c2be7c5-b459-47a3-99dd-184e6afc509c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Phakic status at baseline, n (%)</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="b7249dce-4d7e-4dc3-858d-9a33c2cd679c" valign="top" data-old-attributes=""><p id="65320146-5498-4dba-b61b-d85f34690313" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="07bc21aa-7b15-4dab-87d3-7dc181351244" data-cid="07bc21aa-7b15-4dab-87d3-7dc181351244" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="743 (62.9)" data-replace="743" data-pattern="$1" data-tag-index="288_1" data-time="" data-username="" data-userid="">743</named-content><named-content id="95ef8ba1-a231-4111-9396-b7629bdb40a5" data-cid="95ef8ba1-a231-4111-9396-b7629bdb40a5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="743 (62.9)" data-replace=" (62.9)" data-pattern=" $2" data-tag-index="288_1" data-time="" data-username="" data-userid=""> (62.9)</named-content></p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="6c6e0986-03e3-44cd-acf6-2c75c5a991df" valign="top" data-old-attributes=""><p id="2e0dd9de-fe1a-4012-a338-cc2b9bf7a33a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="8e902061-1d13-4c6a-984f-9d4f9dd1e9fc" data-cid="8e902061-1d13-4c6a-984f-9d4f9dd1e9fc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1005" data-replace="1005" data-pattern="1005" data-tag-index="289_2" data-time="" data-username="" data-userid="">1005</named-content><named-content id="f70e8da2-72b7-4099-9994-b917ac1a7d9e" data-cid="f70e8da2-72b7-4099-9994-b917ac1a7d9e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="1005 (64.6)" data-replace=" (64.6)" data-pattern=" $2" data-tag-index="289_1" data-time="" data-username="" data-userid=""> (64.6)</named-content></p></td></tr><tr data-col-count="3" id="1dd3914c-91d4-4f56-a56d-5990b249d3f3"><td width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="e64f8a06-d072-4d1e-b404-b8084b47c999" valign="top" data-old-attributes=""><p id="303c9639-0441-443f-ba27-5e070118962b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Cataract at baseline, n (%)</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="a76a9ed9-5a7a-4044-9792-4c883764ecae" valign="top" data-old-attributes=""><p id="976a70ae-d5bf-4370-bb2c-8d90adf48613" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="6830ad0c-6cb8-4fc6-8920-e907c1e8c270" data-cid="6830ad0c-6cb8-4fc6-8920-e907c1e8c270" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="317 (42.6)" data-replace="317" data-pattern="$1" data-tag-index="291_1" data-time="" data-username="" data-userid="">317</named-content><named-content id="23e95445-15e2-4c3c-bfbb-d5785a19f663" data-cid="23e95445-15e2-4c3c-bfbb-d5785a19f663" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="317 (42.6)" data-replace=" (42.6)" data-pattern=" $2" data-tag-index="291_1" data-time="" data-username="" data-userid=""> (42.6)</named-content></p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="c3009efa-ee20-4884-bba7-7aa1eb272610" valign="top" data-old-attributes=""><p id="e71c3500-4d23-4328-aceb-403f756f288d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="1c90c019-689d-4b68-8896-8b06e817df73" data-cid="1c90c019-689d-4b68-8896-8b06e817df73" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="280 (27.8)" data-replace="280" data-pattern="$1" data-tag-index="292_1" data-time="" data-username="" data-userid="">280</named-content><named-content id="8f12e3fd-0665-4e8e-bb86-55a7ca77a090" data-cid="8f12e3fd-0665-4e8e-bb86-55a7ca77a090" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="280 (27.8)" data-replace=" (27.8)" data-pattern=" $2" data-tag-index="292_1" data-time="" data-username="" data-userid=""> (27.8)</named-content></p></td></tr><tr data-col-count="3" id="85be9878-e80b-4123-89b1-cc2f81c1df67" data-fill="true"><td width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="95636db1-dbcd-4fd7-a565-01ce7374f07f" valign="top" data-old-attributes=""><p id="fb5fad0f-3dfd-4cc0-a1c7-1739dfb46c9c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Cataract progression or development, n (%)</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="bf6c809a-644b-4c31-be0e-c368eb4598cf" valign="top" data-old-attributes=""><p id="658b539b-bbe4-403e-af89-338ec8735739" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="1b00e115-ac8a-43db-b25d-61b5711b519b" data-cid="1b00e115-ac8a-43db-b25d-61b5711b519b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="186 (25.0)" data-replace="186" data-pattern="$1" data-tag-index="294_1" data-time="" data-username="" data-userid="">186</named-content><named-content id="d985cdd9-1ca1-4b32-ae0f-8b7ed23aeed9" data-cid="d985cdd9-1ca1-4b32-ae0f-8b7ed23aeed9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="186 (25.0)" data-replace=" (25.0)" data-pattern=" $2" data-tag-index="294_1" data-time="" data-username="" data-userid=""> (25.0)</named-content></p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="f8acb391-58b3-4d1d-8801-41fee153489d" valign="top" data-old-attributes=""><p id="88684f97-257c-47fb-bdd1-74fba4b0ca14" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="9f9e2edc-b625-4f03-bc5d-b134f64fd398" data-cid="9f9e2edc-b625-4f03-bc5d-b134f64fd398" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="139 (13.8)" data-replace="139" data-pattern="$1" data-tag-index="295_1" data-time="" data-username="" data-userid="">139</named-content><named-content id="02423a4c-3625-4bf5-9594-41acfa9a66af" data-cid="02423a4c-3625-4bf5-9594-41acfa9a66af" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="139 (13.8)" data-replace=" (13.8)" data-pattern=" $2" data-tag-index="295_1" data-time="" data-username="" data-userid=""> (13.8)</named-content></p></td></tr><tr data-col-count="3" id="638c3800-f51a-40ca-aa13-35bacde86ad6"><td width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="7e181176-153c-4faa-a055-058846360bf0" valign="top" data-old-attributes=""><p id="b10fe801-f0b4-4b9f-9e23-4d5e9913dba9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Conduction of cataract surgery, n (%)</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="dce56ee0-ba3a-49a1-8a8f-239f6c0360d8" valign="top" data-old-attributes=""><p id="4e4d894b-d329-4397-b1e0-d0331e165e10" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="0491ee4d-569e-46ab-a6dc-27c07dae8cf1" data-cid="0491ee4d-569e-46ab-a6dc-27c07dae8cf1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="236 (31.7)" data-replace="236" data-pattern="$1" data-tag-index="297_1" data-time="" data-username="" data-userid="">236</named-content><named-content id="e776257a-bbc4-4fd5-b5d9-c8d470f1586a" data-cid="e776257a-bbc4-4fd5-b5d9-c8d470f1586a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="236 (31.7)" data-replace=" (31.7)" data-pattern=" $2" data-tag-index="297_1" data-time="" data-username="" data-userid=""> (31.7)</named-content></p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="cb7897dd-3ff4-4893-b8a0-9a7558b1c243" valign="top" data-old-attributes=""><p id="88914365-a30a-49d8-88b9-6f06fb295203" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="b3e75d4a-2dd0-4e29-bd48-61ca1b347996" data-cid="b3e75d4a-2dd0-4e29-bd48-61ca1b347996" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="280 (27.8)" data-replace="280" data-pattern="$1" data-tag-index="298_1" data-time="" data-username="" data-userid="">280</named-content><named-content id="9b9402c8-666f-4648-87c5-99a3f3fe94f4" data-cid="9b9402c8-666f-4648-87c5-99a3f3fe94f4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="280 (27.8)" data-replace=" (27.8)" data-pattern=" $2" data-tag-index="298_1" data-time="" data-username="" data-userid=""> (27.8)</named-content></p></td></tr><tr data-col-count="3" id="1ddc5c6a-063f-40c3-9b53-c0489ede1d02" data-fill="true"><td width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="8ebda7d3-e953-451d-9352-ebab5d1ffb82" valign="top" data-old-attributes=""><p id="408a6901-dc22-4fea-b671-31ceb4b9a58e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Prior history of glaucoma, n (%)</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="e989613e-1fb9-4de9-b084-61a5596b4176" valign="top" data-old-attributes=""><p id="5c337a0d-86a9-4873-ba6e-0b8c1ef98ceb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="a6a4b785-be08-42bb-b206-900962a3df61" data-cid="a6a4b785-be08-42bb-b206-900962a3df61" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="90(7.6)" data-replace="90" data-pattern="$1" data-tag-index="300_1" data-time="" data-username="" data-userid="">90</named-content><named-content id="469275aa-7e96-4503-8d6d-7d0260f866de" data-cid="469275aa-7e96-4503-8d6d-7d0260f866de" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(7.6)' to '␣(7.6)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="90(7.6)" data-replace=" (7.6)" data-pattern=" $2" data-tag-index="300_1" data-track-change="(7.6)" data-time="" data-username="" data-userid=""> (7.6)</named-content></p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="a83b17e2-dc42-4371-af78-ca336bc7a233" valign="top" data-old-attributes=""><p id="6bd05a06-f8ce-4256-a1c5-791f7820bb41" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="5108dbf4-ebd0-42df-947e-95176fe9b25b" data-cid="5108dbf4-ebd0-42df-947e-95176fe9b25b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="65(4.2)" data-replace="65" data-pattern="$1" data-tag-index="301_1" data-time="" data-username="" data-userid="">65</named-content><named-content id="e43424a1-09ed-4706-b215-4e90bdcd7697" data-cid="e43424a1-09ed-4706-b215-4e90bdcd7697" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(4.2)' to '␣(4.2)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="65(4.2)" data-replace=" (4.2)" data-pattern=" $2" data-tag-index="301_1" data-track-change="(4.2)" data-time="" data-username="" data-userid=""> (4.2)</named-content></p></td></tr><tr data-col-count="3" id="509d6451-ad32-45d3-b24d-d93bc5fc2b37"><td data-class="" width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="8e35e566-cc21-43f0-82af-125c65d8f3fd" valign="top" data-old-attributes=""><p id="f1384c2e-24cf-496a-9baa-112c5d5194dc" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Prior treatment with AGM, n (%)</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="22487bf0-3a63-4654-b5c4-d15c1fb14e69" valign="top" data-old-attributes=""><p id="a67013d0-4e9c-424c-a5ed-739d55c150e0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="7f46800c-8f29-41d7-bba8-667973b3d75b" data-cid="7f46800c-8f29-41d7-bba8-667973b3d75b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="75 (6.4)" data-replace="75" data-pattern="$1" data-tag-index="303_1" data-time="" data-username="" data-userid="">75</named-content><named-content id="c8fd437b-4973-4e6a-98ed-91198ea8ac14" data-cid="c8fd437b-4973-4e6a-98ed-91198ea8ac14" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="75 (6.4)" data-replace=" (6.4)" data-pattern=" $2" data-tag-index="303_1" data-time="" data-username="" data-userid=""> (6.4)</named-content></p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="62b97ac4-4bb8-42da-b0ad-ca1c01be82c6" valign="top" data-old-attributes=""><p id="3e28d38f-63b9-4145-99c7-da6ab457b0a7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="8382564a-7728-4ef9-abd0-eb98679180a8" data-cid="8382564a-7728-4ef9-abd0-eb98679180a8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="56 (3.6)" data-replace="56" data-pattern="$1" data-tag-index="304_1" data-time="" data-username="" data-userid="">56</named-content><named-content id="a643c659-8e61-4006-8ba8-c07a684a76ec" data-cid="a643c659-8e61-4006-8ba8-c07a684a76ec" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="56 (3.6)" data-replace=" (3.6)" data-pattern=" $2" data-tag-index="304_1" data-time="" data-username="" data-userid=""> (3.6)</named-content></p></td></tr><tr data-col-count="3" id="d3f697f8-8261-456c-a71e-a55851f0d348" data-fill="true"><td data-class="" width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="f8241e71-1ecd-4739-93ca-c82e8c8fcb22" valign="top" data-old-attributes=""><p id="f64934a3-6cbc-4bb7-9877-b7b99e99bc38" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Total cases of glaucoma, n (%)</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="e943220e-aa69-4a68-9f2f-02648d6345f6" valign="top" data-old-attributes=""><p id="00c2b80c-d601-4ce3-a5ba-78878750406d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="d490c8b2-34e4-4434-8b6b-ed155f6a3c91" data-cid="d490c8b2-34e4-4434-8b6b-ed155f6a3c91" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="303 (25.7)" data-replace="303" data-pattern="$1" data-tag-index="306_1" data-time="" data-username="" data-userid="">303</named-content><named-content id="aa4de300-c1b1-4ec9-902b-7cc2c3e5ab05" data-cid="aa4de300-c1b1-4ec9-902b-7cc2c3e5ab05" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="303 (25.7)" data-replace=" (25.7)" data-pattern=" $2" data-tag-index="306_1" data-time="" data-username="" data-userid=""> (25.7)</named-content></p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="8146324c-0de4-41a7-b536-feb9f024b128" valign="top" data-old-attributes=""><p id="45f4d391-58a3-4f7c-8e61-08b85eb23d71" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="f3feb5a9-15c7-4132-88f4-bf28868f5a71" data-cid="f3feb5a9-15c7-4132-88f4-bf28868f5a71" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="385 (24.8)" data-replace="385" data-pattern="$1" data-tag-index="307_1" data-time="" data-username="" data-userid="">385</named-content><named-content id="a59df92f-5939-4d08-bf28-24e431ff88a9" data-cid="a59df92f-5939-4d08-bf28-24e431ff88a9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="385 (24.8)" data-replace=" (24.8)" data-pattern=" $2" data-tag-index="307_1" data-time="" data-username="" data-userid=""> (24.8)</named-content></p></td></tr><tr data-col-count="3" id="f5d9b1f3-b39d-4dbe-952c-3d19b37817bf"><td data-class="" width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="f550e8a3-e164-4e25-bef3-c1ef61d49c00" valign="top" data-old-attributes=""><p id="3a1bf009-4e49-4965-9d8a-cdfac4c6335a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Need for AGM, n (%)</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="0f2996f1-9676-4dfe-b0ff-2baa26509bf7" valign="top" data-old-attributes=""><p id="1b9622b3-11b0-4385-a4c2-cffcb396f592" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="6ef3d5e5-af09-4db1-9e5b-38654ca8e0a1" data-cid="6ef3d5e5-af09-4db1-9e5b-38654ca8e0a1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="277(91.4)" data-replace="277" data-pattern="$1" data-tag-index="309_1" data-time="" data-username="" data-userid="">277</named-content><named-content id="a513726c-c68c-49c1-b72c-d29111ec7053" data-cid="a513726c-c68c-49c1-b72c-d29111ec7053" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(91.4)' to '␣(91.4)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="277(91.4)" data-replace=" (91.4)" data-pattern=" $2" data-tag-index="309_1" data-track-change="(91.4)" data-time="" data-username="" data-userid=""> (91.4)</named-content></p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="ae9b35be-d5c4-40af-8486-e6069170181b" valign="top" data-old-attributes=""><p id="072cb44c-a6b5-4f75-9ae2-8d916a2e7b03" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="89ca9c5e-2f9b-407b-b220-2c1bfc1299e4" data-cid="89ca9c5e-2f9b-407b-b220-2c1bfc1299e4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="351(91.2)" data-replace="351" data-pattern="$1" data-tag-index="310_1" data-time="" data-username="" data-userid="">351</named-content><named-content id="207a95a0-3d32-4b9a-ada2-a98ac298d3b5" data-cid="207a95a0-3d32-4b9a-ada2-a98ac298d3b5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(91.2)' to '␣(91.2)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="351(91.2)" data-replace=" (91.2)" data-pattern=" $2" data-tag-index="310_1" data-track-change="(91.2)" data-time="" data-username="" data-userid=""> (91.2)</named-content></p></td></tr><tr data-col-count="3" id="8a83e5a0-6cb8-4981-9e00-d1e04cb4736b" data-fill="true"><td width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="71a6af1a-3793-40fd-bfd1-0823d5bba595" valign="top" data-old-attributes=""><p id="0da1ae85-6d7c-4716-9771-fb66dfe8093e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Need for surgery, n (%)</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="d6fbef1a-87c3-4a63-a588-3cdbff4365e2" valign="top" data-old-attributes=""><p id="82f52ec0-ffbe-47be-ae5a-b58fd4947612" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="d42a4b18-b934-45ab-bd40-c20d6f99a055" data-cid="d42a4b18-b934-45ab-bd40-c20d6f99a055" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="13(4.3)" data-replace="13" data-pattern="$1" data-tag-index="312_1" data-time="" data-username="" data-userid="">13</named-content><named-content id="2a368281-ad5f-46ae-8167-c621f346b2d9" data-cid="2a368281-ad5f-46ae-8167-c621f346b2d9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(4.3)' to '␣(4.3)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="13(4.3)" data-replace=" (4.3)" data-pattern=" $2" data-tag-index="312_1" data-track-change="(4.3)" data-time="" data-username="" data-userid=""> (4.3)</named-content></p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="2931f9e1-8944-4294-bc84-0a10570370a0" valign="top" data-old-attributes=""><p id="845fab1c-894c-4084-bcaa-f48740efff96" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="1aab90fc-e0ab-448f-9e3b-5bff39322317" data-cid="1aab90fc-e0ab-448f-9e3b-5bff39322317" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="12(3.1)" data-replace="12" data-pattern="$1" data-tag-index="313_1" data-time="" data-username="" data-userid="">12</named-content><named-content id="b4424b28-c87e-4453-b46f-4ff49dee654b" data-cid="b4424b28-c87e-4453-b46f-4ff49dee654b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(3.1)' to '␣(3.1)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="12(3.1)" data-replace=" (3.1)" data-pattern=" $2" data-tag-index="313_1" data-track-change="(3.1)" data-time="" data-username="" data-userid=""> (3.1)</named-content></p></td></tr><tr data-col-count="3" id="78267869-5ed2-40fd-8cc6-8730b5877df6"><td width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="8db210f6-211f-4762-b2a4-3b702a9e2b4a" valign="top" data-old-attributes=""><p id="1b968a47-9707-4e62-b400-9112ac17a38e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Endophthalmitis, n (%)</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="f519c85f-aa55-4e51-9b8a-6fc3b2cf4fc3" valign="top" data-old-attributes=""><p id="b42e548e-ae50-4365-a8c7-3afdb8680def" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="853e5f1a-2ecd-4842-a32f-d3444e533b98" data-cid="853e5f1a-2ecd-4842-a32f-d3444e533b98" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="0 (0)" data-replace="0" data-pattern="$1" data-tag-index="315_1" data-time="" data-username="" data-userid="">0</named-content><named-content id="23932a1d-6a6a-44fa-89b2-137b8e06aadd" data-cid="23932a1d-6a6a-44fa-89b2-137b8e06aadd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="0 (0)" data-replace=" (0)" data-pattern=" $2" data-tag-index="315_1" data-time="" data-username="" data-userid=""> (0)</named-content></p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="e139637d-3926-42ac-bada-3ddfbb2de8ca" valign="top" data-old-attributes=""><p id="a6a6a2ce-3ab4-473b-8429-9017e226eba8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="991f5f89-bc66-4417-8ce4-47c7323daae5" data-cid="991f5f89-bc66-4417-8ce4-47c7323daae5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (0.1)" data-replace="2" data-pattern="$1" data-tag-index="316_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="b316cc58-5721-48c6-a0ef-93d59d485262" data-cid="b316cc58-5721-48c6-a0ef-93d59d485262" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (0.1)" data-replace=" (0.1)" data-pattern=" $2" data-tag-index="316_1" data-time="" data-username="" data-userid=""> (0.1)</named-content></p></td></tr><tr data-col-count="3" id="76a9ca25-5c6a-4db4-9c4b-6504f9ea08a5" data-fill="true"><td width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="2a5802ce-c3b2-4215-b568-9e62456939fa" valign="top" data-old-attributes=""><p id="dc9cb82e-0de0-487a-8d15-9e0eb2254f72" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Vitreous <named-content data-cid="1553859621088" id="21f2b740-c706-40cc-a07c-16383a3c528a" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">hemorrhage</named-content><named-content id="29e2ebb1-7958-45c3-a78f-544bed4908f6" data-cid="1553859621088" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'hemorrhage' to 'haemorrhage'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="9" data-match="hemorrhage" data-replace="haemorrhage" data-pattern="haemorrhage" data-tag-index="317_1" data-function="addTrackChanges" data-track-change="hemorrhage" data-userid="preediting" data-username="Exeter" data-time="1553859621001">haemorrhage</named-content>, n (%)</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="7c7aa8bf-94d2-4903-864e-77f4b26c886c" valign="top" data-old-attributes=""><p id="b89bfafc-1d5f-4263-8ab4-9f9a10e254f4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="101d1872-e106-4f9b-a478-4cfc5bf6f3c5" data-cid="101d1872-e106-4f9b-a478-4cfc5bf6f3c5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="0 (0)" data-replace="0" data-pattern="$1" data-tag-index="318_1" data-time="" data-username="" data-userid="">0</named-content><named-content id="72983bb9-89bd-491f-ab31-d96b27415a6a" data-cid="72983bb9-89bd-491f-ab31-d96b27415a6a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="0 (0)" data-replace=" (0)" data-pattern=" $2" data-tag-index="318_1" data-time="" data-username="" data-userid=""> (0)</named-content></p></td><td data-class="" width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="23fb0f34-fcfb-4bf2-90a5-827801b42339" valign="top" data-old-attributes=""><p id="4b179988-418b-4a54-84a7-91bc0297cfb7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="1bdced3f-8893-4f61-91bc-9d7457a4fcad" data-cid="1bdced3f-8893-4f61-91bc-9d7457a4fcad" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (0" data-replace="1" data-pattern="$1" data-tag-index="319_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="5704c69d-1830-4cce-bff9-b6c6d72d3c8b" data-cid="5704c69d-1830-4cce-bff9-b6c6d72d3c8b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (0" data-replace=" (0" data-pattern=" $2" data-tag-index="319_1" data-time="" data-username="" data-userid=""> (0</named-content><named-content data-cid="1553860016" id="653505a1-f21c-47b3-bcf9-3ce67a6497e2" content-type="del cts-2" specific-use="1553861991869" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:49pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553861991869">.</named-content>.06)</p></td></tr><tr data-col-count="3" id="f509c576-003e-4527-9b06-3c7d1b6bf367"><td data-class="" width="55%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="350ef34c-53e4-4d5e-8bd7-9eb4f5124394" valign="top" data-old-attributes=""><p id="20cf7245-b71b-4313-9194-73c806f2db72" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Retinal detachment, n (%)</p></td><td width="20%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="3c0b5584-4434-42a5-8bbc-6d7559b6a310" valign="top" data-old-attributes=""><p id="737fba74-ef50-4132-8a35-ac4ef5e0d69e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="eeb97933-5fff-4558-814c-cd4cbdd9a047" data-cid="eeb97933-5fff-4558-814c-cd4cbdd9a047" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (0.08)" data-replace="1" data-pattern="$1" data-tag-index="321_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="61a32e79-4b3d-4e70-b1ce-4e2ca8157eb2" data-cid="61a32e79-4b3d-4e70-b1ce-4e2ca8157eb2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (0.08)" data-replace=" (0.08)" data-pattern=" $2" data-tag-index="321_1" data-time="" data-username="" data-userid=""> (0.08)</named-content></p></td><td width="23%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="f4e89722-25d4-480b-9919-8016643e9620" valign="top" data-old-attributes=""><p id="1189a2f1-2ad2-4373-b2c7-ae33677da069" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="a0ee7775-a56c-4ed3-8d77-d943844701ec" data-cid="a0ee7775-a56c-4ed3-8d77-d943844701ec" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="0 (0)" data-replace="0" data-pattern="$1" data-tag-index="322_1" data-time="" data-username="" data-userid="">0</named-content><named-content id="4c4a36b7-18da-4443-9a3d-44098cbc9976" data-cid="4c4a36b7-18da-4443-9a3d-44098cbc9976" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="0 (0)" data-replace=" (0)" data-pattern=" $2" data-tag-index="322_1" data-time="" data-username="" data-userid=""> (0)</named-content></p></td></tr></tbody></table><table-wrap-foot id="23ad5580-4bd0-43a2-861a-9d8f44431de2"><fn data-class="jrnlTblFoot" fn-type="abbrev" data-def-list="true" id="5a503894-3b68-449f-9dba-839083a5c138"><p id="b6a5bfa7-67f4-4e27-976c-63731def88d1"><def-list id="efcf2224-46b9-48ec-9d5b-ea2138c5b269"><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="cb848aeb-48b5-4ff4-9984-641e378f3b1c" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="15e03750-5f9f-48e0-95be-85c5c5833f04">AGM</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="ca2d6405-2f59-4610-959a-ec4b61c1d661"><p id="d64eb385-1dbf-4d23-bcd5-a70122d588ae">anti-glaucoma medications</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="719c298e-06b8-462d-844a-b9d1398372e9" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="f0173c11-9554-4f39-aabd-fd0f67ee706f">BCVA</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="94c12735-3474-4ea7-a235-ade6e5ccbb8b"><p id="92abc111-59ba-4257-8564-367e59e731c3">best corrected visual acuity</p></def>.</def-item></def-list></p></fn></table-wrap-foot></table-wrap><title data-level="3" data-class="jrnlHead3" id="50cb6095-0981-46ab-9d51-645f56fe1ee3">Intraocular pressure rise</title><p data-class="jrnlSecPara" id="99aa896b-f348-4237-9faa-34bc30137243">The average baseline IOP among the overall cohort was <named-content id="bdf6e667-8960-489a-92cc-c70ab692eacd" data-cid="bdf6e667-8960-489a-92cc-c70ab692eacd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="54" data-match="15.31 ± 3.00 mmHg" data-replace="15.31" data-pattern="$1" data-tag-index="21_1" data-time="" data-username="" data-userid="">15.31</named-content><named-content id="a01e1212-09a3-41cb-a494-a8922b9882a0" data-cid="a01e1212-09a3-41cb-a494-a8922b9882a0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣±␣' to '±'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="59" data-match="15.31 ± 3.00 mmHg" data-replace="±" data-pattern="$2" data-tag-index="21_1" data-track-change=" ± " data-time="" data-username="" data-userid="">±</named-content><named-content id="ad031d6b-92c5-49ee-88c5-905def494f1e" data-cid="ad031d6b-92c5-49ee-88c5-905def494f1e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="63" data-match="15.31 ± 3.00 mmHg" data-replace="3.00" data-pattern="$1" data-tag-index="21_1" data-time="" data-username="" data-userid="">3.00</named-content><named-content id="dbd64392-bda6-4e2a-870f-ac7124d485d4" data-cid="dbd64392-bda6-4e2a-870f-ac7124d485d4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmHg' to ' mmHg'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="67" data-match="15.31 ± 3.00 mmHg" data-replace=" mmHg" data-pattern=" $2" data-tag-index="21_1" data-track-change=" mmHg" data-time="" data-username="" data-userid=""> mm<named-content data-cid="1554366308" id="8e9e5fce-a90c-42a2-8cbb-f225cba22624" content-type="ins cts-3" specific-use="1554370318653" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:01pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370318653"> </named-content>Hg</named-content>. At baseline 103 eyes (66.4%) were on anti-glaucoma medications <named-content data-cid="1554366317" id="f8f50b7d-3f82-4320-aad0-65ae99e483dc" content-type="ins cts-3" specific-use="1554370475806" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370475806">(AGM) </named-content>and <named-content data-cid="1553859621005" id="00279c85-6439-4d9c-81b5-dacde4b37c3b" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">7</named-content><named-content id="9f5efeec-6f2d-43e7-8696-640bd6ce2238" data-cid="1553859621005" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '7' to 'seven'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="141" data-match="7" data-pattern="" data-tag-index="21_5" data-function="numberToText,addTrackChanges" data-track-change="7" data-userid="preediting" data-username="Exeter" data-time="1553859621001">seven</named-content> eyes (4.5%) had a history of glaucoma filtration surgery. Intraocular pressure rise was present in 727 eyes (26.5%). Among these eyes, 155 eyes (5.67<named-content data-cid="1554366316" id="d817d61c-4653-474c-a644-06ff288fed1e" content-type="del cts-3" specific-use="1554370408019" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370408019"> </named-content>%) had a prior history of glaucoma and 572 eyes (20.9%) experienced a new onset IOP rise during the follow-up. Among the <named-content id="89ca593c-50a5-41cf-991d-0acfe382634d" data-cid="89ca593c-50a5-41cf-991d-0acfe382634d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="414" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="21_7" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with a new onset of IOP rise, 27 eyes (4.72%) had a transient rise in intraocular pressure without requiring any treatment, while 545 eyes needed anti-glaucoma treatment. In 525 eyes (91.78%) <named-content data-cid="1554366323" id="e3c9a770-9812-4ec9-b180-e8d7d637d360" content-type="del cts-3" specific-use="1554370482822" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370482822">anti-glaucoma medications (</named-content><named-content id="e61d9846-9b6b-4421-8b1f-0cc2ef82ad35" data-cid="e61d9846-9b6b-4421-8b1f-0cc2ef82ad35" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="642" data-match=" (AGM)" data-pattern="" data-tag-index="21_4" data-time="" data-username="" data-userid="">AGM</named-content><named-content data-cid="1554366324" id="01c2c2f9-b2a0-4195-9762-f691686f0081" content-type="del cts-3" specific-use="1554370485620" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370485620">)</named-content> for IOP control were administered, in 18 eyes (3.14<named-content data-cid="1554366329" id="b4f5351c-9c66-4f1c-9c2f-e9934bf8df68" content-type="del cts-3" specific-use="1554370580709" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370580709"> </named-content>%) surgery were conducted and <named-content data-cid="1553859621006" id="b5c430d8-0474-4d9f-847f-9470784dc485" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">2</named-content><named-content id="3e86bbd2-5897-45d7-92c9-e48464ecf484" data-cid="1553859621006" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="729" data-match="2" data-pattern="" data-tag-index="21_6" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1553859621001">two</named-content> eyes (0.35%) eyes required laser trabeculoplasty. We did not find any significant correlation between glaucoma progression and number of dexamethasone implant injections (<named-content id="87de838c-3f28-4738-9566-52950395dbb0" data-cid="87de838c-3f28-4738-9566-52950395dbb0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="902" data-match="p=0.187" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="21_2" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="7b9a2944-f2ec-492c-849f-7dfb32e56c20" data-cid="7b9a2944-f2ec-492c-849f-7dfb32e56c20" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="903" data-match="p=0.187" data-replace="=" data-pattern="$2" data-tag-index="21_2" data-time="" data-username="" data-userid="">=</named-content><named-content id="7f7b2c33-03d3-411b-adf9-3e79bbae708b" data-cid="7f7b2c33-03d3-411b-adf9-3e79bbae708b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="904" data-match="p=0.187" data-replace="0.187" data-pattern="$3" data-tag-index="21_2" data-time="" data-username="" data-userid="">0.187</named-content>)</p><p data-class="jrnlSecPara" id="043093c7-5ac0-4add-bb8d-b06213c08e1a">Prior history of glaucoma was present in <named-content id="89614b46-0b04-4fc3-9988-3c467eda326e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="41" data-match="10.7%" data-replace="10.7" data-pattern="$1" data-tag-index="22_1">10.7</named-content><named-content id="1bb7b2ad-358e-4054-b9da-278250af37f3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="45" data-match="10.7%" data-replace="%" data-pattern="%" data-tag-index="22_1">%</named-content> of the uveitic eyes (16/149 eyes), in <named-content id="b0065096-89a2-4c38-a6cb-5401a0bdf1fb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="85" data-match="5.4%" data-replace="5.4" data-pattern="$1" data-tag-index="22_2">5.4</named-content><named-content id="6a454242-799f-4600-a307-d0fe12033823" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="88" data-match="5.4%" data-replace="%" data-pattern="%" data-tag-index="22_2">%</named-content> of eyes (77/1434 eyes) with diabetic macular <named-content data-cid="1553859621089" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" id="8316993b-f4b7-4d3f-a59a-d61525c47924">edema</named-content><named-content id="2582cb71-83fa-4d10-9add-b0a372e12622" data-cid="1553859621089" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="135" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="22_4" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> and in <named-content id="98b62c97-185c-42cd-838b-196cfc275df9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="148" data-match="5.1%" data-replace="5.1" data-pattern="$1" data-tag-index="22_3">5.1</named-content><named-content id="d4c05a7f-f6ed-41da-b8e9-fe7cd8c45b56" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="151" data-match="5.1%" data-replace="%" data-pattern="%" data-tag-index="22_3">%</named-content> of eyes (27/526 eyes) with retinal venous occlusion.</p><p data-class="jrnlSecPara" id="8ef7b15c-f725-4dec-800b-cd8430996a9b">The rise in IOP in the treatment naïve group was controlled with anti-glaucoma medications in 351 eyes (91.16%) while 12 eyes (3.11<named-content data-cid="1554366330" id="decb70d6-659b-43a7-9cf2-ccd01460e5a1" content-type="del cts-3" specific-use="1554370620832" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370620832"> </named-content>%) needed filtering. In the previously treated group 277 eyes (91.4%) were controlled with topical anti<named-content data-cid="1554366331" id="869bc2cb-1fda-40fd-899f-bcce4c342a13" content-type="del cts-3" specific-use="1554370628340" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370628340"> </named-content><named-content data-cid="1554366332" id="2d6ee4f5-abaa-46a4-88c5-e77822f1d0db" content-type="ins cts-3" specific-use="1554370628548" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370628548">-</named-content>glaucoma medications and 13 eyes (4.29%) needed filtration surgery (<xref id="115c75ae-172c-4d1f-a05d-6f42d5039bbd" ref-type="table" rid="T3" data-citation-string=" T3 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="305" data-match="Table 3" data-pattern="" data-tag-index="23_1"><named-content data-cid="1556001224051" id="4c658a99-7bda-4dd1-9477-4b899460df40" content-type="del cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">Table 3</named-content><named-content data-cid="1556001224051" id="38616201-fd53-46bc-a565-652340d6befa" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">table 3</named-content></xref>). Overall, more than <named-content id="1408a6c7-b055-4bc4-b83a-f603238fe8ef" data-cid="1408a6c7-b055-4bc4-b83a-f603238fe8ef" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="334" data-match="90%" data-replace="90" data-pattern="$1" data-tag-index="23_2" data-time="" data-username="" data-userid="">90</named-content><named-content id="7e3337be-9ac7-4c7f-a5f0-e27e94f52314" data-cid="7e3337be-9ac7-4c7f-a5f0-e27e94f52314" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="336" data-match="90%" data-replace="%" data-pattern="%" data-tag-index="23_2" data-time="" data-username="" data-userid="">%</named-content> of eyes with IOP rise were managed medically, and only <named-content id="16a2af75-ed7a-4435-97e9-272210dc7ae2" data-cid="16a2af75-ed7a-4435-97e9-272210dc7ae2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="393" data-match="0.5%" data-replace="0.5" data-pattern="$1" data-tag-index="23_3" data-time="" data-username="" data-userid="">0.5</named-content><named-content id="4cccd4d1-a6b5-405a-87b1-959b623e9d88" data-cid="4cccd4d1-a6b5-405a-87b1-959b623e9d88" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="396" data-match="0.5%" data-replace="%" data-pattern="%" data-tag-index="23_3" data-time="" data-username="" data-userid="">%</named-content> eyes required filtering surgery.</p><title data-level="3" data-class="jrnlHead3" id="f151b0cf-80d4-40ed-a294-803ec68e9468"><named-content data-cid="1553859621110" id="bea2f6bb-7858-440f-aa99-c8f0c3dd654c" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase">Other Side effects</named-content><named-content data-cid="1553859621110" id="a423d70a-4037-4fb8-baeb-4f2aa178dc55" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase">Other side effects</named-content></title><p data-class="jrnlSecPara" id="5a660ab0-6ce2-4efd-bd11-10eb55860fc6">Other ocular side effects noted in our series were vitreous <named-content data-cid="1553859621090" id="e81cb704-c296-4613-ab33-cd1385b1d3c2" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">hemorrhage</named-content><named-content id="9059f38d-6a31-411c-8fc1-0d42918d0fb2" data-cid="1553859621090" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'hemorrhage' to 'haemorrhage'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="60" data-match="hemorrhage" data-replace="haemorrhage" data-pattern="haemorrhage" data-tag-index="24_7" data-function="addTrackChanges" data-track-change="hemorrhage" data-userid="preediting" data-username="Exeter" data-time="1553859621001">haemorrhage</named-content> in <named-content data-cid="1553859621007" id="2e07f452-a6d0-49af-9e0c-dc0a7b8159a0" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">1</named-content><named-content id="adcae4b2-adf8-4668-af0e-4411ef4c7403" data-cid="1553859621007" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="74" data-match="1" data-pattern="" data-tag-index="24_2" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1553859621001">one</named-content> eye (0.03<named-content data-cid="1554366333" id="ca0d28d8-fa57-4c37-ad64-f5db0e9934fa" content-type="del cts-3" specific-use="1554370658019" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370658019"> </named-content>%), retinal detachment in <named-content data-cid="1553859621008" id="e3fed49a-dc30-4d43-82c1-1dcd761d92bc" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">1</named-content><named-content id="2dea90f7-0b85-4915-afdc-c4bbb47e51b6" data-cid="1553859621008" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="112" data-match="1" data-pattern="" data-tag-index="24_3" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1553859621001">one</named-content> eye (<named-content id="ec8e4c42-f067-4029-aebc-6a34430aedf7" data-cid="ec8e4c42-f067-4029-aebc-6a34430aedf7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="119" data-match="0.03%" data-replace="0.03" data-pattern="$1" data-tag-index="24_1" data-time="" data-username="" data-userid="">0.03</named-content><named-content id="4f253100-bcfd-471e-b756-5207a9ccc27c" data-cid="4f253100-bcfd-471e-b756-5207a9ccc27c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="123" data-match="0.03%" data-replace="%" data-pattern="%" data-tag-index="24_1" data-time="" data-username="" data-userid="">%</named-content><named-content data-cid="1554366334" id="911dd369-329f-4616-b80c-e67e65cad0eb" content-type="del cts-3" specific-use="1554370664179" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370664179"> %</named-content>) and sterile endophthalmitis in <named-content data-cid="1553859621009" id="80e68532-b279-436e-a2ed-75f95d6a9da5" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">2</named-content><named-content id="5900a59c-b6c8-4b01-9627-7e4648debf3e" data-cid="1553859621009" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="159" data-match="2" data-pattern="" data-tag-index="24_4" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1553859621001">two</named-content> eyes (7.3<named-content data-cid="1554366335" id="81368535-e44a-46c6-9c58-21553e1030b0" content-type="del cts-3" specific-use="1554370670003" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370670003"> </named-content>%)). The following systemic conditions were noted in <named-content data-cid="1553859621010" id="645b4027-6b59-45a4-ac82-c75666f97226" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">1</named-content><named-content id="67d3c01e-3854-4039-ba1c-58e30be96c25" data-cid="1553859621010" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="224" data-match="1" data-pattern="" data-tag-index="24_5" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1553859621001">one</named-content> <named-content id="5690114c-798a-4175-bd76-649f66d76590" data-cid="5690114c-798a-4175-bd76-649f66d76590" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="226" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="24_6" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content> each: herpes zoster, death due to renal failure, cerebrovascular occlusion, myocardial infarction and angina. However, these were stated as being unrelated to the dexamethasone implant.</p><title data-level="2" data-class="jrnlHead2" id="c422ee39-3739-4081-91a0-1dd8af08090e"><named-content data-cid="1553859621111" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="02702a31-02d2-4db4-9a8e-44dc2f0882dd">Efficacy Results</named-content><named-content data-cid="1553859621111" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="49dceb71-4677-47ec-83f3-ff0a38f2620a">Efficacy results</named-content></title><p data-class="jrnlSecPara" id="9f8c6bd0-5cbe-4ca1-858b-82bbfe6df12f">The mean overall BCVA at baseline was <named-content id="1b0bfa84-3057-43f2-8af6-b43a20653f2d" data-cid="1b0bfa84-3057-43f2-8af6-b43a20653f2d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="38" data-match="0.55±0.44" data-replace="0.55" data-pattern="$1" data-tag-index="25_3" data-time="" data-username="" data-userid="">0.55</named-content><named-content id="6522fe34-8eb6-4282-91cd-580f1e5392d9" data-cid="6522fe34-8eb6-4282-91cd-580f1e5392d9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="42" data-match="0.55±0.44" data-replace="±" data-pattern="$2" data-tag-index="25_3" data-time="" data-username="" data-userid="">±</named-content><named-content id="09c39a19-e8ae-4227-998a-5489fab76b1d" data-cid="09c39a19-e8ae-4227-998a-5489fab76b1d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="44" data-match="0.55±0.44" data-replace="0.44" data-pattern="$3" data-tag-index="25_3" data-time="" data-username="" data-userid="">0.44</named-content> logMAR while the final BCVA was <named-content id="7d79aff1-2f69-4dc4-87b8-84d99dc409b0" data-cid="7d79aff1-2f69-4dc4-87b8-84d99dc409b0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="81" data-match="0.55±0.44" data-replace="0.55" data-pattern="$1" data-tag-index="25_4" data-time="" data-username="" data-userid="">0.55</named-content><named-content id="8e6c359d-a06d-4c33-afd6-04fc8094affa" data-cid="8e6c359d-a06d-4c33-afd6-04fc8094affa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="85" data-match="0.55±0.44" data-replace="±" data-pattern="$2" data-tag-index="25_4" data-time="" data-username="" data-userid="">±</named-content><named-content id="d6a3fbb4-1d69-4e61-805c-ac41cf8c8e40" data-cid="d6a3fbb4-1d69-4e61-805c-ac41cf8c8e40" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="87" data-match="0.55±0.44" data-replace="0.44" data-pattern="$3" data-tag-index="25_4" data-time="" data-username="" data-userid="">0.44</named-content> logMAR with the mean change being <named-content id="7ce968b9-b518-4553-9bfe-0b3d00da8f53" data-cid="7ce968b9-b518-4553-9bfe-0b3d00da8f53" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="126" data-match="0.007±0.46" data-replace="0.007" data-pattern="$1" data-tag-index="25_5" data-time="" data-username="" data-userid="">0.007</named-content><named-content id="90f65e47-9126-4a12-8ebb-efca9730a4d7" data-cid="90f65e47-9126-4a12-8ebb-efca9730a4d7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="131" data-match="0.007±0.46" data-replace="±" data-pattern="$2" data-tag-index="25_5" data-time="" data-username="" data-userid="">±</named-content><named-content id="b2b3c2cf-9cb9-46dd-9e90-bb4f2ac6e54d" data-cid="b2b3c2cf-9cb9-46dd-9e90-bb4f2ac6e54d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="133" data-match="0.007±0.46" data-replace="0.46" data-pattern="$3" data-tag-index="25_5" data-time="" data-username="" data-userid="">0.46</named-content> logMAR (<named-content id="e9a8c63a-3f1f-42c5-98b0-ac1497e152a4" data-cid="e9a8c63a-3f1f-42c5-98b0-ac1497e152a4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="146" data-match="p=0.87" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="25_6" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="90f7a728-2e1d-4ede-aa21-c7df783d6e53" data-cid="90f7a728-2e1d-4ede-aa21-c7df783d6e53" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="147" data-match="p=0.87" data-replace="=" data-pattern="$2" data-tag-index="25_6" data-time="" data-username="" data-userid="">=</named-content><named-content id="c5367b50-f709-4b8a-a2d3-4274400c26ad" data-cid="c5367b50-f709-4b8a-a2d3-4274400c26ad" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="148" data-match="p=0.87" data-replace="0.87" data-pattern="$3" data-tag-index="25_6" data-time="" data-username="" data-userid="">0.87</named-content>). Although, the overall change in BCVA was not statistically significant, the improvement in BCVA in the retinal venous occlusion group and the diabetic macular <named-content data-cid="1553859621091" id="2fd368b9-b4b7-4742-981d-0db29186866c" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="d8363b80-b3d3-4154-9be3-c16a0e39bf0d" data-cid="1553859621091" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="314" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="25_13" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> subgroups was observed to be significant (<named-content id="9ce66d55-f502-4a7d-98ef-692a1bec23fe" data-cid="9ce66d55-f502-4a7d-98ef-692a1bec23fe" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="362" data-match="p&amp;lt;0.001 and" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="25_7" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="88668d27-0cd2-4cae-a34e-9758e097f698" data-cid="88668d27-0cd2-4cae-a34e-9758e097f698" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="363" data-match="p&amp;lt;0.001 and" data-replace="&lt;" data-pattern="$2" data-tag-index="25_7" data-time="" data-username="" data-userid="">&lt;</named-content><named-content id="61a4a8bd-94b7-4130-952f-04020ed4b02d" data-cid="61a4a8bd-94b7-4130-952f-04020ed4b02d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="364" data-match="p&amp;lt;0.001 and" data-replace="0.001" data-pattern="$3" data-tag-index="25_7" data-time="" data-username="" data-userid="">0.001</named-content><named-content id="066fb4ed-401f-4c7d-8bdf-bcc89e6da37f" data-cid="066fb4ed-401f-4c7d-8bdf-bcc89e6da37f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣and' to ' and'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="369" data-match="p&amp;lt;0.001 and" data-replace=" and" data-pattern=" $6" data-tag-index="25_7" data-track-change=" and" data-time="" data-username="" data-userid=""> and</named-content> <named-content id="a45d4caf-6cbd-418c-89b4-0af201663e8c" data-cid="a45d4caf-6cbd-418c-89b4-0af201663e8c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="374" data-match="p=0.047" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="25_8" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="b2ac1512-6b21-41e4-868e-18984a68b948" data-cid="b2ac1512-6b21-41e4-868e-18984a68b948" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="375" data-match="p=0.047" data-replace="=" data-pattern="$2" data-tag-index="25_8" data-time="" data-username="" data-userid="">=</named-content><named-content id="5995ef91-8eb0-4da4-92d6-1564bfdf1144" data-cid="5995ef91-8eb0-4da4-92d6-1564bfdf1144" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="376" data-match="p=0.047" data-replace="0.047" data-pattern="$3" data-tag-index="25_8" data-time="" data-username="" data-userid="">0.047<named-content data-cid="1554366336" id="36ada94e-e437-4a60-92ec-94cc9b2686b8" content-type="ins cts-3" specific-use="1554370727988" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370727988">,</named-content></named-content> respectively) (<xref id="5b4fbbb8-da4c-4f94-9b2c-53e62ba5756a" ref-type="table" rid="T1" data-citation-string=" T1 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="397" data-match="Table 1" data-pattern="" data-tag-index="25_1"><named-content data-cid="1556001224052" id="0dbab1d8-cbb1-4c9a-bdbe-aeb7fe3a5e4f" content-type="del cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">Table 1</named-content><named-content data-cid="1556001224052" id="9ecdc6ca-ba77-4008-afad-bfaf5e13ead8" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">table 1</named-content></xref>). Baseline BCVA was one of the main factors correlating with the final BCVA on univariate and multivariate regression analysis (<xref id="8d3cfd4a-c0a5-4c8b-bebb-727a5604dfb4" ref-type="table" rid="T4" data-citation-string=" T4 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="533" data-match="Table 4" data-pattern="" data-tag-index="25_2" data-anchor="true"><named-content data-cid="1556001224053" id="7a3c86a6-ed00-4f89-9a1f-5aa01cb8be77" content-type="del cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">Table 4</named-content><named-content data-cid="1556001224053" id="5cd4abf4-c0d9-4fcd-9ed1-40858a18399f" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">table 4</named-content></xref>). Mean overall central macular thickness at baseline and the last <named-content data-cid="1553859621042" id="0230bbc4-83f0-48da-bf2a-3ec9f7581b71" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow up</named-content><named-content id="317bbe38-7922-47ea-aa94-879cbc48488b" data-cid="1553859621042" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="607" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="25_12" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow-up</named-content> was <named-content id="3482db8c-bae1-44e6-a684-8894ddb66580" data-cid="3482db8c-bae1-44e6-a684-8894ddb66580" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="621" data-match="356±36 and" data-replace="356" data-pattern="$1" data-tag-index="25_9" data-time="" data-username="" data-userid="">356</named-content><named-content id="c1983fd6-9f83-4998-ab06-7cf7aa0e9794" data-cid="c1983fd6-9f83-4998-ab06-7cf7aa0e9794" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="624" data-match="356±36 and" data-replace="±" data-pattern="$2" data-tag-index="25_9" data-time="" data-username="" data-userid="">±</named-content><named-content id="ceccab06-1398-4123-b438-52f6879d1f9f" data-cid="ceccab06-1398-4123-b438-52f6879d1f9f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="626" data-match="356±36 and" data-replace="36" data-pattern="$3" data-tag-index="25_9" data-time="" data-username="" data-userid="">36</named-content><named-content id="485a7b30-bc1b-4434-aea2-fef7f28b34a6" data-cid="485a7b30-bc1b-4434-aea2-fef7f28b34a6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣and' to ' and'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="628" data-match="356±36 and" data-replace=" and" data-pattern=" $6" data-tag-index="25_9" data-track-change=" and" data-time="" data-username="" data-userid=""> and</named-content> <named-content id="cb9b6b4a-8963-472f-af7d-11e70337a316" data-cid="cb9b6b4a-8963-472f-af7d-11e70337a316" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="633" data-match="289±97" data-replace="289" data-pattern="$1" data-tag-index="25_10" data-time="" data-username="" data-userid="">289</named-content><named-content id="13230b81-fbc0-4322-b1de-461a5cc45cb9" data-cid="13230b81-fbc0-4322-b1de-461a5cc45cb9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="636" data-match="289±97" data-replace="±" data-pattern="$2" data-tag-index="25_10" data-time="" data-username="" data-userid="">±</named-content><named-content id="e86e3f8e-808b-4ae0-91f3-2b1747cec018" data-cid="e86e3f8e-808b-4ae0-91f3-2b1747cec018" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="638" data-match="289±97" data-replace="97" data-pattern="$3" data-tag-index="25_10" data-time="" data-username="" data-userid="">97</named-content> microns respectively (<named-content id="6cf81fde-458c-41e5-9148-90e0b20b4ae8" data-cid="6cf81fde-458c-41e5-9148-90e0b20b4ae8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="663" data-match="p=0.12" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="25_11" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="b0d6450c-c82c-46a2-8653-bf03f9685d16" data-cid="b0d6450c-c82c-46a2-8653-bf03f9685d16" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="664" data-match="p=0.12" data-replace="=" data-pattern="$2" data-tag-index="25_11" data-time="" data-username="" data-userid="">=</named-content><named-content id="efc441e8-b036-40bf-a8fe-5bc581a9a5cd" data-cid="efc441e8-b036-40bf-a8fe-5bc581a9a5cd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="665" data-match="p=0.12" data-replace="0.12" data-pattern="$3" data-tag-index="25_11" data-time="" data-username="" data-userid="">0.12</named-content>).</p><table-wrap id="BLK_T4" data-id="BLK_T4" data-stream-name="a_T4" position="float"><label id="2d2cee18-478d-4b79-9483-ba8d06a36303"><named-content data-cid="1556001224054" id="07299b0a-c3ac-48ce-bba5-d1fe84de238c" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">Table </named-content><named-content data-cid="1556001224054" id="123a4863-86f5-4d10-8ce5-aff7aca4b847" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">4</named-content></label><caption id="13787fa0-cf07-4573-a1e6-af9a2a8d7d34"><title id="T4" data-id="T4"><named-content data-cid="1554376316698" id="862e8d4a-a588-46d0-b365-a1b4200b00dc" content-type="del cts-1" specific-use="1554376315863" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - 04/04/2019, 4:41 pm" data-track-detail="" data-time="1554376315863" data-username="B020-Baburaj (COPYEDITOR)" data-userid="copyeditor 8576948431" data-type="spelling">Factors</named-content><named-content data-cid="1554376316698" id="79ecdf9c-f2e6-483f-9fd4-7f306ca3ec2f" content-type="ins cts-1" specific-use="1554376315863" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - 04/04/2019, 4:41 pm" data-track-detail="" data-time="1554376315863" data-username="B020-Baburaj (COPYEDITOR)" data-userid="copyeditor 8576948431" data-type="spelling"><named-content data-cid="1554390503" id="b12fa83e-70c5-4d40-b4ea-2807963cf542" content-type="del cts-4" specific-use="1554390823690" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 5653473376" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 8:43pm" data-track-detail="" data-userid="copyeditor 5653473376" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554390823690">4</named-content><named-content data-cid="1554540538" id="32b2c0b0-fb9a-4dae-88f3-3cd2cbccca3a" content-type="del cts-8" specific-use="1554541299053" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Deleted by Gowtham Ram (TYPESETTER) - Apr 6 2019 2:31pm" data-track-detail="" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1554541299053"> </named-content>Factors</named-content> affecting the final visual acuity in the overall cohort and the subgroups, univariate and multivariate regression analysis<named-content data-cid="1553859949" id="f16b49fe-5e6f-42b9-acc8-e10b637ea05e" content-type="del cts-2" specific-use="1553859981056" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:16pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553859981056">.</named-content></title></caption><table data-col-count="7" data-caption-link="T4" id="1b7992ea-64d6-4849-a755-fdcbb115ddef" data-col-widths-px="77.712666666667,72.712666666667,72.712666666667,72.712666666667,72.712666666667,72.712666666667,69.999" data-table-type="doubleColumn" data-old-attributes="&quot;data-col-widths-px&quot;:&quot;77.712666666667,72.712666666667,72.712666666667,72.712666666667,72.712666666667,72.712666666667,70&quot;;" data-changed-attributes="data-col-widths-px"><thead id="27d2ee78-c1ed-4d81-a7d2-06e2591715cb"><tr data-col-count="7" id="d238a739-d502-402d-8b29-65db60ed0289"><td width="20%" rowspan="2" data-original-border="border:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="6fe118b1-bd60-4d25-99c6-878e4051d56f" valign="bottom" data-old-attributes=""><p id="1910b037-553a-4b07-8944-3bafcdb1f6d9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 24.0pt;" data-original-alignment=" text-align: center;">Variables</p></td><td width="41%" colspan="3" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="39483615-fb03-4409-b59b-e5ae0969fa40" valign="bottom" data-old-attributes=""><p id="05eaac1b-4653-45a4-9554-d5f351e11790" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;" data-original-alignment=" text-align: center;">Univariate analysis</p></td><td width="38%" colspan="3" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="80f12d92-7c28-4288-98bf-a799e1fbbb3a" valign="bottom" data-old-attributes=""><p id="bb3a9744-a693-4635-a862-15b48b2eaf0c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;" data-original-alignment=" text-align: center;">Multivariate analysis</p></td></tr><tr data-col-count="7" id="d3cfe330-3fa7-4d7c-9222-d26883fca906"><td data-class="" width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="675c4d30-301f-4bde-b46a-9e4dca6b3b68" valign="bottom" data-old-attributes=""><p id="4758e88e-de83-4046-b3d8-0ce2557c8614" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Coefficient</p></td><td data-class="" width="13%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="f176ce3d-9c24-4d7e-8025-1516a84c309f" valign="bottom" data-old-attributes=""><p id="679d0744-3da9-46ad-bb7f-146581fcda1b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content data-cid="1553859954" id="b0fdee92-87d5-40d7-a5f0-5e5d6500974e" content-type="changeCase sty cts-2" specific-use="1553859998611" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="UPPERCASE Added by Pradheep (PREEDITOR) - 03/29/2019 5:16pm" data-track-detail="" data-track-hint="UPPERCASE Added" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553859998611">P<span data-class="hidden" hidden-track="track" id="258bfb33-51bb-4586-8b42-27bf909ed358">p</span></named-content><named-content data-cid="1553859955" id="d1476cc6-dc41-4c74-a48b-67ea1e1e2779" content-type="ins cts-2" specific-use="1553859999531" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Inserted by Pradheep (PREEDITOR) - Mar 29 2019 5:16pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553859999531"> </named-content><named-content data-cid="1553859953" id="6ad11755-493d-4e6d-9b6f-7c3edf538bfa" content-type="del cts-2" specific-use="1553859994160" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:16pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553859994160">-</named-content>value</p></td><td width="12%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="24ce67f2-cbbf-46bf-82e9-212faee89c3f" valign="bottom" data-old-attributes=""><p id="455ac52a-fdae-4f66-b346-c6e9f0fade1b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="c0187b41-d702-43ef-8396-a7fbea9aabf5"><named-content id="f8e9217e-bd34-4c87-9ad5-e3b0a997c16d" data-cid="f8e9217e-bd34-4c87-9ad5-e3b0a997c16d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="95% CI" data-replace="95%" data-pattern="$1" data-tag-index="329_1" data-time="" data-username="" data-userid="">95%</named-content></bold><named-content id="0335e172-b96e-4911-9e07-fe9e8b00d517" data-cid="0335e172-b96e-4911-9e07-fe9e8b00d517" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '&lt;b␣id=&quot;60ce223e-17cb-47ea-afe4-4f7a0618ee57&quot;&gt;␣CI&lt;/b&gt;' to ' CI'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="3" data-match="95% CI" data-replace=" CI" data-pattern=" $2" data-tag-index="329_1" data-track-change="&lt;b id=&quot;60ce223e-17cb-47ea-afe4-4f7a0618ee57&quot;&gt; CI&lt;/b&gt;" data-time="" data-username="" data-userid=""> CI</named-content></p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="607de31e-2ab7-422b-94f8-6b229389373c" valign="bottom" data-old-attributes=""><p id="769a112d-18db-468d-a465-0f24b024f442" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Coefficient</p></td><td data-class="" width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="ff06be23-0d23-484d-af45-adc3c0d888e4" valign="bottom" data-old-attributes=""><p id="ddc898ae-f754-473a-9570-795a72aebaa0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content data-cid="1553859952" id="65238f2d-f8ac-4151-af7d-16de0da3def7" content-type="changeCase sty cts-2" specific-use="1553859991308" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="UPPERCASE Added by Pradheep (PREEDITOR) - 03/29/2019 5:16pm" data-track-detail="" data-track-hint="UPPERCASE Added" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553859991308">P<span data-class="hidden" hidden-track="track" id="bc1710e4-e9b5-4673-ade4-28c206142e8b">p</span></named-content><named-content data-cid="1553859950" id="8839ea2a-488f-4fda-ba8f-c25d67572e06" content-type="del cts-2" specific-use="1553859985331" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:16pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553859985331">-</named-content><named-content data-cid="1553859951" id="142b3116-32e0-4d97-a363-af059e69bc28" content-type="ins cts-2" specific-use="1553859986232" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Inserted by Pradheep (PREEDITOR) - Mar 29 2019 5:16pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553859986232"> </named-content>value</p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="a7c4c9e7-4892-49b3-a725-dfec0ac8bf67" valign="bottom" data-old-attributes=""><p id="0d0afc00-22e0-4004-97cd-7dd4235f9e1e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="8fe6e02d-2963-4012-b8e5-9eae2d146077"><named-content id="b7a18333-5f93-49db-9a37-d24a3f26ed05" data-cid="b7a18333-5f93-49db-9a37-d24a3f26ed05" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="95% CI" data-replace="95%" data-pattern="$1" data-tag-index="332_1" data-time="" data-username="" data-userid="">95%</named-content></bold><named-content id="e89bc4c0-a787-4576-97c6-006ebfeadc81" data-cid="e89bc4c0-a787-4576-97c6-006ebfeadc81" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '&lt;b␣id=&quot;7895d282-97fe-408d-af33-179e8cae1c5d&quot;&gt;␣CI&lt;/b&gt;' to ' CI'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="3" data-match="95% CI" data-replace=" CI" data-pattern=" $2" data-tag-index="332_1" data-track-change="&lt;b id=&quot;7895d282-97fe-408d-af33-179e8cae1c5d&quot;&gt; CI&lt;/b&gt;" data-time="" data-username="" data-userid=""> CI</named-content></p></td></tr></thead><tbody id="5dead194-69f9-47ff-a40e-b7c8e0c98d67"><tr data-col-count="7" id="352a27fd-bf49-4850-858f-6e9de16eef21" data-fill="true"><td data-class="" width="100%" colspan="7" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="dd4d12c4-57a1-4be5-9e4a-9cbd9316f29f" valign="top" data-old-attributes=""><p id="27894779-50dc-42f0-a21a-9d0b35b9b1e3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Entire series (<named-content id="2e7f88a2-841a-4308-94d2-82ffd9262479" data-cid="2e7f88a2-841a-4308-94d2-82ffd9262479" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="15" data-match="n=2736" data-replace="n" data-pattern="$1" data-tag-index="333_1" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid="">n</named-content><named-content id="33c06a92-de9a-46f1-88ff-7770ff838c53" data-cid="33c06a92-de9a-46f1-88ff-7770ff838c53" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="16" data-match="n=2736" data-replace="=" data-pattern="$2" data-tag-index="333_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="4abee281-e2a9-40dd-8ab6-b7dafcbb3e2e" data-cid="4abee281-e2a9-40dd-8ab6-b7dafcbb3e2e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="17" data-match="n=2736" data-replace="2736" data-pattern="2736" data-tag-index="333_1" data-time="" data-username="" data-userid="">2736</named-content>)</p></td></tr><tr data-col-count="7" id="0c05845f-7172-4aac-ac5e-0c14fe57cb4d"><td data-class="" width="20%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="12a60ef5-7e2c-41c1-8cce-214bdc223fe4" valign="top" data-old-attributes=""><p id="b26d10b5-9cf9-473f-a87a-07f41383524a" data-original-margin=" margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">BCVA baseline</p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="f1f1581a-2143-4d85-9af8-2bcb1fc85406" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="8f881fd7-72af-48ec-9e2d-6c3d77d3ec05" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.449</p></td><td width="13%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="65493624-b946-4248-8e1b-5bcfbeeb4c9d" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="8dc5ae57-1343-4778-b59e-7e976656c6ae" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="ada7deb6-0d77-4ce4-ae3d-e4632247c173"><named-content id="e7f41606-ae57-40e8-a907-7374d0550dd5" data-cid="e7f41606-ae57-40e8-a907-7374d0550dd5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="0" data-match="&amp;lt;0.001" data-replace="&lt;" data-pattern="$2" data-tag-index="336_1" data-time="" data-username="" data-userid="">&lt;</named-content></bold><named-content id="83726000-7d73-4ba6-806e-6792fa1e1443" data-cid="83726000-7d73-4ba6-806e-6792fa1e1443" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="1" data-match="&amp;lt;0.001" data-replace="0.001" data-pattern="$3" data-tag-index="336_1" data-time="" data-username="" data-userid=""><bold id="9127b513-976c-424c-8a17-0689129efbda">0.001</bold></named-content></p></td><td width="12%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="9c9bd1d0-753c-44e3-9eec-0127bc1bd9a5" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="710a0042-0e0a-4d2f-b91a-7cdc9c4074c4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="6592eb12-98ef-49f0-a3a6-2c9e65d57714" data-cid="6592eb12-98ef-49f0-a3a6-2c9e65d57714" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.416, 0.482" data-replace="0.416" data-pattern="$2" data-tag-index="s248_1" data-time="" data-username="" data-userid="">0.416</named-content><named-content id="be6cfe1e-649e-4686-9c6e-aa0b6e6207fb" data-cid="be6cfe1e-649e-4686-9c6e-aa0b6e6207fb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="5" data-match="0.416, 0.482" data-replace=" to " data-pattern="$3 " data-tag-index="s248_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="4e3a6d71-a15b-43bb-9aa6-58574a6f1afe" data-cid="4e3a6d71-a15b-43bb-9aa6-58574a6f1afe" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="7" data-match="0.416, 0.482" data-replace="0.482" data-pattern="$4" data-tag-index="s248_1" data-time="" data-username="" data-userid="">0.482</named-content></p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="90cff035-81b5-4baf-999b-64682894c778" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="5acd31e6-eb08-46e7-a62e-99c42b9896a6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.448</p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="6f82dd33-2458-4690-82f5-11f1c6ae991d" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="dde0e540-998c-4afd-9a7a-464e1568e2f3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="a0f5db0b-6f71-47c8-a27d-08c9c21830a9"><named-content id="b4ff0eb2-8e62-4479-9aca-356b623172d5" data-cid="b4ff0eb2-8e62-4479-9aca-356b623172d5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="0" data-match="&amp;lt;0.001" data-replace="&lt;" data-pattern="$2" data-tag-index="339_1" data-time="" data-username="" data-userid="">&lt;</named-content></bold><named-content id="dea0f208-5750-4d2b-ac41-357f19cdaadf" data-cid="dea0f208-5750-4d2b-ac41-357f19cdaadf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="1" data-match="&amp;lt;0.001" data-replace="0.001" data-pattern="$3" data-tag-index="339_1" data-time="" data-username="" data-userid=""><bold id="13c94a1a-ef8c-41a4-864b-ee88f2421ddf">0.001</bold></named-content></p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="f7f1e644-3d3e-494c-b691-4523c63dba3f" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="acd0735e-b3b3-49df-82f5-9aef20c64107" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="3d3d5274-2eaf-44ec-ae7f-8e102bbc5f41" data-cid="3d3d5274-2eaf-44ec-ae7f-8e102bbc5f41" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.415, 0.481" data-replace="0.415" data-pattern="$2" data-tag-index="s251_1" data-time="" data-username="" data-userid="">0.415</named-content><named-content id="8a45dec8-8efb-4cf0-9801-1b86adfa8b77" data-cid="8a45dec8-8efb-4cf0-9801-1b86adfa8b77" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="5" data-match="0.415, 0.481" data-replace=" to " data-pattern="$3 " data-tag-index="s251_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="9c1d93d6-2a4d-4f17-bf4f-ff9ec5ce3c8e" data-cid="9c1d93d6-2a4d-4f17-bf4f-ff9ec5ce3c8e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="7" data-match="0.415, 0.481" data-replace="0.481" data-pattern="$4" data-tag-index="s251_1" data-time="" data-username="" data-userid="">0.481</named-content></p></td></tr><tr data-col-count="7" id="afddb8af-8f89-438a-a2a5-6a0d33908a38" data-fill="true"><td width="20%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="3a837dfb-4349-4402-919b-2d0c41ff18a6" valign="top" data-old-attributes=""><p id="1983bf17-fdda-41c9-97fa-74e63e9cd4ff" data-original-margin=" margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Total injections</p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="169ec10e-1369-41b8-b8a3-7f6590ef36aa" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="f109ce88-3ef2-4947-a749-8e4dc135f883" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="1f96f310-95b3-4138-a9a1-73429a250693" data-cid="1f96f310-95b3-4138-a9a1-73429a250693" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.009" data-replace="−" data-pattern="−" data-tag-index="342_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="e03a6b40-3e69-4d9a-9df4-42c561393216" data-cid="e03a6b40-3e69-4d9a-9df4-42c561393216" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.009" data-replace="0.009" data-pattern="$2" data-tag-index="342_1" data-time="" data-username="" data-userid="">0.009</named-content></p></td><td data-class="" width="13%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="14948709-b6d9-4eec-8370-4c4d67b46f52" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="5957c4de-a9c6-420b-9d00-05fe0329210e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="5bcd6ead-3bcc-4e97-a726-e1bdf9630c3b">0.050</bold></p></td><td width="12%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="340bc8b2-6807-45ee-a7fe-e9600daaeb13" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="9534580b-c29a-4aa4-a8ea-b43c55c90c27" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="a94aee92-d48f-4043-a5ce-92c117ada717" data-cid="a94aee92-d48f-4043-a5ce-92c117ada717" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.017" data-replace="−" data-pattern="−" data-tag-index="344_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="77485248-1cfe-43c4-91d9-dcf352be7b27" data-cid="77485248-1cfe-43c4-91d9-dcf352be7b27" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.017" data-replace="0.017" data-pattern="$2" data-tag-index="344_1" data-time="" data-username="" data-userid="">0.017</named-content><named-content id="24ebdcd4-2376-45ea-add3-b6eb16104221" data-cid="24ebdcd4-2376-45ea-add3-b6eb16104221" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="6" data-match="-0.017, 0.000" data-replace=" to " data-pattern="$3 " data-tag-index="s255_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="95a64ff0-4c0c-4638-a59e-576076013290" data-cid="95a64ff0-4c0c-4638-a59e-576076013290" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="8" data-match="-0.017, 0.000" data-replace="0.000" data-pattern="$4" data-tag-index="s255_1" data-time="" data-username="" data-userid="">0.000</named-content></p></td><td data-class="" width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="53f84327-282f-4934-bfe8-c35369c768c9" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="209c6719-34cc-47db-93f4-a41bdc57b49d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="184d6cab-f4f3-485f-8d28-955797426c42" data-cid="184d6cab-f4f3-485f-8d28-955797426c42" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.005" data-replace="−" data-pattern="−" data-tag-index="345_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="da54cf78-6404-4668-896a-c8fe19a77bb4" data-cid="da54cf78-6404-4668-896a-c8fe19a77bb4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.005" data-replace="0.005" data-pattern="$2" data-tag-index="345_1" data-time="" data-username="" data-userid="">0.005</named-content></p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="449c1260-e8ca-41b0-94e4-a1f5dcb7eb6c" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="0ef68db8-394d-47b4-9296-2d6b8e5f3a83" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.249</p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="3b3f7d57-9248-4019-aaf7-ec477f71e991" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="cd58319f-cf49-4b8a-94f7-dd03acfdb5ed" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="094a2e33-a411-44b1-9200-e2e089074b14" data-cid="094a2e33-a411-44b1-9200-e2e089074b14" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.012" data-replace="−" data-pattern="−" data-tag-index="347_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="9b18b3f5-46f9-4a87-994f-f88b3ae09c2f" data-cid="9b18b3f5-46f9-4a87-994f-f88b3ae09c2f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.012" data-replace="0.012" data-pattern="$2" data-tag-index="347_1" data-time="" data-username="" data-userid="">0.012</named-content><named-content id="030ed123-6197-44b6-84d5-0ee2f384822a" data-cid="030ed123-6197-44b6-84d5-0ee2f384822a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="6" data-match="-0.012, 0.003" data-replace=" to " data-pattern="$3 " data-tag-index="s258_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="8b1cc20e-35cc-42dd-a0a3-cb15ea3cb237" data-cid="8b1cc20e-35cc-42dd-a0a3-cb15ea3cb237" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="8" data-match="-0.012, 0.003" data-replace="0.003" data-pattern="$4" data-tag-index="s258_1" data-time="" data-username="" data-userid="">0.003</named-content></p></td></tr><tr data-col-count="7" id="22a2bd87-5acc-4678-847b-0f663889c596"><td data-class="" width="100%" colspan="7" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="7e1ee615-294c-4cea-bff6-ea105f8b9033" valign="top" data-old-attributes=""><p id="88049a9f-69c4-40db-9e42-e2edae5a82ab" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Retinal venous occlusion group (<named-content id="7f5d832e-f893-4ac5-86d6-7e8bb6211607" data-cid="7f5d832e-f893-4ac5-86d6-7e8bb6211607" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="32" data-match="n=526" data-replace="n" data-pattern="$1" data-tag-index="348_1" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid="">n</named-content><named-content id="c5b26c3a-5cff-4ff8-add4-b7374fd755e5" data-cid="c5b26c3a-5cff-4ff8-add4-b7374fd755e5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="33" data-match="n=526" data-replace="=" data-pattern="$2" data-tag-index="348_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="f17cc052-ebe6-411f-831c-3de637121271" data-cid="f17cc052-ebe6-411f-831c-3de637121271" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="34" data-match="n=526" data-replace="526" data-pattern="$3" data-tag-index="348_1" data-time="" data-username="" data-userid="">526</named-content>)</p></td></tr><tr data-col-count="7" id="d6b11c04-aace-45a1-9217-2813b6ebe016" data-fill="true"><td width="20%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="532e084f-fd1d-40ed-bb14-287cd0aa66bb" valign="top" data-old-attributes=""><p id="122e607d-0d9e-4b12-98b8-dd15e6f5432d" data-original-margin=" margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Age</p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="3468ce44-ba15-49c1-9f1c-80977cba8507" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="e3b32350-5af2-44aa-8a08-8756585211e5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.005</p></td><td width="13%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="fd930e2d-1365-4989-94cd-1552139e8e01" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="36290171-4fa5-4622-959d-13098f34d01c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="b769c6f9-dd32-4e9b-b25c-f54c77ace5c0">0.006</bold></p></td><td width="12%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="9b3f2be3-f26b-4884-b2a7-1de647cf5a93" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="b2787e64-f9bc-4f43-8c74-bd6a4c6fc2f2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="b6e91ea1-ce25-4ab6-b672-242ee3632240" data-cid="b6e91ea1-ce25-4ab6-b672-242ee3632240" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.001, 0.009" data-replace="0.001" data-pattern="$2" data-tag-index="s263_1" data-time="" data-username="" data-userid="">0.001</named-content><named-content id="4d4db9d2-16b1-44a6-aaf5-70c601909cac" data-cid="4d4db9d2-16b1-44a6-aaf5-70c601909cac" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="5" data-match="0.001, 0.009" data-replace=" to " data-pattern="$3 " data-tag-index="s263_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="a2f511e9-cda7-4f40-9bc5-aa27f2719c6d" data-cid="a2f511e9-cda7-4f40-9bc5-aa27f2719c6d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="7" data-match="0.001, 0.009" data-replace="0.009" data-pattern="$4" data-tag-index="s263_1" data-time="" data-username="" data-userid="">0.009</named-content></p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="358130f4-0c4d-4305-b345-b62d7607531b" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="8e8259a6-9270-42da-9398-7253ae530318" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.005</p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="c59687a5-78cf-45d3-aad2-1fe9ea86bdf7" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="3383858e-95ad-4c27-97e4-d28c4f08b05c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="1358af00-8bcd-4b68-aeba-93a1bb2fdf7e">0.002</bold></p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="9e4d5552-7e2c-4109-ae6d-e187804197a1" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="4a012922-82db-40bc-ada3-a3ab32f8ba92" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="93236371-9f79-4b09-afb2-2ec16b7d7ccc" data-cid="93236371-9f79-4b09-afb2-2ec16b7d7ccc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.002, 0.008" data-replace="0.002" data-pattern="$2" data-tag-index="s266_1" data-time="" data-username="" data-userid="">0.002</named-content><named-content id="d10ae861-0f5d-4ab4-8420-1b1f61abf8ad" data-cid="d10ae861-0f5d-4ab4-8420-1b1f61abf8ad" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="5" data-match="0.002, 0.008" data-replace=" to " data-pattern="$3 " data-tag-index="s266_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="ca5418eb-ccc0-436f-be9e-57184570141e" data-cid="ca5418eb-ccc0-436f-be9e-57184570141e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="7" data-match="0.002, 0.008" data-replace="0.008" data-pattern="$4" data-tag-index="s266_1" data-time="" data-username="" data-userid="">0.008</named-content></p></td></tr><tr data-col-count="7" id="3086f93f-861a-401e-b98f-d1eea403ff93"><td width="20%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="c0370afa-358e-4529-b332-5fc22769cbf8" valign="top" data-old-attributes=""><p id="cae50be0-c645-4169-93d9-17171a640068" data-original-margin=" margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Previous treatment</p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="838b5763-3ebe-440d-9c13-49d2ba9326c9" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="7f837b94-15cd-43be-9d3e-d42da1a48c58" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.106</p></td><td width="13%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="47d2f7fc-d238-41de-b4ea-e7eefaafedcb" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="61e807ae-9e85-4ef2-bc12-b3f36cf47d0b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="78450a1f-df78-4253-9f13-39d249a7e302">0.039</bold></p></td><td data-class="" width="12%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="16d4863c-99d5-4a47-ba4a-4261795e25f1" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="c61456d0-0552-4de2-ade7-3aae3ea4d5bd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.006<named-content data-cid="1554366337" id="882d1e48-a30f-4b51-8e90-f046d77699df" content-type="del cts-3" specific-use="1554370821523" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:10pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370821523">,</named-content><named-content data-cid="1554366338" id="26f4bb04-5a4a-4013-853c-1da43b407ecf" content-type="ins cts-3" specific-use="1554370821760" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:10pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370821760"> to</named-content></p><p id="99080027-4a13-413b-a7fa-7014d954cafb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.206</p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="baec7b56-8022-474e-a173-4673102ed749" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="bae7164e-5eee-47f3-9e2e-99eb83c8be3f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.071</p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="d3c4a57e-ad2a-4502-8059-eaa21f0dd66d" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="e44abab3-3790-480c-8ba3-aaa05d7f0ba8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.120</p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="a1bd003d-727a-47ee-884e-72880e57eab6" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="9062e1b3-a081-449f-8ab1-b8409c93571d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="c34f1ff0-843f-4a32-8d74-20e33817102e" data-cid="c34f1ff0-843f-4a32-8d74-20e33817102e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.018" data-replace="−" data-pattern="−" data-tag-index="363_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="39dd80ec-4f67-4c6f-9f9a-69babcb77190" data-cid="39dd80ec-4f67-4c6f-9f9a-69babcb77190" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.018" data-replace="0.018" data-pattern="$2" data-tag-index="363_1" data-time="" data-username="" data-userid="">0.018</named-content><named-content id="31da0d4f-0094-45e0-a4f7-37539c52249a" data-cid="31da0d4f-0094-45e0-a4f7-37539c52249a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="6" data-match="-0.018, 0.160" data-replace=" to " data-pattern="$3 " data-tag-index="s274_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="c063b954-f786-4086-b0fb-248fb122bd6a" data-cid="c063b954-f786-4086-b0fb-248fb122bd6a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="8" data-match="-0.018, 0.160" data-replace="0.160" data-pattern="$4" data-tag-index="s274_1" data-time="" data-username="" data-userid="">0.160</named-content></p></td></tr><tr data-col-count="7" id="366a084b-c424-404e-aeb6-9d91d73438f2" data-fill="true"><td width="20%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="479c1989-16e3-48a8-b942-308db67df606" valign="top" data-old-attributes=""><p id="0655527b-47c9-4f32-84b1-4c1436837c55" data-original-margin=" margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">BCVA baseline</p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="e44b003d-f729-4429-9834-be1e7be44465" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="b78a5091-82a5-49c5-8551-99bc65c62c51" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.461</p></td><td width="13%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="046e8b40-b1e9-48a1-b316-7ec211cfdd60" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="e53bf137-2ffe-4dfd-b8a4-00857eebfb19" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="8fe7d389-afdd-4436-b9c4-ba51ccc45ddc"><named-content id="ea263cd0-abfd-4e10-b150-1f3ade14cca7" data-cid="ea263cd0-abfd-4e10-b150-1f3ade14cca7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="0" data-match="&amp;lt;0.001" data-replace="&lt;" data-pattern="$2" data-tag-index="366_1" data-time="" data-username="" data-userid="">&lt;</named-content></bold><named-content id="f67be924-148f-4893-adee-2aa1d18ecc5e" data-cid="f67be924-148f-4893-adee-2aa1d18ecc5e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="1" data-match="&amp;lt;0.001" data-replace="0.001" data-pattern="$3" data-tag-index="366_1" data-time="" data-username="" data-userid=""><bold id="a2658e26-435f-4ce0-8651-dd78c99ece76">0.001</bold></named-content></p></td><td width="12%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="99776a94-c348-454b-bc7f-614b3b7ba020" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="1b83307d-7212-4e0a-a57b-7950c36a64ec" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="83ffea26-2860-411a-b01f-279a850ab9f6" data-cid="83ffea26-2860-411a-b01f-279a850ab9f6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.382, 0.539" data-replace="0.382" data-pattern="$2" data-tag-index="s278_1" data-time="" data-username="" data-userid="">0.382</named-content><named-content id="3e18747f-a691-4c64-a08b-c2c5f3bf2e8d" data-cid="3e18747f-a691-4c64-a08b-c2c5f3bf2e8d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="5" data-match="0.382, 0.539" data-replace=" to " data-pattern="$3 " data-tag-index="s278_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="28eaaf55-8133-4f2c-86d7-76867666edbc" data-cid="28eaaf55-8133-4f2c-86d7-76867666edbc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="7" data-match="0.382, 0.539" data-replace="0.539" data-pattern="$4" data-tag-index="s278_1" data-time="" data-username="" data-userid="">0.539</named-content></p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="09bfe220-a840-4beb-b346-470f0034ebe8" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="aec9d452-2153-4f57-856f-2965d7dcfadd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.454</p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="d63b546e-38fc-4480-bbf9-ad6606045502" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="c941463b-d645-41ab-bf05-c0deaed93686" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="6f1ba938-253e-40f9-9ed9-29679b7674da"><named-content id="9bf5ccf4-5853-40d9-bc94-c6d28dba7903" data-cid="9bf5ccf4-5853-40d9-bc94-c6d28dba7903" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="0" data-match="&amp;lt;0.001" data-replace="&lt;" data-pattern="$2" data-tag-index="369_1" data-time="" data-username="" data-userid="">&lt;</named-content></bold><named-content id="63f7b2b5-a78c-406a-9afd-81ef2cc5dac8" data-cid="63f7b2b5-a78c-406a-9afd-81ef2cc5dac8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="1" data-match="&amp;lt;0.001" data-replace="0.001" data-pattern="$3" data-tag-index="369_1" data-time="" data-username="" data-userid=""><bold id="ad91f16e-6efe-4eba-b98c-d5764765943c">0.001</bold></named-content></p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="6cb92bdb-fd9f-4254-a899-840eceec58d6" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="d6db84c1-4a04-4434-a82c-8bfdb11a9599" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="2d916ef9-7b23-4d9c-8884-aa4bc918c3c6" data-cid="2d916ef9-7b23-4d9c-8884-aa4bc918c3c6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.376, 0.532" data-replace="0.376" data-pattern="$2" data-tag-index="s281_1" data-time="" data-username="" data-userid="">0.376</named-content><named-content id="c0718282-f51b-4677-8154-142127db7007" data-cid="c0718282-f51b-4677-8154-142127db7007" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="5" data-match="0.376, 0.532" data-replace=" to " data-pattern="$3 " data-tag-index="s281_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="4fe0f3bb-1ed8-4033-b172-5367e786d16d" data-cid="4fe0f3bb-1ed8-4033-b172-5367e786d16d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="7" data-match="0.376, 0.532" data-replace="0.532" data-pattern="$4" data-tag-index="s281_1" data-time="" data-username="" data-userid="">0.532</named-content></p></td></tr><tr data-col-count="7" id="7f9b1cad-8efd-42ae-9df4-5dad699a4d0d"><td data-class="" width="100%" colspan="7" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d7d36218-2e8f-4dc1-930d-e6746c8a8c23" valign="top" data-old-attributes=""><p id="de30a9be-f211-4caa-974e-81be786bb1fd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Diabetic macular <named-content data-cid="1553859621092" id="2d7bfd9c-2b75-48de-9904-e9890a613386" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="b227c9a0-8675-4864-81fa-d7033616cc58" data-cid="1553859621092" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="17" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="371_2" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> group (<named-content id="e90ce5d3-be41-40a7-926f-dec97de0b977" data-cid="e90ce5d3-be41-40a7-926f-dec97de0b977" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="30" data-match="n=1434" data-replace="n" data-pattern="$1" data-tag-index="371_1" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid="">n</named-content><named-content id="72930d4b-c47f-40a6-8752-d5686e862755" data-cid="72930d4b-c47f-40a6-8752-d5686e862755" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="31" data-match="n=1434" data-replace="=" data-pattern="$2" data-tag-index="371_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="de551c70-6f74-478c-b2a7-a85e5deaf20f" data-cid="de551c70-6f74-478c-b2a7-a85e5deaf20f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="32" data-match="n=1434" data-replace="1434" data-pattern="1434" data-tag-index="371_1" data-time="" data-username="" data-userid="">1434</named-content>)</p></td></tr><tr data-col-count="7" id="18b3b8f0-a261-4304-8c43-7a8a605ebf5e" data-fill="true"><td width="20%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="02010fa6-ec55-4e75-a0c6-deee949635f8" valign="top" data-old-attributes=""><p id="ff46f581-eea9-4d52-8353-7eff61c51de3" data-original-margin=" margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">BCVA baseline</p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="4022abc9-c490-4707-9597-6dd88e58c63c" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="af0e2d6a-26cb-4d57-8157-851694ada2c8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.469</p></td><td width="13%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="d52b1429-69f3-4384-b29b-3b4098ec21b7" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="98525ec1-7f7d-4d89-97c2-f4aebbe6eb5e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="1e009fe7-e778-4050-a3e1-9c55099b0955"><named-content id="39cf7a4d-55fa-40a6-943e-469d7e418aae" data-cid="39cf7a4d-55fa-40a6-943e-469d7e418aae" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="0" data-match="&amp;lt;0.001" data-replace="&lt;" data-pattern="$2" data-tag-index="374_1" data-time="" data-username="" data-userid="">&lt;</named-content></bold><named-content id="89ee624c-bda4-40b3-a62a-14ff0b48fe37" data-cid="89ee624c-bda4-40b3-a62a-14ff0b48fe37" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="1" data-match="&amp;lt;0.001" data-replace="0.001" data-pattern="$3" data-tag-index="374_1" data-time="" data-username="" data-userid=""><bold id="63f33f2e-57d6-4582-9409-e78d2ae61632">0.001</bold></named-content></p></td><td width="12%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="40e5d820-bc3e-4d7a-89a7-982c025f06a4" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="4dbcbf6a-207f-4336-87ee-dad2a215dbfb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="a47b6dbe-3fb3-4192-a9e6-9850ae6c9206" data-cid="a47b6dbe-3fb3-4192-a9e6-9850ae6c9206" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.426, 0.288" data-replace="0.426" data-pattern="$2" data-tag-index="s286_1" data-time="" data-username="" data-userid="">0.426</named-content><named-content id="2287b14a-0ec9-4dfb-a8c4-f74c405ab45d" data-cid="2287b14a-0ec9-4dfb-a8c4-f74c405ab45d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="5" data-match="0.426, 0.288" data-replace=" to " data-pattern="$3 " data-tag-index="s286_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="a52e7440-24d5-4ae1-bff9-c8e113f576f4" data-cid="a52e7440-24d5-4ae1-bff9-c8e113f576f4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="7" data-match="0.426, 0.288" data-replace="0.288" data-pattern="$4" data-tag-index="s286_1" data-time="" data-username="" data-userid="">0.288</named-content></p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="5f7a3451-156d-4c4b-ba36-1ef00a4b681b" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="9e11a899-3310-40d5-ab2e-fa0498e8bf53" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.476</p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="37f5dfb5-1c08-492b-816b-ab32be1b27c0" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="89608012-a667-46af-aea3-be5735dfc0a0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="d9a9756c-7591-4178-ab43-541c577b280e"><named-content id="45915b2b-02aa-4cf8-9dee-b379c7f1669a" data-cid="45915b2b-02aa-4cf8-9dee-b379c7f1669a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="0" data-match="&amp;lt;0.001" data-replace="&lt;" data-pattern="$2" data-tag-index="377_1" data-time="" data-username="" data-userid="">&lt;</named-content></bold><named-content id="9b8e2c4d-1379-4543-b99a-4e107e852f1f" data-cid="9b8e2c4d-1379-4543-b99a-4e107e852f1f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="1" data-match="&amp;lt;0.001" data-replace="0.001" data-pattern="$3" data-tag-index="377_1" data-time="" data-username="" data-userid=""><bold id="641208c9-0ada-4f5c-a428-5e0a16e1b129">0.001</bold></named-content></p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="4d06b876-ec0d-46fc-824f-bf3e0eac3160" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="67c2f549-0064-4748-a770-8bfcb20b6ccb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="f374cea9-4135-4ee2-991c-7dae0db33645" data-cid="f374cea9-4135-4ee2-991c-7dae0db33645" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.433, 0.519" data-replace="0.433" data-pattern="$2" data-tag-index="s289_1" data-time="" data-username="" data-userid="">0.433</named-content><named-content id="6c7499d9-17d7-44b5-b5f6-3988129bd415" data-cid="6c7499d9-17d7-44b5-b5f6-3988129bd415" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="5" data-match="0.433, 0.519" data-replace=" to " data-pattern="$3 " data-tag-index="s289_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="031dc23f-ccf1-4b1e-a241-0ee7a76b82dc" data-cid="031dc23f-ccf1-4b1e-a241-0ee7a76b82dc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="7" data-match="0.433, 0.519" data-replace="0.519" data-pattern="$4" data-tag-index="s289_1" data-time="" data-username="" data-userid="">0.519</named-content></p></td></tr><tr data-col-count="7" id="f50debda-03fa-44a3-ae7d-b2c61513351d"><td width="20%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="228b01e9-e9cf-4eca-ab21-58958261bfa5" valign="top" data-old-attributes=""><p id="10194f1b-aa06-4c20-8038-924f0274681f" data-original-margin=" margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Total injections</p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="eb72fa86-ee30-43de-b675-7e704b1ca98d" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="fe7f8a3d-8241-4c0b-a552-516df5f5ec84" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="f3bd4d76-c581-4dac-a946-69cc3503bcb9" data-cid="f3bd4d76-c581-4dac-a946-69cc3503bcb9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.017" data-replace="−" data-pattern="−" data-tag-index="380_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="34eb3aff-c9b9-46c2-bba1-182667e5b12d" data-cid="34eb3aff-c9b9-46c2-bba1-182667e5b12d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.017" data-replace="0.017" data-pattern="$2" data-tag-index="380_1" data-time="" data-username="" data-userid="">0.017</named-content></p></td><td width="13%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="c6e18811-6f76-4cd5-9d5e-963beb531925" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="289ea9b7-ca56-4a95-9da0-aadafa0f96e8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="7cd86d11-fa2a-4dd5-b30c-a3ed1666392f">0.005</bold></p></td><td data-class="" width="12%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="2fc59c63-3e0e-4952-a6b5-3713716feaf2" data-auto-align="true" data-left-indent="2" data-align="decimal" valign="top" data-old-attributes=""><p id="3122c83e-bf1b-4360-959b-5a390f634386" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="67b02ce8-eb83-40ad-aad2-bc86f4a5c62a" data-cid="67b02ce8-eb83-40ad-aad2-bc86f4a5c62a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="-0.028, -0.005" data-replace="-0.028," data-pattern="$2" data-tag-index="382_1" data-time="" data-username="" data-userid="">-0.028<named-content data-cid="1554366342" id="69e256b7-ed23-4fee-b631-bee72cdc6471" content-type="del cts-3" specific-use="1554370840745" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:10pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370840745">,</named-content></named-content><named-content id="e98fa857-8246-4971-a03f-89d8bee70357" data-cid="e98fa857-8246-4971-a03f-89d8bee70357" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGC&quot;␣data-tag-type=&quot;RNGC&quot;␣data-offset=&quot;6&quot;␣data-match=&quot;-0.028,␣-0.005&quot;␣data-replace=&quot;␣to␣&quot;␣data-pattern=&quot;$3␣&quot;␣data-tag-index=&quot;s293_1&quot;␣id=&quot;34bc3417-fd70-42ce-8258-4fd68bee7b0c&quot;&gt;␣&lt;/span&gt;&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGE&quot;␣data-tag-type=&quot;RNGE&quot;␣data-offset=&quot;8&quot;␣data-match=&quot;-0.028,␣-0.005&quot;␣data-replace=&quot;-0.005&quot;␣data-pattern=&quot;$4&quot;␣data-tag-index=&quot;s293_1&quot;␣id=&quot;48b9bcd3-c6c9-412f-bff5-fc662b62b6db&quot;&gt;-&lt;/span&gt;' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="7" data-match="-0.028, -0.005" data-replace=" to " data-pattern="–" data-tag-index="382_1" data-track-change="&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGC&quot; data-tag-type=&quot;RNGC&quot; data-offset=&quot;6&quot; data-match=&quot;-0.028, -0.005&quot; data-replace=&quot; to &quot; data-pattern=&quot;$3 &quot; data-tag-index=&quot;s293_1&quot; id=&quot;34bc3417-fd70-42ce-8258-4fd68bee7b0c&quot;&gt; &lt;/span&gt;&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGE&quot; data-tag-type=&quot;RNGE&quot; data-offset=&quot;8&quot; data-match=&quot;-0.028, -0.005&quot; data-replace=&quot;-0.005&quot; data-pattern=&quot;$4&quot; data-tag-index=&quot;s293_1&quot; id=&quot;48b9bcd3-c6c9-412f-bff5-fc662b62b6db&quot;&gt;-&lt;/span&gt;" data-time="" data-username="" data-userid=""> to </named-content><named-content id="5321a93e-4ee9-4d81-b720-e93e9b6ae390" data-cid="5321a93e-4ee9-4d81-b720-e93e9b6ae390" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="9" data-match="-0.028, -0.005" data-replace="0.005" data-pattern="$2" data-tag-index="382_1" data-time="" data-username="" data-userid="">0.005</named-content></p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="df889cbe-be94-4408-98aa-15381ae0c723" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="ab04336e-dcd9-439f-9428-b9fb61c07ee1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="056968d1-d8b2-43ee-ae78-6534670f8529" data-cid="056968d1-d8b2-43ee-ae78-6534670f8529" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.003" data-replace="−" data-pattern="−" data-tag-index="383_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="3f63674c-bf83-4a9f-8054-4715bb5603b4" data-cid="3f63674c-bf83-4a9f-8054-4715bb5603b4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.003" data-replace="0.003" data-pattern="$2" data-tag-index="383_1" data-time="" data-username="" data-userid="">0.003</named-content></p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="f5e639ff-ceb1-48dc-874c-ae288e28f21a" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="6f2aae3e-76da-4cd4-b0bb-afcfba99b72c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.558</p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="72a11fb9-d0ad-4803-af6f-966a0e136b90" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="f4d9fe6d-84aa-4e30-b9e1-771c0d5d7507" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="b77dcf2f-9fdc-4b79-abda-ed36a239b182" data-cid="b77dcf2f-9fdc-4b79-abda-ed36a239b182" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.014" data-replace="−" data-pattern="−" data-tag-index="385_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="cc8e581e-93fc-4d1f-98df-74ffafd14068" data-cid="cc8e581e-93fc-4d1f-98df-74ffafd14068" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.014" data-replace="0.014" data-pattern="$2" data-tag-index="385_1" data-time="" data-username="" data-userid="">0.014</named-content><named-content id="d75829c9-7900-4a8d-85fc-b182db0d1a81" data-cid="d75829c9-7900-4a8d-85fc-b182db0d1a81" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="6" data-match="-0.014, 0.007" data-replace=" to " data-pattern="$3 " data-tag-index="s296_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="f7d99d8a-174b-4ff9-8702-6ab53050cf24" data-cid="f7d99d8a-174b-4ff9-8702-6ab53050cf24" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="8" data-match="-0.014, 0.007" data-replace="0.007" data-pattern="$4" data-tag-index="s296_1" data-time="" data-username="" data-userid="">0.007</named-content></p></td></tr><tr data-col-count="7" id="2218ce39-2b6f-46fc-b67a-c59e80243408" data-fill="true"><td width="20%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="f3565346-d702-4291-8f1c-b059fab8ee0e" valign="top" data-old-attributes=""><p id="0a38034c-b744-425e-829c-0686a44c8263" data-original-margin=" margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Glaucoma at <named-content data-cid="1553859621043" id="4ec65ebc-3571-46d6-a053-ba791743d9e6" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow up</named-content><named-content id="85c7a401-5e37-4843-8771-747beaf0937d" data-cid="1553859621043" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="12" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="386_1" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow-up</named-content></p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="86c29c0a-4a86-47e5-9966-1d0e456a2478" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="5f2171f5-5f4b-40e1-a29f-bfb6e4eb6488" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="bd400ad5-9507-4e09-af22-1d4c9ae3366a" data-cid="bd400ad5-9507-4e09-af22-1d4c9ae3366a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.054" data-replace="−" data-pattern="−" data-tag-index="387_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="88b28b7d-4a87-4378-8b02-b6410ada194a" data-cid="88b28b7d-4a87-4378-8b02-b6410ada194a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.054" data-replace="0.054" data-pattern="$2" data-tag-index="387_1" data-time="" data-username="" data-userid="">0.054</named-content></p></td><td width="13%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="1f61f184-7035-47a2-a5bc-226edc86734b" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="9c5eedeb-4707-4243-a1db-c3e9803df692" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="e54a56e3-2c44-4653-93f0-2ff1b6a6e281">0.021</bold></p></td><td data-class="" width="12%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="774106ee-248a-4a72-b076-222751958af7" data-auto-align="true" data-left-indent="2" data-align="decimal" valign="top" data-old-attributes=""><p id="64d94559-5e8f-40e4-9222-fbf889adece2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="f85ba069-8282-422e-8040-b9a6ea7730d8" data-cid="f85ba069-8282-422e-8040-b9a6ea7730d8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="-0.099, -0.008" data-replace="-0.099," data-pattern="$2" data-tag-index="389_1" data-time="" data-username="" data-userid="">-0.099<named-content data-cid="1554366343" id="ca9bb604-d336-45db-8993-37337eecc0f6" content-type="del cts-3" specific-use="1554370845106" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:10pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370845106">,</named-content></named-content><named-content id="3feb7be2-9844-4a5a-8d6d-2f856178e0eb" data-cid="3feb7be2-9844-4a5a-8d6d-2f856178e0eb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGC&quot;␣data-tag-type=&quot;RNGC&quot;␣data-offset=&quot;6&quot;␣data-match=&quot;-0.099,␣-0.008&quot;␣data-replace=&quot;␣to␣&quot;␣data-pattern=&quot;$3␣&quot;␣data-tag-index=&quot;s300_1&quot;␣id=&quot;f37b8119-5652-4d91-8695-f7930c83f58d&quot;&gt;␣&lt;/span&gt;&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGE&quot;␣data-tag-type=&quot;RNGE&quot;␣data-offset=&quot;8&quot;␣data-match=&quot;-0.099,␣-0.008&quot;␣data-replace=&quot;-0.008&quot;␣data-pattern=&quot;$4&quot;␣data-tag-index=&quot;s300_1&quot;␣id=&quot;90dcdd1e-4913-4c73-9c10-a7c6e4783159&quot;&gt;-&lt;/span&gt;' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="7" data-match="-0.099, -0.008" data-replace=" to " data-pattern="–" data-tag-index="389_1" data-track-change="&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGC&quot; data-tag-type=&quot;RNGC&quot; data-offset=&quot;6&quot; data-match=&quot;-0.099, -0.008&quot; data-replace=&quot; to &quot; data-pattern=&quot;$3 &quot; data-tag-index=&quot;s300_1&quot; id=&quot;f37b8119-5652-4d91-8695-f7930c83f58d&quot;&gt; &lt;/span&gt;&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGE&quot; data-tag-type=&quot;RNGE&quot; data-offset=&quot;8&quot; data-match=&quot;-0.099, -0.008&quot; data-replace=&quot;-0.008&quot; data-pattern=&quot;$4&quot; data-tag-index=&quot;s300_1&quot; id=&quot;90dcdd1e-4913-4c73-9c10-a7c6e4783159&quot;&gt;-&lt;/span&gt;" data-time="" data-username="" data-userid=""> to </named-content><named-content id="0754ee56-9a50-42f1-80a7-eb4f14bf164a" data-cid="0754ee56-9a50-42f1-80a7-eb4f14bf164a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="9" data-match="-0.099, -0.008" data-replace="0.008" data-pattern="$2" data-tag-index="389_1" data-time="" data-username="" data-userid="">0.008</named-content></p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="a29b2046-8c60-4ff6-a8d3-0dc410e1680c" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="e9269dee-91f1-4bd3-8e9f-d46b86bc4094" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.027</p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="862d323e-c7d5-4b8c-9745-45c94dc45245" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="c85dc042-4a60-4277-885a-e986c44c7fbf" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.204</p></td><td data-class="" width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="326fb380-862e-4b90-8628-cbb4f5a6141c" data-auto-align="true" data-left-indent="2" data-align="decimal" valign="top" data-old-attributes=""><p id="f6d5ad23-20ce-4160-9165-fb3f64724b5c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="45b165b1-dc81-4c53-8e70-10625fb2d971" data-cid="45b165b1-dc81-4c53-8e70-10625fb2d971" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="-0.015, -0.069" data-replace="-0.015," data-pattern="$2" data-tag-index="392_1" data-time="" data-username="" data-userid="">-0.015<named-content data-cid="1554366344" id="8fcf64d5-0933-476e-a1b8-5772e263b3d8" content-type="del cts-3" specific-use="1554370871714" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370871714">,</named-content></named-content><named-content id="475e6679-7615-4048-851e-c33fcd5198ed" data-cid="475e6679-7615-4048-851e-c33fcd5198ed" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGC&quot;␣data-tag-type=&quot;RNGC&quot;␣data-offset=&quot;6&quot;␣data-match=&quot;-0.015,␣-0.069&quot;␣data-replace=&quot;␣to␣&quot;␣data-pattern=&quot;$3␣&quot;␣data-tag-index=&quot;s303_1&quot;␣id=&quot;3b1f3344-69e6-41ed-bf51-5ffeb6b83db6&quot;&gt;␣&lt;/span&gt;&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGE&quot;␣data-tag-type=&quot;RNGE&quot;␣data-offset=&quot;8&quot;␣data-match=&quot;-0.015,␣-0.069&quot;␣data-replace=&quot;-0.069&quot;␣data-pattern=&quot;$4&quot;␣data-tag-index=&quot;s303_1&quot;␣id=&quot;4aeaa259-9dba-48cc-8fd6-2c73d89af01b&quot;&gt;-&lt;/span&gt;' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="7" data-match="-0.015, -0.069" data-replace=" to " data-pattern="–" data-tag-index="392_1" data-track-change="&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGC&quot; data-tag-type=&quot;RNGC&quot; data-offset=&quot;6&quot; data-match=&quot;-0.015, -0.069&quot; data-replace=&quot; to &quot; data-pattern=&quot;$3 &quot; data-tag-index=&quot;s303_1&quot; id=&quot;3b1f3344-69e6-41ed-bf51-5ffeb6b83db6&quot;&gt; &lt;/span&gt;&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGE&quot; data-tag-type=&quot;RNGE&quot; data-offset=&quot;8&quot; data-match=&quot;-0.015, -0.069&quot; data-replace=&quot;-0.069&quot; data-pattern=&quot;$4&quot; data-tag-index=&quot;s303_1&quot; id=&quot;4aeaa259-9dba-48cc-8fd6-2c73d89af01b&quot;&gt;-&lt;/span&gt;" data-time="" data-username="" data-userid=""> to </named-content><named-content id="f96c921f-7c4a-47cf-9a7d-0328b503ad2d" data-cid="f96c921f-7c4a-47cf-9a7d-0328b503ad2d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="9" data-match="-0.015, -0.069" data-replace="0.069" data-pattern="$2" data-tag-index="392_1" data-time="" data-username="" data-userid="">0.069</named-content></p></td></tr><tr data-col-count="7" id="d6ebadeb-ce52-4b61-a686-ae8394b5be77"><td width="20%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="624105ee-984c-49c1-8066-17e7ee290210" valign="top" data-old-attributes=""><p id="6e35d283-eead-4dc3-a411-52014649097f" data-original-margin=" margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Prior glaucoma</p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="fb41797f-ec80-478b-803c-6f5371a3bd57" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="455f308f-1440-460f-ade5-3650f61efe12" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="94beb2ad-30dc-4859-acc3-07ac699143b8" data-cid="94beb2ad-30dc-4859-acc3-07ac699143b8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.087" data-replace="−" data-pattern="−" data-tag-index="394_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="6304d0dd-0ab6-4c11-9560-b43ec039de5e" data-cid="6304d0dd-0ab6-4c11-9560-b43ec039de5e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.087" data-replace="0.087" data-pattern="$2" data-tag-index="394_1" data-time="" data-username="" data-userid="">0.087</named-content></p></td><td width="13%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="6c9c2aff-1ebd-46ad-b06b-31b75818a236" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="2fe2bad1-a7fb-48ff-93fa-a85e0f45ba5e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="72315fd1-cb01-4d50-9acb-dbd33256fc80">0.049</bold></p></td><td data-class="" width="12%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="5d7c1b9d-e442-432c-9100-63d1f2c05f23" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="f3aab479-0c44-49a2-b279-5af43d869850" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="0a657e22-abcc-4651-bfaa-a78c972ff73f" data-cid="0a657e22-abcc-4651-bfaa-a78c972ff73f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.173" data-replace="−" data-pattern="−" data-tag-index="396_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="e9f98895-e4da-427c-8957-e9a3a5a11ee5" data-cid="e9f98895-e4da-427c-8957-e9a3a5a11ee5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.173" data-replace="0.173" data-pattern="$2" data-tag-index="396_1" data-time="" data-username="" data-userid="">0.173</named-content><named-content id="357aabaf-ff4b-4db8-953a-c77316c62826" data-cid="357aabaf-ff4b-4db8-953a-c77316c62826" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="6" data-match="-0.173, 0.000" data-replace=" to " data-pattern="$3 " data-tag-index="s307_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="6bddab2a-fee6-4160-ba1b-09dd2fe4eedc" data-cid="6bddab2a-fee6-4160-ba1b-09dd2fe4eedc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="8" data-match="-0.173, 0.000" data-replace="0.000" data-pattern="$4" data-tag-index="s307_1" data-time="" data-username="" data-userid="">0.000</named-content></p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="10bab7a0-2b33-406a-8468-cbe9f00a0c1d" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="d7814b13-8ac6-461b-890a-79b6d3616b08" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="042b0977-addd-4e8d-9941-7d0cd295aebf" data-cid="042b0977-addd-4e8d-9941-7d0cd295aebf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.035" data-replace="−" data-pattern="−" data-tag-index="397_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="aed63083-a4e4-436c-b089-332b50627ce7" data-cid="aed63083-a4e4-436c-b089-332b50627ce7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.035" data-replace="0.035" data-pattern="$2" data-tag-index="397_1" data-time="" data-username="" data-userid="">0.035</named-content></p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="608c12fa-9b28-4e9f-b646-264b5f5d5104" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="719b4f6f-fefd-446a-b825-96955b2024de" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.374</p></td><td data-class="" width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="d4744e6c-bddf-40de-9cf5-3189aba49116" data-auto-align="true" data-left-indent="2" data-align="decimal" valign="top" data-old-attributes=""><p id="3a698b35-7e76-4270-ac3e-bd5d6b1ee6a1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="49c115d9-29ee-4a12-9ed1-931e7c93d01a" data-cid="49c115d9-29ee-4a12-9ed1-931e7c93d01a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="-0.113, -0.042" data-replace="-0.113," data-pattern="$2" data-tag-index="399_1" data-time="" data-username="" data-userid="">-0.113<named-content data-cid="1554366345" id="ea1e5ecf-e703-4108-9dee-d6d06ed3a5b3" content-type="del cts-3" specific-use="1554370877362" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370877362">,</named-content></named-content><named-content id="4281c686-d17f-4b3e-a23c-a6a77468c537" data-cid="4281c686-d17f-4b3e-a23c-a6a77468c537" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGC&quot;␣data-tag-type=&quot;RNGC&quot;␣data-offset=&quot;6&quot;␣data-match=&quot;-0.113,␣-0.042&quot;␣data-replace=&quot;␣to␣&quot;␣data-pattern=&quot;$3␣&quot;␣data-tag-index=&quot;s310_1&quot;␣id=&quot;cb3a6aca-7d5e-4e31-8caf-5467d8325efc&quot;&gt;␣&lt;/span&gt;&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGE&quot;␣data-tag-type=&quot;RNGE&quot;␣data-offset=&quot;8&quot;␣data-match=&quot;-0.113,␣-0.042&quot;␣data-replace=&quot;-0.042&quot;␣data-pattern=&quot;$4&quot;␣data-tag-index=&quot;s310_1&quot;␣id=&quot;db03259a-7a51-49ec-9dfa-bbd609a7f970&quot;&gt;-&lt;/span&gt;' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="7" data-match="-0.113, -0.042" data-replace=" to " data-pattern="–" data-tag-index="399_1" data-track-change="&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGC&quot; data-tag-type=&quot;RNGC&quot; data-offset=&quot;6&quot; data-match=&quot;-0.113, -0.042&quot; data-replace=&quot; to &quot; data-pattern=&quot;$3 &quot; data-tag-index=&quot;s310_1&quot; id=&quot;cb3a6aca-7d5e-4e31-8caf-5467d8325efc&quot;&gt; &lt;/span&gt;&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGE&quot; data-tag-type=&quot;RNGE&quot; data-offset=&quot;8&quot; data-match=&quot;-0.113, -0.042&quot; data-replace=&quot;-0.042&quot; data-pattern=&quot;$4&quot; data-tag-index=&quot;s310_1&quot; id=&quot;db03259a-7a51-49ec-9dfa-bbd609a7f970&quot;&gt;-&lt;/span&gt;" data-time="" data-username="" data-userid=""> to </named-content><named-content id="d03275ce-4732-44c4-9c57-9fbfb242fef5" data-cid="d03275ce-4732-44c4-9c57-9fbfb242fef5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="9" data-match="-0.113, -0.042" data-replace="0.042" data-pattern="$2" data-tag-index="399_1" data-time="" data-username="" data-userid="">0.042</named-content></p></td></tr><tr data-col-count="7" id="c44bb3b4-7308-4ca7-bbd1-7b77cd2b4db1" data-fill="true"><td width="20%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="6752733e-3106-43c4-8f09-6f5c65c42b7c" valign="top" data-old-attributes=""><p id="3583c156-9908-4979-b583-f15b08acdcd4" data-original-margin=" margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Steroid responder</p></td><td data-class="" width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="a49510b4-94b5-49d5-8e3f-aa0b17bcc10f" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="6e9c4179-b96f-4d66-aaf1-9e35e4142cbd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="d2af7bac-60cd-40ce-8832-997d92178e7d" data-cid="d2af7bac-60cd-40ce-8832-997d92178e7d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.097" data-replace="−" data-pattern="−" data-tag-index="401_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="37d42f80-a7cd-444f-911c-9904fc4946bc" data-cid="37d42f80-a7cd-444f-911c-9904fc4946bc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.097" data-replace="0.097" data-pattern="$2" data-tag-index="401_1" data-time="" data-username="" data-userid="">0.097</named-content></p></td><td data-class="" width="13%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="a316779a-746d-4341-a8dc-f2a3c40802f0" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="324514dd-5eb0-4837-b3d4-36ead4263c9b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="dd403029-9340-47ed-9b35-04b24f66cf8e">0.009</bold></p></td><td data-class="" width="12%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="d604044c-8e1d-4f69-b840-cf15eac61c09" data-auto-align="true" data-left-indent="2" data-align="decimal" valign="top" data-old-attributes=""><p id="0ff41acb-4061-4ddb-b8b4-caca4d9f5230" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="3cc6dab1-b250-4964-9915-842ee3681877" data-cid="3cc6dab1-b250-4964-9915-842ee3681877" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="-0.171, -0.024" data-replace="-0.171," data-pattern="$2" data-tag-index="403_1" data-time="" data-username="" data-userid="">-0.171<named-content data-cid="1554366346" id="05f89604-eb93-457b-a097-e439c2733df9" content-type="del cts-3" specific-use="1554370886679" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370886679">,</named-content></named-content><named-content id="4f804d0d-e115-4f54-bb35-704c33ac2cda" data-cid="4f804d0d-e115-4f54-bb35-704c33ac2cda" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGC&quot;␣data-tag-type=&quot;RNGC&quot;␣data-offset=&quot;6&quot;␣data-match=&quot;-0.171,␣-0.024&quot;␣data-replace=&quot;␣to␣&quot;␣data-pattern=&quot;$3␣&quot;␣data-tag-index=&quot;s314_1&quot;␣id=&quot;2620768c-b21d-4405-81ae-e92d9c6721c6&quot;&gt;␣&lt;/span&gt;&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGE&quot;␣data-tag-type=&quot;RNGE&quot;␣data-offset=&quot;8&quot;␣data-match=&quot;-0.171,␣-0.024&quot;␣data-replace=&quot;-0.024&quot;␣data-pattern=&quot;$4&quot;␣data-tag-index=&quot;s314_1&quot;␣id=&quot;eb13b28e-93d1-4527-911d-6fc68c602398&quot;&gt;-&lt;/span&gt;' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="7" data-match="-0.171, -0.024" data-replace=" to " data-pattern="–" data-tag-index="403_1" data-track-change="&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGC&quot; data-tag-type=&quot;RNGC&quot; data-offset=&quot;6&quot; data-match=&quot;-0.171, -0.024&quot; data-replace=&quot; to &quot; data-pattern=&quot;$3 &quot; data-tag-index=&quot;s314_1&quot; id=&quot;2620768c-b21d-4405-81ae-e92d9c6721c6&quot;&gt; &lt;/span&gt;&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGE&quot; data-tag-type=&quot;RNGE&quot; data-offset=&quot;8&quot; data-match=&quot;-0.171, -0.024&quot; data-replace=&quot;-0.024&quot; data-pattern=&quot;$4&quot; data-tag-index=&quot;s314_1&quot; id=&quot;eb13b28e-93d1-4527-911d-6fc68c602398&quot;&gt;-&lt;/span&gt;" data-time="" data-username="" data-userid=""> to </named-content><named-content id="122cc0a8-8f8a-4ddd-b510-7c4f0b9d8f69" data-cid="122cc0a8-8f8a-4ddd-b510-7c4f0b9d8f69" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="9" data-match="-0.171, -0.024" data-replace="0.024" data-pattern="$2" data-tag-index="403_1" data-time="" data-username="" data-userid="">0.024</named-content></p></td><td data-class="" width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="093cc950-b48a-4d94-9824-36fc66a507b5" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="9b719aab-214b-4e64-980e-8ead46aea294" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="5f69dcd8-09a1-4d94-8b52-87fa6e9b7a10" data-cid="5f69dcd8-09a1-4d94-8b52-87fa6e9b7a10" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.131" data-replace="−" data-pattern="−" data-tag-index="404_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="601042cf-c194-4067-849a-6eb022ab5932" data-cid="601042cf-c194-4067-849a-6eb022ab5932" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.131" data-replace="0.131" data-pattern="$2" data-tag-index="404_1" data-time="" data-username="" data-userid="">0.131</named-content></p></td><td data-class="" width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="4d81b041-1c84-4e18-a732-032351fb103d" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="e4f833db-5314-4826-82d0-5c7075140ad2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="8aaa8bc1-3797-4216-a3bf-f56c293f5af6"><named-content id="b011fe4e-20a3-449a-bd6c-73ff3fb760d9" data-cid="b011fe4e-20a3-449a-bd6c-73ff3fb760d9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="0" data-match="&amp;lt;0.001" data-replace="&lt;" data-pattern="$2" data-tag-index="405_1" data-time="" data-username="" data-userid="">&lt;</named-content></bold><named-content id="f23283f5-da47-45de-aa9c-943efbe0f347" data-cid="f23283f5-da47-45de-aa9c-943efbe0f347" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="1" data-match="&amp;lt;0.001" data-replace="0.001" data-pattern="$3" data-tag-index="405_1" data-time="" data-username="" data-userid=""><bold id="256d3339-8739-462a-8d7c-716c7bb700e9">0.001</bold></named-content></p></td><td data-class="" width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="492619e9-69b1-4904-bf8c-c861e68967b1" data-auto-align="true" data-left-indent="2" data-align="decimal" valign="top" data-old-attributes=""><p id="65304412-4a56-40db-8040-d6bf7d587686" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="cb666364-40b1-4ec1-bd0e-9ffc034a2a42" data-cid="cb666364-40b1-4ec1-bd0e-9ffc034a2a42" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="-0.196,-0.065" data-replace="-0.196," data-pattern="$2" data-tag-index="406_1" data-time="" data-username="" data-userid="">-0.196<named-content data-cid="1554366347" id="fbcbb0f6-58de-42a8-82f8-806f9bfcb05d" content-type="del cts-3" specific-use="1554370892510" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370892510">,</named-content></named-content><named-content id="ee1c261c-3e7a-49c3-907a-a9a23e69fc61" data-cid="ee1c261c-3e7a-49c3-907a-a9a23e69fc61" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="7" data-match="-0.196,-0.065" data-replace=" to " data-pattern="–" data-tag-index="406_1" data-track-change="-" data-time="" data-username="" data-userid=""> to </named-content><named-content id="e052c298-bc6a-4eb6-b4b4-69501a4c39c7" data-cid="e052c298-bc6a-4eb6-b4b4-69501a4c39c7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="8" data-match="-0.196,-0.065" data-replace="0.065" data-pattern="$2" data-tag-index="406_1" data-time="" data-username="" data-userid="">0.065</named-content></p></td></tr><tr data-col-count="7" id="3f0b27b5-8d72-4eb1-aca4-2395cd81b661"><td data-class="" width="100%" colspan="7" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="59f1b8f9-3569-4018-a134-58046c74f9f0" valign="top" data-old-attributes=""><p id="a9cc6d10-5c46-436b-a4ee-30ef7326c607" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Uveitis group (<named-content id="ef731861-82c1-46cf-9367-3680a272a1e8" data-cid="ef731861-82c1-46cf-9367-3680a272a1e8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="15" data-match="n=149" data-replace="n" data-pattern="$1" data-tag-index="407_1" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid="">n</named-content><named-content id="6d687edd-0d44-4ebc-afbd-41ccb5abd013" data-cid="6d687edd-0d44-4ebc-afbd-41ccb5abd013" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="16" data-match="n=149" data-replace="=" data-pattern="$2" data-tag-index="407_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="27a622f2-b9a8-42f2-87fa-d32be1bf89aa" data-cid="27a622f2-b9a8-42f2-87fa-d32be1bf89aa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="17" data-match="n=149" data-replace="149" data-pattern="$3" data-tag-index="407_1" data-time="" data-username="" data-userid="">149</named-content>)</p></td></tr><tr data-col-count="7" id="2e5f7c07-4521-49eb-b6c0-4d853caec087" data-fill="true"><td width="20%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d174c7d0-51ab-4d31-8b69-8a76ba218081" valign="top" data-old-attributes=""><p id="33b90315-12a3-4bdc-8c5a-440bdda02f96" data-original-margin=" margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">BCVA baseline</p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="0d0268a8-34b5-4e9d-96ba-b48b3beca19d" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="bcc33271-f8f9-420f-8d33-f869baa029ff" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.366</p></td><td width="13%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="0a559e09-998f-42af-a311-c4c542200fdd" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="f0ac0992-0649-40d6-b4fb-a0a9309f440a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="8e5f0b0f-7a74-4dfb-80f8-ae5ac568cbbb"><named-content id="82549df6-47d2-484e-b031-de5a8cda98e2" data-cid="82549df6-47d2-484e-b031-de5a8cda98e2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="0" data-match="&amp;lt;0.001" data-replace="&lt;" data-pattern="$2" data-tag-index="410_1" data-time="" data-username="" data-userid="">&lt;</named-content></bold><named-content id="f9c77ca4-3de9-47d7-8867-dd9d3a527f65" data-cid="f9c77ca4-3de9-47d7-8867-dd9d3a527f65" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="1" data-match="&amp;lt;0.001" data-replace="0.001" data-pattern="$3" data-tag-index="410_1" data-time="" data-username="" data-userid=""><bold id="e6f9d52e-f15f-4ad2-9975-710556a1116c">0.001</bold></named-content></p></td><td width="12%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="e1e2ea93-42b1-4679-80c1-e436713f1123" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="a0f050cf-289d-4a1d-82b7-8c16add95f68" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="30f0058b-d8a9-4c38-8841-e4405ebd56db" data-cid="30f0058b-d8a9-4c38-8841-e4405ebd56db" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.225, 0.442" data-replace="0.225" data-pattern="$2" data-tag-index="s322_1" data-time="" data-username="" data-userid="">0.225</named-content><named-content id="d105c47f-c41b-4e56-8460-cc866d154189" data-cid="d105c47f-c41b-4e56-8460-cc866d154189" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="5" data-match="0.225, 0.442" data-replace=" to " data-pattern="$3 " data-tag-index="s322_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="69ac0dec-b5db-4a0b-aaa8-82426fb347c0" data-cid="69ac0dec-b5db-4a0b-aaa8-82426fb347c0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="7" data-match="0.225, 0.442" data-replace="0.442" data-pattern="$4" data-tag-index="s322_1" data-time="" data-username="" data-userid="">0.442</named-content></p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="3b9d90f9-a98d-4f86-b09d-b03dfdd5527a" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="f8ec6c87-2d4c-40b8-917a-3ec5a3804fc6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">0.364</p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="bb51c6f9-dcb9-4243-87df-8310ec1b0a6e" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="6b33493a-bae2-411e-aaf6-f73de870ee86" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="e289b418-c3ff-4c94-af60-dac715a4db33"><named-content id="4c127c27-d668-414d-a963-b9b7af64a2ae" data-cid="4c127c27-d668-414d-a963-b9b7af64a2ae" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="0" data-match="&amp;lt;0.001" data-replace="&lt;" data-pattern="$2" data-tag-index="413_1" data-time="" data-username="" data-userid="">&lt;</named-content></bold><named-content id="b610b6ff-560e-47ad-b6ab-82ad8552b2cb" data-cid="b610b6ff-560e-47ad-b6ab-82ad8552b2cb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="1" data-match="&amp;lt;0.001" data-replace="0.001" data-pattern="$3" data-tag-index="413_1" data-time="" data-username="" data-userid=""><bold id="62cae4c0-5cd6-4d86-b4ae-c0d544741395">0.001</bold></named-content></p></td><td width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="9f4636f0-d6c6-4e2b-be32-275c62a34599" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="e74f2113-00bb-4790-b8d1-73a6010fb1e0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="ca6ad8e4-37ed-418f-965b-638166bfb7d6" data-cid="ca6ad8e4-37ed-418f-965b-638166bfb7d6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.227, 0.500" data-replace="0.227" data-pattern="$2" data-tag-index="s325_1" data-time="" data-username="" data-userid="">0.227</named-content><named-content id="9f976533-c6d3-4c38-a8df-7ed663d7af70" data-cid="9f976533-c6d3-4c38-a8df-7ed663d7af70" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed ',␣' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="5" data-match="0.227, 0.500" data-replace=" to " data-pattern="$3 " data-tag-index="s325_1" data-track-change=", " data-time="" data-username="" data-userid=""> to </named-content><named-content id="823be6c6-4950-4598-b31a-c135ad506369" data-cid="823be6c6-4950-4598-b31a-c135ad506369" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="7" data-match="0.227, 0.500" data-replace="0.500" data-pattern="$4" data-tag-index="s325_1" data-time="" data-username="" data-userid="">0.500</named-content></p></td></tr><tr data-col-count="7" id="f83126d0-1b33-4fc7-b82d-56f2915fec72"><td width="20%" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="a3b5d58c-fe9a-436c-8c37-f7ced0f529c6" valign="top" data-old-attributes=""><p id="b3384e4b-40b9-4d27-9a0d-cb606a9872a7" data-original-margin=" margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;">Phakic status at baseline</p></td><td width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="420b966e-46eb-498e-9544-434cf9cf77b6" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="2b7ccdb1-b4fb-44ea-8e7a-da4188465710" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="d891dbb7-0d06-4abb-b29b-db08b561d276" data-cid="d891dbb7-0d06-4abb-b29b-db08b561d276" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.209" data-replace="−" data-pattern="−" data-tag-index="416_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="5a1a8cd3-0ebd-4572-b77a-b2f95ad83674" data-cid="5a1a8cd3-0ebd-4572-b77a-b2f95ad83674" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.209" data-replace="0.209" data-pattern="$2" data-tag-index="416_1" data-time="" data-username="" data-userid="">0.209</named-content></p></td><td width="13%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="e70963a5-fea6-47c2-8cf1-102a6f9e047a" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="68d2dcd8-8251-4131-88e6-79e7cf3dfd98" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="bf4d2901-c96f-4208-a6c4-d3e821e1bf63">0.001</bold></p></td><td data-class="" width="12%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="e6a94443-a12a-4deb-8043-d5a986b77d73" data-auto-align="true" data-left-indent="2" data-align="decimal" valign="top" data-old-attributes=""><p id="054b889c-667a-43fe-b2f5-b36b6a8f5dad" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="fa26dd39-6e7c-4688-88f0-e77c4563549c" data-cid="fa26dd39-6e7c-4688-88f0-e77c4563549c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="-0.336, -0.081" data-replace="-0.336," data-pattern="$2" data-tag-index="418_1" data-time="" data-username="" data-userid="">-0.336<named-content data-cid="1554366348" id="e3a1ccd7-d5c6-44ff-b803-c7c2c83c3f73" content-type="del cts-3" specific-use="1554370906035" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370906035">,</named-content></named-content><named-content id="f3700303-b34a-4919-9994-0b2a0263c524" data-cid="f3700303-b34a-4919-9994-0b2a0263c524" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGC&quot;␣data-tag-type=&quot;RNGC&quot;␣data-offset=&quot;6&quot;␣data-match=&quot;-0.336,␣-0.081&quot;␣data-replace=&quot;␣to␣&quot;␣data-pattern=&quot;$3␣&quot;␣data-tag-index=&quot;s329_1&quot;␣id=&quot;8e3f2da7-6f8c-4737-9ea1-f842b5e8c6c1&quot;&gt;␣&lt;/span&gt;&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGE&quot;␣data-tag-type=&quot;RNGE&quot;␣data-offset=&quot;8&quot;␣data-match=&quot;-0.336,␣-0.081&quot;␣data-replace=&quot;-0.081&quot;␣data-pattern=&quot;$4&quot;␣data-tag-index=&quot;s329_1&quot;␣id=&quot;b96c9f81-f9e7-4d10-ae86-590ccdbf7657&quot;&gt;-&lt;/span&gt;' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="7" data-match="-0.336, -0.081" data-replace=" to " data-pattern="–" data-tag-index="418_1" data-track-change="&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGC&quot; data-tag-type=&quot;RNGC&quot; data-offset=&quot;6&quot; data-match=&quot;-0.336, -0.081&quot; data-replace=&quot; to &quot; data-pattern=&quot;$3 &quot; data-tag-index=&quot;s329_1&quot; id=&quot;8e3f2da7-6f8c-4737-9ea1-f842b5e8c6c1&quot;&gt; &lt;/span&gt;&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGE&quot; data-tag-type=&quot;RNGE&quot; data-offset=&quot;8&quot; data-match=&quot;-0.336, -0.081&quot; data-replace=&quot;-0.081&quot; data-pattern=&quot;$4&quot; data-tag-index=&quot;s329_1&quot; id=&quot;b96c9f81-f9e7-4d10-ae86-590ccdbf7657&quot;&gt;-&lt;/span&gt;" data-time="" data-username="" data-userid=""> to </named-content><named-content id="e46d5995-dda3-4562-bf3d-9487d337f60d" data-cid="e46d5995-dda3-4562-bf3d-9487d337f60d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="9" data-match="-0.336, -0.081" data-replace="0.081" data-pattern="$2" data-tag-index="418_1" data-time="" data-username="" data-userid="">0.081</named-content></p></td><td data-class="" width="15%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="a86f0879-3162-44e1-9190-3d7e221ce0e8" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" data-old-attributes=""><p id="3bebf8be-8887-412d-b5cb-8a4b0a642c69" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="22bec9fa-7eb4-4a0c-bfe0-28d7ef4ae980" data-cid="22bec9fa-7eb4-4a0c-bfe0-28d7ef4ae980" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-0.206" data-replace="−" data-pattern="−" data-tag-index="419_1" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="6f2f5c46-9550-48ef-88a9-2acb87db5188" data-cid="6f2f5c46-9550-48ef-88a9-2acb87db5188" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-0.206" data-replace="0.206" data-pattern="$2" data-tag-index="419_1" data-time="" data-username="" data-userid="">0.206</named-content></p></td><td data-class="" width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="61c7efec-28de-4df2-af59-a4678763de0f" data-auto-align="true" data-left-indent="4" data-align="decimal" valign="top" data-old-attributes=""><p id="8c0fc894-5a2c-4bb0-a1dc-2592478e431b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><bold id="8bbbe9d2-039b-4777-b5dc-396d56cf9628">0.001</bold></p></td><td data-class="" width="11%" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="2d5a332c-8a16-4419-8339-89f7a6ad4e90" data-auto-align="true" data-left-indent="2" data-align="decimal" valign="top" data-old-attributes=""><p id="b953ed83-7f72-4233-bb84-3c354188b490" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt;"><named-content id="3e38e9c0-777c-4090-8297-99c095da1ccd" data-cid="3e38e9c0-777c-4090-8297-99c095da1ccd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="-0.323, -0.089" data-replace="-0.323," data-pattern="$2" data-tag-index="421_1" data-time="" data-username="" data-userid="">-0.323<named-content data-cid="1554366349" id="5570ccdd-d96f-4512-8236-d018666670ef" content-type="del cts-3" specific-use="1554370911506" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370911506">,</named-content></named-content><named-content id="0d6bd568-177d-4431-a493-0e42ca40cb5f" data-cid="0d6bd568-177d-4431-a493-0e42ca40cb5f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGC&quot;␣data-tag-type=&quot;RNGC&quot;␣data-offset=&quot;6&quot;␣data-match=&quot;-0.323,␣-0.089&quot;␣data-replace=&quot;␣to␣&quot;␣data-pattern=&quot;$3␣&quot;␣data-tag-index=&quot;s332_1&quot;␣id=&quot;3c7ec726-57ad-49ff-b970-084c9c882950&quot;&gt;␣&lt;/span&gt;&lt;span␣class=&quot;jrnlPatterns&quot;␣data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot;␣title=&quot;RNGE&quot;␣data-tag-type=&quot;RNGE&quot;␣data-offset=&quot;8&quot;␣data-match=&quot;-0.323,␣-0.089&quot;␣data-replace=&quot;-0.089&quot;␣data-pattern=&quot;$4&quot;␣data-tag-index=&quot;s332_1&quot;␣id=&quot;f0c079fb-e747-43a2-9429-d460fc2cdf47&quot;&gt;-&lt;/span&gt;' to '␣to␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="7" data-match="-0.323, -0.089" data-replace=" to " data-pattern="–" data-tag-index="421_1" data-track-change="&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGC&quot; data-tag-type=&quot;RNGC&quot; data-offset=&quot;6&quot; data-match=&quot;-0.323, -0.089&quot; data-replace=&quot; to &quot; data-pattern=&quot;$3 &quot; data-tag-index=&quot;s332_1&quot; id=&quot;3c7ec726-57ad-49ff-b970-084c9c882950&quot;&gt; &lt;/span&gt;&lt;span class=&quot;jrnlPatterns&quot; data-tag-desc=&quot;VAL,RNGS,RNGC,RNGE,UNT&quot; title=&quot;RNGE&quot; data-tag-type=&quot;RNGE&quot; data-offset=&quot;8&quot; data-match=&quot;-0.323, -0.089&quot; data-replace=&quot;-0.089&quot; data-pattern=&quot;$4&quot; data-tag-index=&quot;s332_1&quot; id=&quot;f0c079fb-e747-43a2-9429-d460fc2cdf47&quot;&gt;-&lt;/span&gt;" data-time="" data-username="" data-userid=""> to </named-content><named-content id="096011d2-e214-4675-96ba-697f9802e48f" data-cid="096011d2-e214-4675-96ba-697f9802e48f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="9" data-match="-0.323, -0.089" data-replace="0.089" data-pattern="$2" data-tag-index="421_1" data-time="" data-username="" data-userid="">0.089</named-content></p></td></tr></tbody></table><table-wrap-foot id="2bbf444a-99b8-4677-9a83-fc083ce92061"><fn data-class="jrnlTblFoot" fn-type="abbrev" data-def-list="true" id="9f862adf-85b3-42c6-830e-e446c27c0b26"><p id="32fe2903-da7a-4801-8630-0f9e7690f524"><def-list id="968482b7-f1b3-407b-b430-9d9d4b0e7944"><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="95aead43-5e76-429a-94b7-5e4a2c5c6872" fn-type="abbrev" data-id="T4_FN1"><term data-class="jrnlAbbrevTerm" id="e04ebe24-a53c-49c4-97c4-7a7cc0740c03">BCVA</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="f77d264b-ccd2-4385-8b8d-9b518989b633"><p id="646dca2b-067e-4a2a-ab37-e8ddb3d62016">best corrected visual acuity</p></def>.</def-item></def-list></p></fn></table-wrap-foot></table-wrap><p data-class="jrnlSecPara" id="476089c9-768f-496e-b830-728b7e9b2ff6">The <named-content data-cid="1554366350" id="418f20c0-3f70-420c-a641-465773cc8238" content-type="del cts-3" specific-use="1554370998649" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:13pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370998649">I</named-content><named-content data-cid="1554366351" id="1faddb3f-5adc-404b-9394-c90401b1b403" content-type="ins cts-3" specific-use="1554370998882" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:13pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554370998882">i</named-content>ntravitreal dexamethasone implants were given <named-content id="58f81c3d-cde7-4a2f-93a0-bdd4b6347ead" data-cid="58f81c3d-cde7-4a2f-93a0-bdd4b6347ead" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="51" data-match="pro re nata" data-pattern="" data-tag-index="" data-abbr="PRN" data-time="" data-username="" data-userid="">pro re nata</named-content> (<named-content id="04433be4-9376-49a7-8d97-c5ea6f061ffc" data-cid="04433be4-9376-49a7-8d97-c5ea6f061ffc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="64" data-match=" (PRN)" data-pattern="" data-tag-index="26_5" data-time="" data-username="" data-userid="">PRN</named-content>) in <named-content id="c5610dc7-9dff-4940-a3ea-6975737b6175" data-cid="c5610dc7-9dff-4940-a3ea-6975737b6175" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="72" data-match="2749" data-replace="2749" data-pattern="2749" data-tag-index="26_6" data-time="" data-username="" data-userid="">2749</named-content> eyes, while other eyes received it on an interval ranging from <named-content id="edbb8d4a-98de-425a-bf05-1c0822d82daa" data-cid="edbb8d4a-98de-425a-bf05-1c0822d82daa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="140" data-match="3 to 6" data-replace="3" data-pattern="$2" data-tag-index="26_2" data-time="" data-username="" data-userid="">3</named-content><named-content id="9345a95d-969a-4add-adae-1529d3f06bc5" data-cid="9345a95d-969a-4add-adae-1529d3f06bc5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGC" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="141" data-match="3 to 6" data-replace=" to " data-pattern=" $3 " data-tag-index="26_2" data-time="" data-username="" data-userid=""> to </named-content><named-content id="442cfd70-5b9b-49aa-9544-471e3e88d0f2" data-cid="442cfd70-5b9b-49aa-9544-471e3e88d0f2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="145" data-match="3 to 6" data-replace="6" data-pattern="$4" data-tag-index="26_2" data-time="" data-username="" data-userid="">6</named-content> monthly basis. The mean number of injections was <named-content id="8e075ff7-2d5e-4363-95e9-d3ac0bc07094" data-cid="8e075ff7-2d5e-4363-95e9-d3ac0bc07094" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="196" data-match="2.09±1.75" data-replace="2.09" data-pattern="$1" data-tag-index="26_1" data-time="" data-username="" data-userid="">2.09</named-content><named-content id="8f13e300-1a4a-4f23-b9ab-90815fdd9d09" data-cid="8f13e300-1a4a-4f23-b9ab-90815fdd9d09" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="200" data-match="2.09±1.75" data-replace="±" data-pattern="$2" data-tag-index="26_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="5223b2a0-0fb4-4fbe-ae32-0495d7cd884d" data-cid="5223b2a0-0fb4-4fbe-ae32-0495d7cd884d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="202" data-match="2.09±1.75" data-replace="1.75" data-pattern="$3" data-tag-index="26_1" data-time="" data-username="" data-userid="">1.75</named-content> (range <named-content id="ae78d930-ff9e-4729-8c35-f1838aa882d7" data-cid="ae78d930-ff9e-4729-8c35-f1838aa882d7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="214" data-match="1 to 15)" data-replace="1" data-pattern="$2" data-tag-index="26_3" data-time="" data-username="" data-userid="">1</named-content><named-content id="876b24ac-075d-4e7e-9047-2fa0916e9f49" data-cid="876b24ac-075d-4e7e-9047-2fa0916e9f49" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGC" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="215" data-match="1 to 15)" data-replace=" to " data-pattern=" $3 " data-tag-index="26_3" data-time="" data-username="" data-userid=""> to </named-content><named-content id="a37117ce-c13e-4d98-a6a4-16a79c1ff7a6" data-cid="a37117ce-c13e-4d98-a6a4-16a79c1ff7a6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="219" data-match="1 to 15)" data-replace="15)" data-pattern="$4" data-tag-index="26_3" data-time="" data-username="" data-userid="">15)</named-content> with repeated number of injections being required in <named-content id="f7a1d65a-8b12-4022-8740-5c7ed8b7e3c8" data-cid="f7a1d65a-8b12-4022-8740-5c7ed8b7e3c8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="276" data-match="1298" data-replace="1298" data-pattern="1298" data-tag-index="26_7" data-time="" data-username="" data-userid="">1298</named-content> eyes. More than <named-content data-cid="1553859621011" id="3410c51f-ad21-4357-8d9d-f7c6e8b36527" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">6</named-content><named-content id="60d4f7ab-23ed-4a27-ba7d-9b9493dc60d1" data-cid="1553859621011" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '6' to 'six'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="297" data-match="6" data-pattern="" data-tag-index="26_8" data-function="numberToText,addTrackChanges" data-track-change="6" data-userid="preediting" data-username="Exeter" data-time="1553859621001">six</named-content> injections were required in 183 <named-content id="ecc6945b-279a-492b-8957-3c654b03e3d9" data-cid="ecc6945b-279a-492b-8957-3c654b03e3d9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="331" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="26_9" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with the interval between injections being <named-content id="80cf3939-9ad2-4ff9-82bc-d7144e339093" data-cid="80cf3939-9ad2-4ff9-82bc-d7144e339093" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="383" data-match="3- 4" data-replace="3" data-pattern="$2" data-tag-index="26_4" data-time="" data-username="" data-userid="">3</named-content><named-content id="7cec9895-ffdb-4afe-a4c3-15b12fb1d41a" data-cid="7cec9895-ffdb-4afe-a4c3-15b12fb1d41a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="384" data-match="3- 4" data-replace="–" data-pattern="–" data-tag-index="26_4" data-track-change="- " data-time="" data-username="" data-userid=""><named-content data-cid="1554366352" id="5b3950d3-0d98-41dc-a0c1-17e1309b883a" content-type="del cts-3" specific-use="1554371054910" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:14pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371054910">–</named-content></named-content><named-content id="2a71f477-8fdc-4862-8a49-80f738ba87bd" data-cid="2a71f477-8fdc-4862-8a49-80f738ba87bd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="386" data-match="3- 4" data-replace="4" data-pattern="$4" data-tag-index="26_4" data-time="" data-username="" data-userid=""><named-content data-cid="1554366353" id="3b1a3fb2-8281-443e-9c91-b6bd1fb0d282" content-type="ins cts-3" specific-use="1554371055146" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:14pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371055146"> to </named-content>4</named-content> monthly or on PRN basis.</p><title data-level="1" data-class="jrnlHead1" id="16c6875e-d946-4f86-a493-28f264959ad1"><named-content data-cid="1553859621112" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="b25a2d85-0737-4959-be4f-ec0e833e062f">DISCUSSION</named-content><named-content data-cid="1553859621112" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase" id="c8fa3a22-274f-45f6-97b1-7564ceae66e2">Discussion</named-content></title><p data-class="jrnlSecPara" id="7b8d01fa-fc4b-4421-b87a-1b70c6016c76">Intravitreal dexamethasone implant as a therapeutic option for macular <named-content data-cid="1553859621093" id="2d0139fa-07ba-46c0-8f82-40f6b54b03d6" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="bf506970-c997-46e2-aa04-a3ee34f1c223" data-cid="1553859621093" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="71" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="27_12" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> has an advantage over anti-VEGF in its prolonged duration of action.<xref id="738d86de-14e9-440c-a2c3-c648b97b7b7a" ref-type="bibr" rid="R15 R16 R17 R18 R25" data-citation-string=" R15 R16 R17 R18 R25 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="146" data-match="15-18 25" data-pattern="" data-tag-index="27_1" data-track-change="15-18 25"><sup id="8ae9f293-f774-4599-8ef5-1c40d3446375">15–18 25</sup></xref> In our study we conducted a retrospective analysis of <named-content id="f5079c24-232c-49ec-b93a-8afa847ab42d" data-cid="f5079c24-232c-49ec-b93a-8afa847ab42d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="210" data-match="2736" data-replace="2736" data-pattern="2736" data-tag-index="27_8" data-time="" data-username="" data-userid="">2736</named-content> <named-content id="a0b844b2-c45f-49d4-a8b2-21bb9608494f" data-cid="a0b844b2-c45f-49d4-a8b2-21bb9608494f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="215" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="27_10" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> from 25 countries treated with <named-content id="f5a3e6b4-4f62-43f0-9ad7-94b3b8f6dde5" data-cid="f5a3e6b4-4f62-43f0-9ad7-94b3b8f6dde5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="255" data-match="6015" data-replace="6015" data-pattern="6015" data-tag-index="27_9" data-time="" data-username="" data-userid="">6015</named-content> intravitreal dexamethasone implants in total over a period of <named-content id="501596c3-b2d6-4473-8b7d-607e6339476e" data-cid="501596c3-b2d6-4473-8b7d-607e6339476e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="322" data-match="5 years" data-replace="5" data-pattern="$1" data-tag-index="27_5" data-time="" data-username="" data-userid="">5</named-content><named-content id="4614044f-441c-4c2e-9dde-ad640c3ea29c" data-cid="4614044f-441c-4c2e-9dde-ad640c3ea29c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="323" data-match="5 years" data-replace=" years" data-pattern=" $2" data-tag-index="27_5" data-time="" data-username="" data-userid=""> years</named-content>. The main aim of our study was to assess the safety profile of a large intravitreal series. In total 576 eyes (<named-content id="2cbc4e1f-f2c9-4cf6-9f48-0db636b9996a" data-cid="2cbc4e1f-f2c9-4cf6-9f48-0db636b9996a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="441" data-match="32.5%" data-replace="32.5" data-pattern="$1" data-tag-index="27_6" data-time="" data-username="" data-userid="">32.5</named-content><named-content id="404780ed-1253-4cd3-a533-0b2ec710f2b9" data-cid="404780ed-1253-4cd3-a533-0b2ec710f2b9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="445" data-match="32.5%" data-replace="%" data-pattern="%" data-tag-index="27_6" data-time="" data-username="" data-userid="">%</named-content> of phakic eyes) developed significant cataract requiring surgical intervention during the follow-up period. Cataract progression was observed in 259 phakic eyes (14.6%) which did not require surgical removal. The other common side effect noted was <named-content data-cid="1554366357" id="7b10e618-5a4e-4189-83ce-7f6066fc1620" content-type="del cts-3" specific-use="1554371292056" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:18pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371292056">a </named-content>intraocular pressure. A total of 727 eyes (26.5%) had intraocular pressure rise<named-content id="fa906dd6-5340-4143-9a28-aba00fa598f5" data-cid="fa906dd6-5340-4143-9a28-aba00fa598f5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣&gt;␣' to '⍽&gt;'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="776" data-match="rise &amp;gt; 25 mmHg" data-replace=" &gt;" data-pattern=" $2" data-tag-index="27_3" data-track-change=" &amp;gt; " data-time="" data-username="" data-userid=""> &gt;</named-content><named-content id="eb9f55b9-e523-4f80-bad8-822051d27567" data-cid="eb9f55b9-e523-4f80-bad8-822051d27567" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="779" data-match="rise &amp;gt; 25 mmHg" data-replace="25" data-pattern="$1" data-tag-index="27_3" data-time="" data-username="" data-userid="">25</named-content><named-content id="b3810919-6c77-4dce-b277-53789319e225" data-cid="b3810919-6c77-4dce-b277-53789319e225" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmHg' to ' mmHg'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="781" data-match="rise &amp;gt; 25 mmHg" data-replace=" mmHg" data-pattern=" $2" data-tag-index="27_3" data-track-change=" mmHg" data-time="" data-username="" data-userid=""> mm<named-content data-cid="1554366358" id="6effaf94-94f5-49fd-9d43-c3864667672d" content-type="ins cts-3" specific-use="1554371299068" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:18pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371299068"> </named-content>Hg</named-content> with 155 eyes (5.67<named-content data-cid="1554366359" id="ff742901-dd69-4d7d-90d5-e1adabb13cc8" content-type="del cts-3" specific-use="1554371304402" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:18pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371304402"> </named-content>%) having prior history of glaucoma and <named-content id="d9d89a8d-989e-4d60-9c16-0ba87fe284cf" data-cid="d9d89a8d-989e-4d60-9c16-0ba87fe284cf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="847" data-match="572 (20.9%)" data-replace="572" data-pattern="$1" data-tag-index="27_2" data-time="" data-username="" data-userid="">572</named-content><named-content id="b7e9ec93-21e7-43c9-928c-c4523dfdfaea" data-cid="b7e9ec93-21e7-43c9-928c-c4523dfdfaea" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="850" data-match="572 (20.9%)" data-replace=" (20.9%)" data-pattern=" $2" data-tag-index="27_2" data-time="" data-username="" data-userid=""> (20.9%)</named-content> having new onset IOP rise. Endophthalmitis (0.07%), retinal detachment (0.03%) and vitreous <named-content data-cid="1553859621094" id="579c1254-582b-4280-a1a8-82a52cd2ff38" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">hemorrhage</named-content><named-content id="1d57cc5b-eec0-46c2-bf39-58b77ba47c27" data-cid="1553859621094" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'hemorrhage' to 'haemorrhage'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="951" data-match="hemorrhage" data-replace="haemorrhage" data-pattern="haemorrhage" data-tag-index="27_13" data-function="addTrackChanges" data-track-change="hemorrhage" data-userid="preediting" data-username="Exeter" data-time="1553859621001">haemorrhage</named-content> were other rarer side effects noted in our <named-content id="3186b378-e2a1-48e5-bd17-dd1a32cb1a2c" data-cid="3186b378-e2a1-48e5-bd17-dd1a32cb1a2c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1005" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="27_11" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>.</p><p data-class="jrnlSecPara" id="99e2740c-708f-4f21-a5ad-0a218c9b0930">The GENEVA study was one of the first to show the efficacy of dexamethasone implant in eyes with retinal vein occlusion.<xref id="b0a61d0a-5c94-48b4-b2f0-e27a105c3eec" ref-type="bibr" rid="R26" data-citation-string=" R26 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="121" data-match="26" data-pattern="" data-tag-index="28_2" data-track-change="26"><sup id="5986cbe7-280f-4c87-9027-a39055b88ff2">26</sup></xref> In <named-content id="590279f5-87e5-4357-96e3-255595fce0bd" data-cid="590279f5-87e5-4357-96e3-255595fce0bd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="128" data-match="15%" data-replace="15" data-pattern="$1" data-tag-index="28_12" data-time="" data-username="" data-userid="">15</named-content><named-content id="4f80e47a-2e07-4bc5-8214-77e0adf97353" data-cid="4f80e47a-2e07-4bc5-8214-77e0adf97353" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="130" data-match="15%" data-replace="%" data-pattern="%" data-tag-index="28_12" data-time="" data-username="" data-userid="">%</named-content> of the study eyes the trial reported an intraocular pressure elevation of at least <named-content id="110315ed-f9ae-4dfc-aa65-eb3a2c14d11d" data-cid="110315ed-f9ae-4dfc-aa65-eb3a2c14d11d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="215" data-match="25 mmHg" data-replace="25" data-pattern="$1" data-tag-index="28_13" data-time="" data-username="" data-userid="">25</named-content><named-content id="66631938-2f43-4de0-90c7-8723ba300578" data-cid="66631938-2f43-4de0-90c7-8723ba300578" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmHg' to ' mmHg'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="217" data-match="25 mmHg" data-replace=" mmHg" data-pattern=" $2" data-tag-index="28_13" data-track-change=" mmHg" data-time="" data-username="" data-userid=""> mm<named-content data-cid="1554366360" id="f803aeaa-14db-48b3-8c35-9d72a4a2e7ed" content-type="ins cts-3" specific-use="1554371516657" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:21pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371516657"> </named-content>Hg</named-content>, peaking at day 60 and normalising by day 180 and more. Other studies showed an intraocular pressure rise in <named-content id="5c6fa586-63a2-4766-b9c0-0f3da960f71c" data-cid="5c6fa586-63a2-4766-b9c0-0f3da960f71c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '12' to '12%'" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="PRE" data-offset="332" data-match="12 to 27%" data-replace="12%" data-pattern="$2$6" data-tag-index="28_8" data-track-change="12" data-time="" data-username="" data-userid="">12%</named-content><named-content id="9019070c-191c-4567-9a0b-32880ede7c86" data-cid="9019070c-191c-4567-9a0b-32880ede7c86" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNG" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="RNG" data-offset="334" data-match="12 to 27%" data-replace=" to " data-pattern=" $4 " data-tag-index="28_8" data-time="" data-username="" data-userid=""> to </named-content><named-content id="1ba6d6c6-b308-4124-ad03-c0bd2311b2c9" data-cid="1ba6d6c6-b308-4124-ad03-c0bd2311b2c9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="VAL" data-offset="338" data-match="12 to 27%" data-replace="27" data-pattern="$1" data-tag-index="28_8" data-time="" data-username="" data-userid="">27</named-content><named-content id="4b276f9c-fe85-4787-b0fa-1a06a3e07e48" data-cid="4b276f9c-fe85-4787-b0fa-1a06a3e07e48" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="UNT" data-offset="340" data-match="12 to 27%" data-replace="%" data-pattern="%" data-tag-index="28_8" data-time="" data-username="" data-userid="">%</named-content> of the eyes except for the study by Zarranz-Ventura <named-content id="d0419de7-d825-408e-bab0-70253c4cd929" data-cid="d0419de7-d825-408e-bab0-70253c4cd929" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="394" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="28_22" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="84d6aab8-5f20-46ff-a417-e43de5b54e69">et al</italic></named-content><named-content id="3457d0be-d021-413e-af8a-835eb00249b8" data-cid="3457d0be-d021-413e-af8a-835eb00249b8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ETLDOT" data-track-detail="" data-tag-desc="ETLDOT" data-tag-type="ETLDOT" data-offset="399" data-match="." data-replace="delete" data-pattern="delete" data-tag-index="28_27" data-time="" data-username="" data-userid=""><named-content id="4c60a8a3-8785-4db7-8d4c-ae57cd9bd293" data-cid="4c60a8a3-8785-4db7-8d4c-ae57cd9bd293" content-type="del cts-1" specific-use="1553859621001 data-cid=" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001 data-cid=">.</named-content></named-content> (82 eyes) and <named-content data-cid="1554366361" id="f053a9d1-962e-47fc-a16c-110cb5887104" content-type="del cts-3" specific-use="1554371608898" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:23pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371608898">Meyer et Al</named-content><named-content data-cid="1554366362" id="6ecde042-7c04-484d-a1ec-7951b7e0a8e1" content-type="ins cts-3" specific-use="1554371609140" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:23pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371609140">Mayer <italic data-class="sty cts-3" data-cid="1554366373" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371633437" data-track-hint="Italic Added" id="5c948fdb-bd09-41ad-a9da-36943af2bd13" data-title="Italic Added by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:23pm">et al</italic></named-content><named-content data-cid="1554366374" id="ee379b3d-ecff-4ce1-9d7b-672a1a4a0126" content-type="del cts-3" specific-use="1554371647449" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:24pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371647449">.</named-content> (64 eyes) which showed an intraocular pressure rise of approximately <named-content id="7fb06680-94a8-42de-aa5f-61f3780529b1" data-cid="7fb06680-94a8-42de-aa5f-61f3780529b1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="497" data-match="40%" data-replace="40" data-pattern="$1" data-tag-index="28_15" data-time="" data-username="" data-userid="">40</named-content><named-content id="c8492e13-dab5-4e19-9c49-6c0067582f3b" data-cid="c8492e13-dab5-4e19-9c49-6c0067582f3b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="499" data-match="40%" data-replace="%" data-pattern="%" data-tag-index="28_15" data-time="" data-username="" data-userid="">%</named-content> (<xref id="f7832fe1-0ee4-4bc1-9164-182384ccbed4" ref-type="table" rid="T5" data-citation-string=" T5 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="502" data-match="Table 5" data-pattern="" data-tag-index="28_1" data-anchor="true"><named-content data-cid="1556001224055" id="2d11a41e-c3de-4f85-a787-057cf00fe8a1" content-type="del cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">Table 5</named-content><named-content data-cid="1556001224055" id="12077140-42db-43c6-812a-82c9897b13e9" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">table 5</named-content></xref>).<xref id="51768d35-a686-4afb-82de-fe60f4b682e4" ref-type="bibr" rid="R27 R28 R29 R30 R31" data-citation-string=" R27 R28 R29 R30 R31 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="512" data-match="27-31" data-pattern="" data-tag-index="28_3" data-track-change="27-31"><sup id="f33847a5-2bef-4b67-90cd-d4169536d48d">27–31</sup></xref> The small sample size in these studies could possibly be the reason for the higher percentages observed. Malclès<named-content data-cid="1554366375" id="cd2ab8eb-6853-4534-a155-f03f7b5d0b3a" content-type="del cts-3" specific-use="1554371694775" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:24pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371694775"> A </named-content><named-content id="99fce0ab-6beb-43ba-a8de-4b1ae8e53dbb" data-cid="99fce0ab-6beb-43ba-a8de-4b1ae8e53dbb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="635" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="28_23" data-track-change="et al" data-time="" data-username="" data-userid=""> <italic id="a8ba19b6-ffed-4846-b4be-7d3b49b89491"><named-content data-cid="1554366376" id="8968e14f-5199-447a-980b-950368a5b234" content-type="ins cts-3" specific-use="1554371697099" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:24pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371697099"/>et al</italic></named-content><named-content id="9063e856-767b-458c-b23b-1cc4502608f5" data-cid="9063e856-767b-458c-b23b-1cc4502608f5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ETLDOT" data-track-detail="" data-tag-desc="ETLDOT" data-tag-type="ETLDOT" data-offset="640" data-match="." data-replace="delete" data-pattern="delete" data-tag-index="28_28" data-time="" data-username="" data-userid=""><named-content id="5d2e3262-4d88-46d8-a013-cb8f477816ec" data-cid="5d2e3262-4d88-46d8-a013-cb8f477816ec" content-type="del cts-1" specific-use="1553859621001 data-cid=" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001 data-cid=">.</named-content></named-content> in the SAFODEX study reviewed charts of 361 <named-content id="4e98c4ed-9763-4dd8-8fa2-c851093edc8e" data-cid="4e98c4ed-9763-4dd8-8fa2-c851093edc8e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="686" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="28_29" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> who received <named-content id="f7f52c1f-2f4f-426f-bc71-7032029a7728" data-cid="f7f52c1f-2f4f-426f-bc71-7032029a7728" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="708" data-match="1000" data-replace="1000" data-pattern="1000" data-tag-index="28_25" data-time="" data-username="" data-userid="">1000</named-content> intravitreal dexamethasone implant injection observed ocular hypertension (IOP<named-content id="368b9c87-da10-4692-be47-eab8e439b8ef" data-cid="368b9c87-da10-4692-be47-eab8e439b8ef" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣&gt;' to '⍽&gt;'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="791" data-match="IOP &amp;gt;25mm" data-replace=" &gt;" data-pattern=" $2" data-tag-index="28_9" data-track-change=" &amp;gt;" data-time="" data-username="" data-userid=""> &gt;</named-content><named-content id="ff1c9a1b-e958-4a24-8318-13567bacfc6f" data-cid="ff1c9a1b-e958-4a24-8318-13567bacfc6f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="793" data-match="IOP &amp;gt;25mm" data-replace="25" data-pattern="$3" data-tag-index="28_9" data-time="" data-username="" data-userid="">25</named-content><named-content id="cebe8d52-13a3-4d76-9ff2-f87ae89d0d8e" data-cid="cebe8d52-13a3-4d76-9ff2-f87ae89d0d8e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'mm' to ' mm'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="795" data-match="IOP &amp;gt;25mm" data-replace=" mm" data-pattern=" $6" data-tag-index="28_9" data-track-change="mm" data-time="" data-username="" data-userid=""> mm</named-content> Hg or rise in IOP more than <named-content id="99791361-e9ea-41b0-9055-808ef73ddb9d" data-cid="99791361-e9ea-41b0-9055-808ef73ddb9d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="826" data-match="10 mm" data-replace="10" data-pattern="$1" data-tag-index="28_16" data-time="" data-username="" data-userid="">10</named-content><named-content id="55a32594-6962-407e-be32-85cb60622352" data-cid="55a32594-6962-407e-be32-85cb60622352" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mm' to ' mm'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="828" data-match="10 mm" data-replace=" mm" data-pattern=" $2" data-tag-index="28_16" data-track-change=" mm" data-time="" data-username="" data-userid=""> mm</named-content> Hg) in <named-content id="4425addc-d51d-434b-a6f2-86b3e5bdb51c" data-cid="4425addc-d51d-434b-a6f2-86b3e5bdb51c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="839" data-match="20%" data-replace="20" data-pattern="$1" data-tag-index="28_17" data-time="" data-username="" data-userid="">20</named-content><named-content id="ffb7b732-530c-4c7f-a154-7971bc9428a0" data-cid="ffb7b732-530c-4c7f-a154-7971bc9428a0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="841" data-match="20%" data-replace="%" data-pattern="%" data-tag-index="28_17" data-time="" data-username="" data-userid="">%</named-content> of injected eyes and a recent study by Zarranz-Ventura <named-content id="9594845e-97ad-48dc-885b-1adda0b48467" data-cid="9594845e-97ad-48dc-885b-1adda0b48467" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="898" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="28_24" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="81f434b0-44b0-43f0-9053-1a01699825d7">et al</italic></named-content> found a cumulative probability of IOP rise of <named-content id="678bdc44-225f-4ef5-8eb3-fd2e12f8050b" data-cid="678bdc44-225f-4ef5-8eb3-fd2e12f8050b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="950" data-match="30%" data-replace="30" data-pattern="$1" data-tag-index="28_18" data-time="" data-username="" data-userid="">30</named-content><named-content id="40dac114-7497-4953-9cc0-8c33363e0fc0" data-cid="40dac114-7497-4953-9cc0-8c33363e0fc0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="952" data-match="30%" data-replace="%" data-pattern="%" data-tag-index="28_18" data-time="" data-username="" data-userid="">%</named-content> in 429 eyes at <named-content id="b66f6a87-5814-4cb2-870a-3f8e6a76e931" data-cid="b66f6a87-5814-4cb2-870a-3f8e6a76e931" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="969" data-match="24 months" data-replace="24" data-pattern="$1" data-tag-index="28_19" data-time="" data-username="" data-userid="">24</named-content><named-content id="0c2a38b9-ad68-4648-b0a9-07426514b43c" data-cid="0c2a38b9-ad68-4648-b0a9-07426514b43c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="971" data-match="24 months" data-replace=" months" data-pattern=" $2" data-tag-index="28_19" data-time="" data-username="" data-userid=""> months</named-content>, similar to our study.<xref id="b738ec6a-166a-418c-9926-f30d64538690" ref-type="bibr" rid="R23 R32" data-citation-string=" R23 R32 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1002" data-match="23 32" data-pattern="" data-tag-index="28_4" data-track-change="23 32"><sup id="dc209027-9994-46c4-b331-b0a39e9214bf">23 32</sup></xref> Filho <named-content data-cid="1554366377" id="c0ec0893-7664-4a96-ba87-1a51d588abb4" content-type="del cts-3" specific-use="1554371768453" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:26pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371768453">et. Al.</named-content><named-content data-cid="1554366378" id="f9234a8e-5110-4861-9a26-c149a320993d" content-type="ins cts-3" specific-use="1554371768695" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:26pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371768695"><italic data-class="sty cts-3" data-cid="1554366383" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371775029" data-track-hint="Italic Added" id="705897e3-86f7-453e-b6a1-dd271ebf6f6a" data-title="Italic Added by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:26pm">et al</italic></named-content> (study of 329 eyes) and Lowder <named-content data-cid="1554366384" id="452d6bbc-1628-4de2-a7ff-23c963fba8ec" content-type="del cts-3" specific-use="1554371791127" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:26pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371791127">et Al.</named-content><named-content data-cid="1554366385" id="50ee870d-2d19-42f2-9750-3f4e8ffb294a" content-type="ins cts-3" specific-use="1554371791372" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:26pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371791372"><italic data-class="sty cts-3" data-cid="1554366390" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371796907" data-track-hint="Italic Added" id="6514ed8d-3fff-47ce-a8a0-5079a9494b20" data-title="Italic Added by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:26pm">et al</italic></named-content> (229 eyes) noted an intraocular pressure rise in only <named-content id="a6967fd5-bb2c-41e3-8e91-537b0d28e28f" data-cid="a6967fd5-bb2c-41e3-8e91-537b0d28e28f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PRE" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="PRE" data-offset="1116" data-match="7.4% and 7.1% cases" data-replace="7.4" data-pattern="$2" data-tag-index="28_7" data-time="" data-username="" data-userid="">7.4</named-content><named-content id="59b2863f-f96d-4dc2-8791-3457bb948920" data-cid="59b2863f-f96d-4dc2-8791-3457bb948920" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PREP" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="PREP" data-offset="1119" data-match="7.4% and 7.1% cases" data-replace="%" data-pattern="$3" data-tag-index="28_7" data-time="" data-username="" data-userid="">%</named-content><named-content id="df7ae16c-1e55-4b82-b57e-004f51aa5c2f" data-cid="df7ae16c-1e55-4b82-b57e-004f51aa5c2f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNG" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="RNG" data-offset="1120" data-match="7.4% and 7.1% cases" data-replace=" and " data-pattern=" $4 " data-tag-index="28_7" data-time="" data-username="" data-userid=""> and </named-content><named-content id="bbf51241-1a61-46ce-84fb-71653d443a15" data-cid="bbf51241-1a61-46ce-84fb-71653d443a15" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="VAL" data-offset="1125" data-match="7.4% and 7.1% cases" data-replace="7.1" data-pattern="$1" data-tag-index="28_7" data-time="" data-username="" data-userid="">7.1</named-content><named-content id="c5b7c7e9-8691-48c8-b84c-8db8b5cea194" data-cid="c5b7c7e9-8691-48c8-b84c-8db8b5cea194" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="UNT" data-offset="1128" data-match="7.4% and 7.1% cases" data-replace="%" data-pattern="%" data-tag-index="28_7" data-time="" data-username="" data-userid="">%</named-content><named-content id="8620bdd1-c825-4db9-b48b-cb33e694c241" data-cid="8620bdd1-c825-4db9-b48b-cb33e694c241" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="UNT" data-offset="1129" data-match="7.4% and 7.1% cases" data-replace=" cases" data-pattern=" $7" data-tag-index="28_7" data-time="" data-username="" data-userid=""> cases</named-content> with dexamethasone implant respectively.<xref id="28a19645-7ff2-4e2e-aaa5-f7c0ab377f25" ref-type="bibr" rid="R25 R33" data-citation-string=" R25 R33 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1177" data-match="25 33" data-pattern="" data-tag-index="28_5" data-track-change="25 33"><sup id="20c177ff-f712-42d4-997e-b23b4cb32466">25 33</sup></xref> In our study intraocular pressure rise was noted in 727 eyes (26.5%), <named-content data-cid="1553859621044" id="b4488269-dd6d-4331-8141-31ed846d82a2" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">amongst</named-content><named-content id="8838a8e3-7e65-47f9-af44-2933ceb14dd6" data-cid="1553859621044" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'amongst' to 'among'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1254" data-match="amongst" data-replace="among" data-pattern="among" data-tag-index="28_30" data-function="addTrackChanges" data-track-change="amongst" data-userid="preediting" data-username="Exeter" data-time="1553859621001">among</named-content> which 103 eyes (0.13%) had pre<named-content data-cid="1554366639" id="a9a50888-6a93-4147-9ed0-ffe1379c2739" content-type="ins cts-3" specific-use="1554374948449" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:19pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374948449">-</named-content>existing glaucoma and <named-content id="f40ac1f2-ff06-4226-a8a1-42ed97f74686" data-cid="f40ac1f2-ff06-4226-a8a1-42ed97f74686" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="1314" data-match="525 (72.2%)" data-replace="525" data-pattern="$1" data-tag-index="28_6" data-time="" data-username="" data-userid="">525</named-content><named-content id="ecabc0f7-6bba-49a8-81ab-9520511acbc0" data-cid="ecabc0f7-6bba-49a8-81ab-9520511acbc0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1317" data-match="525 (72.2%)" data-replace=" (72.2%)" data-pattern=" $2" data-tag-index="28_6" data-time="" data-username="" data-userid=""> (72.2%)</named-content> eyes with post-injection intraocular rise required AGM for IOP control. Overall, glaucoma filtering surgery was required in 25 eyes (0.91%), <named-content data-cid="1553859621045" id="1c35e0e9-5f3f-456c-ba07-34686ea385d1" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">amongst</named-content><named-content id="376fc5d8-0fd8-4d84-84cf-1c701beb798f" data-cid="1553859621045" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'amongst' to 'among'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1467" data-match="amongst" data-replace="among" data-pattern="among" data-tag-index="28_31" data-function="addTrackChanges" data-track-change="amongst" data-userid="preediting" data-username="Exeter" data-time="1553859621001">among</named-content> which <named-content data-cid="1553859621012" id="1461a4c9-f4d9-48be-8146-18d044f79a14" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">7</named-content><named-content id="aa13e964-4b3b-41e7-8b9b-6e3075e51dac" data-cid="1553859621012" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '7' to 'seven'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1481" data-match="7" data-pattern="" data-tag-index="28_26" data-function="numberToText,addTrackChanges" data-track-change="7" data-userid="preediting" data-username="Exeter" data-time="1553859621001">seven</named-content> eyes (0.9%) had pre-existing glaucoma and 18 eyes (2.47%) had new onset post injection IOP rise.</p><table-wrap id="BLK_T5" data-id="BLK_T5" data-stream-name="a_T5" position="float"><label id="a925c0ee-cbd7-4909-b740-3c94e3db2124"><named-content data-cid="1556001224056" id="3ffaacd8-dd87-4a60-92bf-019364da1beb" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">Table </named-content><named-content data-cid="1556001224056" id="29c7c9af-c7ea-4deb-864a-b4c8b3eb4a2d" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">5</named-content></label><caption id="263f9752-0001-4988-b6c0-fd8483e848c9"><title id="T5" data-id="T5"><named-content data-cid="1554376334050" id="6dc6e61a-8d4a-4d0c-b87d-c631f7037499" content-type="del cts-1" specific-use="1554376334040" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - 04/04/2019, 4:42 pm" data-track-detail="" data-time="1554376334040" data-username="B020-Baburaj (COPYEDITOR)" data-userid="copyeditor 8576948431" data-type="spelling"><named-content data-cid="1553859621113" id="3868763e-2d40-4875-a42b-233555fc205b" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase">Comparison of safety profile between our study and other Dexamethasone implant studies</named-content><named-content data-cid="1553859621113" id="668ebd7b-ed40-4fcf-88d6-0c23b01a6154" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase">Comparison</named-content></named-content><named-content data-cid="1554376334050" id="1162ee74-b340-443d-91b2-920533a8d0a9" content-type="ins cts-1" specific-use="1554376334040" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - 04/04/2019, 4:42 pm" data-track-detail="" data-time="1554376334040" data-username="B020-Baburaj (COPYEDITOR)" data-userid="copyeditor 8576948431" data-type="spelling"><named-content data-cid="1554395235" id="3edeab12-db4c-44b7-b438-c68cabefe5aa" content-type="del cts-6" specific-use="1554396280018" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 10:14pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554396280018">5</named-content><named-content data-cid="1554540539" id="febc070b-c392-4a72-b1ee-0f0b66ace871" content-type="del cts-8" specific-use="1554541303526" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Deleted by Gowtham Ram (TYPESETTER) - Apr 6 2019 2:31pm" data-track-detail="" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1554541303526"> </named-content>Comparison</named-content><named-content data-cid="1553859621113" id="afacd414-cde1-4027-9326-487245cb7c94" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001" data-reason="truecase"> of safety profile between our study and other dexamethasone implant studies</named-content></title></caption><table data-col-count="8" data-caption-link="T5" id="a6d5ccd6-5efe-4eb9-8323-3a5c90c62893" data-col-widths-px="75.0345,55.0345,54.0345,57.0345,84.0345,63.0345,53.0345,70.033" data-table-type="doubleColumn" data-old-attributes="&quot;data-font-size&quot;:&quot;undefined&quot;;&quot;data-col-widths-px&quot;:&quot;73.1595,43.1595,43.1595,46.1595,117.1595,73.1595,47.1595,68.1595&quot;;&quot;data-table-type&quot;:&quot;doubleColumn&quot;" data-changed-attributes="data-font-size,data-col-widths-px" data-font-size="6.5px"><thead id="fc1f6f42-02b1-4716-98cc-384e5084b5dc" data-old-attributes="&quot;data-font-size&quot;:&quot;undefined&quot;;" data-changed-attributes="data-font-size" data-font-size="6.5px"><tr data-col-count="8" id="f5c222ba-7e80-4bed-819c-c32a00876da5"><td data-original-border="border:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="8acfb3f5-ec9b-4043-b32a-fe9b3a4a93a0" data-possbibref="true" valign="bottom" data-old-attributes=""><p id="64443d05-33fb-42c8-87a7-80f6a9f9be1a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Study</p></td><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="32a9f11a-50b8-42d3-bee6-b012e8790c39" valign="bottom" data-old-attributes=""><p id="8a006f72-bbe0-483b-89d1-4aa983bcb090" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">No of eyes</p><p id="d0e8d265-23fa-43e8-b03a-8188ab540046" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(<named-content data-cid="1554366391" id="0794352a-218f-43ba-97aa-9ecc0db2df6a" content-type="del cts-3" specific-use="1554371920330" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:28pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371920330">N</named-content><named-content data-cid="1554366392" id="c67d3072-4066-4671-b78e-d69418553ed5" content-type="ins cts-3" specific-use="1554371920576" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:28pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554371920576">n</named-content>o of injections)</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="243cc25d-44c0-4036-b1d1-a990a3df3800" valign="bottom" data-old-attributes=""><p id="d7e91177-8954-4b12-9beb-ea359334aaad" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1553859621046" id="d667d3fc-6c91-4ece-b99c-80d7b67954cc" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">Follow up</named-content><named-content id="c69c8a6e-b868-4502-a2db-5ce89d8858ac" data-cid="1553859621046" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'Follow␣up' to 'Follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="0" data-match="Follow up" data-replace="Follow-up" data-pattern="Follow-up" data-tag-index="426_1" data-function="addTrackChanges" data-track-change="Follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">Follow-up</named-content></p></td><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="7c1e20d4-2893-4faf-b3f4-853969bc3b21" valign="bottom" data-old-attributes=""><p id="c15ed423-fe52-4169-b9de-2c21fea73f12" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Indications</p></td><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="9d42d4b7-4e58-42dd-9887-6fcc25f1a753" valign="bottom" data-old-attributes=""><p id="1b3c9779-1ee7-4846-a9fb-a261bd1ebaae" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Rise in IOP</p></td><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="f4fc0ed1-fe5b-47e8-b4ed-8f89b07aa9f4" valign="bottom" data-old-attributes=""><p id="eb839e90-c720-43bf-87d6-3f0713576f88" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Cataract</p></td><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="0544d062-2bb7-421b-9bbc-fbbc12839ef2" valign="bottom" data-old-attributes=""><p id="cee96242-174b-4dcd-a18f-de094b7ebbeb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Systemic adverse events</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="e53a1259-04ea-4a88-b11a-d7c5baeb8996" valign="bottom" data-old-attributes=""><p id="9358882b-d962-42f8-a19f-1afa37abf944" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Other side effects</p></td></tr></thead><tbody id="3c4292a7-95ef-4da5-8225-e9a1ac53173a" data-old-attributes="&quot;data-font-size&quot;:&quot;undefined&quot;;" data-changed-attributes="data-font-size" data-font-size="6.5px"><tr data-col-count="8" id="79b215ef-91ea-48ff-8360-ee96b44316be" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="431afcef-b062-4a0a-9520-72045d153d71" data-possbibref="true" valign="top" data-old-attributes=""><p id="bc6226fb-af78-40c8-8ed9-48be3b246cea" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Our study</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="1ed59883-c7b9-438c-8751-9886d60dc81c" valign="top" data-old-attributes=""><p id="fe66d855-3fea-40c7-91b0-e11790e22f67" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="c0c497f0-325b-4126-a0f7-8ab0abcf8e57" data-cid="c0c497f0-325b-4126-a0f7-8ab0abcf8e57" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="2736" data-replace="2736" data-pattern="2736" data-tag-index="433_1" data-time="" data-username="" data-userid="">2736</named-content></p><p id="da56b76e-9cb6-4c9c-81b2-450b2127746b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(6015)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="5de71942-e586-4d56-96a2-2143a0c2fc30" valign="top" data-old-attributes=""><p id="f2f7d93e-8ffc-49ce-9291-46126aca2095" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="1a30998f-606d-4aaf-bafa-ef13b57d71cf" data-cid="1a30998f-606d-4aaf-bafa-ef13b57d71cf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="18.9±16.1 months" data-replace="18.9" data-pattern="$1" data-tag-index="435_1" data-time="" data-username="" data-userid="">18.9</named-content><named-content id="605c396e-3948-4392-9032-11ecd817fe03" data-cid="605c396e-3948-4392-9032-11ecd817fe03" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="18.9±16.1 months" data-replace="±" data-pattern="$2" data-tag-index="435_1" data-time="" data-username="" data-userid="">±</named-content><named-content id="efef6d1b-7544-4148-a944-fbd67fd8f682" data-cid="efef6d1b-7544-4148-a944-fbd67fd8f682" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="18.9±16.1 months" data-replace="16.1" data-pattern="$1" data-tag-index="435_1" data-time="" data-username="" data-userid="">16.1</named-content><named-content id="d5ddfe8f-fcf2-46dc-89c1-670593d6918c" data-cid="d5ddfe8f-fcf2-46dc-89c1-670593d6918c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="10" data-match="18.9±16.1 months" data-replace=" months" data-pattern=" $2" data-tag-index="435_1" data-time="" data-username="" data-userid=""> months</named-content> (range: <named-content id="a08111ca-746d-44f4-bd12-07143143f5d0" data-cid="a08111ca-746d-44f4-bd12-07143143f5d0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="26" data-match="6 - 102 months" data-replace="6" data-pattern="$2" data-tag-index="435_2" data-time="" data-username="" data-userid="">6</named-content><named-content id="1c0852d3-93aa-4342-acbc-6ff57d34798d" data-cid="1c0852d3-93aa-4342-acbc-6ff57d34798d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣-␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="27" data-match="6 - 102 months" data-replace="–" data-pattern="–" data-tag-index="435_2" data-track-change=" - " data-time="" data-username="" data-userid=""><named-content data-cid="1554366413" id="e102cb5d-8201-46dc-890c-5466454990ef" content-type="del cts-3" specific-use="1554372127542" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:32pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372127542">–</named-content></named-content><named-content id="326c0e96-8d3d-4071-b469-409e4a43164e" data-cid="326c0e96-8d3d-4071-b469-409e4a43164e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="30" data-match="6 - 102 months" data-replace="102" data-pattern="$1" data-tag-index="435_2" data-time="" data-username="" data-userid=""><named-content data-cid="1554366414" id="af78fee9-1936-469f-844e-8b3c9daa6023" content-type="ins cts-3" specific-use="1554372127797" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:32pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372127797"> to </named-content>102</named-content><named-content id="0facde16-4cdb-4309-896a-0d8d51bb6f26" data-cid="0facde16-4cdb-4309-896a-0d8d51bb6f26" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="33" data-match="6 - 102 months" data-replace=" months" data-pattern=" $2" data-tag-index="435_2" data-time="" data-username="" data-userid=""> months</named-content>)</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="1eaf8dab-70f3-48e0-977c-f8e5816bfdca" valign="top" data-old-attributes=""><p id="9b2a4e6a-98df-4b46-afc5-e33d1c618e09" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content rid="734d202f-3f65-4af2-828e-95beaa6f1a82" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="8f786dfb-d61a-4383-9afe-065ac4502f9a" content-type="jrnlQueryRef" specific-use="start" data-answered="true" data-style=""/>DME</p><p id="a133e58f-b668-4bd8-86b8-3be72a3d936a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RVO<named-content rid="734d202f-3f65-4af2-828e-95beaa6f1a82" data-class="jrnlQueryRef" data-type="end" content-type="jrnlQueryRef" specific-use="end" id="594d0932-92e5-474c-bdec-ee96569f5141" data-query-type="action" data-answered="true"/></p><p id="bbf1f6c0-4ba4-44e6-bebe-2ec92e363304" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Uveitis</p><p id="217a1d70-5938-4bb7-9950-f2e6acc4314d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Irvine<named-content data-cid="1554395221" id="3eb7985f-ae6c-4f4f-b8d9-2f93179ac807" content-type="del cts-6" specific-use="1554395396225" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 9:59pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395396225"> </named-content><named-content data-cid="1554366470" id="fab99b46-7705-4df1-a0ae-0564faa0c434" content-type="del cts-3" specific-use="1554373269995" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:51pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373269995">G</named-content><named-content data-cid="1554366471" id="60b8be6e-8eb8-45ea-9a10-51726808ae71" content-type="ins cts-3" specific-use="1554373270241" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:51pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373270241"><named-content data-cid="1554395222" id="0aa268e9-b23d-4998-b05a-5fcca97690d9" content-type="ins cts-6" specific-use="1554395396528" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 9:59pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395396528">-</named-content><named-content data-cid="1554395223" id="074c2c67-c964-485d-ae64-4b8179b931c7" content-type="del cts-6" specific-use="1554395398790" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 9:59pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395398790">g</named-content></named-content><named-content data-cid="1554395224" id="4072d855-5aef-467d-9d6d-7ae28a2d6365" content-type="ins cts-6" specific-use="1554395399076" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 9:59pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395399076">G</named-content>ass</p><p data-class="jrnlDeleted" id="64d0f4af-faee-49ad-aef2-2665e5c73cf2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" contenteditable="true" old-class="jrnlTblBody" data-role="copyeditor"><named-content data-cid="1554395225" id="259f0549-e8a9-49de-8006-e262d7fc2539" content-type="del cts-6" specific-use="1554395530215" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 10:02pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395530215">Misc</named-content><icepaste id="9d85d5ed-0e70-4ba0-8d3a-6da860f43263"/></p><named-content data-cid="1554395226" id="09df97f6-dcc5-48d4-b072-77cce761d0da" content-type="ins cts-6" specific-use="1554395534907" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 10:02pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395534907">Miscellaneous</named-content></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="dbffe2d0-d565-41cd-af79-ee5255ca7db6" valign="top" data-old-attributes=""><p id="4ac41dcd-5c98-4e34-9342-6e3047a9fc2c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="997582c2-f12e-45c8-8d7e-ae2a9c308bd3" data-cid="997582c2-f12e-45c8-8d7e-ae2a9c308bd3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="20%" data-replace="20" data-pattern="$1" data-tag-index="441_1" data-time="" data-username="" data-userid="">20</named-content><named-content id="fc38933a-177e-4a60-ab21-4e92dbfa9e4a" data-cid="fc38933a-177e-4a60-ab21-4e92dbfa9e4a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="2" data-match="20%" data-replace="%" data-pattern="%" data-tag-index="441_1" data-time="" data-username="" data-userid="">%</named-content> glaucoma</p><p id="6f5dda01-bba5-4880-8559-9264c9ca7ffd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(2%<named-content data-cid="1554366485" id="41783406-3d1f-43e5-a588-c3d62926155c" content-type="ins cts-3" specific-use="1554373945149" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:02pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373945149"> </named-content>-<named-content data-cid="1554366486" id="f6e5ee03-1006-4c0d-b18c-27891852bb0c" content-type="ins cts-3" specific-use="1554373945845" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:02pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373945845"> </named-content>no Rx, 91%<named-content data-cid="1554366487" id="e213d360-3772-4e38-bc35-20fa29240533" content-type="ins cts-3" specific-use="1554373948461" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:02pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373948461"> </named-content>-AGM,<named-content data-cid="1554366490" id="513ca894-8997-4239-ba51-e2e200f2c49c" content-type="ins cts-3" specific-use="1554373961262" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:02pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373961262"> </named-content>3.14%<named-content data-cid="1554366488" id="2ffc27dc-be24-4fec-a3a1-12ff744e931c" content-type="ins cts-3" specific-use="1554373951403" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:02pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373951403"> </named-content>-surgery,<named-content data-cid="1554366489" id="b52aa96b-10cd-4f15-87a3-4259a44459f2" content-type="ins cts-3" specific-use="1554373954129" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:02pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373954129"> </named-content>0.35%<named-content data-cid="1554366491" id="cce19c76-b4b7-4a10-baa5-6d5a133a12cf" content-type="ins cts-3" specific-use="1554373966570" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:02pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373966570"> </named-content>-<named-content rid="25610cd7-15ef-4687-b4ee-31f17f10dbd3" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="156dfb8e-1816-4068-b271-24223c9f69cd" content-type="jrnlQueryRef" specific-use="start" data-answered="true" data-style=""/>SLT<named-content rid="25610cd7-15ef-4687-b4ee-31f17f10dbd3" data-class="jrnlQueryRef" data-type="end" id="8ce3667a-825d-44db-891f-fe720e0e79e5" content-type="jrnlQueryRef" specific-use="end" data-answered="true"/>)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="9bd88489-9bb6-4d05-a18f-236f32e7e1f8" valign="top" data-old-attributes=""><p id="48070b4c-b397-4583-9447-fc04266bda37" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">47.1%</p><p id="a10771cc-c573-4d84-a149-6ec5eed17531" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">32.5%<named-content data-cid="1554366484" id="bfe7bb38-1c7d-42b6-a6b0-e590f3cc1535" content-type="ins cts-3" specific-use="1554373940236" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:02pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373940236"> </named-content>-surgery</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="a6acde47-f704-4b17-a555-0093d0eaab63" valign="top" data-old-attributes=""><p id="cb10b34d-8f4c-4c75-a251-85b41235bf2b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Death due to chronic renal failure,</p><p id="72ae7d3d-e3e6-4af6-90cf-8d3f3bd56719" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1554366472" id="4f9b457e-7d2f-44ce-a57d-ed07f3832d4e" content-type="del cts-3" specific-use="1554373300317" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:51pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373300317">H</named-content><named-content data-cid="1554366473" id="4f2b6346-4c47-4e04-b4e7-b6f4793fb6e3" content-type="ins cts-3" specific-use="1554373300570" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:51pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373300570">h</named-content>erpes zoster</p><p id="73011156-01f1-481d-bf7b-f8f16e027dbb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(both unrelated to Ozurdex)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="32336f24-f600-4370-8d35-e3b8429401ec" valign="top" data-old-attributes=""><p id="438ee407-4689-4cf9-b783-70e03e63b3d5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1554366468" id="cc0112ba-bb06-41f9-b4c1-6c57ebb3a4cb" content-type="del cts-3" specific-use="1554373264044" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:51pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373264044">2-E</named-content><named-content data-cid="1554366493" id="47d1e0ed-713a-4aa5-83d1-910e46d2e041" content-type="ins cts-3" specific-use="1554373980441" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373980441">E</named-content>ndophthalmitis<named-content data-cid="1554366494" id="5eff44d9-6a1b-412f-b23e-3d98b38f60d2" content-type="ins cts-3" specific-use="1554373982239" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373982239"> - 2</named-content></p><p id="00571e12-951b-451d-9a2d-477e282e4572" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1554366498" id="7789d86b-891f-4476-ad51-48923af43fc4" content-type="del cts-3" specific-use="1554373985193" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373985193">1-</named-content>RD<named-content data-cid="1554366500" id="f78d2148-f13e-4249-96fc-4cd78961c851" content-type="ins cts-3" specific-use="1554373987241" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373987241"> - 1</named-content></p></td></tr><tr data-col-count="8" id="0062c8bc-787a-4f66-837d-07ad9b572688"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="1ef7265a-a140-45f0-bb97-23e3faf35c1d" data-possbibref="true" valign="top" data-old-attributes=""><p id="5361fc91-ef5d-4452-822c-a456de8e69cd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content rid="2dbaf59a-17f0-4046-9ac6-422722a9f598" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="87e755ff-5905-4a77-be2c-c2c2db782d32" content-type="jrnlQueryRef" specific-use="start" data-answered="true"/>Boyer<named-content rid="2dbaf59a-17f0-4046-9ac6-422722a9f598" data-class="jrnlQueryRef" data-type="end" id="bd2b0ae4-264d-4061-aaf0-e3dc063add61" content-type="jrnlQueryRef" specific-use="end" data-answered="true"/> <named-content id="e8360661-98c9-49fc-93da-998019093b50" data-cid="e8360661-98c9-49fc-93da-998019093b50" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="6" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="450_1" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="e5147b4f-0386-40c6-8fed-9d1762cc2dd6">et al</italic></named-content> <named-content data-cid="1554366393" id="be3f637b-5df4-48a6-afbf-ed83739d9915" content-type="del cts-3" specific-use="1554372014420" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:30pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372014420">O</named-content><named-content data-cid="1554366394" id="dc030da1-b429-4aac-876c-0bb066fbbac3" content-type="ins cts-3" specific-use="1554372014678" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:30pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372014678">o</named-content>pthalmology<named-content data-cid="1553859984" id="43b0e848-d373-4be1-a6ea-9202ad464a89" content-type="ins cts-2" specific-use="1553860867248" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Inserted by Pradheep (PREEDITOR) - Mar 29 2019 5:31pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860867248"> </named-content>2014<sup id="ef70609c-d058-45de-b581-641982346458"><named-content data-cid="1553859985" id="9179fcd8-8265-441b-afd8-46fc60eb2d7b" content-type="del cts-2" specific-use="1553860884775" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:31pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860884775">19</named-content><xref id="77e3731c-03ee-46d9-90ab-04e0f6242a75" ref-type="bibr" rid="R19" data-citation-string=" R19 " data-track="ins" data-cid="1553860882418" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553860882418" data-cite-type="insert"><sup id="21dfdfbf-364e-4aaa-b91f-4ae98dab3a9f">19</sup></xref></sup></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="32066762-874e-4813-b075-1adc5802f12d" valign="top" data-old-attributes=""><p id="810bc221-6711-44ff-925c-efc5a4452512" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="db76d8d0-3b7f-49cf-beff-bcc8d4040afc" data-cid="db76d8d0-3b7f-49cf-beff-bcc8d4040afc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1048" data-replace="1048" data-pattern="1048" data-tag-index="451_1" data-time="" data-username="" data-userid="">1048</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="60c1ea0e-30df-4eef-b36e-ee1111c16050" valign="top" data-old-attributes=""><p id="920dca85-6bf4-4f79-840e-1d281ebc7c16" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="c04d1b56-0ee8-49f4-bf27-0379a2741e5e" data-cid="c04d1b56-0ee8-49f4-bf27-0379a2741e5e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="3 years" data-replace="3" data-pattern="$1" data-tag-index="452_1" data-time="" data-username="" data-userid="">3</named-content><named-content id="2b314365-c85a-4b21-8421-a907d1ed9b13" data-cid="2b314365-c85a-4b21-8421-a907d1ed9b13" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1" data-match="3 years" data-replace=" years" data-pattern=" $2" data-tag-index="452_1" data-time="" data-username="" data-userid=""> years</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="247f12b0-68cb-43c1-8761-63936f1af0f5" valign="top" data-old-attributes=""><p id="f956dcc1-893f-4e3d-82c6-93d2e1339e7d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">DME</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="66acb79f-598e-4829-97fc-81988ebac70e" valign="top" data-old-attributes=""><p id="1cc484a2-7f39-40d2-bc7f-2de91b4d6f36" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="198fa35d-09b2-40aa-b354-de4fc0c23f80" data-cid="198fa35d-09b2-40aa-b354-de4fc0c23f80" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '700' to '700'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="700" data-pattern="" data-tag-index="454_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">700</named-content> mcg<named-content data-cid="1554366505" id="06914a7e-005c-4825-98f9-8d360c13aaa3" content-type="ins cts-3" specific-use="1554374000028" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374000028"> </named-content>-</p><p id="95b36429-64ff-40a5-9732-09ea160c9e33" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Iop rise<named-content data-cid="1554366506" id="c59cdadb-4c74-4b85-afac-fd9b08c9d497" content-type="ins cts-3" specific-use="1554374002243" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374002243"> </named-content>- <named-content id="914c9ec6-fd89-4b17-bfa0-02677417acd4" data-cid="914c9ec6-fd89-4b17-bfa0-02677417acd4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="10" data-match="125(36%)" data-replace="125" data-pattern="$1" data-tag-index="455_1" data-time="" data-username="" data-userid="">125</named-content><named-content id="e84187ee-5014-4a4d-b59a-8d0a7d426376" data-cid="e84187ee-5014-4a4d-b59a-8d0a7d426376" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(36%)' to '␣(36%)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="13" data-match="125(36%)" data-replace=" (36%)" data-pattern=" $2" data-tag-index="455_1" data-track-change="(36%)" data-time="" data-username="" data-userid=""> (36%)</named-content></p><p id="d986e128-3455-4526-9de3-1231b7d793b4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="c7ed0d2e-a9f2-40b7-beb6-aa388150c26b" data-cid="c7ed0d2e-a9f2-40b7-beb6-aa388150c26b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="144(41.5" data-replace="144" data-pattern="$1" data-tag-index="456_1" data-time="" data-username="" data-userid="">144</named-content><named-content id="13d5c819-e0af-4ef0-a9de-cd1eab2fb73e" data-cid="13d5c819-e0af-4ef0-a9de-cd1eab2fb73e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(41.5' to '␣(41.5'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="144(41.5" data-replace=" (41.5" data-pattern=" $2" data-tag-index="456_1" data-track-change="(41.5" data-time="" data-username="" data-userid=""> (41.5</named-content>%<named-content data-cid="1554366507" id="29d7c51c-be5e-4dc3-b9bc-5f135b815c1c" content-type="ins cts-3" specific-use="1554374004851" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374004851"> </named-content>-<named-content data-cid="1554366508" id="c37b69db-6579-42bf-b04d-b83d545bf850" content-type="ins cts-3" specific-use="1554374005729" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374005729"> </named-content>AGM</p><p id="57fa5868-ddd2-491d-809d-4573af08db21" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="b752144c-5366-4887-bb85-27acece9af46" data-cid="b752144c-5366-4887-bb85-27acece9af46" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="2-0.6%" data-replace="2" data-pattern="$2" data-tag-index="457_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="c8ad756d-8164-41d7-85a8-2e1750c234ed" data-cid="c8ad756d-8164-41d7-85a8-2e1750c234ed" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '%–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="1" data-match="2-0.6%" data-replace="%–" data-pattern="%–" data-tag-index="457_1" data-track-change="-" data-time="" data-username="" data-userid="">%<named-content data-cid="1554366509" id="d5bbd337-50aa-4278-9be5-2899d22e2d37" content-type="ins cts-3" specific-use="1554374007933" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374007933"> </named-content>–<named-content data-cid="1554366510" id="6a96e927-fda7-4a02-8d27-1bedb12a631f" content-type="ins cts-3" specific-use="1554374008702" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374008702"> </named-content></named-content><named-content id="6dfc2c7e-ca86-4141-a5ff-7474d7751578" data-cid="6dfc2c7e-ca86-4141-a5ff-7474d7751578" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="2" data-match="2-0.6%" data-replace="0.6%" data-pattern="$4" data-tag-index="457_1" data-time="" data-username="" data-userid="">0.6%<named-content data-cid="1554366511" id="4a2e4e45-79d2-4a01-8656-229d90b48ae8" content-type="ins cts-3" specific-use="1554374010254" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374010254"> </named-content></named-content>-<named-content data-cid="1554366512" id="2ec2fca6-3e7d-4a1c-b1b9-c5890e9e8a1d" content-type="ins cts-3" specific-use="1554374011170" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374011170"> </named-content>trab)</p><p id="45335aa4-91c8-4912-b133-130476de663c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">350<named-content data-cid="1554366513" id="630d5045-f1d1-4abf-adcb-89bc3dd3325a" content-type="ins cts-3" specific-use="1554374013954" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374013954"> </named-content>mcg</p><p id="2bb08e68-ff7f-4ec6-b1ca-8d5aa8a8814d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Iop rise <named-content id="47db223a-f721-4390-b2d5-de4b88267821" data-cid="47db223a-f721-4390-b2d5-de4b88267821" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="9" data-match="117(34.1%)" data-replace="117" data-pattern="$1" data-tag-index="459_1" data-time="" data-username="" data-userid="">117</named-content><named-content id="a7a366b7-0870-4e1a-bd8e-b08fd3fdde74" data-cid="a7a366b7-0870-4e1a-bd8e-b08fd3fdde74" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(34.1%)' to '␣(34.1%)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="12" data-match="117(34.1%)" data-replace=" (34.1%)" data-pattern=" $2" data-tag-index="459_1" data-track-change="(34.1%)" data-time="" data-username="" data-userid=""> (34.1%)</named-content></p><p id="3beea004-dec1-4ccd-ba17-6bafa69d7fc2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="ea9bae3c-2d7b-4e8d-9b32-ac40e4e1c26e" data-cid="ea9bae3c-2d7b-4e8d-9b32-ac40e4e1c26e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="129(37.6" data-replace="129" data-pattern="$1" data-tag-index="460_1" data-time="" data-username="" data-userid="">129</named-content><named-content id="47ad785b-29a9-47a6-9c2f-444d86d119de" data-cid="47ad785b-29a9-47a6-9c2f-444d86d119de" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(37.6' to '␣(37.6'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="129(37.6" data-replace=" (37.6" data-pattern=" $2" data-tag-index="460_1" data-track-change="(37.6" data-time="" data-username="" data-userid=""> (37.6</named-content>%<named-content data-cid="1554366514" id="fa74b3c7-7d82-4499-b283-28bf694aa75c" content-type="ins cts-3" specific-use="1554374016470" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374016470"> </named-content>-<named-content data-cid="1554366515" id="90739da2-2035-4f03-b56a-b542c6c24c3f" content-type="ins cts-3" specific-use="1554374017119" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374017119"> </named-content>AGM<named-content data-cid="1554366518" id="3f09a778-3f5a-440b-8c5c-9ca1e27b4c76" content-type="ins cts-3" specific-use="1554374029750" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374029750">)</named-content>,<named-content id="84c6d8ce-73e5-46c4-97df-c3bed62ac4de" data-cid="84c6d8ce-73e5-46c4-97df-c3bed62ac4de" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="14" data-match="1(0.3" data-replace="1" data-pattern="$1" data-tag-index="460_2" data-time="" data-username="" data-userid="">1</named-content><named-content id="c258ce30-9da0-4053-b047-0bd09eb0dec3" data-cid="c258ce30-9da0-4053-b047-0bd09eb0dec3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(0.3' to '␣(0.3'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="15" data-match="1(0.3" data-replace=" (0.3" data-pattern=" $2" data-tag-index="460_2" data-track-change="(0.3" data-time="" data-username="" data-userid=""> (0.3</named-content>%<named-content data-cid="1554366516" id="a58ea96e-862e-4d2d-b6ec-822ac3e0a79c" content-type="ins cts-3" specific-use="1554374019138" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374019138"> </named-content>-<named-content data-cid="1554366517" id="7a90ee6a-3c76-420b-8349-2c09d5cc4c13" content-type="ins cts-3" specific-use="1554374019682" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374019682"> </named-content>trab)</p><p id="d4b216c4-8d15-4c7e-9a11-aaff4c171152" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Sham</p><p id="f437dc37-3917-4057-841e-484436e68fc2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="9e773516-8aa0-4f24-af39-3d30ef57a7fa" data-cid="9e773516-8aa0-4f24-af39-3d30ef57a7fa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="18(5.1%)" data-replace="18" data-pattern="$1" data-tag-index="462_1" data-time="" data-username="" data-userid="">18</named-content><named-content id="97fc20f9-1df8-4c21-870f-9dd83e529b2d" data-cid="97fc20f9-1df8-4c21-870f-9dd83e529b2d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(5.1%)' to '␣(5.1%)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="18(5.1%)" data-replace=" (5.1%)" data-pattern=" $2" data-tag-index="462_1" data-track-change="(5.1%)" data-time="" data-username="" data-userid=""> (5.1%)</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="f4179a68-fd91-452e-aabd-3aacaa1dc05d" valign="top" data-old-attributes=""><p id="aca49643-9748-4420-8311-1883518e397b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">67.9%</p><p id="844d7664-39d1-41fe-8553-225af7a1c372" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(59.2%<named-content data-cid="1554366519" id="19f83a23-abd7-40d7-918b-3454e8816736" content-type="ins cts-3" specific-use="1554374039850" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:03pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374039850"> </named-content>-surgery</p><p id="26cc7a2a-e4f9-4b37-8e6e-62bc3f761103" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">64.1%</p><p id="52ffaf9f-a678-41ef-9ade-57baeb3964ab" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(52.3%<named-content data-cid="1554366520" id="97abac92-771e-4149-9403-160fd920808a" content-type="ins cts-3" specific-use="1554374042747" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374042747"> </named-content>-surgery)</p><p id="743b4cde-e040-45c3-af16-206d9cb2e2a7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">20.4%</p><p id="a0f3dfc5-759b-4478-8d54-60eb99d53ef0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(7.2%<named-content data-cid="1554366521" id="3d44a5cd-83a6-4d3f-978a-68089e412ce8" content-type="ins cts-3" specific-use="1554374050241" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374050241"> </named-content>-surgery)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="b77ac728-04f0-43b2-b55f-f554c03516ef" valign="top" data-old-attributes=""><p id="938a08e8-ea54-49b0-a749-d01abdb25e06" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Nil</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="7862408d-4343-4218-826f-cb3e3e9561be" valign="top" data-old-attributes=""><p id="63a473ae-f1bd-4ea1-b115-49234aba60e6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Vitreous <named-content data-cid="1554376211862" id="6b49cdbc-d798-46a9-9a50-f4f12f5ab0d7" content-type="del cts-1" specific-use="1554376210954" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - 04/04/2019, 4:40 pm" data-track-detail="" data-time="1554376210954" data-username="B020-Baburaj (COPYEDITOR)" data-userid="copyeditor 8576948431" data-type="spelling">hemorrhage</named-content><named-content data-cid="1554376211862" id="e93edc10-b315-4117-8eda-ed070bcd35fc" content-type="ins cts-1" specific-use="1554376210954" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - 04/04/2019, 4:40 pm" data-track-detail="" data-time="1554376210954" data-username="B020-Baburaj (COPYEDITOR)" data-userid="copyeditor 8576948431" data-type="spelling">haemorrhage</named-content><named-content data-cid="1554366522" id="d00d9838-6af7-4895-b5c7-2d41a0a595a9" content-type="ins cts-3" specific-use="1554374052132" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374052132"> </named-content>-1</p></td></tr><tr data-col-count="8" id="e2bcbf97-702d-4a1d-ab95-854ad7b71648" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="fc78d839-4e13-4a63-9305-b703ed691526" data-possbibref="true" valign="top" data-old-attributes=""><p id="fec49b3a-6913-4b06-b831-4aff7652af1e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Schmit<named-content data-cid="1554366395" id="09f3b890-1c11-4479-85a4-263e9ac12280" content-type="del cts-3" specific-use="1554372037925" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:30pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372037925">Z K</named-content><named-content data-cid="1554366396" id="fb391ea0-048e-4c61-a30f-634f2d136aed" content-type="ins cts-3" specific-use="1554372038175" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:30pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372038175">z <italic data-class="sty cts-3" data-cid="1554366403" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372069938" data-track-hint="Italic Added" id="8559c336-666f-4448-aa17-fc60ed652609" data-title="Italic Added by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:31pm">et al</italic></named-content> ZERO study</p><p id="e21bd096-4313-473f-82fa-be13e5839542" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">2014<sup id="6f8b0de7-87af-482e-b334-9a08ffbaa85f"><named-content data-cid="1553859987" id="98344bbd-d8f6-4653-b57d-bfd5a354478f" content-type="del cts-2" specific-use="1553860894462" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:31pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860894462">20</named-content><xref id="d8df7d10-18b5-4e25-a428-85f049ed36e5" ref-type="bibr" rid="R20" data-citation-string=" R20 " data-track="ins" data-cid="1553860893446" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553860893446" data-cite-type="insert"><sup id="53b87adb-24d3-48b9-be09-b1645ba576b5">20</sup></xref></sup></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="e25d242a-2ea2-4318-bd5a-97fe9b727c73" valign="top" data-old-attributes=""><p id="0dde387c-2db3-49cc-94a8-21c5249b66d4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">342</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="99801ef7-ba9d-4faf-a336-6d64655a091b" valign="top" data-old-attributes=""><p id="0b04a8df-1bfc-4409-bc3c-c14fad85734e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="aa23fdbd-c775-44de-942d-19754543ff10" data-cid="aa23fdbd-c775-44de-942d-19754543ff10" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="8 months" data-replace="8" data-pattern="$1" data-tag-index="474_1" data-time="" data-username="" data-userid="">8</named-content><named-content id="723d5033-1a33-47ca-9d54-421dc540de3d" data-cid="723d5033-1a33-47ca-9d54-421dc540de3d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1" data-match="8 months" data-replace=" months" data-pattern=" $2" data-tag-index="474_1" data-time="" data-username="" data-userid=""> months</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="391348b9-a9c9-4e0f-bdcc-b6276090f17a" valign="top" data-old-attributes=""><p id="c4fa8f6b-13cc-446e-b8f2-15c615d0453d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RVO</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="b500c74a-5c1d-46e1-9567-e64f700fff7f" valign="top" data-old-attributes=""><p id="19111ca8-74fa-47d3-a57b-25438101b3af" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">20%</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="a76535d2-2196-48a9-9bfb-cd5a70fb6913" valign="top" data-old-attributes=""><p id="750d9e81-a6de-4a70-b162-3af1d74f254b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">0.2%<named-content data-cid="1554366529" id="fc4613ff-c992-46d6-aeb3-9ffa8837a73b" content-type="ins cts-3" specific-use="1554374067905" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374067905"> </named-content>-surgery</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="cd717935-4c36-4dbe-bf2f-246563f6c560" valign="top" data-old-attributes=""><p id="83726536-1cb2-4535-acf0-bb8937b194bc" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="d97bcfbc-2f25-4e7e-8c29-48ca0cd91401" valign="top" data-old-attributes=""><p id="f1fc06a1-b039-40ff-b031-d19c832be24d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Macular hole<named-content data-cid="1554366523" id="837c5a3f-8976-49ec-a242-36f5d8d5d235" content-type="ins cts-3" specific-use="1554374059953" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374059953"> </named-content>-<named-content data-cid="1554366524" id="a473b056-2859-46b3-9750-1b683d344487" content-type="ins cts-3" specific-use="1554374060596" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374060596"> </named-content>2</p><p id="8417f366-39b6-4e4e-84ca-40fe3340d537" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Implant dislocation anteriorly<named-content data-cid="1554366525" id="6284d0ae-48f3-410d-b8b7-012276ff72e6" content-type="ins cts-3" specific-use="1554374062859" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374062859"> </named-content>-<named-content data-cid="1554366526" id="a5e783f0-52a1-430a-8128-f3db1b33b4eb" content-type="ins cts-3" specific-use="1554374063347" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374063347"> </named-content>2</p><p id="993111ae-3ae9-4e2f-b9d4-54b7579d2ce0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Vitreous <named-content data-cid="1554376344626" id="5e43403f-e0ce-4d05-8c8c-51365161c9e8" content-type="del cts-1" specific-use="1554376344337" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - 04/04/2019, 4:42 pm" data-track-detail="" data-time="1554376344337" data-username="B020-Baburaj (COPYEDITOR)" data-userid="copyeditor 8576948431" data-type="spelling">hemorrhage</named-content><named-content data-cid="1554376344626" id="dbdecc7a-2e0d-45b5-8f13-7b5bcbc7057a" content-type="ins cts-1" specific-use="1554376344337" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - 04/04/2019, 4:42 pm" data-track-detail="" data-time="1554376344337" data-username="B020-Baburaj (COPYEDITOR)" data-userid="copyeditor 8576948431" data-type="spelling">haemorrhage</named-content><named-content data-cid="1554366527" id="170ca314-3a4d-422b-b067-bfe5ae8425d2" content-type="ins cts-3" specific-use="1554374064955" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374064955"> </named-content>-<named-content data-cid="1554366528" id="4abba38d-96c4-4d8f-9834-b92151a3f7bf" content-type="ins cts-3" specific-use="1554374065547" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374065547"> </named-content>6</p></td></tr><tr data-col-count="8" id="4a8f8576-dfae-4ec2-a281-695c5e61e0cf"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d3100e04-5bee-4bc1-9008-58bdaba558ff" data-possbibref="true" valign="top" data-old-attributes=""><p id="407779b1-94dd-4a36-83ae-0d183bbd4e14" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Filho<named-content data-cid="1554366404" id="5cdb1696-7fd3-49b4-ad79-f8ee8fdaaf74" content-type="ins cts-3" specific-use="1554372072332" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:31pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372072332"> <italic data-class="sty cts-3" data-cid="1554366410" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372078180" data-track-hint="Italic Added" id="e85db702-8c5b-426f-8a3b-88f8a0fcbd6e" data-title="Italic Added by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:31pm">et al</italic></named-content></p><p id="6f5f8a8e-3862-487f-b9d1-c0d9290add64" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1554366411" id="35aac3fd-bd0d-44b1-8ac3-a455038d7e05" content-type="del cts-3" specific-use="1554372088278" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:31pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372088278">O</named-content><named-content data-cid="1554366412" id="4156913a-7243-41b0-ad39-38e2db3eb948" content-type="ins cts-3" specific-use="1554372088535" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:31pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372088535">o</named-content>phthalmologica <named-content data-cid="1554366423" id="bcb9d504-9c30-4d72-b6cd-41a972bf3009" content-type="ins cts-3" specific-use="1554372271986" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:34pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372271986">2019</named-content><named-content data-cid="1554366418" id="26df0c47-4c7f-402a-84e5-f00dcd421c63" content-type="del cts-3" specific-use="1554372261780" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:34pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372261780">2018</named-content><sup id="5968fa2d-004a-4548-a302-403d4fa68025"><named-content data-cid="1553859989" id="cf879779-1608-404c-a813-a03bfd722f95" content-type="del cts-2" specific-use="1553860903808" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:31pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860903808">25</named-content><xref id="19e7f972-e143-4905-8498-4bd6d0e15062" ref-type="bibr" rid="R25" data-citation-string=" R25 " data-track="ins" data-cid="1553860902186" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553860902186" data-cite-type="insert"><sup id="36253896-37ae-43aa-a23d-4e22f5da294e">25</sup></xref></sup></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="eb10bac9-77d6-4653-b00e-7c84b3701de3" valign="top" data-old-attributes=""><p id="2c87f245-6a42-4eae-85c4-8840167d8ff3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">329</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="7253a585-8fbe-47cc-a7c5-cd6c5e23c49a" valign="top" data-old-attributes=""><p id="001418e2-a92a-4f43-b847-da0ac6f03ef8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not specified</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="40dede8c-200d-4fe3-add0-231653deaa42" valign="top" data-old-attributes=""><p id="57d0569f-42ff-4735-bea4-04534866add8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">DME</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="96d8bf3b-2ea8-4758-b348-3daa8340b107" valign="top" data-old-attributes=""><p id="35c2c03e-b059-45c5-8746-30d36f2b83de" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">7.4%</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="d381688d-978e-47f6-ae13-a8068cb74f78" valign="top" data-old-attributes=""><p id="b5311b07-dce9-4c46-b8bb-d2b33d45dd8b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">4%</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="b1112e4c-b7ae-4cbc-9cc4-2734b7995c97" valign="top" data-old-attributes=""><p id="3907ac99-12ca-46f5-9a04-8440b786515d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="1202689d-4831-4f1c-8da3-c63cee8034fe" valign="top" data-old-attributes=""><p id="e5616041-317b-4cf7-a9b1-0ec74876e1ab" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Endophthalmitis<named-content data-cid="1554366530" id="a9794c5e-164b-4c6d-981f-2e282d87a3b9" content-type="ins cts-3" specific-use="1554374071126" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374071126"> </named-content>-<named-content data-cid="1554366531" id="2d9f3c17-565d-4170-b472-45f200c9e598" content-type="ins cts-3" specific-use="1554374072111" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374072111"> </named-content><named-content data-cid="1554366532" id="b7611728-d2e4-4462-9ebc-46d78eda4c0f" content-type="del cts-3" specific-use="1554374073826" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374073826">Nil</named-content><named-content data-cid="1554366533" id="c0b48884-53f4-4638-957d-74ba31902c0b" content-type="ins cts-3" specific-use="1554374074108" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374074108">nil</named-content></p></td></tr><tr data-col-count="8" id="2c16398d-dce7-4f8e-ac52-996c25342fb3" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="3ab19e37-174b-4b60-8b33-6d7d733d57e1" data-possbibref="true" valign="top" data-old-attributes=""><p id="f09cc834-4a73-4aee-99c1-b9878d6ce779" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content rid="c9275d62-57bc-43f9-8340-8d0f83b5a792" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="e88ad3a7-096a-4ad6-8590-8798101d3b15" content-type="jrnlQueryRef" specific-use="start" data-answered="true"/>GENEVA<named-content rid="c9275d62-57bc-43f9-8340-8d0f83b5a792" data-class="jrnlQueryRef" data-type="end" id="732e0bd3-f8e0-4517-8caa-ffb738840752" data-query-type="action" content-type="jrnlQueryRef" specific-use="end" data-answered="true"/></p><p id="eeb4b912-92c1-4d51-9d59-bd3741dcd4a5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1554366427" id="ad62a230-b8bb-4004-86aa-3541fd457c86" content-type="ins cts-3" specific-use="1554372288176" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:34pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372288176">o</named-content><named-content data-cid="1554366428" id="9a333c52-329f-475a-95fd-9d5e5ea21d80" content-type="del cts-3" specific-use="1554372289867" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:34pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372289867">O</named-content>phthalmology 2011<sup id="e4718cbc-4687-4c85-ab60-7c9370ed25cb"><named-content data-cid="1553859991" id="80a23274-75ce-41fb-a968-5f9f77033ce8" content-type="del cts-2" specific-use="1553860911843" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:31pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860911843">26</named-content><xref id="8b9f26d7-c3c1-4c82-8d9c-72fc6036a389" ref-type="bibr" rid="R26" data-citation-string=" R26 " data-track="ins" data-cid="1553860910834" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553860910834" data-cite-type="insert"><sup id="9d5581f1-d92d-4949-8310-c0169994e715">26</sup></xref></sup></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="b058fd10-4e3e-4c19-8753-d1cecbce5790" valign="top" data-old-attributes=""><p id="a69c4a4f-427a-4add-8358-28e2e2cc9f1f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="085e4ab1-6ce5-4eeb-a164-53d116e5d47b" data-cid="085e4ab1-6ce5-4eeb-a164-53d116e5d47b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1256" data-replace="1256" data-pattern="1256" data-tag-index="492_1" data-time="" data-username="" data-userid="">1256</named-content></p><p id="2cf807bd-7ed9-4d65-9dd3-5d9326dbf425" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(<named-content data-cid="1553859621013" id="8cf75ad7-e3d0-44da-92a1-8fcd4f3fc299" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">2</named-content><named-content id="b968891c-7368-448a-80c4-92bd198a7c61" data-cid="1553859621013" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1" data-match="2" data-pattern="" data-tag-index="493_1" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1553859621001">two</named-content> injections)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="68fdc9b9-9d3e-4826-ad1e-c01906c239d0" valign="top" data-old-attributes=""><p id="27bffaf7-7b0f-49df-b456-c2181fc5a6af" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="9fb6e2af-937b-4f35-b5f9-8b65182f7a73" data-cid="9fb6e2af-937b-4f35-b5f9-8b65182f7a73" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="12 months" data-replace="12" data-pattern="$1" data-tag-index="494_1" data-time="" data-username="" data-userid="">12</named-content><named-content id="9bdb32dd-7a84-4559-ac26-15be1c2e6fab" data-cid="9bdb32dd-7a84-4559-ac26-15be1c2e6fab" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="2" data-match="12 months" data-replace=" months" data-pattern=" $2" data-tag-index="494_1" data-time="" data-username="" data-userid=""> months</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="770d67f4-e3f9-4a9f-8991-3a442b1178a8" valign="top" data-old-attributes=""><p id="b9b811d4-0c70-45e5-8bba-c640ce54198f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">BRVO</p><p id="d9debbae-0c84-4db8-9e3e-db9120f0e412" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">CRVO</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="602afe24-de5a-4dab-8431-09d72ea1c572" valign="top" data-old-attributes=""><p id="8ae0fd04-5333-4029-bdfb-15c7605766a9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">12.6%</p><p id="be446ac8-bc6d-4e6b-a314-6d96fcf2f911" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Controlled with AGM</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="d17187b4-2837-449f-89e0-ca288c6f15f2" valign="top" data-old-attributes=""><p id="0afe8d2b-62c3-4c24-bce2-f258f3852a97" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="6133fbc2-b1a0-4df9-bf5f-c582bec8cff7" data-cid="6133fbc2-b1a0-4df9-bf5f-c582bec8cff7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="29.8%" data-replace="29.8" data-pattern="$1" data-tag-index="499_1" data-time="" data-username="" data-userid="">29.8</named-content><named-content id="c90595cd-2e74-4fcd-b937-51841c91fef4" data-cid="c90595cd-2e74-4fcd-b937-51841c91fef4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="4" data-match="29.8%" data-replace="%" data-pattern="%" data-tag-index="499_1" data-time="" data-username="" data-userid="">%</named-content> 700<named-content data-cid="1554366536" id="2a9c6b7f-f9e9-4000-9870-e857f6223ef6" content-type="ins cts-3" specific-use="1554374084004" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374084004"> </named-content>mcg</p><p id="be85ca3f-084b-44c7-af49-715d35a531e4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="41523a4d-a0b4-4ba8-86ac-667ed40f29fa" data-cid="41523a4d-a0b4-4ba8-86ac-667ed40f29fa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="5.7%" data-replace="5.7" data-pattern="$1" data-tag-index="500_1" data-time="" data-username="" data-userid="">5.7</named-content><named-content id="03b2c195-5732-4d09-964b-5b4431a465c7" data-cid="03b2c195-5732-4d09-964b-5b4431a465c7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="3" data-match="5.7%" data-replace="%" data-pattern="%" data-tag-index="500_1" data-time="" data-username="" data-userid="">%</named-content> sham</p><p id="5005cd50-668e-4697-bb84-9595de57fe5d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(1.3%<named-content data-cid="1554366537" id="18fa9ebb-68b0-4a44-a954-f8d5a7718a47" content-type="ins cts-3" specific-use="1554374086252" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374086252"> </named-content>-surgery)</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="f8c3eaeb-6cf4-42f9-a3eb-8975ac352229" valign="top" data-old-attributes=""><p id="526ef043-82ed-444b-b7a0-899204bc205d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="ccb07705-9299-45e0-b3c8-6edb55ee7ed6" valign="top" data-old-attributes=""><p id="78238a93-3854-4a63-8ba4-21abaca8581f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Retinal detachment<named-content data-cid="1554366538" id="7eb60f9a-847a-4617-8666-ee863cd591e0" content-type="ins cts-3" specific-use="1554374091427" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:04pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374091427"> </named-content>-1</p></td></tr><tr data-col-count="8" id="e95213f5-8aa7-4ea6-aba1-980819869e14"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="1af3aba6-a28b-4a57-842c-b89fb5873622" data-possbibref="true" valign="top" data-old-attributes=""><p id="a7078b40-5d3b-43a9-b11c-a8853b6ef716" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content rid="5f09a7f0-e5db-4ed9-9e5f-2b8fbeda4aa4" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="typesetter" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="d2942113-3839-4da8-8100-b7a8f294ab51" content-type="jrnlQueryRef" specific-use="start" data-replied="true"/>Li <italic data-class="sty cts-3" data-cid="1554366429" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372765760" data-track-hint="Italic Added" id="f5c27124-b772-4b73-8a0c-6e40dc78f571" data-title="Italic Added by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:42pm"><named-content rid="0971378c-b413-427b-9dbc-7ce1501848d9" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="typesetter" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="82624e13-fbea-4bcc-95b6-05c7d646a7e5" content-type="jrnlQueryRef" specific-use="start" data-answered="true"/>et<named-content rid="0971378c-b413-427b-9dbc-7ce1501848d9" data-class="jrnlQueryRef" data-type="end" id="b245a7f9-a14c-4f00-b929-25dcd2acd6ea" data-query-type="action" content-type="jrnlQueryRef" specific-use="end" data-answered="true"/> al<named-content rid="5f09a7f0-e5db-4ed9-9e5f-2b8fbeda4aa4" data-class="jrnlQueryRef" data-type="end" id="7546bcc9-84ab-46c1-ac0c-63829478e4a5" content-type="jrnlQueryRef" specific-use="end" data-replied="true"/></italic></p><p id="a3162364-da84-4907-abc4-382d7f97ef35" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Graefes 2018<xref id="4d180082-3768-42c2-aada-3bb59197143a" ref-type="bibr" rid="R27" data-citation-string=" R27 " data-track="ins" data-cid="1554530450141" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1554530450141" data-cite-type="insert"><sup id="fc1321fc-9803-45e8-af53-a69bbbdbe11d">27</sup></xref><named-content data-cid="1554529183" id="c5d121fd-38d4-446b-97dc-b8d566bb338b" content-type="del cts-8" specific-use="1554530485626" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Deleted by Gowtham Ram (TYPESETTER) - Apr 6 2019 11:31am" data-track-detail="" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1554530485626"> </named-content><sup id="b853f23b-97fb-4d6f-90df-456739a616dd"><named-content data-cid="1553859993" id="42fb97d2-18a5-4133-8ac5-1f45fbf768ec" content-type="del cts-2" specific-use="1553860942670" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:32pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860942670">29</named-content><xref id="0cf5d4b4-ee7e-416b-9d60-ac93e3f6e8ef" ref-type="bibr" rid="R29" data-citation-string=" R29 " data-track="del" data-cid="1554530347293" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1554530347293" data-cite-type="delete"><sup id="8a39a613-307d-41fa-a0b7-4cd726b5b97c">29</sup></xref></sup></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="06cf0590-0f03-43ba-827e-a9e3bc8fc857" valign="top" data-old-attributes=""><p id="e981255b-0c77-4668-aa0e-b579b55132a5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="f9c5f49a-beff-43fe-8d8a-d0a96e7e393b" data-cid="f9c5f49a-beff-43fe-8d8a-d0a96e7e393b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '259' to '259'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="259" data-pattern="" data-tag-index="506_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">259</named-content> eyes</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="74bffe1c-bf75-4d9f-8b78-22a618597d11" valign="top" data-old-attributes=""><p id="8e0c0cd6-02b3-4bce-b32a-f1c8e013f5cf" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="d40db2ce-d5a0-4aa4-9b85-aa66a405c618" data-cid="d40db2ce-d5a0-4aa4-9b85-aa66a405c618" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="6 months" data-replace="6" data-pattern="$1" data-tag-index="507_1" data-time="" data-username="" data-userid="">6</named-content><named-content id="069be8fb-e5eb-4281-9dfe-7167d30c32e3" data-cid="069be8fb-e5eb-4281-9dfe-7167d30c32e3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1" data-match="6 months" data-replace=" months" data-pattern=" $2" data-tag-index="507_1" data-time="" data-username="" data-userid=""> months</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="47e7672f-7a6e-4b46-ad3a-0f7a86fe1b64" valign="top" data-old-attributes=""><p id="d43b20c9-6150-43b0-92e4-0e7542f6670e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RVO</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="9f06bd3b-3cef-4af3-b5e2-ff54bbf61fe8" valign="top" data-old-attributes=""><p id="b662b6f8-ac03-4bf8-a838-977753fb3cbd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="5f31cdd0-9024-4c41-b6c5-f943d6d86c81" data-cid="5f31cdd0-9024-4c41-b6c5-f943d6d86c81" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="27.1%" data-replace="27.1" data-pattern="$1" data-tag-index="509_2" data-time="" data-username="" data-userid="">27.1</named-content><named-content id="df775a40-ab57-450f-ba12-d1f59f397354" data-cid="df775a40-ab57-450f-ba12-d1f59f397354" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="4" data-match="27.1%" data-replace="%" data-pattern="%" data-tag-index="509_2" data-time="" data-username="" data-userid="">%</named-content> increase in <named-content id="67b032a9-8dba-46ff-9f20-5ed0e0cd9f73" data-cid="67b032a9-8dba-46ff-9f20-5ed0e0cd9f73" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="18" data-match="IOP&amp;gt;10 mm" data-replace="IOP" data-pattern="$1" data-tag-index="509_1" data-time="" data-username="" data-userid="">IOP<named-content data-cid="1554366474" id="7ddf293f-b95c-424f-bc57-8059374e2389" content-type="ins cts-3" specific-use="1554373660490" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:57pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373660490"> </named-content></named-content><named-content id="eb4a992c-0098-43be-9df3-9e3e0b1e8715" data-cid="eb4a992c-0098-43be-9df3-9e3e0b1e8715" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="21" data-match="IOP&amp;gt;10 mm" data-replace="&gt;" data-pattern="$2" data-tag-index="509_1" data-time="" data-username="" data-userid="">&gt;</named-content><named-content id="98bb8fcf-7fa5-46e5-bc29-25194189ae14" data-cid="98bb8fcf-7fa5-46e5-bc29-25194189ae14" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="22" data-match="IOP&amp;gt;10 mm" data-replace="10" data-pattern="$3" data-tag-index="509_1" data-time="" data-username="" data-userid="">10</named-content><named-content id="babd6164-6b89-4341-b935-a8ca806d7ba4" data-cid="babd6164-6b89-4341-b935-a8ca806d7ba4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mm' to ' mm'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="24" data-match="IOP&amp;gt;10 mm" data-replace=" mm" data-pattern=" $6" data-tag-index="509_1" data-track-change=" mm" data-time="" data-username="" data-userid=""> mm</named-content> Hg</p><p id="22019efa-a54e-4888-8896-a9667bd8c2e0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">23.3%<named-content id="85e06061-af7e-48b2-96c2-127511c98616" data-cid="85e06061-af7e-48b2-96c2-127511c98616" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="5" data-match="-&amp;gt;25 mm" data-replace="-" data-pattern="$1" data-tag-index="510_1" data-time="" data-username="" data-userid=""><named-content data-cid="1554366475" id="429a1ed9-c2d4-491a-b45d-fdbedd4f2be0" content-type="del cts-3" specific-use="1554373671831" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:57pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373671831">-</named-content></named-content><named-content id="4b3c1ddf-5b19-48d7-adf2-8f60b90c175a" data-cid="4b3c1ddf-5b19-48d7-adf2-8f60b90c175a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="6" data-match="-&amp;gt;25 mm" data-replace="&gt;" data-pattern="$2" data-tag-index="510_1" data-time="" data-username="" data-userid=""><named-content data-cid="1554366476" id="eaf71eb6-18fc-41db-a9e3-cb543465df06" content-type="ins cts-3" specific-use="1554373672092" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:57pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373672092"> </named-content>&gt;</named-content><named-content id="9dcd8611-b56d-42ad-98ad-66848b5b7d92" data-cid="9dcd8611-b56d-42ad-98ad-66848b5b7d92" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="7" data-match="-&amp;gt;25 mm" data-replace="25" data-pattern="$3" data-tag-index="510_1" data-time="" data-username="" data-userid="">25</named-content><named-content id="119c7f9d-45a5-4645-824e-404eb56986fa" data-cid="119c7f9d-45a5-4645-824e-404eb56986fa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mm' to ' mm'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="9" data-match="-&amp;gt;25 mm" data-replace=" mm" data-pattern=" $6" data-tag-index="510_1" data-track-change=" mm" data-time="" data-username="" data-userid=""> mm</named-content> Hg</p><p id="04feb14a-4c59-4cb3-b082-e7056423a3a0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="951bbe14-60dd-485d-8b7f-f3bf31f4be84" data-cid="951bbe14-60dd-485d-8b7f-f3bf31f4be84" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="6.2%&amp;gt;35 mm" data-replace="6.2%" data-pattern="$1" data-tag-index="511_1" data-time="" data-username="" data-userid="">6.2%<named-content data-cid="1554366477" id="4bd1bfaa-d809-415c-b04d-039c429d3f00" content-type="ins cts-3" specific-use="1554373673845" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:57pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373673845"> </named-content></named-content><named-content id="a03bc875-300f-4366-b079-02c6b2596c92" data-cid="a03bc875-300f-4366-b079-02c6b2596c92" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="4" data-match="6.2%&amp;gt;35 mm" data-replace="&gt;" data-pattern="$2" data-tag-index="511_1" data-time="" data-username="" data-userid="">&gt;</named-content><named-content id="03df1ca5-1d3f-440f-886a-c5333628a1d9" data-cid="03df1ca5-1d3f-440f-886a-c5333628a1d9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="5" data-match="6.2%&amp;gt;35 mm" data-replace="35" data-pattern="$3" data-tag-index="511_1" data-time="" data-username="" data-userid="">35</named-content><named-content id="2df62a02-3f7d-4828-b20f-66fc4d569c6f" data-cid="2df62a02-3f7d-4828-b20f-66fc4d569c6f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mm' to ' mm'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="7" data-match="6.2%&amp;gt;35 mm" data-replace=" mm" data-pattern=" $6" data-tag-index="511_1" data-track-change=" mm" data-time="" data-username="" data-userid=""> mm</named-content> Hg</p><p id="4d86e3fd-c913-4b27-8480-47b778182ded" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(<named-content id="c9586f5d-842c-412d-ad0b-b52c79e29f62" data-cid="c9586f5d-842c-412d-ad0b-b52c79e29f62" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="34.9%" data-replace="34.9" data-pattern="$1" data-tag-index="512_1" data-time="" data-username="" data-userid="">34.9</named-content><named-content id="e111f82f-617a-4750-9e31-ef4331e3c98b" data-cid="e111f82f-617a-4750-9e31-ef4331e3c98b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="5" data-match="34.9%" data-replace="%" data-pattern="%" data-tag-index="512_1" data-time="" data-username="" data-userid="">%</named-content> -<named-content data-cid="1554366478" id="3e9e8bb2-e81c-4108-ab89-4a924c1c8171" content-type="ins cts-3" specific-use="1554373676799" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:57pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373676799"> </named-content>AGM</p><p id="c28b7906-fa87-46e4-961f-2f9a6d11b0a2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">1<named-content data-cid="1554366539" id="8037b63c-aa2e-4d2d-93af-bf8f1f30428e" content-type="ins cts-3" specific-use="1554374100005" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374100005"> </named-content>-<named-content data-cid="1554366540" id="f7c71b57-4e75-4499-bc35-11b549abdfe1" content-type="ins cts-3" specific-use="1554374100631" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374100631"> </named-content>LT)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="90d467ad-7eb8-4c47-9d47-d38ca0557266" valign="top" data-old-attributes=""><p id="2638b25a-e9e9-416a-8a61-90ed4a70c747" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="275652fc-264a-474c-aaa7-b5ce7f781648" data-cid="275652fc-264a-474c-aaa7-b5ce7f781648" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="1.6 %" data-replace="1.6" data-pattern="$1" data-tag-index="514_1" data-time="" data-username="" data-userid="">1.6</named-content><named-content id="c1eefcb4-7586-47fc-bb3b-e270433b3068" data-cid="c1eefcb4-7586-47fc-bb3b-e270433b3068" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣%' to '%'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="3" data-match="1.6 %" data-replace="%" data-pattern="%" data-tag-index="514_1" data-track-change=" %" data-time="" data-username="" data-userid="">%</named-content> IVD <named-content id="a6224e8d-a330-4c5e-857a-323d282a4aa3" data-cid="a6224e8d-a330-4c5e-857a-323d282a4aa3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'Vs' to 'vs'" data-track-detail="" data-tag-desc="VERSUS" data-tag-type="VERSUS" data-offset="10" data-match="Vs" data-replace="vs" data-pattern="vs" data-tag-index="514_3" data-track-change="Vs" data-time="" data-username="" data-userid="">vs</named-content> <named-content id="8de81fca-5962-4005-b397-f3095977dc8d" data-cid="8de81fca-5962-4005-b397-f3095977dc8d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '0' to '0'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="13" data-match="0" data-pattern="" data-tag-index="514_2" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">0</named-content> sham</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="4534ce85-55f4-4632-a2ad-ebcad4bf4024" valign="top" data-old-attributes=""><p id="4dea7b04-8958-41ea-bf30-827b2183bdb5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">AV block</p><p id="50da8bcb-bbac-41f5-8562-c03b9bb1f480" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Cerebral infarction (unrelated to Dex implant)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="a5592f1f-8487-457e-bb02-0cee14f8f6af" valign="top" data-old-attributes=""><p id="8ed4393a-2a36-46f8-804c-5c6b5a032e1c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Conjunctival <named-content data-cid="1553859621095" id="b8eaf09e-0cd5-432e-b1ed-d2a2b43c7016" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">hemorrhage</named-content><named-content id="a59422ee-417d-4908-9ae0-3809e6e779e3" data-cid="1553859621095" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'hemorrhage' to 'haemorrhage'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="13" data-match="hemorrhage" data-replace="haemorrhage" data-pattern="haemorrhage" data-tag-index="517_6" data-function="addTrackChanges" data-track-change="hemorrhage" data-userid="preediting" data-username="Exeter" data-time="1553859621001">haemorrhage</named-content> <named-content id="2a0289dd-d8e3-4676-949d-51d4523c559d" data-cid="2a0289dd-d8e3-4676-949d-51d4523c559d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="24" data-match="24 (18.6)" data-replace="24" data-pattern="$1" data-tag-index="517_1" data-time="" data-username="" data-userid="">24</named-content><named-content id="953ab6dd-fc60-4167-a945-12e7a2be5810" data-cid="953ab6dd-fc60-4167-a945-12e7a2be5810" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="26" data-match="24 (18.6)" data-replace=" (18.6)" data-pattern=" $2" data-tag-index="517_1" data-time="" data-username="" data-userid=""> (18.6)</named-content> Conjunctival <named-content data-cid="1554366479" id="24ed9666-a6f5-422c-a39c-8b5a9a8b527c" content-type="del cts-3" specific-use="1554373724245" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:58pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373724245">hyperemia</named-content><icepaste id="3fd0d042-e9b2-4f11-9884-f0a3a0be6f9e"/><named-content data-cid="1554366480" id="d332fc19-901f-4ace-9af6-3f6053575238" content-type="ins cts-3" specific-use="1554373729383" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:58pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373729383"><span id="ba949592-ad5f-4c33-b6ac-c8d84baa9e06">hyperaemia</span></named-content> <named-content id="f0e01fcf-5241-4263-8cfb-f2ac2d3700bb" data-cid="f0e01fcf-5241-4263-8cfb-f2ac2d3700bb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="57" data-match="17 (13.2)" data-replace="17" data-pattern="$1" data-tag-index="517_2" data-time="" data-username="" data-userid="">17</named-content><named-content id="3daca10e-05db-4ef8-b2f4-cc4d731f8949" data-cid="3daca10e-05db-4ef8-b2f4-cc4d731f8949" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="59" data-match="17 (13.2)" data-replace=" (13.2)" data-pattern=" $2" data-tag-index="517_2" data-time="" data-username="" data-userid=""> (13.2)</named-content> Conjunctival <named-content data-cid="1553859621096" id="454ec81a-335e-4e4d-8b3e-b1c44c31af74" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="07118440-81a5-4e62-9d66-adc39d244496" data-cid="1553859621096" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="80" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="517_7" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content> <named-content id="7d14b99a-718c-417e-956d-c3ca4ade5995" data-cid="7d14b99a-718c-417e-956d-c3ca4ade5995" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="86" data-match="4 (3.1)" data-replace="4" data-pattern="$1" data-tag-index="517_3" data-time="" data-username="" data-userid="">4</named-content><named-content id="f665d331-ae6f-4be0-b589-ffb5b450c047" data-cid="f665d331-ae6f-4be0-b589-ffb5b450c047" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="87" data-match="4 (3.1)" data-replace=" (3.1)" data-pattern=" $2" data-tag-index="517_3" data-time="" data-username="" data-userid=""> (3.1)<named-content data-cid="1554366541" id="e0e824a7-4e5c-4a65-87b8-d3ee754e96a7" content-type="ins cts-3" specific-use="1554374116050" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374116050"> </named-content></named-content>Eye pain <named-content id="c30e35a8-ceae-4152-b90b-bad11ecaa728" data-cid="c30e35a8-ceae-4152-b90b-bad11ecaa728" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="102" data-match="3 (2.3)" data-replace="3" data-pattern="$1" data-tag-index="517_4" data-time="" data-username="" data-userid="">3</named-content><named-content id="3c2041c9-9a51-4fff-8432-470faffe9d7f" data-cid="3c2041c9-9a51-4fff-8432-470faffe9d7f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="103" data-match="3 (2.3)" data-replace=" (2.3)" data-pattern=" $2" data-tag-index="517_4" data-time="" data-username="" data-userid=""> (2.3)</named-content> Headache <named-content id="0e4e0e75-8a20-43d0-909b-1f03abb8a966" data-cid="0e4e0e75-8a20-43d0-909b-1f03abb8a966" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="119" data-match="3 (2.3)" data-replace="3" data-pattern="$1" data-tag-index="517_5" data-time="" data-username="" data-userid="">3</named-content><named-content id="f417a5f5-6710-486f-8d2f-3b064385cf31" data-cid="f417a5f5-6710-486f-8d2f-3b064385cf31" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="120" data-match="3 (2.3)" data-replace=" (2.3)" data-pattern=" $2" data-tag-index="517_5" data-time="" data-username="" data-userid=""> (2.3)</named-content></p></td></tr><tr data-col-count="8" id="031cca1f-934a-414d-8a49-cb0d22fa20dc" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="00bebfd3-bad1-4184-b433-ada7f47561ba" data-possbibref="true" valign="top" data-old-attributes=""><p id="f31138ee-abe2-473d-a061-280dc49c82f2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content rid="88c9a2a3-a5e6-4f9e-8a5c-a27bf6a8aaff" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="typesetter" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="232f4911-e789-46d3-8047-a635a164e931" content-type="jrnlQueryRef" specific-use="start" data-replied="true"/>Eter N<named-content rid="88c9a2a3-a5e6-4f9e-8a5c-a27bf6a8aaff" data-class="jrnlQueryRef" data-type="end" id="7a0415e6-5c5f-4efb-ab93-e9af31a40cdd" content-type="jrnlQueryRef" specific-use="end" data-replied="true"/></p><p id="855f9c1e-1d6c-4ecd-ab19-5be269809e59" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Graefes</p><p id="aba4b5d7-20e8-4d76-9be5-565e65caedcf" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">2017<xref id="8b9f9930-79e2-4742-9b21-1820fe5ce200" ref-type="bibr" rid="R28" data-citation-string=" R28 " data-track="ins" data-cid="1554530459926" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1554530459926" data-cite-type="insert"><sup id="80753369-de22-4995-b0e3-6b2773a77955">28</sup></xref><named-content data-cid="1554529184" id="90c69aa9-8e8a-4ba1-927a-d89f2a467684" content-type="del cts-8" specific-use="1554530490292" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Deleted by Gowtham Ram (TYPESETTER) - Apr 6 2019 11:31am" data-track-detail="" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1554530490292"> </named-content><sup id="d98a8783-397c-4d19-99d0-91a0e6a92121"><named-content data-cid="1553859995" id="7166ba8d-da76-4f8c-b482-134c4d59e81d" content-type="del cts-2" specific-use="1553860951884" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:32pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860951884">30</named-content><xref id="0a2bc030-32db-4c7d-bb87-cbbe6bc83eda" ref-type="bibr" rid="R30" data-citation-string=" R30 " data-track="del" data-cid="1554530308489" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1554530308489" data-cite-type="delete"><sup id="0d5475f8-45a8-429d-8f34-b0fa98c6bfc8">30</sup></xref></sup></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="a7d08625-2625-42fd-83c5-1589fd17db94" valign="top" data-old-attributes=""><p id="314f7faa-a968-44fc-87b2-fd68078bbbe9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="d46a1568-ac77-477b-a6ab-a1472986562a" data-cid="d46a1568-ac77-477b-a6ab-a1472986562a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '573' to '573'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="573" data-pattern="" data-tag-index="521_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">573</named-content> eyes</p><p id="24fb72aa-8095-4e85-8348-0dc94c7491c5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(668 implants)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="5035bef1-fdec-48eb-b35f-e965762d1084" valign="top" data-old-attributes=""><p id="b7077da3-df50-483b-851e-6a53362134df" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="860aff37-bf74-430d-942b-d55e2b987b4a" data-cid="860aff37-bf74-430d-942b-d55e2b987b4a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="6 months" data-replace="6" data-pattern="$1" data-tag-index="523_1" data-time="" data-username="" data-userid="">6</named-content><named-content id="94472c31-6896-45f0-85c7-d174c7ee249d" data-cid="94472c31-6896-45f0-85c7-d174c7ee249d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1" data-match="6 months" data-replace=" months" data-pattern=" $2" data-tag-index="523_1" data-time="" data-username="" data-userid=""> months</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="fd926025-fcc4-4901-98cb-e5d50c7b96fa" valign="top" data-old-attributes=""><p id="367bcf39-b192-4995-9793-22ab2f560fed" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RVO</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="549de960-3b83-4ac9-aef5-d8e4cb5b779e" valign="top" data-old-attributes=""><p id="15f77e8a-0a5c-496f-9e54-ce69e909af63" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">13.2%<named-content data-cid="1554366542" id="869f3c6d-feab-4a75-8422-cf330e2313fa" content-type="ins cts-3" specific-use="1554374129699" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374129699"> </named-content>IOP<named-content id="4224a3d7-b1b4-4e1c-b945-04e289d10abb" data-cid="4224a3d7-b1b4-4e1c-b945-04e289d10abb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '&gt;' to '⍽&gt;'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="8" data-match="IOP&amp;gt;25 mm" data-replace=" &gt;" data-pattern=" $2" data-tag-index="525_1" data-track-change="&amp;gt;" data-time="" data-username="" data-userid=""> &gt;</named-content><named-content id="d869448c-93ab-44e1-91ab-d055353649a1" data-cid="d869448c-93ab-44e1-91ab-d055353649a1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="9" data-match="IOP&amp;gt;25 mm" data-replace="25" data-pattern="$3" data-tag-index="525_1" data-time="" data-username="" data-userid="">25</named-content><named-content id="83f95b2e-1674-4495-b1e2-bb48292c72d0" data-cid="83f95b2e-1674-4495-b1e2-bb48292c72d0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mm' to ' mm'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="11" data-match="IOP&amp;gt;25 mm" data-replace=" mm" data-pattern=" $6" data-tag-index="525_1" data-track-change=" mm" data-time="" data-username="" data-userid=""> mm</named-content> Hg</p><p id="40ec9485-f389-4bc1-b5a4-4e6969ca30ef" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(<named-content id="714a0bd6-de7e-4926-aead-7b69e4ccbf44" data-cid="714a0bd6-de7e-4926-aead-7b69e4ccbf44" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="39%" data-replace="39" data-pattern="$1" data-tag-index="526_1" data-time="" data-username="" data-userid="">39</named-content><named-content id="fc3f827f-5143-4afe-80e3-867080cde7ff" data-cid="fc3f827f-5143-4afe-80e3-867080cde7ff" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="3" data-match="39%" data-replace="%" data-pattern="%" data-tag-index="526_1" data-time="" data-username="" data-userid="">%</named-content> of these needed AGM</p><p id="be8303ad-16c6-4b68-b87a-dc1f04029eb2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">1.6%<named-content data-cid="1554366543" id="e47a4686-efee-42d6-a0ab-bb75897b1b0d" content-type="ins cts-3" specific-use="1554374131792" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374131792"> </named-content>-<named-content data-cid="1554366544" id="41b7141d-aa3a-4d68-9855-365287b31fbd" content-type="ins cts-3" specific-use="1554374132766" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374132766"> </named-content>LT)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="967118b8-ab42-4bad-8b60-e781ea01b296" valign="top" data-old-attributes=""><p id="6f4c298e-92ca-481f-a4fb-dcae5d0bcf2e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">6.1%<named-content data-cid="1554366545" id="67ff9a09-05e5-4012-9e27-a2b7fa966c96" content-type="ins cts-3" specific-use="1554374135123" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374135123"> </named-content>-surgery</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="9abc08fc-69af-465d-9e9f-db92386182e4" valign="top" data-old-attributes=""><p id="7182f463-9f90-4c0f-9701-558d51af9fd1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="1cf3551e-806a-4eb8-8ae7-b858bfc01cc9" valign="top" data-old-attributes=""><p id="e928ab33-048e-4820-a5f2-847e5ef13aaa" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1554395229" id="26be8e53-6087-435b-b536-f45daded8299" content-type="del cts-6" specific-use="1554395625740" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 10:03pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395625740">n</named-content><named-content data-cid="1554395230" id="045a6f1c-13a8-4517-a774-5af24875d39c" content-type="ins cts-6" specific-use="1554395626004" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 10:03pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395626004">N</named-content>il</p></td></tr><tr data-col-count="8" id="6ad3bf2d-8582-45e4-a83b-997126c5c922"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="44f508bb-9547-401a-9038-0fd3a912b562" data-possbibref="true" valign="top" data-old-attributes=""><p data-class="jrnlDeleted" id="66457811-b154-4a91-abc2-69333c8d9d06" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" contenteditable="true" old-class="jrnlTblBody" data-role="copyeditor"><named-content data-cid="1554366435" id="25d13cf6-40d9-44d3-b7f2-a767509e5cec" content-type="del cts-3" specific-use="1554372933770" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:45pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372933770">Malcles A</named-content><icepaste id="76deff02-3acd-4672-a737-4394407f6357"/></p><p id="d2614b7f-41a3-400a-ac55-324681726902" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1554366436" id="39b5da77-e918-4f8c-8e80-56b36cde061f" content-type="ins cts-3" specific-use="1554372939229" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:45pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372939229"><span id="dd98fa98-26f8-4fc1-8991-c6a256a266b1">Malclès</span> <italic data-class="sty cts-3" data-cid="1554366444" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372946246" data-track-hint="Italic Added" id="5fbfd2a8-76eb-42e4-985c-500ea9666a5a" data-title="Italic Added by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:45pm">et al</italic> </named-content>Retina 2017</p><p id="1a566ec4-b73b-42e8-a4c3-54831252027e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">SAFODEX<sup id="1cc6ad8f-e961-4342-a254-a19fe5b46616"><named-content data-cid="1553859997" id="c785af7e-1246-4104-ad9c-1c4e43305d5b" content-type="del cts-2" specific-use="1553860981743" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:33pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860981743">23</named-content><xref id="303177ba-bada-498d-bef5-89e552b98303" ref-type="bibr" rid="R23" data-citation-string=" R23 " data-track="ins" data-cid="1553860979222" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553860979222" data-cite-type="insert"><sup id="9dd395d9-ccf0-48e7-aa3e-e0eb6b6ec685">23</sup></xref></sup></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="e2995693-1deb-4e53-8906-e449e170804a" valign="top" data-old-attributes=""><p id="26b12b58-4e87-43d4-9724-33cae7cdcadf" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="10db59df-c89b-449c-89ee-38c5a983cc61" data-cid="10db59df-c89b-449c-89ee-38c5a983cc61" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '421' to '421'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="421" data-pattern="" data-tag-index="534_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">421</named-content> eyes</p><p id="322a4b33-8686-4268-8e53-b78d009c2123" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(<named-content id="59bc8bb5-9217-42e3-a436-76b6177a17f2" data-cid="59bc8bb5-9217-42e3-a436-76b6177a17f2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="1" data-match="1000" data-replace="1000" data-pattern="1000" data-tag-index="535_1" data-time="" data-username="" data-userid="">1000</named-content> injections)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="84a556d0-44ed-4221-baf4-68a748c75595" valign="top" data-old-attributes=""><p id="a86c8988-7088-441d-b25b-482c9b67533f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="74823c90-5f78-40c1-9036-a071b0d95da8" data-cid="74823c90-5f78-40c1-9036-a071b0d95da8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="16.8 months" data-replace="16.8" data-pattern="$1" data-tag-index="536_1" data-time="" data-username="" data-userid="">16.8</named-content><named-content id="2279e627-ba5b-4ad3-add9-e2288b8f57c5" data-cid="2279e627-ba5b-4ad3-add9-e2288b8f57c5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="4" data-match="16.8 months" data-replace=" months" data-pattern=" $2" data-tag-index="536_1" data-time="" data-username="" data-userid=""> months</named-content></p><p id="9503a6b0-9c30-46f4-99f5-0c4d37a0cf14" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="271c2bd9-7677-4bf0-b49d-3c030ac95b85" data-cid="271c2bd9-7677-4bf0-b49d-3c030ac95b85" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="(3-55 years" data-replace="(3" data-pattern="$2" data-tag-index="537_1" data-time="" data-username="" data-userid="">(3</named-content><named-content id="e3aff2e0-b9ed-4ae7-8e36-8f36290b1ba2" data-cid="e3aff2e0-b9ed-4ae7-8e36-8f36290b1ba2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="2" data-match="(3-55 years" data-replace="–" data-pattern="–" data-tag-index="537_1" data-track-change="-" data-time="" data-username="" data-userid=""><named-content data-cid="1554366430" id="803bc785-b979-4d43-9098-bba90481bc38" content-type="del cts-3" specific-use="1554372905996" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:45pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372905996">–</named-content></named-content><named-content id="ea28431c-66f2-4a65-9714-496daa0dd26a" data-cid="ea28431c-66f2-4a65-9714-496daa0dd26a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="3" data-match="(3-55 years" data-replace="55" data-pattern="$4" data-tag-index="537_1" data-time="" data-username="" data-userid=""><named-content data-cid="1554366431" id="5f8994ba-63f6-4476-9c43-b87eb82bb08e" content-type="ins cts-3" specific-use="1554372906261" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:45pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372906261"> to </named-content>55</named-content><named-content id="a31cb301-12c3-4dfb-b3d0-077822ffb432" data-cid="a31cb301-12c3-4dfb-b3d0-077822ffb432" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="5" data-match="(3-55 years" data-replace=" years" data-pattern=" $5" data-tag-index="537_1" data-time="" data-username="" data-userid=""> years</named-content>)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="54935203-a2be-4c83-96a7-8a73435f88b7" valign="top" data-old-attributes=""><p id="58d8d0b7-377d-4781-8c5c-cbbe2dd0cba5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RVO</p><p id="7b6a13b1-430d-4ee7-8841-f21ec4a4195f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">DME</p><p id="e31f4fab-89ef-4fbf-8384-73d295b6889a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Post surgical others</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="e913b215-b251-4c7a-b101-c1cfdc74fd4c" valign="top" data-old-attributes=""><p id="c3f19138-79e8-49af-967d-74b4b4747ab5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">28.5%</p><p id="4b9ef196-b3c1-4aa5-b9e5-2588a19ec719" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">31%<named-content data-cid="1554366546" id="d07f5c2e-564d-469d-8b76-2a80c85a530c" content-type="ins cts-3" specific-use="1554374138660" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374138660"> </named-content>-<named-content data-cid="1554366547" id="ce195b43-ff34-4da6-9a66-0fd768de6f51" content-type="ins cts-3" specific-use="1554374139472" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374139472"> </named-content>AGM</p><p id="40c04825-0813-47f6-ae47-a01ca35344b5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">07%<named-content data-cid="1554366548" id="82d53ba3-43ba-47f1-b34a-e891c4217113" content-type="ins cts-3" specific-use="1554374140768" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374140768"> </named-content>-<named-content data-cid="1554366549" id="16075060-132e-41c5-a66f-94eeeb902a85" content-type="ins cts-3" specific-use="1554374141349" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374141349"> </named-content>surgery</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="1c2e08fe-6b33-4b31-86b0-8d1b1e190ccc" valign="top" data-old-attributes=""><p id="dd954ce1-fa9e-41f8-ba73-217412aac83c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="c83e4521-7e51-48f2-9872-08e92a9e1be3" valign="top" data-old-attributes=""><p id="2a064ec5-2388-4015-a4e4-c7c8634aaefa" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="e8053ebb-9ad4-47e2-88c6-21417447a9ac" valign="top" data-old-attributes=""><p id="21882acf-7cad-4e03-b231-07cbe0811e12" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1554395231" id="0f70c479-c003-473c-9e47-9521313501f3" content-type="del cts-6" specific-use="1554395630181" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 10:03pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395630181">n</named-content><named-content data-cid="1554395232" id="304ede90-139c-494c-8cf3-2e537caffae5" content-type="ins cts-6" specific-use="1554395630443" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 10:03pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395630443">N</named-content>il</p></td></tr><tr data-col-count="8" id="a2847c2b-5725-4f6e-98e0-52c780fc305f" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d19e130e-3930-4195-a0ef-c0d426a76aae" data-possbibref="true" valign="top" data-old-attributes=""><p id="259d9c3e-a0b3-4eb2-9df8-5df6395a7c17" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Nagpal <named-content data-cid="1554366448" id="8e147f92-dea5-495d-90c8-d87fddc7777e" content-type="del cts-3" specific-use="1554372975007" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:46pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372975007">M</named-content><named-content data-cid="1554366449" id="b063f9fd-de76-4816-8c6f-c864dc3b0bc4" content-type="ins cts-3" specific-use="1554372975286" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:46pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372975286"><italic data-class="sty cts-3" data-cid="1554366454" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554372981102" data-track-hint="Italic Added" id="26bf69c3-a4b1-4ff6-a994-9edd646222ac" data-title="Italic Added by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:46pm">et al</italic></named-content></p><p id="89fa5157-ab5b-4465-9b2f-cf453082191b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">TaiwanJ 2018<sup id="2fb68d43-b21a-459b-9e52-a607a801c0b4"><named-content data-cid="1553859999" id="11112ed5-ee1b-44d2-8575-3cb13d337389" content-type="del cts-2" specific-use="1553860990355" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:33pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553860990355">29</named-content><xref id="1dcc3dae-d8d9-4aa6-9eae-1656c0f160e1" ref-type="bibr" rid="R29" data-citation-string=" R29 " data-track="ins" data-cid="1553860988648" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553860988648" data-cite-type="insert"><sup id="6f11c621-388e-42ef-9e15-52c04db9f998">29</sup></xref></sup></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="f9e48acd-21fc-4ac3-8b14-d26c6b43c7e4" valign="top" data-old-attributes=""><p id="a2eaaa7a-a757-4b02-965e-2282985bcc17" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">116</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="fbee3f6a-cd5d-407e-8d3d-27d01ed217fc" valign="top" data-old-attributes=""><p id="44321496-bda0-40ca-9aca-e9ea36551112" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="34948590-acf2-4b5c-a6d8-f48659d3ff04" data-cid="34948590-acf2-4b5c-a6d8-f48659d3ff04" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="24months" data-replace="24" data-pattern="$1" data-tag-index="550_1" data-time="" data-username="" data-userid="">24</named-content><named-content id="6a8ebd99-ef31-4a87-a6e9-f6d8244bb0cc" data-cid="6a8ebd99-ef31-4a87-a6e9-f6d8244bb0cc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'months' to ' months'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="2" data-match="24months" data-replace=" months" data-pattern=" $2" data-tag-index="550_1" data-track-change="months" data-time="" data-username="" data-userid=""> months</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="8bbc558f-de5d-4225-9985-e483e08c8c27" valign="top" data-old-attributes=""><p id="68e39fd4-8aea-47fc-a52d-d44498646b06" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">DME</p><p id="a50abf74-8166-42ce-ba5d-e18225b984ae" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RVO</p><p id="1b61a07f-0b96-4c91-9512-5f82a22d9c21" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1554395227" id="25d8624e-fb07-449e-9dce-12aed524a02c" content-type="del cts-6" specific-use="1554395566454" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 10:02pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395566454">Infec</named-content><icepaste id="7d0939d9-3603-4fa0-b23d-2171348af1ff"/><named-content data-cid="1554395228" id="759a5806-d360-4e39-a051-7bb8aaf6b999" content-type="ins cts-6" specific-use="1554395570809" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 10:02pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395570809">Infectious</named-content> uveitis</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="b48e16e3-9385-41bf-870e-dce804613466" valign="top" data-old-attributes=""><p id="5ea57e7a-843b-4e61-a645-b3f0c92e02e4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="23665c9a-0f9b-4f82-ab4b-76c8b16856f8" data-cid="23665c9a-0f9b-4f82-ab4b-76c8b16856f8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '12' to '12'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="12" data-pattern="" data-tag-index="554_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">12</named-content> cases<named-content data-cid="1554366481" id="865b7ff2-6660-4f27-9de2-ece075073334" content-type="ins cts-3" specific-use="1554373750948" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:59pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373750948"> </named-content>(10.3%)</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="e6da985c-7212-435e-b123-c48fa6484917" valign="top" data-old-attributes=""><p id="684a4f25-1bf4-49ac-ad29-8bdc07728342" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1553859621014" id="a35885ac-f5e6-45e7-a248-4897327f0a66" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">9</named-content><named-content id="ec34095c-9d30-430b-b9f3-07961ea3d3f2" data-cid="1553859621014" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '9' to 'nine'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="9" data-pattern="" data-tag-index="555_1" data-function="numberToText,addTrackChanges" data-track-change="9" data-userid="preediting" data-username="Exeter" data-time="1553859621001">nine</named-content> eyes</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="417e56cf-c6d8-4cdf-8c3f-df67df21fe87" valign="top" data-old-attributes=""><p id="b925895a-18a1-4130-a392-0f44196dc374" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="2b8d750d-f529-4e9b-8001-a7547d8416fa" valign="top" data-old-attributes=""><p id="d087d72a-60db-4c61-8f9e-452639e9930f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1554395233" id="b7de37de-c23f-4326-83f6-3cde320278e4" content-type="del cts-6" specific-use="1554395634100" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 10:03pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395634100">n</named-content><named-content data-cid="1554395234" id="951e534c-c04e-4348-ace6-6e0fa82f7550" content-type="ins cts-6" specific-use="1554395634368" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 1148283224" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 10:03pm" data-track-detail="" data-userid="copyeditor 1148283224" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554395634368">N</named-content>il</p></td></tr><tr data-col-count="8" id="d39de782-cc0c-4437-a211-71e5a1ec76a6"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="bb336e74-d078-4f3b-94aa-e50b3d1c6a01" data-possbibref="true" valign="top" data-old-attributes=""><p id="63abdfb4-8764-4fbc-9e2c-c06e48781952" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content rid="0f811813-c9a9-4802-ab00-ba8b546daa37" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="typesetter" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="f0c81107-76ee-4cca-a535-e34166bd619e" content-type="jrnlQueryRef" specific-use="start" data-replied="true"/>Zarranz-Ventura<named-content rid="0f811813-c9a9-4802-ab00-ba8b546daa37" data-class="jrnlQueryRef" data-type="end" id="01d6326b-f314-48b9-9b9a-ad9467b361a1" data-query-type="action" content-type="jrnlQueryRef" specific-use="end" data-replied="true"/> <italic data-class="sty cts-3" data-cid="1554366455" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373000306" data-track-hint="Italic Added" id="8173cae0-8404-406b-a938-3f22d47f7e99" data-title="Italic Added by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:46pm">et al</italic></p><p id="4d2a1099-ac31-41a0-872c-faeb0c66a1f2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">2014<sup id="f9835af9-b591-4259-9db9-903d0ab3329d"><named-content data-cid="1553860001" id="ef069e46-7114-474e-ab65-fa33126b293c" content-type="del cts-2" specific-use="1553861001428" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:33pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553861001428">33</named-content><xref id="c8583503-ec18-417d-a01b-fb2d23c5f222" ref-type="bibr" rid="R33" data-citation-string=" R33 " data-track="del" data-cid="1554530222005" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1554530222005" data-cite-type="insert"><sup id="304ed173-9ff6-4280-acd7-c5954dc6ed64">33</sup></xref><xref id="0a47fb1a-f792-4e0c-b4c4-96dbe409882e" ref-type="bibr" rid="R30" data-citation-string=" R30 " data-track="ins" data-cid="1554530222011" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1554530222011" data-cite-type="insert"><sup id="19355331-6783-42a2-a71d-fdcaafa8c269">30</sup></xref></sup></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="a0c39e84-37ed-4091-9d11-56a15733bcca" valign="top" data-old-attributes=""><p id="a347e382-4955-4ada-88f5-8ef7245b7cb0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="f7f3307c-f24b-4e73-b1ea-14f511f32a3d" data-cid="f7f3307c-f24b-4e73-b1ea-14f511f32a3d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '82' to '82'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="82" data-pattern="" data-tag-index="560_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">82</named-content> eyes</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="754f2cea-54a4-4e5a-a525-8fef0656c437" valign="top" data-old-attributes=""><p id="bdc5cbba-101b-4a31-bab0-c938a9ac7391" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">12<named-content data-cid="1554366550" id="66eb7810-9204-4179-a98f-c86e5525a1d7" content-type="del cts-3" specific-use="1554374158511" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374158511">mths</named-content><named-content data-cid="1554366551" id="1e0d10bf-3bb1-4390-8e3d-41299d1b4579" content-type="ins cts-3" specific-use="1554374158814" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:05pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374158814"> months</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="c9e1a150-fe95-449a-88a3-d60c5e9565bf" valign="top" data-old-attributes=""><p id="fb9f1a41-ee1e-4caa-8831-180498cc10b7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Uveitis</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="d73ed6a4-d3c7-44c9-ad80-ee16d14374ba" valign="top" data-old-attributes=""><p id="3e4b5b8a-5593-4dd8-bd10-5b2cfb99a726" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="966d7771-e9d3-4ef9-ba96-733abf31f46c" data-cid="966d7771-e9d3-4ef9-ba96-733abf31f46c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="40.2%(2.4%)" data-replace="40.2%" data-pattern="$1" data-tag-index="563_1" data-time="" data-username="" data-userid="">40.2%</named-content><named-content id="92def190-b6e3-49df-9730-8a1af08e3f25" data-cid="92def190-b6e3-49df-9730-8a1af08e3f25" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(2.4%)' to '␣(2.4%)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="5" data-match="40.2%(2.4%)" data-replace=" (2.4%)" data-pattern=" $2" data-tag-index="563_1" data-track-change="(2.4%)" data-time="" data-username="" data-userid=""> (2.4%)</named-content></p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="0c1c2587-d8bb-4121-a419-d540a7833b83" valign="top" data-old-attributes=""><p id="6504aa2d-0021-4cf8-bb47-a2998a7d0452" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="9e30e9b9-a19a-49f1-86d6-2e2e0bb54bfd" data-cid="9e30e9b9-a19a-49f1-86d6-2e2e0bb54bfd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="4(4.8%)" data-replace="4" data-pattern="$1" data-tag-index="564_1" data-time="" data-username="" data-userid="">4</named-content><named-content id="2178b00f-e3e4-4b25-a762-517a50bb56ee" data-cid="2178b00f-e3e4-4b25-a762-517a50bb56ee" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(4.8%)' to '␣(4.8%)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="4(4.8%)" data-replace=" (4.8%)" data-pattern=" $2" data-tag-index="564_1" data-track-change="(4.8%)" data-time="" data-username="" data-userid=""> (4.8%)</named-content></p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="c9c5aeb0-f201-498d-8c9f-ce9b493a6265" valign="top" data-old-attributes=""><p id="c4a9ba4b-ecae-4e2f-9ccc-237a3c15c8e8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="7b23a352-6735-45c9-95b0-29cecb797f66" valign="top" data-old-attributes=""><p id="545fcf6b-834a-4732-ac55-ab694839e667" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Vitreous <named-content data-cid="1554376370664" id="e64f1e30-2446-4145-aac9-f80718bb374c" content-type="del cts-1" specific-use="1554376369852" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - 04/04/2019, 4:42 pm" data-track-detail="" data-time="1554376369852" data-username="B020-Baburaj (COPYEDITOR)" data-userid="copyeditor 8576948431" data-type="spelling">hemorrhage</named-content><named-content data-cid="1554376370664" id="e4ed4168-5667-481d-a574-826d4c6b4c00" content-type="ins cts-1" specific-use="1554376369852" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - 04/04/2019, 4:42 pm" data-track-detail="" data-time="1554376369852" data-username="B020-Baburaj (COPYEDITOR)" data-userid="copyeditor 8576948431" data-type="spelling">haemorrhage</named-content><named-content data-cid="1554366562" id="9f683234-34fa-452b-8629-07427308244a" content-type="ins cts-3" specific-use="1554374176788" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374176788"> </named-content>-1 eye</p></td></tr><tr data-col-count="8" id="a7622af5-c899-4f13-8973-1c412dfa0c70" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="2ecf422b-b54e-4a0d-a547-f606d2bc05ba" data-possbibref="true" valign="top" data-old-attributes=""><p id="ea24e33f-4204-4be5-9efd-a740f5a6a7ac" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Mayer <italic data-class="sty cts-3" data-cid="1554366465" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373093282" data-track-hint="Italic Added" id="c4a65c10-2645-4fe0-9019-ea42e71297d3" data-title="Italic Added by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:48pm">et al</italic></p><p id="d5c6aad8-13b7-4410-87e8-fb3484189fc1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1554366456" id="fa5f0ee2-44be-4db0-a925-b0aaab258160" content-type="del cts-3" specific-use="1554373069327" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:47pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373069327">E</named-content><named-content data-cid="1554366457" id="348f75d9-9106-4176-9e02-e98a933913ed" content-type="ins cts-3" specific-use="1554373069592" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:47pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373069592">e</named-content>ye 2013<sup id="f55cabde-b938-4762-a88f-02422ff676b6"><named-content data-cid="1553860003" id="048e40ef-9eea-4f1a-8502-68080bac1cfa" content-type="del cts-2" specific-use="1553861010378" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:33pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553861010378">31</named-content><xref id="96cb417a-ee22-4fb7-a3f7-fda7ed530c9b" ref-type="bibr" rid="R31" data-citation-string=" R31 " data-track="ins" data-cid="1553861009355" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553861009355" data-cite-type="insert"><sup id="cb55b6e6-4fc9-410f-ba2b-44d0cff404a3">31</sup></xref></sup></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="659d34b7-8a00-49db-8071-3cec7ef73566" valign="top" data-old-attributes=""><p id="c5e284dd-2994-44a0-9cd6-be4b8f5f9436" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="39a519ea-78cc-4554-8b1f-429c57e89b60" data-cid="39a519ea-78cc-4554-8b1f-429c57e89b60" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '64' to '64'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="64" data-pattern="" data-tag-index="569_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">64</named-content> eyes</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="553258e9-f63e-4241-b918-4be00be01ae3" valign="top" data-old-attributes=""><p id="01931d36-bfe8-4293-a6b8-682c455fc7cd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="7f5da9f9-fe8a-4308-b71a-2449673309a3" data-cid="7f5da9f9-fe8a-4308-b71a-2449673309a3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="12 months" data-replace="12" data-pattern="$1" data-tag-index="570_1" data-time="" data-username="" data-userid="">12</named-content><named-content id="460b303f-957e-40d7-b725-4e14c39ba08e" data-cid="460b303f-957e-40d7-b725-4e14c39ba08e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="2" data-match="12 months" data-replace=" months" data-pattern=" $2" data-tag-index="570_1" data-time="" data-username="" data-userid=""> months</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="5e941544-c841-4a33-a0cd-108ed09dc7a4" valign="top" data-old-attributes=""><p id="9ea37bb1-cd56-4f1f-9e9c-70a6a2379b26" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">BRVO</p><p id="e0ee620c-1414-4504-8a33-2b6f6c0453b0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">CRVO</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="dea0ae93-f027-4790-9e6b-7ae5fd9ddfe0" valign="top" data-old-attributes=""><p id="3f2e8ff7-44e1-4fd9-802a-8f33a9a3d148" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="2f5f3fe9-8e88-4661-904d-b6b0cb8f1e75" data-cid="2f5f3fe9-8e88-4661-904d-b6b0cb8f1e75" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="40%" data-replace="40" data-pattern="$1" data-tag-index="573_1" data-time="" data-username="" data-userid="">40</named-content><named-content id="3a285cbe-1c9d-4d86-8377-caf403b6071e" data-cid="3a285cbe-1c9d-4d86-8377-caf403b6071e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="2" data-match="40%" data-replace="%" data-pattern="%" data-tag-index="573_1" data-time="" data-username="" data-userid="">%</named-content> rise in IOP</p><p id="114cf43b-0182-4144-9f7a-3595746bb3cd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(1<named-content data-cid="1554391814" id="83fddcca-b4d7-413c-93cd-94da59d53b98" content-type="ins cts-5" specific-use="1554392031238" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 2740356018" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 9:03pm" data-track-detail="" data-userid="copyeditor 2740356018" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554392031238"> </named-content>CPC, others –AGM)</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="d1ac63d2-c8fc-4b09-950c-6b34000c085d" valign="top" data-old-attributes=""><p id="5a4494e5-01c8-47d4-acc4-a2a11610609b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="bfe82fbe-a08c-4595-a726-fcf558ceb0e8" valign="top" data-old-attributes=""><p id="6a20edf0-b5cb-4c2e-9082-d4636605abcc" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="03894bbc-d1e4-4b59-969b-6d92c9f679fe" valign="top" data-old-attributes=""><p id="3a35358c-114b-48eb-ab00-bd876d66d950" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1554366564" id="45769eaf-d7bb-4194-acf6-f43c2c5b1967" content-type="del cts-3" specific-use="1554374186771" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374186771">1</named-content><named-content data-cid="1554366564" id="d60c84cb-e3f3-464a-9943-5adfd3498aff" content-type="del cts-3" specific-use="1554374186771" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374186771">-</named-content>RD<named-content data-cid="1554366565" id="874e66aa-a2c9-44db-a25c-09e566630af4" content-type="ins cts-3" specific-use="1554374187821" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374187821"> - 1</named-content></p></td></tr><tr data-col-count="8" id="53696388-c275-4e28-bbf9-6adada70fe1e"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="12cfd716-2363-464d-bcd5-c4876f98cb74" data-possbibref="true" valign="top" data-old-attributes=""><p id="2a10e760-2f37-4e7d-89e7-8bbf2b406eca" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Lowder<named-content data-cid="1554366458" id="f3b57801-f621-4324-a067-803d5a0d497a" content-type="ins cts-3" specific-use="1554373085114" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:48pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373085114"> <italic data-class="sty cts-3" data-cid="1554366464" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373089008" data-track-hint="Italic Added" id="be3718b5-7ccc-4c1c-b254-fdace2b789d9" data-title="Italic Added by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:48pm">et al</italic></named-content></p><p id="e6e2e0b3-45b7-458d-beb9-01c75b73c4fc" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">2011<sup id="5a011704-9a36-45d0-9443-c5352113d215"><named-content data-cid="1553860005" id="750f24d8-afd4-4398-aa2a-2ba390c851a2" content-type="del cts-2" specific-use="1553861018104" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:33pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553861018104">33</named-content><xref id="ec1bf33d-06d4-47d4-a703-54308af4c547" ref-type="bibr" rid="R33" data-citation-string=" R33 " data-track="ins" data-cid="1553861017096" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553861017096" data-cite-type="insert"><sup id="fc65f07b-034e-48a9-9673-9cd26b58ce6b">33</sup></xref></sup></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="1be94c9f-69d5-4004-a58c-edf2bf76c704" valign="top" data-old-attributes=""><p id="60d8111a-07b5-48ec-b389-d9a6b0dd077c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">229</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="a9c41fdf-cc8f-4013-940b-acd8c0bc9b81" valign="top" data-old-attributes=""><p id="69e983a9-404e-4102-b3d9-50cb0ebc5268" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="a4454d34-05e8-4990-abc3-7b8ee813dc0d" data-cid="a4454d34-05e8-4990-abc3-7b8ee813dc0d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="26 weeks" data-replace="26" data-pattern="$1" data-tag-index="581_1" data-time="" data-username="" data-userid="">26</named-content><named-content id="40baf438-570c-44d0-8e0d-6890e8738512" data-cid="40baf438-570c-44d0-8e0d-6890e8738512" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="2" data-match="26 weeks" data-replace=" weeks" data-pattern=" $2" data-tag-index="581_1" data-time="" data-username="" data-userid=""> weeks</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="e57befca-b2c9-462e-b205-fdca61a16881" valign="top" data-old-attributes=""><p id="21a791aa-6717-4761-8b98-5fccdd317c88" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Uveitis</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="59be48f0-ef48-40d6-98a9-daf2871a8817" valign="top" data-old-attributes=""><p id="281d31b2-9871-4c9f-be0e-75b279719679" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="f470f52a-f11b-4d8e-b9ff-41cb71ea5bef" data-cid="f470f52a-f11b-4d8e-b9ff-41cb71ea5bef" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="7.1%(700" data-replace="7.1%" data-pattern="$1" data-tag-index="583_1" data-time="" data-username="" data-userid="">7.1%</named-content><named-content id="c0e6adbc-d1f9-48a8-8221-109ec11e86a0" data-cid="c0e6adbc-d1f9-48a8-8221-109ec11e86a0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(700' to '␣(700'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="7.1%(700" data-replace=" (700" data-pattern=" $2" data-tag-index="583_1" data-track-change="(700" data-time="" data-username="" data-userid=""> (700<named-content data-cid="1554366482" id="6f10f42f-3bc2-4b9a-81c2-b39c6c5158b6" content-type="ins cts-3" specific-use="1554373811622" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:00pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373811622"> </named-content></named-content>mcg)</p><p id="3f16f5ea-3add-4e1c-b4f3-7985e27d680f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="9aee560b-cd4c-48b6-93d8-4d411ae36ae5" data-cid="9aee560b-cd4c-48b6-93d8-4d411ae36ae5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="8.7%(350" data-replace="8.7%" data-pattern="$1" data-tag-index="584_1" data-time="" data-username="" data-userid="">8.7%</named-content><named-content id="ed37ac36-336b-489b-aadd-10fec892e942" data-cid="ed37ac36-336b-489b-aadd-10fec892e942" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(350' to '␣(350'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="8.7%(350" data-replace=" (350" data-pattern=" $2" data-tag-index="584_1" data-track-change="(350" data-time="" data-username="" data-userid=""> (350</named-content> mcg)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="af4e64be-8e88-4e1c-853e-dd861ac6cb03" valign="top" data-old-attributes=""><p id="bccf4c1d-2dca-40e4-8cfb-e2f39b09c688" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="b78e4bd2-d282-4dff-93e9-3fdc16f9f466" data-cid="b78e4bd2-d282-4dff-93e9-3fdc16f9f466" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '700' to '700'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="700" data-pattern="" data-tag-index="585_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">700</named-content> mcg</p><p id="5d3d2d4a-41bd-4b26-8ce5-638d1872da08" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">15%</p><p id="bdb941ae-ac23-426f-9945-c06961b90150" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(1.6%<named-content data-cid="1554366569" id="b784b4b6-3eef-43ce-83b9-9f7d9b7ff403" content-type="ins cts-3" specific-use="1554374201086" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374201086"> </named-content>-surgery)</p><p id="59667ad8-15bd-4b2b-907e-c60769528b73" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">350<named-content data-cid="1554366483" id="a9172fe6-efb9-4f00-ad9d-99a1f06edbbf" content-type="ins cts-3" specific-use="1554373816037" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:00pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373816037"> </named-content>mcg</p><p id="8561a594-b421-4f30-96fe-372a8f5f064b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">12%</p><p id="b8027a2f-2638-42d8-8358-afb781b8883e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(0<named-content data-cid="1554366570" id="2fe69df5-44b3-4238-87dd-0e2fd5692ef6" content-type="ins cts-3" specific-use="1554374203460" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374203460"> </named-content>-surgery)</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="cfc715b1-a3d4-4f64-93f6-83abdf7a5ba9" valign="top" data-old-attributes=""><p id="4ac53843-e70a-46e9-9ddc-d992cda3e4ca" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="2de3c3f5-b7f1-4e39-83ea-807b7da6a338" valign="top" data-old-attributes=""><p id="b10d01ff-cc11-4514-b279-3c12c5649570" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Endophthalmitis (sterile)<named-content data-cid="1554366574" id="d108fc75-d937-4a98-84ca-a04b3f5fcf8b" content-type="ins cts-3" specific-use="1554374221058" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374221058"> </named-content><named-content id="ef415bb1-c87f-4a53-803c-0290de675453" data-cid="ef415bb1-c87f-4a53-803c-0290de675453" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="25" data-match="-1" data-replace="−" data-pattern="−" data-tag-index="592_1" data-track-change="-" data-time="" data-username="" data-userid="">−<named-content data-cid="1554366573" id="88cf4c2f-968c-4a4f-b380-136121b7af6b" content-type="ins cts-3" specific-use="1554374210147" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374210147"> </named-content></named-content><named-content id="fb3d9bbb-eae5-4c9d-9c72-0dab867e767e" data-cid="fb3d9bbb-eae5-4c9d-9c72-0dab867e767e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="26" data-match="-1" data-replace="1" data-pattern="$2" data-tag-index="592_1" data-time="" data-username="" data-userid="">1</named-content> eye</p><p id="e2bd9c15-76e4-4bd8-b3ad-7df9aea63fc1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RD<named-content data-cid="1554366571" id="5184087f-b4e6-4914-94aa-14442c3b3316" content-type="ins cts-3" specific-use="1554374206819" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374206819"> </named-content>-<named-content data-cid="1554366572" id="9f3cbe9c-3692-47dd-bdf1-aede56e7a834" content-type="ins cts-3" specific-use="1554374208735" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:06pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374208735"> </named-content>2 eyes</p></td></tr><tr data-col-count="8" id="2e8df1d3-fb87-4e8f-b0ea-1a1b0b63c077" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="fa0eccd0-b037-4663-b4e5-6554f991d8ce" data-possbibref="true" valign="top" data-old-attributes=""><p id="bb27fa36-52cd-4c06-b1d3-00f840854ee4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Zarranz-Ventura <named-content id="adb382b5-12b7-4545-87ca-4756a21c8770" data-cid="adb382b5-12b7-4545-87ca-4756a21c8770" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="16" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="594_1" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="c221eec2-39bc-4eed-b350-479a603561a4">et al</italic></named-content> 2019<sup id="d1a992c9-4f51-47b2-88c4-03920f2720b3"><named-content data-cid="1553860007" id="8018104c-74f5-4591-a376-da0aa960a3dd" content-type="del cts-2" specific-use="1553861029026" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:33pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553861029026">32</named-content><xref id="80920934-e8d6-421a-9393-2f9da396b0b1" ref-type="bibr" rid="R32" data-citation-string=" R32 " data-track="ins" data-cid="1553861027630" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553861027630" data-cite-type="insert"><sup id="c7bf4a65-fcdb-491d-92db-8372006b66e3">32</sup></xref></sup></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="c73d6819-4f5b-4198-9ca3-51258ba9af66" valign="top" data-old-attributes=""><p id="e54c2a58-9196-4d58-976f-1b84ae5607cb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="cfb89075-c6fe-4f2b-8582-a80b9c11a2cb" data-cid="cfb89075-c6fe-4f2b-8582-a80b9c11a2cb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '429' to '429'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="429" data-pattern="" data-tag-index="595_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">429</named-content> eyes (705 injections)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="05e05d56-f9e6-423f-87d2-c899561c8504" valign="top" data-old-attributes=""><p id="8d80d80d-cd62-41a5-9094-0f9ca2a09e8a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="ab02ac61-3982-45ef-ba60-c11b8375962e" data-cid="ab02ac61-3982-45ef-ba60-c11b8375962e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="24 months" data-replace="24" data-pattern="$1" data-tag-index="596_1" data-time="" data-username="" data-userid="">24</named-content><named-content id="24342965-1537-4c34-8c91-a7e0c3259fb0" data-cid="24342965-1537-4c34-8c91-a7e0c3259fb0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="2" data-match="24 months" data-replace=" months" data-pattern=" $2" data-tag-index="596_1" data-time="" data-username="" data-userid=""> months</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="5090d209-303d-46c1-abd1-14587f6d2784" valign="top" data-old-attributes=""><p id="862dcac9-4b9e-4321-88bc-075ef9a81d91" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">DME</p><p id="331c2b93-72be-4de2-88e5-488e01648ba4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RVO</p><p id="5d293cdc-dca9-4ebd-8a49-90c423a29b08" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Uveitis</p><p id="09bdc64c-5a02-4be2-b19e-bd06a290c627" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Off-label</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="cfc94aa5-b940-4180-be4d-8d3467760de8" valign="top" data-old-attributes=""><p id="36002b95-fe0e-4d9a-9a0c-b2750f41e90b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">28.7%<sup id="62ebc231-c64b-4b7d-acc3-77989ca86eed">*</sup> IOP change<named-content id="12945b0e-b8ee-461c-92e1-0525b11a6f43" data-cid="12945b0e-b8ee-461c-92e1-0525b11a6f43" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '&gt;' to '⍽&gt;'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="17" data-match="change&amp;gt;10 mmHg" data-replace=" &gt;" data-pattern=" $2" data-tag-index="601_1" data-track-change="&amp;gt;" data-time="" data-username="" data-userid=""> &gt;</named-content><named-content id="cb03766b-f3fd-4a1f-bd01-ccee4e9e3d06" data-cid="cb03766b-f3fd-4a1f-bd01-ccee4e9e3d06" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="18" data-match="change&amp;gt;10 mmHg" data-replace="10" data-pattern="$3" data-tag-index="601_1" data-time="" data-username="" data-userid="">10</named-content><named-content id="4c8b3238-77eb-4a19-9aa9-671c3dfbe46b" data-cid="4c8b3238-77eb-4a19-9aa9-671c3dfbe46b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmHg' to ' mmHg'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="20" data-match="change&amp;gt;10 mmHg" data-replace=" mmHg" data-pattern=" $6" data-tag-index="601_1" data-track-change=" mmHg" data-time="" data-username="" data-userid=""> <named-content data-cid="1554376385994" id="8e3d5898-630a-4a0d-b6ff-669b836545be" content-type="del cts-1" specific-use="1554376385521" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - 04/04/2019, 4:43 pm" data-track-detail="" data-time="1554376385521" data-username="B020-Baburaj (COPYEDITOR)" data-userid="copyeditor 8576948431" data-type="spelling">mmHg</named-content><named-content data-cid="1554376385994" id="ccaf2cd2-c351-475f-9d59-8ecc821011a8" content-type="ins cts-1" specific-use="1554376385521" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - 04/04/2019, 4:43 pm" data-track-detail="" data-time="1554376385521" data-username="B020-Baburaj (COPYEDITOR)" data-userid="copyeditor 8576948431" data-type="spelling">mm Hg</named-content></named-content></p><p id="60f2b83a-133b-4143-8ee0-7117d38f5e0c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">30%<sup id="eba85f1c-f7c1-41c1-a0be-b9eaf43b2d40">*</sup><named-content id="0232db1e-cbb6-4120-905b-c01090577c5b" data-cid="0232db1e-cbb6-4120-905b-c01090577c5b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="4" data-match="-&amp;gt;25 mm" data-replace="-" data-pattern="$1" data-tag-index="602_1" data-time="" data-username="" data-userid="">-<named-content data-cid="1554366576" id="1bf0fdc4-a53f-4628-a6ba-817848eddd29" content-type="ins cts-3" specific-use="1554374231266" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374231266"> </named-content></named-content><named-content id="908ce7fd-d065-46b4-a2e9-300ad38043b9" data-cid="908ce7fd-d065-46b4-a2e9-300ad38043b9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="5" data-match="-&amp;gt;25 mm" data-replace="&gt;" data-pattern="$2" data-tag-index="602_1" data-time="" data-username="" data-userid="">&gt;</named-content><named-content id="32549ef4-9d8c-43af-a79b-7f85d52fc779" data-cid="32549ef4-9d8c-43af-a79b-7f85d52fc779" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="6" data-match="-&amp;gt;25 mm" data-replace="25" data-pattern="$3" data-tag-index="602_1" data-time="" data-username="" data-userid="">25</named-content><named-content id="681bdcd5-88f4-46a0-a6dd-0b11ce3aa85a" data-cid="681bdcd5-88f4-46a0-a6dd-0b11ce3aa85a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mm' to ' mm'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="8" data-match="-&amp;gt;25 mm" data-replace=" mm" data-pattern=" $6" data-tag-index="602_1" data-track-change=" mm" data-time="" data-username="" data-userid=""> mm</named-content> Hg</p><p id="d2044703-30d5-41e6-b9ea-79f5cdbc4abf" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">7%<sup id="0ff76d9e-1b43-4761-b93a-41084cc2dfe1">*</sup><named-content id="4552c2af-3df5-4cea-b71e-3cb13acc1056" data-cid="4552c2af-3df5-4cea-b71e-3cb13acc1056" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="3" data-match="&amp;gt;35 mm" data-replace="&gt;" data-pattern="$2" data-tag-index="603_1" data-time="" data-username="" data-userid="">&gt;</named-content><named-content id="40f425de-b065-4e4b-841a-badb758c4a79" data-cid="40f425de-b065-4e4b-841a-badb758c4a79" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="4" data-match="&amp;gt;35 mm" data-replace="35" data-pattern="$3" data-tag-index="603_1" data-time="" data-username="" data-userid="">35</named-content><named-content id="f4d9fd39-ed55-4481-9837-88322d73fb00" data-cid="f4d9fd39-ed55-4481-9837-88322d73fb00" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mm' to ' mm'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="6" data-match="&amp;gt;35 mm" data-replace=" mm" data-pattern=" $6" data-tag-index="603_1" data-track-change=" mm" data-time="" data-username="" data-userid=""> mm</named-content> Hg</p><p id="d388dd5f-2eaa-4bf9-ac1d-a026cfe90c6f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">54%<sup id="d8d84fa2-7d23-4743-81f3-c74a4d3a2b7e">*</sup> -<named-content data-cid="1554366578" id="d8f2cff4-ddb2-4967-b6f8-d2d51c6322c0" content-type="ins cts-3" specific-use="1554374235324" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374235324"> </named-content>AGM</p><p id="f9b163ef-2522-40a2-a743-27ef232874e9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">0.9%<named-content data-cid="1554366579" id="aac23b73-a768-450f-a28d-b5489a236452" content-type="ins cts-3" specific-use="1554374236514" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374236514"> </named-content>-<named-content data-cid="1554366580" id="adbb5a7a-f11e-46e3-8732-f9d1b97deb67" content-type="ins cts-3" specific-use="1554374237034" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374237034"> </named-content>glaucoma surgery</p><p id="c074d60a-86a3-443e-9860-8464ecdac624" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(<sup id="d6cf9755-3182-4115-9b9f-475a3b98720e">*</sup><named-content data-cid="1554366581" id="44ee2a31-bf0a-4e51-9363-4c2619b91b95" content-type="del cts-3" specific-use="1554374242244" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374242244">C</named-content><named-content data-cid="1554366582" id="591d2fdd-c8e3-4ee9-aa75-7dbe61d4cd76" content-type="ins cts-3" specific-use="1554374242536" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374242536">c</named-content>umulative probabilities at <named-content id="d1181623-db0d-41dc-beeb-9bec19a7014f" data-cid="d1181623-db0d-41dc-beeb-9bec19a7014f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="30" data-match="24 months" data-replace="24" data-pattern="$1" data-tag-index="606_1" data-time="" data-username="" data-userid="">24</named-content><named-content id="1e96a231-2f74-4b62-ad92-294b933e465c" data-cid="1e96a231-2f74-4b62-ad92-294b933e465c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="32" data-match="24 months" data-replace=" months" data-pattern=" $2" data-tag-index="606_1" data-time="" data-username="" data-userid=""> months</named-content>)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="27aded5c-aed3-482f-ad92-e9cba170052d" valign="top" data-old-attributes=""><p id="263e4664-043f-4d6f-88ea-75aa4262839a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="b2ca1288-acd9-430e-9e16-c8dd7dd7a28a" valign="top" data-old-attributes=""><p id="03178fa2-cdaa-41a1-a287-1648525ad42e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="73cdd615-d9c3-4ed0-9435-92cdaecc309b" valign="top" data-old-attributes=""><p id="bef1ef62-a101-467c-9bd2-0a297c06e73e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">None</p></td></tr><tr data-col-count="8" id="837f46f7-4f9d-4b19-b445-8a00259d4eaa"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="a839b64f-ae5c-4757-9193-bf4a56dacace" data-possbibref="true" valign="top" data-old-attributes=""><p id="3116bcb4-360e-457c-9938-e874f0a6e0ca" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content rid="d7a6b4ba-c006-4fec-885c-138133f61121" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="typesetter" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="477c7415-b9f6-4221-b7c7-bd7b71afac31" content-type="jrnlQueryRef" specific-use="start" data-replied="true"/>Reid GA<named-content rid="d7a6b4ba-c006-4fec-885c-138133f61121" data-class="jrnlQueryRef" data-type="end" id="25bc1ea9-4d17-40f7-84bb-f28c4136671a" content-type="jrnlQueryRef" specific-use="end" data-replied="true"/></p><p id="9115dc28-2621-4a71-9f71-451a57a30470" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Retina 2015<sup id="011a8ff6-ec8a-441d-ad0e-419fc910ced9"><named-content data-cid="1553860009" id="7e13531a-8590-4cd1-ad77-2b5db917ca1f" content-type="del cts-2" specific-use="1553861036859" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:33pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553861036859">37</named-content><xref id="9c8f6402-916b-44a4-9c57-4a027945c989" ref-type="bibr" rid="R37" data-citation-string=" R37 " data-track="del" data-cid="1554530170030" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1554530170030" data-cite-type="insert"><sup id="934e16b0-0c14-418f-8fcc-1f489cdbd51c">37</sup></xref><xref id="5146add9-3236-422d-a72d-54fa943df66e" ref-type="bibr" rid="R34" data-citation-string=" R34 " data-track="ins" data-cid="1554530170052" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1554530170052" data-cite-type="insert"><sup id="fd187ffe-e82f-4e25-ae23-4526376ebfb8">34</sup></xref></sup></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="a2277f19-870e-41f3-88d5-6f0859dfafcc" valign="top" data-old-attributes=""><p id="a5a0aaf5-3804-4513-8c0f-547eebf807d3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="6f8a1141-0042-4137-93fa-e644326f717b" data-cid="6f8a1141-0042-4137-93fa-e644326f717b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '61' to '61'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="61" data-pattern="" data-tag-index="612_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">61</named-content> eyes</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="616980bb-34f8-4224-ab7c-a370160c7ef2" valign="top" data-old-attributes=""><p id="178de9ab-6cbc-4ba0-a42e-01f876d71acb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="fde6f6e9-f9a0-404c-a26d-5404fc131dbc" data-cid="fde6f6e9-f9a0-404c-a26d-5404fc131dbc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="6 months" data-replace="6" data-pattern="$1" data-tag-index="613_1" data-time="" data-username="" data-userid="">6</named-content><named-content id="ae723829-b07e-4205-978e-d74fe27fbe1c" data-cid="ae723829-b07e-4205-978e-d74fe27fbe1c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1" data-match="6 months" data-replace=" months" data-pattern=" $2" data-tag-index="613_1" data-time="" data-username="" data-userid=""> months</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="c25c542b-f002-4df1-81b8-e08394aa889f" valign="top" data-old-attributes=""><p id="2114456d-641f-4eba-93cc-807a2c423e9c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RVO</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="6905cf17-6c64-46a0-96fa-34cecfd1486c" valign="top" data-old-attributes=""><p id="afc73286-fdf7-410a-99bd-c44eb89c1955" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="6078782d-d4d7-4e51-8d04-cb9795c14fe2" data-cid="6078782d-d4d7-4e51-8d04-cb9795c14fe2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="10(12%)" data-replace="10" data-pattern="$1" data-tag-index="615_1" data-time="" data-username="" data-userid="">10</named-content><named-content id="50d62bac-c20a-42a5-b726-61f88a2af24b" data-cid="50d62bac-c20a-42a5-b726-61f88a2af24b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(12%)' to '␣(12%)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="10(12%)" data-replace=" (12%)" data-pattern=" $2" data-tag-index="615_1" data-track-change="(12%)" data-time="" data-username="" data-userid=""> (12%)</named-content></p><p id="658f5f56-09a6-43cd-91f4-9610fd5b0fed" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">11%<named-content data-cid="1554366601" id="5f176604-38ae-4201-8bae-4e8162e1a512" content-type="ins cts-3" specific-use="1554374294136" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374294136"> </named-content>-<named-content data-cid="1554366602" id="062a607e-e082-45f6-a44f-efb43b163dfa" content-type="ins cts-3" specific-use="1554374294972" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374294972"> </named-content>AGM</p><p id="0b584746-bfec-4448-8890-380bedb42199" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">1.2%<named-content data-cid="1554366603" id="f365dc3c-5e99-4be6-b0d4-41b4ed3faa56" content-type="ins cts-3" specific-use="1554374296112" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374296112"> </named-content>-<named-content data-cid="1554366604" id="05e0e32c-c84b-48c3-90d1-ae696cfdffe4" content-type="ins cts-3" specific-use="1554374296605" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374296605"> </named-content>surgery</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="7f297d15-0aba-4b02-8420-a19f3cc1c7f9" valign="top" data-old-attributes=""><p id="377a7bb3-ceb5-426b-897a-03c2dbbbd09b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1553859621015" id="e2e93445-f7f0-411a-b56f-e880bc636f5c" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">1</named-content><named-content id="c028c061-6f37-4045-b245-d4a351edcf68" data-cid="1553859621015" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="1" data-pattern="" data-tag-index="618_1" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1553859621001"><named-content data-cid="1554366587" id="74ab2788-60ea-4acb-8bc3-3dee647874d1" content-type="del cts-3" specific-use="1554374268093" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374268093">one</named-content></named-content><named-content data-cid="1554366588" id="b5c7575c-00c5-4658-99b9-9dad3177734e" content-type="ins cts-3" specific-use="1554374268389" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374268389">First</named-content> implant<named-content data-cid="1554366583" id="49489227-71ed-41eb-b62b-31354ea81e1e" content-type="ins cts-3" specific-use="1554374251074" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374251074"> </named-content>-<named-content data-cid="1554366584" id="e68191bf-fdea-496e-95ca-d62f5fc0b7b1" content-type="ins cts-3" specific-use="1554374252514" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374252514"> </named-content>13.2%</p><p id="0175c8b9-fdd1-4643-817a-8be71e7ff9ba" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1553859621017" id="71d15f87-f719-4da4-afd0-65398989854a" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">2<sup id="64f31a45-f1cb-4ecb-b753-a3b389bd63ab">nd</sup></named-content><named-content id="27e899cd-5783-4eb3-a458-dc6d023f324d" data-cid="1553859621017" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '2&lt;sup id=&quot;64f31a45-f1cb-4ecb-b753-a3b389bd63ab&quot;&gt;nd&lt;/sup&gt;' to 'second'" data-track-detail="" data-tag-desc="ORDI" data-tag-type="ORDI" data-offset="0" data-match="2nd" data-pattern="" data-tag-index="619_1" data-function="numberToText,addTrackChanges" data-track-change="2&lt;sup id=&quot;64f31a45-f1cb-4ecb-b753-a3b389bd63ab&quot;&gt;nd&lt;/sup&gt;" data-userid="preediting" data-username="Exeter" data-time="1553859621001"><named-content data-cid="1554366593" id="22a97abf-d84a-4ca0-92eb-bb9a46974f82" content-type="del cts-3" specific-use="1554374279725" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374279725">s</named-content><named-content data-cid="1554366594" id="14a015c6-8e91-40e7-aa38-1836c4c8ad6c" content-type="ins cts-3" specific-use="1554374280022" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374280022">S</named-content>econd</named-content> implant<named-content data-cid="1554366585" id="0ff4b0b9-856c-493d-b482-e35e8f706520" content-type="ins cts-3" specific-use="1554374256631" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374256631"> </named-content>-<named-content data-cid="1554366586" id="c736f516-73b0-432f-89de-0d2e11fae580" content-type="ins cts-3" specific-use="1554374258178" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:07pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374258178"> </named-content>45%</p><p id="554bacdf-b344-4611-b9b8-bec4c52d7546" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1553859621018" id="ed737fd9-d5dd-4317-9a15-268539f17d20" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">3<sup id="87ca1135-ce99-4bd2-85e4-01466797ee78">rd</sup></named-content><named-content id="556cfc29-d0ce-48ac-b2f2-a009d274e70e" data-cid="1553859621018" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '3&lt;sup id=&quot;87ca1135-ce99-4bd2-85e4-01466797ee78&quot;&gt;rd&lt;/sup&gt;' to 'third'" data-track-detail="" data-tag-desc="ORDI" data-tag-type="ORDI" data-offset="0" data-match="3rd" data-pattern="" data-tag-index="620_1" data-function="numberToText,addTrackChanges" data-track-change="3&lt;sup id=&quot;87ca1135-ce99-4bd2-85e4-01466797ee78&quot;&gt;rd&lt;/sup&gt;" data-userid="preediting" data-username="Exeter" data-time="1553859621001"><named-content data-cid="1554366595" id="2bae8665-4aa0-4b5c-b287-89c769907047" content-type="del cts-3" specific-use="1554374284564" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374284564">t</named-content><named-content data-cid="1554366596" id="d2988711-5688-4ec3-94b4-7e0741773faa" content-type="ins cts-3" specific-use="1554374284862" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374284862">T</named-content>hird</named-content> implant<named-content data-cid="1554366597" id="8605f128-b3e3-4cc1-a026-2be89ad50bd1" content-type="ins cts-3" specific-use="1554374286981" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374286981"> </named-content>-<named-content data-cid="1554366598" id="f4dcb00f-6c0b-4427-9445-a6abd40ea5b7" content-type="ins cts-3" specific-use="1554374287998" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374287998"> </named-content>60%</p><p id="6eca574d-ac51-481f-8072-6cfcb97784d4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">24.1%<named-content data-cid="1554366599" id="4458dfbd-3cb1-4611-a2c1-b993f630732f" content-type="ins cts-3" specific-use="1554374289857" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374289857"> </named-content>-<named-content data-cid="1554366600" id="5a4cfd3e-7324-4b08-aa4d-0d69a4b0cec7" content-type="ins cts-3" specific-use="1554374290914" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374290914"> </named-content>cataract surgery</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="4caf55a4-69cf-458d-9765-73c7e4c22f3d" valign="top" data-old-attributes=""><p id="10f828ec-75b2-4e2d-af71-74b095019c4b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="89821028-9b90-42f7-bdc2-2f329cd0718c" valign="top" data-old-attributes=""><p id="e940a6b1-1c76-4fba-819f-b456d8e4e701" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">None</p></td></tr><tr data-col-count="8" id="4abe3ac6-519a-4a71-90de-b72939294aae" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="34bc0671-bd5e-4147-a293-f6cba9108c4e" data-possbibref="true" valign="top" data-old-attributes=""><p id="b431dfaa-87c7-401f-b10e-b2bb87c65b79" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Maturi <named-content id="b69c0dff-3de0-43db-b92e-35ab2f9ccd4b" data-cid="b69c0dff-3de0-43db-b92e-35ab2f9ccd4b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="7" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="624_1" data-track-change="et al" data-time="" data-username="" data-userid=""><named-content data-cid="1554366466" id="49d52aa2-2c8d-4ade-8934-2c34d5fc95a5" content-type="styrm cts-3" specific-use="1554373172294" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Italic Removed by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:49pm" data-track-detail="" data-format-command="italic" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373172294" data-track-hint="Italic Removed"><italic id="714ebd91-2e61-4e60-94e0-0df8c9f9f5e0">et al</italic></named-content></named-content> MEAD study 2016<sup id="06ff8180-f71f-43aa-bc82-582a06e3343d"><named-content data-cid="1553860011" id="c9af5006-93c9-4c57-9acd-74fa13606d7d" content-type="del cts-2" specific-use="1553861045046" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:34pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553861045046">36</named-content><xref id="600cad29-4ebb-4e6e-b9d6-eed513f53fdd" ref-type="bibr" rid="R36" data-citation-string=" R36 " data-track="ins" data-cid="1553861044080" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553861044080" data-cite-type="insert"><sup id="556d4faf-adee-4f34-b353-3b73cab3a521">36</sup></xref></sup></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="61335844-9383-4cd1-8a6c-6b9aef78d1a1" valign="top" data-old-attributes=""><p id="2adb9b26-44d9-4cc9-91fd-ba770b9531a4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="c6a50486-bc61-40b0-ab1e-0cbe65a358a6" data-cid="c6a50486-bc61-40b0-ab1e-0cbe65a358a6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '1040' to '1040'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="1040" data-pattern="" data-tag-index="625_2" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">1040</named-content> eyes</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="91ac7ed3-3ac3-4085-8fed-b69539457d6d" valign="top" data-old-attributes=""><p id="77ba9dbe-36dc-40ee-8844-280a782cc7ff" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="cb54dfe7-b779-4b63-9360-ea0976125613" data-cid="cb54dfe7-b779-4b63-9360-ea0976125613" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="3 years" data-replace="3" data-pattern="$1" data-tag-index="626_1" data-time="" data-username="" data-userid="">3</named-content><named-content id="84ed72b0-993a-403e-bcb4-987001b89bc5" data-cid="84ed72b0-993a-403e-bcb4-987001b89bc5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1" data-match="3 years" data-replace=" years" data-pattern=" $2" data-tag-index="626_1" data-time="" data-username="" data-userid=""> years</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="6990314b-3253-4c33-af59-b6e7b20ef00e" valign="top" data-old-attributes=""><p id="ed0a38ef-d975-4495-9962-39699543a696" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Diabetic macular <named-content data-cid="1553859621097" id="bee7611c-7fe7-4789-948b-c004b814bfaa" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="d8f915c7-f4d2-4b9e-a93a-79b1cef8a3ae" data-cid="1553859621097" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="17" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="627_1" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="9f3c27ee-b474-4f10-a208-f877ff39c70e" valign="top" data-old-attributes=""><p id="1a98faec-6130-4536-9a2b-6540532733f0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="728523e5-f2e4-4a27-ba47-be2c06925326" data-cid="728523e5-f2e4-4a27-ba47-be2c06925326" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '700' to '700'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="700" data-pattern="" data-tag-index="628_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">700</named-content> mcg<named-content data-cid="1554366605" id="8f35c1d2-c996-498e-a1c4-03f437b4b517" content-type="ins cts-3" specific-use="1554374303588" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374303588"> </named-content>-<named-content data-cid="1554366606" id="396a0612-55ea-4412-893e-4fa78d178471" content-type="ins cts-3" specific-use="1554374304316" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374304316"> </named-content>36.0%</p><p id="020f9716-08b7-45ce-ae57-c96c0e32fe9c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="2e4c8cab-f8d9-431a-be9b-0402ad31ac08" data-cid="2e4c8cab-f8d9-431a-be9b-0402ad31ac08" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '350' to '350'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="350" data-pattern="" data-tag-index="629_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">350</named-content> mcg<named-content data-cid="1554366607" id="f158294c-30c0-4c4c-8554-6d454ea923da" content-type="ins cts-3" specific-use="1554374306577" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374306577"> </named-content>-<named-content data-cid="1554366608" id="096b1551-6080-4490-8cac-4604151ae5b5" content-type="ins cts-3" specific-use="1554374307200" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374307200"> </named-content>34.1%</p><p id="c8e0f7c4-2e04-496d-9e6c-6ba3dd4af768" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Sham<named-content data-cid="1554366609" id="f40d374c-be3d-4770-b38a-524e16855727" content-type="ins cts-3" specific-use="1554374308802" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374308802"> </named-content>-<named-content data-cid="1554366610" id="57e72c6d-4065-4f9f-8aab-97286a03c53a" content-type="ins cts-3" specific-use="1554374309392" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374309392"> </named-content>5.1%</p><p id="b73fcffa-dd44-42e1-8aed-74fb14bf3a99" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">AGM (41.5%/37.6%/9.1%)</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="3b72a76e-bcb5-4f0d-a3f8-62f3fc83ba8e" valign="top" data-old-attributes=""><p id="811bd788-e790-4a4e-a3f1-fb0e60da5de5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="b0e76315-841d-4cf9-8968-0b29aff04472" data-cid="b0e76315-841d-4cf9-8968-0b29aff04472" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="24%" data-replace="24" data-pattern="$1" data-tag-index="632_1" data-time="" data-username="" data-userid="">24</named-content><named-content id="68fb5ad4-4ecd-463c-a18d-560c4eb1b108" data-cid="68fb5ad4-4ecd-463c-a18d-560c4eb1b108" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="2" data-match="24%" data-replace="%" data-pattern="%" data-tag-index="632_1" data-time="" data-username="" data-userid="">%</named-content> -surgery</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="01fb2d15-7b10-43f5-99b2-a5da6d066898" valign="top" data-old-attributes=""><p id="5d86944b-8417-4d95-8bdc-b81a3e9edae8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="2ed61979-2845-4325-bd9d-132af399d2a8" valign="top" data-old-attributes=""><p id="93c0b2aa-635a-41c7-84c6-ca6df507bbb1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">None</p></td></tr><tr data-col-count="8" id="fa0b2de0-bfb9-440e-96a7-07f5da55feab"><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="4ce34c9f-a254-412d-9465-4203f9e53303" data-possbibref="true" valign="top" data-old-attributes=""><p id="18d2a8fc-e7c2-411c-b70c-ff68fda6a114" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Ozkaya<named-content data-cid="1554366467" id="dd91540a-a365-404b-87f8-053ef59329ef" content-type="del cts-3" specific-use="1554373200218" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 3:50pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554373200218"> A</named-content></p><p id="2e376027-f5e0-4816-bcd7-9a60c306e9fc" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Int Jo 2017<sup id="18c7467b-0615-4bab-a7ba-2672b8e41f18"><named-content data-cid="1553860013" id="6e120fab-2dec-4f49-957e-2ef6ad6233f9" content-type="del cts-2" specific-use="1553861052746" xlink:title="Pradheep (PREEDITOR)" alt="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-title="Deleted by Pradheep (PREEDITOR) - Mar 29 2019 5:34pm" data-track-detail="" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-username="Pradheep (PREEDITOR)" data-time="1553861052746">37</named-content><xref id="9e4243bb-7724-4835-b451-5a713ee8480e" ref-type="bibr" rid="R37" data-citation-string=" R37 " data-track="ins" data-cid="1553861051864" data-username="Pradheep (PREEDITOR)" data-userid="preeditor e08e910d-c111-44ed-9f81-d3874d44cbda" data-time="1553861051864" data-cite-type="insert"><sup id="ef999258-4d29-44b2-ab47-d14ce6a18668">37</sup></xref></sup></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="b96aebc2-b500-439b-b846-325e8f03ec2a" valign="top" data-old-attributes=""><p id="2f2cbad0-257a-413d-9c2f-9f537f97d80f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="67601d1f-cf53-4996-8f58-692d3c9f199b" data-cid="67601d1f-cf53-4996-8f58-692d3c9f199b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '87' to '87'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="87" data-pattern="" data-tag-index="637_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">87</named-content> eyes</p><p id="f134f6f4-fb9b-447e-af9d-7a888b8eedf7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="63d01d52-0f23-4d99-84db-67b7ba5d560f" data-cid="63d01d52-0f23-4d99-84db-67b7ba5d560f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from '104' to '104'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="0" data-match="104" data-pattern="" data-tag-index="638_1" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">104</named-content> injections</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="24b59a8e-0c0a-4b07-87ba-fc8e05b69057" valign="top" data-old-attributes=""><p id="95759790-ccc9-42ca-822b-f9bfdf6a08cb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="203e7269-3561-47e5-a790-fd0e2a72b217" data-cid="203e7269-3561-47e5-a790-fd0e2a72b217" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="2 years" data-replace="2" data-pattern="$1" data-tag-index="639_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="75a0ab2e-08a7-4ab0-9c19-9c1bd3739176" data-cid="75a0ab2e-08a7-4ab0-9c19-9c1bd3739176" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1" data-match="2 years" data-replace=" years" data-pattern=" $2" data-tag-index="639_1" data-time="" data-username="" data-userid=""> years</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="8e3e3fb2-cc66-451f-9434-75c7daf5b4fa" valign="top" data-old-attributes=""><p id="cf00a59b-e5c1-43c7-9af5-6f6905d1dd5e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">BRVO</p><p id="0b5dd1b5-add2-4d29-a95f-166ca89d97e8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content rid="bd72e454-f2e1-424f-9267-51cbbc24b27b" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="6fda19cc-460c-4277-ad31-3934a4a74de6" content-type="jrnlQueryRef" specific-use="start" data-answered="true"/>IVD <named-content id="e41c62b3-4175-4744-ad5f-d80a77732d7b" data-cid="e41c62b3-4175-4744-ad5f-d80a77732d7b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'Vs' to 'vs'" data-track-detail="" data-tag-desc="VERSUS" data-tag-type="VERSUS" data-offset="4" data-match="Vs" data-replace="vs" data-pattern="vs" data-tag-index="641_1" data-track-change="Vs" data-time="" data-username="" data-userid="">vs</named-content> RBZ<named-content rid="bd72e454-f2e1-424f-9267-51cbbc24b27b" data-class="jrnlQueryRef" data-type="end" id="4414aaf5-65e3-44c3-b61d-5a2babc6992a" content-type="jrnlQueryRef" specific-use="end" data-answered="true"/></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="07fcf9af-1af1-49d0-880d-4ea6838ddc95" valign="top" data-old-attributes=""><p id="2c174036-b44e-4e10-8a02-c84f29d7a3a3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="7d2a976f-7528-4d1d-8a38-6fbe7f77d1c7" data-cid="7d2a976f-7528-4d1d-8a38-6fbe7f77d1c7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="0" data-match="27.3%" data-replace="27.3" data-pattern="$1" data-tag-index="642_2" data-time="" data-username="" data-userid="">27.3</named-content><named-content id="42111951-abfc-4197-9c9f-301eb13dead9" data-cid="42111951-abfc-4197-9c9f-301eb13dead9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="4" data-match="27.3%" data-replace="%" data-pattern="%" data-tag-index="642_2" data-time="" data-username="" data-userid="">%</named-content><named-content id="cc7e4bf5-47dc-4150-8e6e-9defcc9c3ced" data-cid="cc7e4bf5-47dc-4150-8e6e-9defcc9c3ced" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣Vs␣' to '␣vs␣'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="5" data-match="27.3% Vs 0" data-replace=" vs " data-pattern=" vs " data-tag-index="642_1" data-track-change=" Vs " data-time="" data-username="" data-userid=""> vs </named-content><named-content id="b84f4c31-d045-4b1b-898f-35a8718ef703" data-cid="b84f4c31-d045-4b1b-898f-35a8718ef703" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="9" data-match="27.3% Vs 0" data-replace="0" data-pattern="$4" data-tag-index="642_1" data-time="" data-username="" data-userid="">0</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="2eb7c4f1-b60c-4278-9081-10cf4e0aee1f" valign="top" data-old-attributes=""><p id="a2d453e1-1ae6-4112-854a-c23d1d51d8a3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">46.1%(IVD) <named-content id="1b724829-dc7a-48e3-805e-105d05e40d05" data-cid="1b724829-dc7a-48e3-805e-105d05e40d05" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'Vs' to 'vs'" data-track-detail="" data-tag-desc="VERSUS" data-tag-type="VERSUS" data-offset="11" data-match="Vs" data-replace="vs" data-pattern="vs" data-tag-index="643_1" data-track-change="Vs" data-time="" data-username="" data-userid="">vs</named-content> 5.7%(RBZ)</p><p id="d0e140e1-8dc9-4b5c-a779-371b5522d1aa" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">IVD-5(0.12%)<named-content data-cid="1554366611" id="0f443ed5-36f0-4415-ad0d-2e214d73f313" content-type="ins cts-3" specific-use="1554374327524" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374327524"> </named-content>-<named-content data-cid="1554366612" id="0ec5d26c-8774-4138-bf9c-7ff72b3c2474" content-type="ins cts-3" specific-use="1554374328670" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:08pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374328670"> </named-content>surgery</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="ede4210a-e50a-4f37-8b29-8786891fcdeb" valign="top" data-old-attributes=""><p id="1341939d-2d6b-473a-8c37-12d1650f5158" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not reported</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="e1aee59e-543e-4904-a30b-160a705473cd" valign="top" data-old-attributes=""><p id="78b32e7d-0149-4a61-9509-d8f871ff76ec" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">None</p></td></tr></tbody></table><table-wrap-foot id="11a6b1b4-204a-4cbf-827c-39b0088b1e1d"><fn data-class="jrnlTblFoot" fn-type="abbrev" data-def-list="true" id="31836a30-c482-4d63-a6e5-2b1760890774" contenteditable="true"><p id="59df9d6d-dc30-4cdc-a121-82f6edb59a93"><def-list id="68122f58-47a1-4d7c-9c03-4348f6e1fca1"><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="6fc121a7-7535-49c9-a8df-00e71f6bb011" fn-type="abbrev" data-id="T5_FN1"><term data-class="jrnlAbbrevTerm" id="9199f9b6-06e9-4026-a384-1affeb86d8c4">AGM</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="b57ba576-361e-4e56-ba8c-b248c0e98d09"><p id="32d00be0-73b4-4ecd-8e6c-ff5a2f2575e3">anti-glaucoma medication</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="5bb9bbe1-8489-4f09-b32f-219f66c5d693" fn-type="abbrev" data-id="T5_FN1"><term data-class="jrnlAbbrevTerm" id="db5be512-d646-4367-a4cd-988326736411">BRVO</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="c292a0d2-c626-4614-8e7e-ed0375864a00"><p id="a3137eee-3899-4735-9f44-aa5d72c2a79b">branch retinal vein occlusion</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="a5eb137a-ee7a-40f7-acfe-78c097d891de" fn-type="abbrev" data-id="T5_FN1"><term data-class="jrnlAbbrevTerm" id="95346fb5-b210-4604-8326-9485f3bc5b47">CRVO</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="b2201477-cd7a-409d-8ebd-bdcc9e761f24"><p id="fcf2ca61-df1c-428f-9d1e-ca15b7d1a3d7">central retinal vein occlusion</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="7ba374f3-1ee9-4691-8210-9034f1c96fb9" fn-type="abbrev" data-id="T5_FN1"><term data-class="jrnlAbbrevTerm" id="3d6187cf-e5cc-4d62-9494-2c7600c21ca7">DME</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="5cee45b4-4119-4c0b-8417-a53d32d50e55"><p id="9d6a0445-f47d-4d11-b212-13df3c723e32">diabetic macular edema</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="27f8dfb4-b833-4ceb-a793-8143c6d46672" fn-type="abbrev" data-id="T5_FN1"><term data-class="jrnlAbbrevTerm" id="021417f2-b253-4d23-91c3-9ed18ba70135">IOP</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="73cca977-3c71-4ca5-a612-0bb65b56900e"><p id="2dd60554-1fe3-465f-b78e-de8253fd1bef">intraocular pressure</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="272d2f01-65ca-4b3d-8622-f7d6891f81e9" fn-type="abbrev" data-id="T5_FN1"><term data-class="jrnlAbbrevTerm" id="6a569265-4e7a-4c99-9e72-cc5ea08f9c05">IVD</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="653f4c7b-e0be-432d-bc67-1323d88f8768"><p id="941a56c8-38b1-4175-a5b1-aa4b6235f6aa">intravitreal dexamethasone</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="9a7a8b94-2d3a-4521-a2bc-bc960a53b2d7" fn-type="abbrev" data-id="T5_FN1"><term data-class="jrnlAbbrevTerm" id="90aa58be-e33c-4d16-8b08-c1854b7f6587">RBZ</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="2438a6fd-9dbc-40c3-af4c-aa20009aed8c"><p id="678e4e2a-ff34-4fd5-b2cf-71a1d4a051e2">ranibizumab</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="d03653b9-613d-4655-b8ec-198b8e3eefda" fn-type="abbrev" data-id="T5_FN1"><term data-class="jrnlAbbrevTerm" id="599acff3-07d7-4d1a-8b77-f135acbc7bb1">RD</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="890c4915-bc50-4512-83f9-ffe1c947fcb6"><p id="4e111441-0335-4097-a012-dd5d6e758937">retinal detachment</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="6695adb4-98e7-4c7f-9849-0ee0e7ebe71d" fn-type="abbrev" data-id="T5_FN1"><term data-class="jrnlAbbrevTerm" id="76c6ee10-6f1c-4cac-88a2-d60ef70d4d80">RVO</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="b1f37f7f-74a6-47ad-bf01-84965b1960e0"><p id="6b27a06e-74b4-4f36-a555-a41fac7b6d2e">retinal vein occlusion</p></def>; </def-item><def-item data-class="jrnlTblDefItem" alphabetical-order="true" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" id="e9031a72-c11e-4e66-99f2-e9a18c426a66" fn-type="abbrev" data-id="T5_FN1"><term data-class="jrnlAbbrevTerm" id="3bd57ce9-07dc-491a-a1b9-b9f767eb7fd8">SLT</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="16372da5-f9e6-4012-8a72-14a16c354060"><p id="f82acaa5-7a0e-46db-ad10-1df891493d5d">Selective Laser Trabeculoplasty</p></def>.</def-item></def-list></p></fn></table-wrap-foot></table-wrap><p data-class="jrnlSecPara" id="c0f8b0ef-9500-4635-992c-5431861d46bf"><named-content rid="b12f3f73-8c91-4a70-a92b-d6d6ba29d106" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="typesetter" data-query-from="publisher" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="c87d5bcb-ea10-4b22-9696-e14bf61c053b" content-type="jrnlQueryRef" specific-use="start" data-style="" data-replied="true"/>Although<named-content rid="b12f3f73-8c91-4a70-a92b-d6d6ba29d106" data-class="jrnlQueryRef" data-type="end" id="70a09abe-3409-4ba2-98b2-d03af24eeaeb" content-type="jrnlQueryRef" specific-use="end" data-replied="true"/> ocular hypertension is a known side effect of intraocular steroid injections, the IOP rise following dexamethasone implant could be managed by topical anti<named-content data-cid="1554366617" id="5edcd93b-0b64-46e8-bdfc-82d3f6bd4a3d" content-type="ins cts-3" specific-use="1554374421621" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:10pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374421621">-</named-content>glaucoma medications in <named-content id="64b4460c-acdb-400d-a869-50f645cddbd4" data-cid="64b4460c-acdb-400d-a869-50f645cddbd4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="188" data-match="91%" data-replace="91" data-pattern="$1" data-tag-index="29_8" data-time="" data-username="" data-userid="">91</named-content><named-content id="11de17ec-7764-4af3-8f03-fffab77565b3" data-cid="11de17ec-7764-4af3-8f03-fffab77565b3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="190" data-match="91%" data-replace="%" data-pattern="%" data-tag-index="29_8" data-time="" data-username="" data-userid="">%</named-content> eyes, which was similar to other studies like the SAFODEX study (<named-content id="79a50ea0-bc4f-4ca6-8aa7-1d11f76804b6" data-cid="79a50ea0-bc4f-4ca6-8aa7-1d11f76804b6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="257" data-match="97%" data-replace="97" data-pattern="$1" data-tag-index="29_9" data-time="" data-username="" data-userid="">97</named-content><named-content id="5075fdbb-619a-4625-8d5b-6f957e175599" data-cid="5075fdbb-619a-4625-8d5b-6f957e175599" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="259" data-match="97%" data-replace="%" data-pattern="%" data-tag-index="29_9" data-time="" data-username="" data-userid="">%</named-content> cases managed with topical AGM).<xref id="c81dc8ba-3fcf-4e52-ad3d-9392da5b8888" ref-type="bibr" rid="R23" data-citation-string=" R23 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="295" data-match="23" data-pattern="" data-tag-index="29_1" data-track-change="23"><sup id="27f86b43-6496-4fd2-beba-f98ad437ddcf">23</sup></xref> We did not find any significant correlation between glaucoma progression and number of dexamethasone implant injections (<named-content id="bbd7aec7-22de-4e6a-8f0c-ee8a336b38c4" data-cid="bbd7aec7-22de-4e6a-8f0c-ee8a336b38c4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="420" data-match="p=0.187" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="29_5" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="0dc65dea-cceb-4622-a051-4a68689aa66f" data-cid="0dc65dea-cceb-4622-a051-4a68689aa66f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="421" data-match="p=0.187" data-replace="=" data-pattern="$2" data-tag-index="29_5" data-time="" data-username="" data-userid="">=</named-content><named-content id="f05a72d5-1de6-4ddd-a301-a6f81fc67a60" data-cid="f05a72d5-1de6-4ddd-a301-a6f81fc67a60" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="422" data-match="p=0.187" data-replace="0.187" data-pattern="$3" data-tag-index="29_5" data-time="" data-username="" data-userid="">0.187</named-content>) in our study, similar to other studies which also showed that repeated injections of dexamethasone implant was not found to have any cumulative effect on the IOP.<xref id="4d1404d8-c917-4c3d-83e3-e955277be4b1" ref-type="bibr" rid="R34 R35" data-citation-string=" R34 R35 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="592" data-match="34 35" data-pattern="" data-tag-index="29_2" data-track-change="34 35"><sup id="c8712c27-0eab-4f27-a618-346f1a6c0dae">34 35</sup></xref> Younger age, male sex, <named-content data-cid="1554366618" id="da5f83bb-3f4f-4847-b074-a682a57a8706" content-type="del cts-3" specific-use="1554374460672" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374460672">T</named-content><named-content data-cid="1554366619" id="fe5bea9d-8b19-47c5-910d-f8b29ac71386" content-type="ins cts-3" specific-use="1554374460971" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374460971">t</named-content>ype <named-content data-cid="1553859621016" id="a4fbe4b3-2e35-4a47-911d-381cd51bbd68" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">1</named-content><named-content id="2d274a38-86fb-49e2-93fb-1239733dd2fe" data-cid="1553859621016" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="627" data-match="1" data-pattern="" data-tag-index="29_12" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1553859621001"><named-content data-cid="1554366620" id="dd140e3d-c8de-46c9-a947-41bf50503cb5" content-type="del cts-3" specific-use="1554374473383" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374473383">one</named-content></named-content><named-content data-cid="1554366621" id="afed25b3-5d8a-4493-b800-37e482cd95a9" content-type="ins cts-3" specific-use="1554374473717" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374473717">1</named-content> diabetes, pre<named-content data-cid="1554366640" id="3c48bfd4-c841-41b8-83de-bc5616a52976" content-type="ins cts-3" specific-use="1554374961516" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:19pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374961516">-</named-content>existing glaucoma treated with dual or triple therapy<named-content data-cid="1554366622" id="951be46e-1e75-48b7-bda5-60064cd16d89" content-type="del cts-3" specific-use="1554374479345" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374479345">,</named-content> and a history of retinal vein occlusion or uveitis were significant risk factors for ocular hypertension after dexamethasone implant injection in a multivariate analysis from the study by Malclès<named-content data-cid="1554366623" id="601cd25d-578b-4e44-a3a0-283180cd16d9" content-type="del cts-3" specific-use="1554374499329" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374499329"> A</named-content> <named-content id="2d5e7b31-7461-4e3c-aa3d-f573dbf8fce2" data-cid="2d5e7b31-7461-4e3c-aa3d-f573dbf8fce2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="896" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="29_11" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="0f56b6ea-04bb-4ff8-bfe2-6f724d51cfac">et al</italic></named-content>.<xref id="b5cbfee4-36f1-4c09-9faa-3d9e60a75cde" ref-type="bibr" rid="R23" data-citation-string=" R23 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="904" data-match="23" data-pattern="" data-tag-index="29_3" data-track-change="23"><sup id="43770c61-2ec4-49f9-bf83-da0c9762cdba">23</sup></xref> The MEAD study also observed that the IOP rise with intravitreal dexamethasone implant is mild and predictable with IOP peak occurring at <named-content id="9eff2b4a-e649-416a-9cb0-6b0f6efb937a" data-cid="9eff2b4a-e649-416a-9cb0-6b0f6efb937a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="1046" data-match="6-8 weeks" data-replace="6" data-pattern="$2" data-tag-index="29_6" data-time="" data-username="" data-userid="">6</named-content><named-content id="bcbe0e63-13b2-4d12-a221-8e610f011360" data-cid="bcbe0e63-13b2-4d12-a221-8e610f011360" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="1047" data-match="6-8 weeks" data-replace="–" data-pattern="–" data-tag-index="29_6" data-track-change="-" data-time="" data-username="" data-userid=""><named-content data-cid="1554366624" id="9b433a16-d50e-41ed-b461-214b8cc8b1d4" content-type="del cts-3" specific-use="1554374507825" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374507825">–</named-content></named-content><named-content id="b8f874f8-3836-44bf-a14d-fa5b3aa9bf7a" data-cid="b8f874f8-3836-44bf-a14d-fa5b3aa9bf7a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="1048" data-match="6-8 weeks" data-replace="8" data-pattern="$4" data-tag-index="29_6" data-time="" data-username="" data-userid=""><named-content data-cid="1554366625" id="f4cada25-7b49-4167-acde-8a4f2d13f3df" content-type="ins cts-3" specific-use="1554374508130" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:11pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374508130"> to </named-content>8</named-content><named-content id="988da820-6b58-4cc6-b1c8-b62643ec1962" data-cid="988da820-6b58-4cc6-b1c8-b62643ec1962" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="1049" data-match="6-8 weeks" data-replace=" weeks" data-pattern=" $5" data-tag-index="29_6" data-time="" data-username="" data-userid=""> weeks</named-content> and returning to baseline by around <named-content id="3a1b20cb-0bc6-46b1-8cb5-cfded8605d55" data-cid="3a1b20cb-0bc6-46b1-8cb5-cfded8605d55" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="1092" data-match="3 to 4 months" data-replace="3" data-pattern="$2" data-tag-index="29_7" data-time="" data-username="" data-userid="">3</named-content><named-content id="ee28daeb-14ef-4f83-b73b-ff9b87a61de1" data-cid="ee28daeb-14ef-4f83-b73b-ff9b87a61de1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGC" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="1093" data-match="3 to 4 months" data-replace=" to " data-pattern=" $3 " data-tag-index="29_7" data-time="" data-username="" data-userid=""> to </named-content><named-content id="afcb4ecf-d4a4-49ba-afa4-a087787c1f56" data-cid="afcb4ecf-d4a4-49ba-afa4-a087787c1f56" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="1097" data-match="3 to 4 months" data-replace="4" data-pattern="$1" data-tag-index="29_7" data-time="" data-username="" data-userid="">4</named-content><named-content id="809ca91e-d186-48ec-a0f7-a9b28e7682fd" data-cid="809ca91e-d186-48ec-a0f7-a9b28e7682fd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="1098" data-match="3 to 4 months" data-replace=" months" data-pattern=" $2" data-tag-index="29_7" data-time="" data-username="" data-userid=""> months</named-content>.<xref id="acdc0447-2eaa-413b-9570-c8f12218a9bc" ref-type="bibr" rid="R36" data-citation-string=" R36 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1107" data-match="36" data-pattern="" data-tag-index="29_4" data-track-change="36"><sup id="02b33c23-afb5-45dd-b56e-4bfa2de7604e">36</sup></xref></p><p data-class="jrnlSecPara" id="69755be4-95bd-489e-a4d7-eee021a16df0">Amongst 1772 phakic eyes (64.8%) in our study, 835 eyes (47.1%) were noted to have cataract with 576 eyes (32.5%) requiring cataract surgery on follow-up while 259 eyes (<named-content id="2e34b636-5573-4d18-891f-aa7f6fc9be0b" data-cid="2e34b636-5573-4d18-891f-aa7f6fc9be0b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="170" data-match="14.6%" data-replace="14.6" data-pattern="$1" data-tag-index="30_12" data-time="" data-username="" data-userid="">14.6</named-content><named-content id="cb42db53-f5c1-4a6d-979d-2a4bdd937bf4" data-cid="cb42db53-f5c1-4a6d-979d-2a4bdd937bf4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="174" data-match="14.6%" data-replace="%" data-pattern="%" data-tag-index="30_12" data-time="" data-username="" data-userid="">%</named-content>) had visually insignificant cataract not requiring surgery. The <named-content id="e65e5d13-ba0b-4a9a-bf7c-75f8155d901c" data-cid="e65e5d13-ba0b-4a9a-bf7c-75f8155d901c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="241" data-match="12-month" data-replace="12" data-pattern="$1" data-tag-index="30_13" data-time="" data-username="" data-userid="">12</named-content><named-content id="f6a54756-3f1d-4c4e-844e-99db83d75dc1" data-cid="f6a54756-3f1d-4c4e-844e-99db83d75dc1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-month' to ' month'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="243" data-match="12-month" data-replace=" month" data-pattern=" $2" data-tag-index="30_13" data-track-change="-month" data-time="" data-username="" data-userid=""> month</named-content> GENEVA study wherein the <named-content id="a403cc6e-e9e9-4e93-97ee-3b71d096db06" data-cid="a403cc6e-e9e9-4e93-97ee-3b71d096db06" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="275" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="30_31" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> were treated with <named-content data-cid="1554366629" id="856eb0e8-8662-4d47-bcb2-bf97ddf19e1d" content-type="del cts-3" specific-use="1554374535471" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:12pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374535471">2</named-content><named-content data-cid="1554366630" id="a735c511-2cbb-4f2d-a411-8e0bcb605be4" content-type="ins cts-3" specific-use="1554374535784" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:12pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374535784">two</named-content> injections of dexamethasone implant noted cataract progression in <named-content id="f30761f2-da3a-4222-8713-88516b40cafc" data-cid="f30761f2-da3a-4222-8713-88516b40cafc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="370" data-match="29.8%" data-replace="29.8" data-pattern="$1" data-tag-index="30_14" data-time="" data-username="" data-userid="">29.8</named-content><named-content id="cb5daea4-6fa4-41b5-96e8-fe06a5b012f9" data-cid="cb5daea4-6fa4-41b5-96e8-fe06a5b012f9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="374" data-match="29.8%" data-replace="%" data-pattern="%" data-tag-index="30_14" data-time="" data-username="" data-userid="">%</named-content> eyes with <named-content id="69670c13-f1e3-4de9-8819-c31160267f57" data-cid="69670c13-f1e3-4de9-8819-c31160267f57" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="386" data-match="1.3%" data-replace="1.3" data-pattern="$1" data-tag-index="30_15" data-time="" data-username="" data-userid="">1.3</named-content><named-content id="ceabc931-5dc3-4805-b11c-eff363b46d89" data-cid="ceabc931-5dc3-4805-b11c-eff363b46d89" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="389" data-match="1.3%" data-replace="%" data-pattern="%" data-tag-index="30_15" data-time="" data-username="" data-userid="">%</named-content> requiring cataract surgery. Studies have reported progression of cataract following intravitreal dexamethasone implants from <named-content id="a039748a-35fd-4f53-9576-03f94f26dfbe" data-cid="a039748a-35fd-4f53-9576-03f94f26dfbe" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PRE" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="PRE" data-offset="516" data-match="0.3% to 47%" data-replace="0.3" data-pattern="$2" data-tag-index="30_7" data-time="" data-username="" data-userid="">0.3</named-content><named-content id="af50f4b4-6b09-4742-9a36-b0eafcf06823" data-cid="af50f4b4-6b09-4742-9a36-b0eafcf06823" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PREP" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="PREP" data-offset="519" data-match="0.3% to 47%" data-replace="%" data-pattern="$3" data-tag-index="30_7" data-time="" data-username="" data-userid="">%</named-content><named-content id="a9823e60-b1cc-4f1c-ae37-8381c5a560d6" data-cid="a9823e60-b1cc-4f1c-ae37-8381c5a560d6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNG" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="RNG" data-offset="520" data-match="0.3% to 47%" data-replace=" to " data-pattern=" $4 " data-tag-index="30_7" data-time="" data-username="" data-userid=""> to </named-content><named-content id="0d1cd3cb-cbea-4333-9a0f-5ea1e0e41ff8" data-cid="0d1cd3cb-cbea-4333-9a0f-5ea1e0e41ff8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="VAL" data-offset="524" data-match="0.3% to 47%" data-replace="47" data-pattern="$1" data-tag-index="30_7" data-time="" data-username="" data-userid="">47</named-content><named-content id="888ae61a-9b04-400c-ba9b-e33ada97e774" data-cid="888ae61a-9b04-400c-ba9b-e33ada97e774" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="UNT" data-offset="526" data-match="0.3% to 47%" data-replace="%" data-pattern="%" data-tag-index="30_7" data-time="" data-username="" data-userid="">%</named-content> (<xref id="248cd6c9-d0f6-48cc-9d87-fb08515293a8" ref-type="table" rid="T5" data-citation-string=" T5 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="529" data-match="Table 5" data-pattern="" data-tag-index="30_1"><named-content data-cid="1556001224057" id="1dbe9b88-7486-475e-858e-24d9b728c012" content-type="del cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">Table 5</named-content><named-content data-cid="1556001224057" id="135f38ab-e2e7-436f-9df7-ae21b8b00751" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">table 5</named-content></xref>). The variations in the sample size and the <named-content data-cid="1553859621047" id="d58fb6d4-598a-4931-bdab-c37528146f5e" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow up</named-content><named-content id="4209b7b8-b3d6-4c7f-acf7-835993488bc2" data-cid="1553859621047" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="581" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="30_32" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow-up</named-content> periods could explain the wide range of cataract progression in the studies. Studies including eyes with uveitis showed a greater occurrence of cataract as uveitis itself could also predispose the secondary cataract (<xref id="be33a5ae-96f5-4bb5-ba78-c6b49aad2627" ref-type="table" rid="T5" data-citation-string=" T5 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="808" data-match="Table 5" data-pattern="" data-tag-index="30_2"><named-content data-cid="1556001224058" id="be6a9bbb-6d1a-4981-8d53-6823106875be" content-type="del cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">Table 5</named-content><named-content data-cid="1556001224058" id="ed19662c-49fa-4f51-a263-0e3869f746c3" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">table 5</named-content></xref>). The large number of phakic eyes at baseline (64%) with <named-content id="6c6179f7-a990-47a5-ac23-cbbb157b149e" data-cid="6c6179f7-a990-47a5-ac23-cbbb157b149e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="873" data-match="33.7 %" data-replace="33.7" data-pattern="$1" data-tag-index="30_18" data-time="" data-username="" data-userid="">33.7</named-content><named-content id="0241cb52-cb2a-4aa4-88ed-00032b00fdd9" data-cid="0241cb52-cb2a-4aa4-88ed-00032b00fdd9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣%' to '%'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="877" data-match="33.7 %" data-replace="%" data-pattern="%" data-tag-index="30_18" data-track-change=" %" data-time="" data-username="" data-userid="">%</named-content> of them having cataract at baseline could explain the greater percentage of cataract in our series. Reid <named-content id="c03d221f-e762-4318-a7a5-b15bb7f87dcd" data-cid="c03d221f-e762-4318-a7a5-b15bb7f87dcd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="985" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="30_22" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="0ecae467-3ad8-4cec-bfed-73725871a140">et al</italic></named-content> in their study found that the incidence of cataract after the first implant was <named-content id="c9fab094-78d7-4063-b521-08a028e377d6" data-cid="c9fab094-78d7-4063-b521-08a028e377d6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="1071" data-match="13.2%" data-replace="13.2" data-pattern="$1" data-tag-index="30_19" data-time="" data-username="" data-userid="">13.2</named-content><named-content id="01d1c581-19e2-4b3d-91f7-d7277b687c7c" data-cid="01d1c581-19e2-4b3d-91f7-d7277b687c7c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1075" data-match="13.2%" data-replace="%" data-pattern="%" data-tag-index="30_19" data-time="" data-username="" data-userid="">%</named-content> which increased to <named-content id="022ed173-ae1f-438a-9068-2b44313dbe0c" data-cid="022ed173-ae1f-438a-9068-2b44313dbe0c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="1096" data-match="45 %" data-replace="45" data-pattern="$1" data-tag-index="30_20" data-time="" data-username="" data-userid="">45</named-content><named-content id="238d6e3e-a0f5-461d-ac59-bce9414a05f8" data-cid="238d6e3e-a0f5-461d-ac59-bce9414a05f8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣%' to '%'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1098" data-match="45 %" data-replace="%" data-pattern="%" data-tag-index="30_20" data-track-change=" %" data-time="" data-username="" data-userid="">%</named-content> and <named-content id="a70406cd-dd02-49f3-a972-f87e1efc9489" data-cid="a70406cd-dd02-49f3-a972-f87e1efc9489" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="1105" data-match="60 %" data-replace="60" data-pattern="$1" data-tag-index="30_21" data-time="" data-username="" data-userid="">60</named-content><named-content id="7e3de681-96ec-45f9-8b2d-84a500165960" data-cid="7e3de681-96ec-45f9-8b2d-84a500165960" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣%' to '%'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1107" data-match="60 %" data-replace="%" data-pattern="%" data-tag-index="30_21" data-track-change=" %" data-time="" data-username="" data-userid="">%</named-content> after the <named-content data-cid="1553859621019" id="17ca0980-c021-481d-a3e6-eb3475b0b6bc" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">2<sup id="23027d49-d4c5-47c4-9042-738ca9e08e53">nd</sup></named-content><named-content id="47e33160-a551-4083-b513-cb56ec6fd684" data-cid="1553859621019" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '2&lt;sup id=&quot;23027d49-d4c5-47c4-9042-738ca9e08e53&quot;&gt;nd&lt;/sup&gt;' to 'second'" data-track-detail="" data-tag-desc="ORDI" data-tag-type="ORDI" data-offset="1120" data-match="2nd" data-pattern="" data-tag-index="30_25" data-function="numberToText,addTrackChanges" data-track-change="2&lt;sup id=&quot;23027d49-d4c5-47c4-9042-738ca9e08e53&quot;&gt;nd&lt;/sup&gt;" data-userid="preediting" data-username="Exeter" data-time="1553859621001">second</named-content> and <named-content data-cid="1553859621020" id="4a2bcbce-f822-4ef8-bae3-da3bc827cc0b" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">3<sup id="c4b79fcf-12ef-4e51-a63b-e1c189afa84d">rd</sup></named-content><named-content id="72ffb561-4b4d-473c-b6cc-278b4be70581" data-cid="1553859621020" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '3&lt;sup id=&quot;c4b79fcf-12ef-4e51-a63b-e1c189afa84d&quot;&gt;rd&lt;/sup&gt;' to 'third'" data-track-detail="" data-tag-desc="ORDI" data-tag-type="ORDI" data-offset="1128" data-match="3rd" data-pattern="" data-tag-index="30_26" data-function="numberToText,addTrackChanges" data-track-change="3&lt;sup id=&quot;c4b79fcf-12ef-4e51-a63b-e1c189afa84d&quot;&gt;rd&lt;/sup&gt;" data-userid="preediting" data-username="Exeter" data-time="1553859621001">third</named-content> implants<named-content data-cid="1554366633" id="5a0ad03c-025a-4713-aad0-174f413dce48" content-type="del cts-3" specific-use="1554374654102" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:14pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374654102"> </named-content>.<named-content data-cid="1554366634" id="98de8e09-7ce7-4f46-bdb4-3169563c155d" content-type="ins cts-3" specific-use="1554374655296" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:14pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374655296"> </named-content>They observed significantly higher rates of cataract surgeries in the <named-content data-cid="1553859621021" id="079f6ceb-8380-4bd6-b98c-57bf41d22199" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">2<sup id="c86d41a6-89c9-4557-bbeb-4f315a24527c">nd</sup></named-content><named-content id="3b4caccb-b73c-40ff-b2b2-8d24d4c207ae" data-cid="1553859621021" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '2&lt;sup id=&quot;c86d41a6-89c9-4557-bbeb-4f315a24527c&quot;&gt;nd&lt;/sup&gt;' to 'second'" data-track-detail="" data-tag-desc="ORDI" data-tag-type="ORDI" data-offset="1212" data-match="2nd" data-pattern="" data-tag-index="30_27" data-function="numberToText,addTrackChanges" data-track-change="2&lt;sup id=&quot;c86d41a6-89c9-4557-bbeb-4f315a24527c&quot;&gt;nd&lt;/sup&gt;" data-userid="preediting" data-username="Exeter" data-time="1553859621001">second</named-content> and <named-content data-cid="1553859621022" id="6a5a24b9-832e-4728-ae01-2efcfa2284d8" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">3<sup id="9dd50dc1-397b-4ea9-b63b-a2f6ce9cd29a">rd</sup></named-content><named-content id="272fbd64-7107-4428-943b-d6945ba67ce0" data-cid="1553859621022" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from '3&lt;sup id=&quot;9dd50dc1-397b-4ea9-b63b-a2f6ce9cd29a&quot;&gt;rd&lt;/sup&gt;' to 'third'" data-track-detail="" data-tag-desc="ORDI" data-tag-type="ORDI" data-offset="1220" data-match="3rd" data-pattern="" data-tag-index="30_28" data-function="numberToText,addTrackChanges" data-track-change="3&lt;sup id=&quot;9dd50dc1-397b-4ea9-b63b-a2f6ce9cd29a&quot;&gt;rd&lt;/sup&gt;" data-userid="preediting" data-username="Exeter" data-time="1553859621001">third</named-content> implant group when <named-content data-cid="1553859621048" id="fed4014f-dae5-42bd-870e-5958ed3baf44" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">compared to</named-content><named-content id="f4a919d4-c131-47f5-9f11-153e5761e4c9" data-cid="1553859621048" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1243" data-match="compared to" data-replace="compared with" data-pattern="compared with" data-tag-index="30_33" data-function="addTrackChanges" data-track-change="compared to" data-userid="preediting" data-username="Exeter" data-time="1553859621001">compared with</named-content> the single implant group.<xref id="dd34a531-cf5a-411e-b261-372ab798649e" ref-type="bibr" rid="R34" data-citation-string=" R34 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1281" data-match="34" data-pattern="" data-tag-index="30_4" data-track-change="34"><sup id="abb37867-ddcd-43b9-af7e-b1c7d08b3e1f">34</sup></xref> Similar to their study we also found a statistically significant increase in cataract progression in eyes receiving more number of <named-content data-cid="1554366635" id="28b38c0b-d8ad-4836-9a69-89eb39f7f4d9" content-type="del cts-3" specific-use="1554374698268" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:14pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374698268">o</named-content><named-content data-cid="1554366636" id="f94794e5-e602-4047-a9ae-bcdf228386bb" content-type="ins cts-3" specific-use="1554374698577" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:14pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374698577">O</named-content>zurdex injections (<named-content id="e68c5422-5076-43da-8796-c7842a2669a9" data-cid="e68c5422-5076-43da-8796-c7842a2669a9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="1436" data-match="p= 0.004" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="30_9" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="98db5731-b031-4674-9c16-7183ae2126c2" data-cid="98db5731-b031-4674-9c16-7183ae2126c2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '=␣' to '='" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="1437" data-match="p= 0.004" data-replace="=" data-pattern="$2" data-tag-index="30_9" data-track-change="= " data-time="" data-username="" data-userid="">=</named-content><named-content id="19572e6f-79ff-40c9-b31a-8034af3c60e6" data-cid="19572e6f-79ff-40c9-b31a-8034af3c60e6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="1439" data-match="p= 0.004" data-replace="0.004" data-pattern="$3" data-tag-index="30_9" data-time="" data-username="" data-userid="">0.004</named-content>) although the co-relation co-efficient was small (<named-content id="b4ea9aeb-959e-4173-bcf0-bceeb355db02" data-cid="b4ea9aeb-959e-4173-bcf0-bceeb355db02" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="1495" data-match="r=0.057" data-replace="r" data-pattern="$1" data-tag-index="30_10" data-time="" data-username="" data-userid="">r</named-content><named-content id="713ba1b0-82cf-499a-8916-a30574e233d5" data-cid="713ba1b0-82cf-499a-8916-a30574e233d5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="1496" data-match="r=0.057" data-replace="=" data-pattern="$2" data-tag-index="30_10" data-time="" data-username="" data-userid="">=</named-content><named-content id="13cea4bb-5444-4470-be8d-325722e190b2" data-cid="13cea4bb-5444-4470-be8d-325722e190b2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="1497" data-match="r=0.057" data-replace="0.057" data-pattern="$3" data-tag-index="30_10" data-time="" data-username="" data-userid="">0.057</named-content>). Occurrence of sterile endophthalmitis following intravitreal dexamethasone implant was very low in our study (0.07%) along with other rarer side effects like vitreous <named-content data-cid="1553859621098" id="1ee13446-3f52-4741-84e4-bbda7f65dbe6" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">hemorrhage</named-content><named-content id="0ab031c0-4c96-4c1a-9112-ba9325e1f93e" data-cid="1553859621098" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'hemorrhage' to 'haemorrhage'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="1672" data-match="hemorrhage" data-replace="haemorrhage" data-pattern="haemorrhage" data-tag-index="30_34" data-function="addTrackChanges" data-track-change="hemorrhage" data-userid="preediting" data-username="Exeter" data-time="1553859621001">haemorrhage</named-content> (0.03%) and retinal detachment (0.03%). Most of the studies did not observe side effects other than raised intraocular pressure and cataract. Endophthalmitis, vitreous <named-content data-cid="1553859621099" id="5ea6d09a-93d0-453d-be8d-d6255e8d0d20" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">hemorrhage</named-content><named-content id="9e3a1ec7-300e-4217-930d-e3c5b59a0ca2" data-cid="1553859621099" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'hemorrhage' to 'haemorrhage'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="1851" data-match="hemorrhage" data-replace="haemorrhage" data-pattern="haemorrhage" data-tag-index="30_35" data-function="addTrackChanges" data-track-change="hemorrhage" data-userid="preediting" data-username="Exeter" data-time="1553859621001">haemorrhage</named-content> and retinal detachment were other rare adverse events noted in other studies similar to ours (<xref id="1632d1e0-b0bb-4a46-848b-d70366fbc65b" ref-type="table" rid="T5" data-citation-string=" T5 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="1956" data-match="Table 5" data-pattern="" data-tag-index="30_3"><named-content data-cid="1556001224059" id="45306ab2-bf55-4cc2-9c17-d4749c5f3e6a" content-type="del cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">Table 5</named-content><named-content data-cid="1556001224059" id="24b4b20e-51cc-4649-b751-3e62fd41de6f" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">table 5</named-content></xref>). A study by <named-content rid="4cc3abd0-588f-490e-9c92-7c2bd4663d20" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="adaeebf7-e773-4ed1-bdac-18c1689caeda" content-type="jrnlQueryRef" specific-use="start" data-answered="true"/>Li<named-content rid="4cc3abd0-588f-490e-9c92-7c2bd4663d20" data-class="jrnlQueryRef" data-type="end" id="8a1c5ccd-4f2c-4ae8-8f15-fc7540500874" content-type="jrnlQueryRef" specific-use="end" data-answered="true"/> <named-content id="24656185-456e-4f11-8024-7bb4a7ecfb4b" data-cid="24656185-456e-4f11-8024-7bb4a7ecfb4b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="1980" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="30_23" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="7fac82e8-b0fb-4ac8-b7ed-9aa1be86af6c">et al</italic></named-content><named-content id="b789c97d-245c-4099-9144-c03e78d67660" data-cid="b789c97d-245c-4099-9144-c03e78d67660" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ETLDOT" data-track-detail="" data-tag-desc="ETLDOT" data-tag-type="ETLDOT" data-offset="1985" data-match="." data-replace="delete" data-pattern="delete" data-tag-index="30_29" data-time="" data-username="" data-userid=""><named-content id="d57003a4-32f2-46c4-b83d-ca0392cfbc2d" data-cid="d57003a4-32f2-46c4-b83d-ca0392cfbc2d" content-type="del cts-1" specific-use="1553859621001 data-cid=" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001 data-cid=">.</named-content></named-content> noted conjunctival <named-content data-cid="1553859621100" id="ba6d4830-3017-44c2-ab72-8011c49a2de4" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">hemorrhage</named-content><named-content id="c2848531-851a-44be-9189-471417ac9de5" data-cid="1553859621100" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'hemorrhage' to 'haemorrhage'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="2006" data-match="hemorrhage" data-replace="haemorrhage" data-pattern="haemorrhage" data-tag-index="30_36" data-function="addTrackChanges" data-track-change="hemorrhage" data-userid="preediting" data-username="Exeter" data-time="1553859621001">haemorrhage</named-content> (18.6%) followed by conjunctival hyper<named-content data-cid="1554366647" id="27904e74-3351-4782-90da-0178876102f7" content-type="ins cts-3" specific-use="1554376421573" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:43pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554376421573">a</named-content>emia (13.2%) as the other most common side effects in their series.<xref id="a8aee041-7365-47a6-b456-bc85debc7998" ref-type="bibr" rid="R27" data-citation-string=" R27 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="2123" data-match="27" data-pattern="" data-tag-index="30_5" data-track-change="27"><sup id="fe81baf0-994e-4b4f-bed8-f3121600b813">27</sup></xref></p><p data-class="jrnlSecPara" id="a9ce89f9-00e1-42de-b6a4-9cccbdf564c2"><named-content data-cid="1553859621049" id="a3988a00-f179-4e33-aadc-56827fa73856" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">Amongst</named-content><named-content id="ac6b6ae8-222a-469c-9053-68d8ec238f9f" data-cid="1553859621049" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'Amongst' to 'Among'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="0" data-match="Amongst" data-replace="Among" data-pattern="Among" data-tag-index="31_12" data-function="addTrackChanges" data-track-change="Amongst" data-userid="preediting" data-username="Exeter" data-time="1553859621001">Among</named-content> the various subgroups, the uveitic group had a lesser percentage of eyes with cataract at baseline (22.1%), however, the number of eyes requiring cataract surgery in this subgroup was higher (39.8%) <named-content data-cid="1553859621050" id="e0564b12-af73-497c-8a79-47c2789d09f5" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">compared to</named-content><named-content id="eecd58c7-8aeb-40cb-a085-066cb0c6e54f" data-cid="1553859621050" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="207" data-match="compared to" data-replace="compared with" data-pattern="compared with" data-tag-index="31_13" data-function="addTrackChanges" data-track-change="compared to" data-userid="preediting" data-username="Exeter" data-time="1553859621001">compared with</named-content> the RVO (28.9%) and the DME subgroup (31.0%) (<xref id="3b2d020e-5efa-4211-a06e-84ecdf0a64ef" ref-type="table" rid="T1" data-citation-string=" T1 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="265" data-match="Table 1" data-pattern="" data-tag-index="31_1"><named-content data-cid="1556001224060" id="80303bbc-d27d-4ce4-83d0-33338a8393bb" content-type="del cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">Table 1</named-content><named-content data-cid="1556001224060" id="cb308c8b-1cec-43c3-a483-41fcfd83b4fd" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">table 1</named-content></xref>). Other studies with uveitis have observed occurrence of cataract ranging from <named-content id="ed973a4e-79f0-40c8-96ed-d00f45b92ee7" data-cid="ed973a4e-79f0-40c8-96ed-d00f45b92ee7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT,OPR,VALS,UNTS" data-tag-type="VAL" data-offset="352" data-match="4.8 % to 15 %" data-pattern="" data-tag-index="31_5" data-time="" data-username="" data-userid="">4.8</named-content><named-content id="551800b8-7469-4ffc-8465-46e278034a23" data-cid="551800b8-7469-4ffc-8465-46e278034a23" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT,OPR,VALS,UNTS" data-tag-type="UNT" data-offset="355" data-match="4.8 % to 15 %" data-pattern="" data-tag-index="31_5" data-time="" data-username="" data-userid=""><named-content data-cid="1554366637" id="b32eff94-1847-4e71-bef1-158dbef83bc2" content-type="del cts-3" specific-use="1554374887179" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:18pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374887179"> </named-content>%</named-content><named-content id="f7d40759-0ebc-4429-9e90-82fa6ed04042" data-cid="f7d40759-0ebc-4429-9e90-82fa6ed04042" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAL,UNT,OPR,VALS,UNTS" data-tag-type="OPR" data-offset="357" data-match="4.8 % to 15 %" data-pattern="" data-tag-index="31_5" data-time="" data-username="" data-userid=""> to </named-content><named-content id="996c9862-2818-455c-b87c-255e8db0f51f" data-cid="996c9862-2818-455c-b87c-255e8db0f51f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VALS" data-track-detail="" data-tag-desc="VAL,UNT,OPR,VALS,UNTS" data-tag-type="VALS" data-offset="361" data-match="4.8 % to 15 %" data-pattern="" data-tag-index="31_5" data-time="" data-username="" data-userid="">15</named-content><named-content id="42d5273a-2777-4d68-a386-5b0f748486c3" data-cid="42d5273a-2777-4d68-a386-5b0f748486c3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNTS" data-track-detail="" data-tag-desc="VAL,UNT,OPR,VALS,UNTS" data-tag-type="UNTS" data-offset="363" data-match="4.8 % to 15 %" data-pattern="" data-tag-index="31_5" data-time="" data-username="" data-userid=""><named-content data-cid="1554366638" id="bb01378d-c2d4-42e1-9ba1-bc46d36ee87f" content-type="del cts-3" specific-use="1554374889224" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:18pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554374889224"> </named-content>%</named-content> (<xref id="f5b29c44-0eab-487c-85f2-0d75411cd882" ref-type="table" rid="T5" data-citation-string=" T5 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="367" data-match="Table 5" data-pattern="" data-tag-index="31_2"><named-content data-cid="1556001224061" id="c3d40a33-aeeb-4b18-aa1c-a380188623fb" content-type="del cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">Table 5</named-content><named-content data-cid="1556001224061" id="5146b827-c87c-431c-8d33-41282ae460d7" content-type="ins cts-1" specific-use="1553859641000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859641000">table 5</named-content></xref>). Ozkaya <named-content id="250ed011-6ed9-4ed5-a336-c4559b155b24" data-cid="250ed011-6ed9-4ed5-a336-c4559b155b24" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="384" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="31_9" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="28190a23-de0c-4457-842f-bfb0306400c3">et al</italic></named-content><named-content id="26d5afdc-4ce5-4339-b5cc-907648b0449d" data-cid="26d5afdc-4ce5-4339-b5cc-907648b0449d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ETLDOT" data-track-detail="" data-tag-desc="ETLDOT" data-tag-type="ETLDOT" data-offset="389" data-match="." data-replace="delete" data-pattern="delete" data-tag-index="31_11" data-time="" data-username="" data-userid=""><named-content id="88c296dd-dd90-458b-b1c3-25a44d8a34c7" data-cid="88c296dd-dd90-458b-b1c3-25a44d8a34c7" content-type="del cts-1" specific-use="1553859621001 data-cid=" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001 data-cid=">.</named-content></named-content> reported on <named-content id="26a9838e-773f-4ccb-923b-a31e9773792b" data-cid="26a9838e-773f-4ccb-923b-a31e9773792b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="403" data-match="47%" data-replace="47" data-pattern="$1" data-tag-index="31_8" data-time="" data-username="" data-userid="">47</named-content><named-content id="218f48cf-3465-4246-bc53-fabfe3eef451" data-cid="218f48cf-3465-4246-bc53-fabfe3eef451" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="405" data-match="47%" data-replace="%" data-pattern="%" data-tag-index="31_8" data-time="" data-username="" data-userid="">%</named-content> eyes with cataract in their study.<xref id="f23c4547-d1e5-46a0-9bb3-bf67429ad2d5" ref-type="bibr" rid="R37" data-citation-string=" R37 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="442" data-match="37" data-pattern="" data-tag-index="31_3" data-track-change="37"><sup id="78dd2b4b-dbaa-4677-9ec4-dcae3d94262c">37</sup></xref> Furino <named-content id="0741905d-2e44-4f57-aa1f-32ed7043b715" data-cid="0741905d-2e44-4f57-aa1f-32ed7043b715" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="453" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="31_10" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="e49577c9-e009-4cb5-96aa-a611cb23fdea">et al</italic></named-content> combined phacoemulsification and dexamethasone implant and proposed that it may be an effective approach for <named-content id="24c59c4e-e44e-451a-b4ef-dd59cca9705d" data-cid="24c59c4e-e44e-451a-b4ef-dd59cca9705d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="568" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="31_14" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with cataract and diabetic macular <named-content data-cid="1553859621101" id="5342d123-df83-448f-88de-6c99e1929ebc" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">edema</named-content><named-content id="73c3b7a4-3580-4996-86df-4b961d637d7a" data-cid="1553859621101" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'edema' to 'oedema'" data-track-detail="" data-tag-desc="SPELL" data-tag-type="SPELL" data-offset="612" data-match="edema" data-replace="oedema" data-pattern="oedema" data-tag-index="31_15" data-function="addTrackChanges" data-track-change="edema" data-userid="preediting" data-username="Exeter" data-time="1553859621001">oedema</named-content>.<xref id="437506a2-1629-455a-bf21-6f0c3e735189" ref-type="bibr" rid="R38" data-citation-string=" R38 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="619" data-match="38" data-pattern="" data-tag-index="31_4" data-track-change="38"><sup id="dc4d275b-7651-4714-83c0-8a1ab9c28ca5">38</sup></xref> An elderly cohort and pre-existing cataract and uveitis could possibly account for the higher occurrence of cataract in the study populations.</p><p data-class="jrnlSecPara" id="2e4f00ca-82ea-4993-af97-687a61b58bbe">Limitations of our study include the retrospective nature with lack of uniformity in treatment and <named-content data-cid="1553859621051" id="1cbc0e8d-f2ac-4f3f-a2c1-0100707ae3f1" content-type="del cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow up</named-content><named-content id="6f6192c5-8c91-4b27-acf6-9051c1e53924" data-cid="1553859621051" content-type="ins cts-1" specific-use="1553859621001" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="99" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="32_1" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1553859621001">follow-up</named-content> protocol as it contains pooled data from all over the world. The strength of our study is the safety profile following a large number of injections (6015) in large number of <named-content id="1bcc9128-9989-45fa-abaa-ad86b583228e" data-cid="1bcc9128-9989-45fa-abaa-ad86b583228e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="283" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="32_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> in real clinical practice across the world.</p><p data-class="jrnlSecPara" id="6e2b2b06-91e3-41ec-9a4b-b38ccd38fa33">In conclusion, our study of <named-content id="7506318e-915e-432d-afa8-e6e617a51cd1" data-cid="7506318e-915e-432d-afa8-e6e617a51cd1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="28" data-match="6015" data-replace="6015" data-pattern="6015" data-tag-index="33_3" data-time="" data-username="" data-userid="">6015</named-content> dexamethasone implant injections revealed visually significant cataract necessitating surgery (32.5%) and an intraocular pressure rise (26.5%) as the major treatable side effects of the implant. Among the <named-content id="79d7ca0b-84a8-4581-8896-7ab3449a5ed4" data-cid="79d7ca0b-84a8-4581-8896-7ab3449a5ed4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="238" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="33_4" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with intraocular pressure rise, more than <named-content id="f481df91-72e0-409a-acf6-4b068573650e" data-cid="f481df91-72e0-409a-acf6-4b068573650e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="289" data-match="90%" data-replace="90" data-pattern="$1" data-tag-index="33_1" data-time="" data-username="" data-userid="">90</named-content><named-content id="d801c51c-37b2-4bbf-97e0-2d408a99e6f7" data-cid="d801c51c-37b2-4bbf-97e0-2d408a99e6f7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="291" data-match="90%" data-replace="%" data-pattern="%" data-tag-index="33_1" data-time="" data-username="" data-userid="">%</named-content> were well controlled with topical anti<named-content data-cid="1554366641" id="b2ed0a17-6323-4c35-8fe8-bf70842a8ded" content-type="ins cts-3" specific-use="1554375021247" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:20pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554375021247">-</named-content>glaucoma medications and only <named-content id="0fda928d-4165-4928-b3c1-7858e5be1a06" data-cid="0fda928d-4165-4928-b3c1-7858e5be1a06" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="361" data-match="3.43%" data-replace="3.43" data-pattern="$1" data-tag-index="33_2" data-time="" data-username="" data-userid="">3.43</named-content><named-content id="88053a72-b67c-433d-8a15-338c8921f311" data-cid="88053a72-b67c-433d-8a15-338c8921f311" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="365" data-match="3.43%" data-replace="%" data-pattern="%" data-tag-index="33_2" data-time="" data-username="" data-userid="">%</named-content> requiring glaucoma filtering surgery. Dexamethasone implant appears to be a safe in various retinal conditions in real<named-content data-cid="1554366642" id="faf46f8d-e77d-4cfc-9dc8-99afd08ef029" content-type="del cts-3" specific-use="1554375031295" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Deleted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:20pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554375031295"> </named-content><named-content data-cid="1554366643" id="2d6952ea-ba24-4298-bf4f-1d8d1ec758bc" content-type="ins cts-3" specific-use="1554375031606" xlink:title="B020-Baburaj (COPYEDITOR)" alt="copyeditor 8576948431" data-title="Inserted by B020-Baburaj (COPYEDITOR) - Apr 4 2019 4:20pm" data-track-detail="" data-userid="copyeditor 8576948431" data-username="B020-Baburaj (COPYEDITOR)" data-time="1554375031606">-</named-content>life situations.</p><p colorcode="#" headweightage="17" data-class="jrnlDeleted" id="c8643359-9f32-4e09-a82e-d43a7b62eec8">International Ozurdex Study Group:</p></body><back id="db45908c-0511-4608-b0e9-885daedd6224" data-edited="true" data-edited-version="2"><ref-list section="back" node-xpath="back" id="347a3320-34b7-43c0-bb6a-603c3df464bb"><title data-level="1" id="9e6152b1-edd4-4418-b494-b6fae8f99057">References</title><ref data-class="jrnlRefText" id="R1" data-id="R1" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R1" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/22749677" data-doi="10.1016/j.ajpath.2012.06.006" data-validated="true"><label id="54e46f5f-22c4-4ceb-90af-ebb2a1c7c387">1</label><element-citation publication-type="journal" id="c1ea4546-5443-49ea-a31a-d397aaeaf5a8"><person-group person-group-type="author" id="db2b3dcd-43cd-46e6-bc55-5ee8c6263dcc"><name id="db890ffe-8acd-4043-92f3-490d9640893e"><surname id="d7fd4d87-58f9-4a43-82d5-0c4fb90b1a21">Kim</surname> <given-names id="82aa6854-e9dd-4370-bfbb-933da6e8d36b">LA</given-names></name><x>, </x><name id="1f87ec8d-f9b7-44e1-b523-4ca007d4d9f1"><surname id="56e95ebd-6c13-4fa4-be0f-09b5b0154f42">D'Amore</surname> <given-names id="0cca858f-b02b-47e5-8a95-bb9eb4f5c0f6">PA</given-names></name></person-group><x>. </x><article-title id="19fa2100-746b-44eb-a76f-d8d600e9d08a">A brief history of anti-VEGF for the treatment of ocular angiogenesis</article-title><x>. </x><source id="dba5894f-bd2d-4c7f-a79a-d987f6915e87">Am J Pathol</source><x> </x><year id="12c3d79c-a612-4536-a0bc-f795bd43dd56">2012</year><x>;</x><volume id="0a16dba8-3772-4c8d-8bda-1049e03e3664">181</volume><x>:</x><fpage id="c97d47e5-c252-4f86-a447-8aae725cba59">376</fpage><x>–</x><lpage id="904ff9a5-df6d-465f-a2b4-bbd56c342ab0">9</lpage><x>.</x><pub-id pub-id-type="doi" id="5b412b47-a224-4754-9bec-a80a085a1039">10.1016/j.ajpath.2012.06.006</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R2" data-id="R2" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R2" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/15625332" data-doi="10.1056/NEJMoa042760" data-validated="true"><label id="22928cda-17c6-4521-a6f1-ba846719e1c4">2</label><element-citation publication-type="journal" id="137af47e-ef68-486e-9943-8cae586b09b5"><person-group person-group-type="author" id="340a8510-46a3-4942-a52e-47ec512e1bad"><name id="c8c061fd-bfcb-4563-a3a3-6efe298ee36a"><surname id="919dacc6-2a47-47da-995b-c2081e8516ce">Gragoudas</surname> <given-names id="c7e405e9-05b7-4a64-8793-e50d308b1222">ES</given-names></name><x>, </x><name id="2887b5ef-2528-4d4f-9aec-68682a0bf8d2"><surname id="18d17fb8-dbcc-49c3-81d3-af65fc606a62">Adamis</surname> <given-names id="ec005dc6-23cd-4615-815d-d9a450ff26cc">AP</given-names></name><x>, </x><name id="ca3e06ae-751e-45a4-9053-9cc9bd8bba63"><surname id="a636ff77-d280-4923-9834-cedbc74b7c83">Cunningham</surname> <given-names id="e9ec3a0a-ca4a-4cd7-b574-bcc8d3261164">ET</given-names></name><x>, </x><etal data-class="RefEtal" id="411bce0f-230f-4ea7-9cf6-7730f286e0ee">et al</etal></person-group><x>. </x><article-title id="68201a98-19ce-4e93-b814-014a39fab4d8">Pegaptanib for neovascular age-related macular degeneration</article-title><x>. </x><source id="2acf4d2a-9cf1-4f10-848b-5990ed76a0f1">N Engl J Med</source><x> </x><year id="f1321f2f-0100-498a-97d7-84d7e9a7218b">2004</year><x>;</x><volume id="7affc218-32e1-45a9-bdf8-034aa3d4dd11">351</volume><x>:</x><fpage id="e1284eb3-fca5-4e1f-96d3-1521445bf7cf">2805</fpage><x>–</x><lpage id="00cffc53-628c-45b9-a38b-a78f09248b78">16</lpage><x>.</x><pub-id pub-id-type="doi" id="9cacbbe4-c5f0-4d68-81ba-7c7c162857cb">10.1056/NEJMoa042760</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R3" data-id="R3" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R3" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/20714176" data-doi="10.1159/000315155" data-validated="true"><label id="3d8d05ba-4b87-4f35-a073-3b58ee89eb20">3</label><element-citation publication-type="journal" id="4fb379e1-6f4a-476b-be31-8e08bb57816d"><person-group person-group-type="author" id="dc1c7fd8-00d5-45d8-a20a-0dbf32435d2c"><name id="3e6b74b5-913b-4813-b898-c72330f9d4b8"><surname id="3fa14ff4-bff5-4e80-abfc-c655bdf4ed4e">Scholl</surname> <given-names id="fecb308a-8368-4ee8-9fd0-0fb75e431efb">S</given-names></name><x>, </x><name id="e3e5bcd5-6fc7-443d-a3d3-247f4e71a659"><surname id="e2687fd0-84a7-421f-b009-9988303d506a">Kirchhof</surname> <given-names id="b49a6059-ac34-4f66-9046-432fbc63a997">J</given-names></name><x>, </x><name id="b95e260b-3653-44df-83da-e17afdf9490e"><surname id="19cda443-9f94-41a1-8f66-68f288d9805c">Augustin</surname> <given-names id="addf6841-0c2f-4a67-aa6b-c63ab0683a74">AJ</given-names></name></person-group><x>. </x><article-title id="980549e7-c369-4b15-90fd-39ac5425ed7f">Pathophysiology of macular edema</article-title><x>. </x><source id="d4cf5c36-fb6e-4604-b446-ef7c10003f51">Ophthalmologica</source><x> </x><year id="01fb6120-4962-4cf2-a21f-183fcb1d918c">2010</year><x>;</x><volume id="34930e83-9afa-4a81-a974-9b1b88b305a5">224</volume><x>(</x><issue id="e7d258fc-3e6e-438b-b038-7efc6d0bd84b">Suppl 1</issue><x>):</x><fpage id="071eaf07-4452-4cae-b69a-7d57b6809b13">8</fpage><x>–</x><lpage id="1eb35a58-f9ce-40bc-a949-42e0791cf23d">15</lpage><x>.</x><pub-id pub-id-type="doi" id="cb1b5ed7-cda6-4c39-a12a-04927f170e28">10.1159/000315155</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R4" data-id="R4" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R4" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/21684606" data-doi="10.1016/j.ophtha.2011.02.022" data-validated="true"><label id="75fa8a13-7b76-4cc9-a431-662623786487">4</label><element-citation publication-type="journal" id="cbf22cc5-5fed-4b3b-891e-967dc49eeec9"><person-group person-group-type="author" id="3742aa11-e533-44ab-97f6-52a7ba9b7732"><name id="82e42b7a-88db-44e4-8889-4aee82536c48"><surname id="e2dee5bc-858a-4bf7-a230-1fc4f4fc7b0a">Brown</surname> <given-names id="1ec2c0f4-eee1-4a2b-a283-fbb51c5d3eba">DM</given-names></name><x>, </x><name id="9f874a57-fae4-4fea-a180-a39f8f39c512"><surname id="da62f377-946b-41ef-bcff-f021762e2f85">Campochiaro</surname> <given-names id="5cbe65e2-3a23-437e-9bb0-246e4ca6dfc4">PA</given-names></name><x>, </x><name id="12249c4d-e581-4dd8-b53b-693a5faef171"><surname id="ed01677d-fe90-4dc2-927a-4efad8528c12">Bhisitkul</surname> <given-names id="162c5cd5-3baf-4b92-b9f7-85d5329fbd66">RB</given-names></name><x>, </x><etal data-class="RefEtal" id="17c7987f-2ab7-4fba-8188-09c5542fca50">et al</etal></person-group><x>. </x><article-title id="0e1e8e9a-a3ba-4c2a-a537-0ec5d0e313ee">Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study</article-title><x>. </x><source id="69f98f38-40df-4396-8c27-a41c6b19d9d2">Ophthalmology</source><x> </x><year id="0f44ad09-bb85-476a-b6ba-11215345e6df">2011</year><x>;</x><volume id="821430f5-885b-44ec-8f42-daa53654d1d6">118</volume><x>:</x><fpage id="5e8c5d17-f4d2-4d46-97af-42d175042908">1594</fpage><x>–</x><lpage id="e5182769-0ccc-4757-bbfe-9d43a0c9358e">602</lpage><x>.</x><pub-id pub-id-type="doi" id="dec44ee7-71c5-4d2a-aa92-cfd8a93635ab">10.1016/j.ophtha.2011.02.022</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R5" data-id="R5" data-styled="RefText" data-duplicate-id="R4" data-class-name="RefText" data-reftype="journal" data-valid-id="R5" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/21715011" data-doi="10.1016/j.ophtha.2011.02.038" data-validated="true"><label id="1d14ba1e-0597-49f9-b6ca-58d499928845">5</label><element-citation publication-type="journal" id="81f1cb0f-24bf-4346-9478-5111997deb00"><person-group person-group-type="author" id="eca92338-d42f-48b3-8355-87b0c794bdaf"><name id="f92bc64e-9d0b-473d-bb95-e5e25542e2bb"><surname id="0fe53718-166a-4ad1-9171-e28e364cba40">Campochiaro</surname> <given-names id="941d225f-32bb-4274-bcdf-c45a0c5a5292">PA</given-names></name><x>, </x><name id="5c0c2dd5-1661-4292-afcc-9b0d83631cd6"><surname id="f8c5a51c-0ca4-48d1-a65d-965ade2a2eed">Brown</surname> <given-names id="0f36ef01-9fa2-4557-a013-613ffb750f96">DM</given-names></name><x>, </x><name id="4416430f-5b19-4676-be4e-1d421a4fd71c"><surname id="19a9c511-fb43-425c-baea-ef9219821072">Awh</surname> <given-names id="850143db-45af-4169-a15f-16c6789d7ab3">CC</given-names></name><x>, </x><etal data-class="RefEtal" id="95d26ca0-dd92-411c-970e-4e3e121a3cdf">et al</etal></person-group><x>. </x><article-title id="972296c7-f332-4873-aac4-98a2a072e02f">Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study</article-title><x>. </x><source id="6a600eb4-bb0d-4f21-9b55-8b3aff08f04f">Ophthalmology</source><x> </x><year id="f873ab84-3b43-42cc-bf74-cf004567018c">2011</year><x>;</x><volume id="3ed8c6a7-8e32-479a-8923-04ddd27c50c6">118</volume><x>:</x><fpage id="83575546-083a-4107-a1ac-f058eb1e9a47">2041</fpage><x>–</x><lpage id="bfbd79a8-a00b-4fff-8c81-ec1964b1f38b">9</lpage><x>.</x><pub-id pub-id-type="doi" id="a7f6048e-d7b6-41bd-8c47-96ae4137ec1e">10.1016/j.ophtha.2011.02.038</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R6" data-id="R6" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R6" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/19752419" data-doi="10.1001/archophthalmol.2009.234" data-validated="true"><label id="80bbc1bf-f987-4303-8960-26efa3cccfb1">6</label><element-citation publication-type="journal" id="49f67ab2-1681-4993-98e4-69fd970e0a3a"><person-group person-group-type="author" id="59016701-68f7-442c-b1dc-8c7c05ae2147"><name id="f75bb317-11a2-4e58-8ea5-330d14a8ebf0"><surname id="47c137b9-64c1-4fc1-8ec8-ff6958cb0c97">Ip</surname> <given-names id="4ac1d516-f9c5-4273-a5b1-1cc9cf0e9057">MS</given-names></name><x>, </x><name id="29aea706-7c1b-4a8e-9981-31f1f6d8635f"><surname id="3c569ebc-e25c-4ad0-886b-c6d22b8c61d2">Scott</surname> <given-names id="51aadd2f-622a-4c02-b9a7-f05277e4cedb">IU</given-names></name><x>, </x><name id="9f65cfee-0fc5-4fb6-aed3-3b95981efb1c"><surname id="fecc7922-c804-4a4a-857e-9479919afad3">VanVeldhuisen</surname> <given-names id="07c674d5-7510-4999-90f4-8706a7013292">PC</given-names></name><x>, </x><etal data-class="RefEtal" id="43f1e0e1-b511-48ac-91d9-c684db4cb8e8">et al</etal></person-group><x>. </x><article-title id="4b96667a-3b9f-4b0d-94d9-6811072f4404">A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (Score) study report 5</article-title><x>. </x><source id="fd11529c-a182-4dfc-9174-29f59b671f6e">Arch Ophthalmol</source><x> </x><year id="7f3ad89c-bb76-4cfa-b54a-cc0fad63c387">2009</year><x>;</x><volume id="79365817-b415-4f33-9cd1-f0a2326f7fb3">127</volume><x>:</x><fpage id="3fa0e148-0458-45fe-b2c8-8867aa8c603c">1101</fpage><x>–</x><lpage id="713088f3-f646-4efa-8a58-8e619d4435f1">14</lpage><x>.</x><pub-id pub-id-type="doi" id="2bd3a987-dee0-4921-8526-7fa5647ae465">10.1001/archophthalmol.2009.234</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R7" data-id="R7" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R7" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/20427088" data-doi="10.1016/j.ophtha.2010.02.031" data-validated="true"><label id="2808b0e2-88b6-4845-993e-dcd45845d154">7</label><element-citation publication-type="journal" id="2a930e9b-6887-416e-ba38-d436aa7d4240"><person-group person-group-type="author" id="f89e7717-b94b-4b3a-80c9-421d3c4f2de5"><name id="73b8bdcb-ce93-499d-9e7e-3236394a4305"><surname id="8d8d45df-2f5e-4444-807f-9abcdf232b59">Elman</surname> <given-names id="8c80445a-860f-4928-b42e-592c561498be">MJ</given-names></name><x>, </x><name id="b4b8519f-cea6-40a7-bad4-2e3dbfde4b71"><surname id="8320c4e5-45f1-4c7f-b0b3-ef0a55bfdbdd">Aiello</surname> <given-names id="d54257c8-21fe-4567-9842-176120ad058a">LP</given-names></name><x>, </x><name id="b8c39286-3f55-4cca-acd5-b43e051b0091"><surname id="3d34f570-4ecc-41aa-bb44-ab49a10b4088">Beck</surname> <given-names id="4cb23c76-ef08-4f5e-a5bb-69b287a8a995">RW</given-names></name><x>, </x><etal data-class="RefEtal" id="d18bcf3b-fe2a-4c75-b5d2-80b6c20a7f8d">et al</etal></person-group><x>. </x><article-title id="4fd80ff0-3f64-4e04-af3e-a8a37722c033">Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema</article-title><x>. </x><source id="1a372dc8-1894-4627-9c93-280a2ef8a2fb">Ophthalmology</source><x> </x><year id="8e83861d-b003-4399-9cf4-361a1cdfeaf0">2010</year><x>;</x><volume id="beb38138-fc8f-4c47-b0b6-88ee7a16a566">117</volume><x>:</x><fpage id="062a4194-eb48-4822-b334-6492821f6ba9">1064</fpage><x>–</x><lpage id="1369ed5f-0615-4533-aeae-c8869d513125">77</lpage><x>.</x><pub-id pub-id-type="doi" id="16a9fdea-3739-44c3-a353-6168fdd55525">10.1016/j.ophtha.2010.02.031</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R8" data-id="R8" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R8" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/24526927" data-doi="10.1155/2014/989501" data-validated="true"><label id="1186a539-35ce-471d-b0e7-685092b270f6">8</label><element-citation publication-type="journal" id="20ca4e70-932d-49b3-9aa7-b51ac45fe57a"><person-group person-group-type="author" id="bc1fe07c-9247-46c7-a228-dffd9c2c0f18"><name id="01a730d9-8ca8-4d11-86ea-1ab8eb7d183f"><surname id="7853cf1b-0ad3-400f-a4bb-4d572b031d8e">Sarao</surname> <given-names id="f923f7cd-d069-42ed-99d2-e2e8f890cfdf">V</given-names></name><x>, </x><name id="0c8ebd1c-098e-4800-b361-b2b1df4fe2df"><surname id="8429d3af-e7a2-473c-9f2f-2058628a0402">Veritti</surname> <given-names id="eab55608-6f0a-4c30-b725-79020bfe0d71">D</given-names></name><x>, </x><name id="bfbe01a5-9f8a-4b31-97e9-66d2d1d81990"><surname id="22b32ebe-6c3a-488d-a478-47cb97c72c50">Boscia</surname> <given-names id="da14632e-3a12-4224-a5bf-2832d2352aea">F</given-names></name><x>, </x><etal data-class="RefEtal" id="b2efac8a-6120-457b-8dff-61411e5dd581">et al</etal></person-group><x>. </x><article-title id="d7cdcfd6-bad8-4fe8-8820-dcfb6db53297">Intravitreal steroids for the treatment of retinal diseases</article-title><x>. </x><source id="d81ffa43-b74e-4d82-8517-3d77b039c6db">ScientificWorldJournal</source><x> </x><year id="dbc7aad3-680b-4843-9dde-0f7e90fb4571">2014</year><x>;</x><volume id="1a81e440-0527-49d4-93bd-381cb9613c1a">2014</volume><x>:</x><fpage id="3f73c141-7427-4f38-a17a-bb072394b1bd">1</fpage><x>–</x><lpage id="67163b40-3348-4db1-a054-b093b51ab228">14</lpage><x>.</x><pub-id pub-id-type="doi" id="4a3a5f7f-a289-467a-a12f-f43edf123a61">10.1155/2014/989501</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R9" data-id="R9" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R9" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/27293415" data-doi="10.1159/000444077" data-validated="true"><label id="9a95fdc5-deaf-4d27-88af-a2f4e5aa9883">9</label><element-citation publication-type="journal" id="2a66c7ff-ed9c-4fbe-b571-97488a6d568c"><person-group person-group-type="author" id="cf3f0408-7781-4d10-ac4d-9b2eafbaf079"><name id="a12753d5-1dc2-4b91-bd5e-71c2625881f4"><surname id="4c858a16-ce9f-4c9e-bf94-0a744c5e504b">Bulut</surname> <given-names id="bc7a1eec-5aee-427e-9909-658207526b92">MN</given-names></name><x>, </x><name id="83ae6b12-35c4-4329-9601-966c9b8c48d9"><surname id="c2d89f8e-1ca9-4399-996b-c24abaec0436">Çallı</surname> <given-names id="7e568ab5-1f36-46eb-b1b9-13f6f1669f24">Ümit</given-names></name><x>, </x><name id="238ac41c-0cf7-4738-be15-4045accc8167"><surname id="5e42e591-a980-4d99-a341-0db9a6a607a1">Göktaş</surname> <given-names id="f9408192-c334-4ed6-b212-72c0f4a1a3e3">E</given-names></name><x>, </x><etal data-class="RefEtal" id="e06832ff-4406-4486-98fd-00722d9a2c47">et al</etal></person-group><x>. </x><article-title id="a518dbea-2e79-4a31-8b0c-d4302d95f030">Use of an intravitreal dexamethasone implant (Ozurdex) in a case with accidental foveal photocoagulation by Alexandrite laser</article-title><x>. </x><source id="daee6ce0-ede2-4a0f-a6e4-616ee677d9fa">Case Rep Ophthalmol</source><x> </x><year id="cc0678b5-2bda-443c-95bd-f350a82c659f">2016</year><x>;</x><volume id="fc62f9a0-455a-4716-b9a7-82cadeeff45d">7</volume><x>:</x><fpage id="fc174c9e-3b04-43e4-b2d5-21999c1ad988">130</fpage><x>–</x><lpage id="6c7eb4cf-34e3-492f-b526-4f7da4eee30e">4</lpage><x>.</x><pub-id pub-id-type="doi" id="fbbc323f-a5a6-498c-9380-ceacd4684862">10.1159/000444077</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R10" data-id="R10" data-styled="RefText" data-class-name="RefText" data-reftype="book" data-valid-id="R10" data-validated="true"><label id="cdeeb871-9ae1-4e00-adcb-6c7a9b7aabdf">10</label><element-citation publication-type="book" id="c6d72251-37f2-45ed-8874-adfeacf71462"><person-group person-group-type="author" id="22185fdc-389b-4c97-a098-118367af7f1a"><collab id="b84a4786-f035-470e-bd9c-c001983c2ab3">Ozurdex (Dexamethasonr Intravitreal Implant 0.7 mg)</collab></person-group><x>. </x><source id="d18e6ecd-380b-4716-a0df-4b16051e1de5">Product monograph</source><x>. </x><publisher-loc id="dbda4b72-6c9f-4054-b169-b7971c0c39a4">ON Canada</publisher-loc><x>: </x><publisher-name id="dff8a047-5d35-40af-b819-1e28310ec581">Allergan Inc</publisher-name><x>, </x><year id="7942cd9f-dfe6-4110-a336-2643660304c8">2015</year><x>.</x></element-citation></ref><ref data-class="jrnlRefText" id="R11" data-id="R11" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R11" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/27105838" data-doi="10.1080/17425247.2016.1182488" data-validated="true"><label id="e2568c0d-4149-45a0-87d7-7b22a2e8f1f4">11</label><element-citation publication-type="journal" id="096bf0f5-3b8d-44ef-a2b2-a94fe7202862"><person-group person-group-type="author" id="ca340f4e-2c22-4fea-9b5e-7f413117084a"><name id="1e547fc0-9867-4370-951e-a7c72150b401"><surname id="20c903ed-0da4-4c69-a08c-5577d12eeb35">Hadayer</surname> <given-names id="833126df-965e-4cf1-a010-11627dc2601a">A</given-names></name><x>, </x><name id="d3330bc0-064e-466a-a55a-b9fb9558f1d0"><surname id="b850b94c-41cf-4b02-aefd-b3f268599ce5">Schaal</surname> <given-names id="63aacebf-87f2-40f3-80f0-91f9c005e06f">S</given-names></name></person-group><x>. </x><article-title id="f17c1e0d-ae21-40c5-8d08-2b2135b91183">Delivery of steroids into the eye for the treatment of macular edema</article-title><x>. </x><source id="25d8b378-b892-4d0f-9718-514ca62d8931">Expert Opin Drug Deliv</source><x> </x><year id="fa198958-80fa-48a2-8ce7-a9cc4e164df9">2016</year><x>;</x><volume id="b3522886-cc60-49a7-afe7-bb938e23c76c">13</volume><x>:</x><fpage id="f467e3cc-9880-42a6-b960-1f1b429d1520">1083</fpage><x>–</x><lpage id="dc43f227-8cfb-4d8d-9f58-2d5896b72937">91</lpage><x>.</x><pub-id pub-id-type="doi" id="9ca57add-ceff-4a36-b31e-97d97094e581">10.1080/17425247.2016.1182488</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R12" data-id="R12" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R12" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/17353400" data-doi="10.1001/archopht.125.3.309" data-validated="true"><label id="f0dac1b4-4781-4d42-9f8d-2cb2fd171308">12</label><element-citation publication-type="journal" id="21b1dee6-46b8-43cc-b8ce-d258a23d3356"><person-group person-group-type="author" id="5963f8ba-60ba-4114-9ff3-c434670ba75d"><name id="6a57191c-9974-4541-b304-e40e6ad6c213"><surname id="efc8b98c-8148-4143-8d19-a505c986b3f3">Kuppermann</surname> <given-names id="228f285b-dd61-448d-a474-a4d1d17fd732">BD</given-names></name><x>, </x><name id="67a7f261-01b3-47c1-9c1f-a785c966382b"><surname id="415c3bb0-f932-4473-b315-47c23fb55c91">Blumenkranz</surname> <given-names id="ffc7f316-1720-4682-b593-cb5eb688b10e">MS</given-names></name><x>, </x><name id="5e28ace4-62ad-401d-b2d6-5b2e7c120c11"><surname id="417e9e51-11cc-40fb-a83f-0a997b16918a">Haller</surname> <given-names id="c7ea7611-5299-4e8b-8008-aa9cb3c35002">JA</given-names></name><x>, </x><etal data-class="RefEtal" id="8bcc4b03-8c69-43e6-943b-3b914230b35e">et al</etal></person-group><x>. </x><article-title id="d4dd8b12-504e-491c-af2d-209afe697713">Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema</article-title><x>. </x><source id="4ac5c37b-0958-430a-b764-56aa45796d4d">Arch Ophthalmol</source><x> </x><year id="f995090b-248b-4e3b-8aa9-c12450390294">2007</year><x>;</x><volume id="0a7b3d72-2351-4c2c-804d-d3993bb83ed6">125</volume><x>:</x><fpage id="025f64f5-4d17-4b79-9629-9545ce624536">309</fpage><x>–</x><lpage id="8e31a262-4cde-4551-b728-2b880420e127">17</lpage><x>.</x><pub-id pub-id-type="doi" id="ed99f948-c529-4083-9809-f86fe3c7364e">10.1001/archopht.125.3.309</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R13" data-id="R13" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R13" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/20212194" data-doi="10.1001/archophthalmol.2010.44" data-validated="true"><label id="de2c9643-0e71-4482-b2a4-27e671aaaeca">13</label><element-citation publication-type="journal" id="e521632b-be16-4d86-bcf3-30db0a4ca783"><person-group person-group-type="author" id="67bb275d-eb1e-4f8d-af32-27ce756f09f1"><name id="18cf6b9b-864a-4db8-a8d5-532c757c1e04"><surname id="b3039c8f-bc6e-4756-b30c-e748342119c3">Kuppermann</surname> <given-names id="d85495da-6dc6-4a74-8357-e0542d68fe27">BD</given-names></name><x>, </x><name id="f25d2157-ab03-411d-b1b3-f9115efc012a"><surname id="4e9cc203-962c-44ba-894d-b47fbcf65b0d">Chou</surname> <given-names id="75bbbb6b-a903-46a6-8a22-b60e5d876b33">C</given-names></name><x>, </x><name id="2a755636-0543-4a37-885a-68c62f9e453c"><surname id="056afe51-846e-47b9-9067-f8d39c8914b0">Weinberg</surname> <given-names id="aa9f23ed-aa23-4975-be24-b5cfa215e78e">DV</given-names></name><x>, </x><etal data-class="RefEtal" id="f65b4be2-12eb-4cd2-8f68-a8aad2d2bdaa">et al</etal></person-group><x>. </x><article-title id="6ea8d240-08cf-4c65-b78e-e4b037e3f87f">Intravitreous dexamethasone effects on different patterns of diabetic macular edema</article-title><x>. </x><source id="9b719ddf-9f7b-42d4-8ebc-d105ddc25603">Arch Ophthalmol</source><x> </x><year id="dd386918-50b8-4361-92a9-bda7cf0ee0d4">2010</year><x>;</x><volume id="a6014ca1-4a6d-4733-b678-122790a52c2f">128</volume><x>:</x><fpage id="971a2d73-e89c-4c76-b9d9-4fe7ae5b7d25">642</fpage><x>–</x><lpage id="42288c5e-4f45-4f13-979d-dfbb49e06c02">3</lpage><x>.</x><pub-id pub-id-type="doi" id="e95c8e97-caba-477c-993e-dbd44668ea13">10.1001/archophthalmol.2010.44</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R14" data-id="R14" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R14" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/23687501" data-doi="10.1159/000351176" data-validated="true"><label id="300cb365-4bd3-4c8c-a365-85c757b3ca57">14</label><element-citation publication-type="journal" id="deb6e8d2-a3ae-4df6-99ff-e58f87c4f4cd"><person-group person-group-type="author" id="05b53582-9223-420a-b851-53cbbfaedde4"><name id="ef10dc87-7db3-432e-bc11-2f07b09c8b66"><surname id="50233d67-d51e-43ca-9fd7-f83fb3f351ae">Reibaldi</surname> <given-names id="22320a28-47b9-47c0-ab80-df2084706ffe">M</given-names></name><x>, </x><name id="676df0c4-7081-48d3-b971-b0f5b98d8d76"><surname id="2db57d4d-f6c4-400d-8ea3-29e0d0668906">Russo</surname> <given-names id="00f3012f-47af-4bf0-b8eb-9d68d045e001">A</given-names></name><x>, </x><name id="d38c8e17-4f47-49ba-9e05-10f566f78285"><surname id="8bd58048-f960-416e-89e7-c249a4f15ee1">Longo</surname> <given-names id="a0fd9e56-4df5-4ae4-a51b-dd8a3526885f">A</given-names></name><x>, </x><etal data-class="RefEtal" id="8e151c8e-542f-4374-ab34-335935cb1b66">et al</etal></person-group><x>. </x><article-title id="8b4d98b5-7202-4fb3-b05e-486e1d9ed1d3">Rhegmatogenous retinal detachment with a high risk of proliferative vitreoretinopathy treated with episcleral surgery and an intravitreal dexamethasone 0.7-mg implant</article-title><x>. </x><source id="ca022307-d78f-4175-be0b-f87f36e82035">Case Rep Ophthalmol</source><x> </x><year id="8d6f3c3b-c912-4498-b5b9-9e2a04e5d324">2013</year><x>;</x><volume id="c217fd5e-da64-418b-8271-7c4a6d71be65">4</volume><x>:</x><fpage id="9463067f-3532-480f-8145-b29f713f791c">79</fpage><x>–</x><lpage id="2cb26316-7ecc-4b55-ad3e-731d172f92df">83</lpage><x>.</x><pub-id pub-id-type="doi" id="d0437854-4835-436d-b008-514cb7dc4711">10.1159/000351176</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R15" data-id="R15" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R15" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/22529805" data-doi="10.1159/000337144" data-validated="true"><label id="cc342ea9-0d2d-4f8d-ba68-05a0f2c09979">15</label><element-citation publication-type="journal" id="c320d4ff-536f-4e0a-bb56-660669a364d1"><person-group person-group-type="author" id="a003aabc-dddf-4a2a-9351-c3377b355845"><name id="c166cd13-f197-4c96-a87f-d910d715e8e6"><surname id="2393e547-136d-4845-bbf0-59b8d638ff40">Russo</surname> <given-names id="57869b0d-3ae5-4a0b-ad60-89e4da7153b3">A</given-names></name><x>, </x><name id="d3ebcd7c-ff3a-4929-b0e8-8dd6515c8673"><surname id="db5f4f91-3856-40da-9aa3-88f9fb7d7879">Avitabile</surname> <given-names id="f1411d2c-d2a1-4281-8680-a28218fba8c4">T</given-names></name><x>, </x><name id="3c8adaa6-834c-4e8a-b857-335f04606fe4"><surname id="f348d0a1-90f2-42d1-97e2-a326eb8d6ab2">Uva</surname> <given-names id="c151bda0-f30b-4c49-a8ec-f1ac2d2a0fc3">M</given-names></name><x>, </x><etal data-class="RefEtal" id="afeea6ef-bc8f-4c2b-a25f-94b30ae19b60">et al</etal></person-group><x>. </x><article-title id="f0fe144b-8e3e-4ff9-a812-cef4dc59e5cf">Radiation macular edema after Ru-106 plaque brachytherapy for choroidal melanoma resolved by an intravitreal dexamethasone 0.7-mg implant</article-title><x>. </x><source id="e40367b3-8234-42b9-be9b-886f57e67c5b">Case Rep Ophthalmol</source><x> </x><year id="ef94e13f-031a-4305-9fa0-61b413624025">2012</year><x>;</x><volume id="b39b3e3a-2982-4620-952f-30e8ad3dbeec">3</volume><x>:</x><fpage id="9d7a77a2-919d-4cd5-9dff-68cad9f66b6e">71</fpage><x>–</x><lpage id="0b2eff3b-2a79-426d-86d7-4af3548940c2">6</lpage><x>.</x><pub-id pub-id-type="doi" id="d82a565a-a611-4b84-beb4-2a119100f2cb">10.1159/000337144</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R16" data-id="R16" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R16" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/22125533" data-doi="10.1159/000332424" data-validated="true"><label id="24d6ed83-009a-492d-822a-0de0363f8ef3">16</label><element-citation publication-type="journal" id="ac118c06-05aa-43c6-b239-af0cd9d4a6a1"><person-group person-group-type="author" id="362f52a0-2786-486e-adc9-51845e3d897a"><name id="9e74f836-7b84-44ae-ae3c-86a8574814e6"><surname id="dc7e19b0-f109-4888-a156-1d1e0ac260c5">Meyer</surname> <given-names id="052099db-aa6c-4d2b-8007-2d72fead112f">LM</given-names></name><x>, </x><name id="a58911f0-dbeb-4de8-8145-531ef1a74fb1"><surname id="60d73c7a-c161-4e8f-b61c-286f1148cca1">Schönfeld</surname> <given-names id="5f1cd6f1-105a-4419-8ce4-f5b876b8bd43">C-L</given-names></name></person-group><x>. </x><article-title id="44993aba-f4d9-40b9-abbf-936135559faa">Cystoid macular edema after complicated cataract surgery resolved by an intravitreal dexamethasone 0.7-mg implant</article-title><x>. </x><source id="4cfd3f86-4ff3-483e-a2b9-37d4b0415f16">Case Rep Ophthalmol</source><x> </x><year id="aa1f5612-7bf1-453a-ab41-5d73485173a0">2011</year><x>;</x><volume id="bfc82376-174f-490d-933d-4ae46201b9c3">2</volume><x>:</x><fpage id="63ab98e0-ce99-41f0-abe4-3902b74f56f1">319</fpage><x>–</x><lpage id="60c1a264-3b37-4554-bb4d-40d71df30ced">22</lpage><x>.</x><pub-id pub-id-type="doi" id="13cbc187-d9ba-4b55-9569-75b55f03fe06">10.1159/000332424</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R17" data-id="R17" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R17" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/27915343" data-doi="10.1159/000448057" data-validated="true"><label id="155e8e7b-bfcc-4bd1-90da-7c028a042404">17</label><element-citation publication-type="journal" id="7203e291-377d-4757-b4c4-3678a7dbe120"><person-group person-group-type="author" id="09ac4fec-45e0-4563-8359-99f6254f545e"><name id="d9c26134-cf74-4f3b-9400-6918747fecec"><surname id="b6d749ea-5d64-4c0a-9646-5bd75d2514b4">Klamann</surname> <given-names id="04cd8af9-2db6-4392-adf4-7b3f644ee698">A</given-names></name><x>, </x><name id="bbf889fb-8a19-4d1b-ac56-b0cdbd279926"><surname id="fbb9fa9e-fa89-424b-b89f-0d2bbea11def">Böttcher</surname> <given-names id="cc3be422-7752-404f-90b7-432cfd0f9e2b">K</given-names></name><x>, </x><name id="0f31cfcb-41aa-44a5-b7ed-73a93ef34859"><surname id="8048d28b-3637-42d3-bf5b-53b4f78e593a">Ackermann</surname> <given-names id="661075e2-d1cc-4f2c-9894-3bfe514fb12a">P</given-names></name><x>, </x><etal data-class="RefEtal" id="4c80d40b-e841-4fe0-a2b0-8ddf15d73022">et al</etal></person-group><x>. </x><article-title id="8ad90ad3-164c-43a1-a44d-29e2e758c958">Intravitreal dexamethasone implant for the treatment of postoperative macular edema</article-title><x>. </x><source id="fd4888fb-9b53-424d-9763-43fbcb95e84b">Ophthalmologica</source><x> </x><year id="0e67c25f-28d6-486b-a278-b64554c352a4">2016</year><x>;</x><volume id="61374322-45d4-414a-90dc-2ec176c8bb3a">236</volume><x>:</x><fpage id="f842ce07-e859-4a44-b6eb-b4b2ab7b31cb">181</fpage><x>–</x><lpage id="57cbdb47-588b-4412-a827-a1fb6106ca94">5</lpage><x>.</x><pub-id pub-id-type="doi" id="187dbb15-235a-45f5-bb0b-c3d1afa85345">10.1159/000448057</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R18" data-id="R18" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R18" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/26040225" data-doi="10.1016/j.jcjo.2015.01.007" data-validated="true"><label id="d7317a7a-1e7a-4d08-9540-2df2fcd63cd6">18</label><element-citation publication-type="journal" id="69ecc261-b8f7-4c9e-9a2d-367ed44ecd97"><person-group person-group-type="author" id="ab87e5bc-6aaf-4ee8-8b08-673ea63fe3e5"><name id="985d16ec-924d-414b-bef9-d1dee494998f"><surname id="aed616c0-6c3f-497f-be31-d6d734158efa">Lei</surname> <given-names id="0c57bc50-e1e8-48c9-98f3-0e616846f522">S</given-names></name><x>, </x><name id="84dcf804-5d31-4540-acf4-0902c985cce7"><surname id="957dd652-3518-4954-abf0-3520041caf90">Lam</surname> <given-names id="54a7ded2-d985-498b-a5c3-562f6bf61c5c">W-C</given-names></name></person-group><x>. </x><article-title id="9fd1efcf-b658-40a4-b3dc-239aa9a2914b">Efficacy and safety of dexamethasone intravitreal implant for refractory macular edema in children</article-title><x>. </x><source id="75419b33-854e-497e-8f32-97945fd8abc1">Can J Ophthalmol</source><x> </x><year id="a775fe6d-3748-4a01-ae6d-9b5d9d68b68c">2015</year><x>;</x><volume id="713a8382-63fb-4bd4-999f-cece11dcb52a">50</volume><x>:</x><fpage id="914468d0-e9f8-4feb-afb6-a9333e9a4c94">236</fpage><x>–</x><lpage id="1b55dc69-173e-4d17-acff-7604553f1eb8">41</lpage><x>.</x><pub-id pub-id-type="doi" id="c4f7bd09-5ee6-4cf9-a41e-768acec64313">10.1016/j.jcjo.2015.01.007</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R19" data-id="R19" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R19" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/24907062" data-doi="10.1016/j.ophtha.2014.04.024" data-validated="true"><label id="0aeb3eb5-cf0c-4109-a48c-0bf53239fab5">19</label><element-citation publication-type="journal" id="a9a0784a-db0b-489e-8732-60374b65cfb6"><person-group person-group-type="author" id="421c6b6c-3bcf-490d-a2de-40c962f180ed"><name id="4855ad4e-779d-422c-9b02-9ab0c5b8c4a3"><surname id="a8762ebb-b049-4e21-b616-6c0a32eda7d8">Boyer</surname> <given-names id="49300b11-e8ed-4961-b071-4356ffa6c066">DS</given-names></name><x>, </x><name id="4b36c214-4705-4e7e-a0ed-9cf6e5114cce"><surname id="4ff32b63-f72b-4943-a706-476afe58a4af">Yoon</surname> <given-names id="3c422928-a5d2-4df1-ae88-2d5daee8ffb8">YH</given-names></name><x>, </x><name id="20d069ad-6072-4449-bce4-545c2fae6f8a"><surname id="8263069b-14a7-433a-8e80-28f536fbd72c">Belfort</surname> <given-names id="82552531-fd0f-4fec-bc3d-3ae85654cd79">R</given-names></name><x>, </x><etal data-class="RefEtal" id="54452605-d607-4864-af38-ef2b26f16c26">et al</etal></person-group><x>. </x><article-title id="934c25ae-4a97-4105-9f02-69944735fc6b">Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema</article-title><x>. </x><source id="3a6f12e8-2fd3-417e-ae4f-7c526042c967">Ophthalmology</source><x> </x><year id="9e6cb259-7ca9-4b9d-82e7-0b53d5950e89">2014</year><x>;</x><volume id="6dc1fe32-a84a-4066-bd68-08f9514f0321">121</volume><x>:</x><fpage id="2429d9d9-c095-4938-8014-3bfd9f55e699">1904</fpage><x>–</x><lpage id="060660d9-10b9-4e38-8c6f-c974f7ea9f52">14</lpage><x>.</x><pub-id pub-id-type="doi" id="c2c47545-48e9-4972-a38f-18de03b98f7a">10.1016/j.ophtha.2014.04.024</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R20" data-id="R20" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R20" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/23559321" data-doi="10.1007/s00347-012-2737-2" data-validated="true"><label id="5b11f7d3-c3c7-40fd-9e9f-b1e95f59800e">20</label><element-citation publication-type="journal" id="aa4d2cff-d0f6-4fa5-ab06-d60dae1d36b7"><person-group person-group-type="author" id="a614b1ea-d5ca-4a26-9811-3e55c3c4e048"><name id="cde7b4a3-6051-4ff6-88c4-a6a9c294a99c"><surname id="44685eb1-d636-4ba2-8d1a-f1f43efa2830">Schmitz</surname> <given-names id="ed01c777-712b-4eda-ba31-c26845936b01">K</given-names></name><x>, </x><name id="1447ba90-a98c-45e2-853f-2d2e509b92ea"><surname id="8754603a-6553-4a1e-9521-abd1b1a47509">Maier</surname> <given-names id="f18dda3c-e365-424e-812d-10f804823246">M</given-names></name><x>, </x><name id="41709c4f-b9b8-4f08-b4cb-ade9acc3be2f"><surname id="883e5c4d-4ee7-4e36-bd18-735a1142bd2f">Clemens</surname> <given-names id="d2b5b443-d347-4331-9b29-997280aa8ba5">CR</given-names></name><x>, </x><etal data-class="RefEtal" id="d217d34f-9cee-4725-a484-31e74a00ed66">et al</etal></person-group><x>. </x><article-title id="3b9800ec-beba-4392-83c9-d9e9a678a2fd">[Reliability and safety of intravitreal Ozurdex injections. The ZERO study]</article-title><x>. </x><source id="4ccfdff1-28ea-49bf-a930-40ef6bc9e19d">Ophthalmologe</source><x> </x><year id="bb3c7a16-5ef3-42fc-8849-b712fd734159">2014</year><x>;</x><volume id="75eb4254-940d-47ab-8522-b81783e440ef">111</volume><x>:</x><fpage id="a246745f-30fa-415a-950d-d9c11ba27fb8">44</fpage><x>–</x><lpage id="2f31e4bc-5dff-4832-9de4-83fdcc146fe6">52</lpage><x>.</x><pub-id pub-id-type="doi" id="70e7417b-9e7e-46f7-889c-697fa4c37dc4">10.1007/s00347-012-2737-2</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R21" data-id="R21" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R21" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/30084068" data-doi="10.1007/s00417-018-4095-5" data-validated="true"><label id="23cccfcb-3b2c-4790-8f0b-d7da0197a3e4">21</label><element-citation publication-type="journal" id="2c42a383-af48-4e84-a146-7ebf6b4bc409"><person-group person-group-type="author" id="4c6d6d2d-eadf-4c2b-804f-1b049ab9b7f3"><name id="625bff20-3c31-41ea-a4fa-adbfbf7e9124"><surname id="78a9b29a-fa81-4b65-ad40-28c77fc858c5">Blanc</surname> <given-names id="c9e53792-2d1d-4beb-b91b-309157503972">J</given-names></name><x>, </x><name id="6ad89b5b-9907-444c-9906-d7e9930ae630"><surname id="f1bcf8ed-2fca-435a-8494-87ae6dbc0ec0">Kodjikian</surname> <given-names id="09e9c2e8-54e5-4af7-956b-7b172cd54572">L</given-names></name><x>, </x><name id="78b550e0-873a-4d2f-b8cd-58696dd06131"><surname id="6390ae77-0fee-4989-93bf-0971ae346b47">Bron</surname> <given-names id="9a6a54d5-396d-445d-b88a-b237d61bd674">A</given-names></name><x>, </x><etal data-class="RefEtal" id="430ff848-74f9-4cc3-aa84-ab28ecc3d170">et al</etal></person-group><x>. </x><article-title id="6294138b-40f1-4b12-9378-1333bf25d21a">Response to safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience</article-title><x>. </x><source id="0276362d-3172-4c54-853f-e6dec7e2a6f1">Graefes Arch Clin Exp Ophthalmol</source><x> </x><year id="b83c962f-37a8-49da-bfd6-57c489cd0c91">2018</year><x>;</x><volume id="a1d88050-016a-475b-af7e-241421a15a96">256</volume><x>.</x><pub-id pub-id-type="doi" id="2525ab4c-a9f3-4a65-9c91-c6197db6a92e">10.1007/s00417-018-4095-5</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R22" data-id="R22" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R22" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/23480270" data-doi="10.1089/jop.2012.0253" data-validated="true"><label id="62e665e2-d783-487f-9c8e-e49b1d137200">22</label><element-citation publication-type="journal" id="2643caac-b264-417c-9bda-e41cedc26fb9"><person-group person-group-type="author" id="eff8432d-d4c7-4d57-9498-43b3628e12bf"><name id="3b8a9f8d-0808-4e2d-a80e-c2d5c46ae29b"><surname id="d78506f2-5baa-4fc9-957f-587b5550aaf8">Meyer</surname> <given-names id="dd313bb5-3b46-4fbe-8b9a-c7ee5671abdb">LM</given-names></name><x>, </x><name id="e1949dec-df5f-4c59-ba1b-e70ac3d5c930"><surname id="141bdc52-72b3-4398-92fa-65943ff5087a">Schönfeld</surname> <given-names id="1e9aae48-f678-467c-a5a6-2ec2b0e7fbfb">C-L</given-names></name></person-group><x>. </x><article-title id="45ded51a-587e-4323-b5a5-e6fd1c6e5db6">Secondary glaucoma after intravitreal dexamethasone 0.7 Mg implant in patients with retinal vein occlusion: a one-year follow-up</article-title><x>. </x><source id="4a8dbc8b-1d37-4303-87bd-1e51ae8ca184">J Ocul Pharmacol Ther</source><x> </x><year id="6195a70d-0f13-4866-bb24-14fd6d63d916">2013</year><x>;</x><volume id="c68ec294-1047-4558-be13-20b6c3b55f2d">29</volume><x>:</x><fpage id="51b55d54-296b-4bed-af2b-e66f2170b74f">560</fpage><x>–</x><lpage id="40c593ab-6633-4ffe-9200-61d852fd42e5">5</lpage><x>.</x><pub-id pub-id-type="doi" id="ce68c524-a1f6-47df-9064-186326298994">10.1089/jop.2012.0253</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R23" data-id="R23" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R23" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/27768641" data-doi="10.1097/IAE.0000000000001369" data-validated="true"><label id="ecee1457-ee4e-432a-92a9-773ae1c1d30c">23</label><element-citation publication-type="journal" id="64cf64ef-438c-4fbc-9468-a659556bcd6c"><person-group person-group-type="author" id="c1bd0d8d-7464-407f-b2e5-74c8fabfa96e"><name id="268b637f-a0c9-46a6-ac09-4e8f133973c2"><surname id="e38cf565-92e1-4bc8-9bac-8baf67b904fe">Malclès</surname> <given-names id="7d50fc59-2a47-451a-ac73-e5767fbabbd6">A</given-names></name><x>, </x><name id="615fb37b-a23a-47ea-a2c3-af80aaf56c30"><surname id="a4f0d7e4-45c1-4e64-8718-98ecf4e8b70a">Dot</surname> <given-names id="9284f419-ed7c-4296-95bf-f0b46c19feee">C</given-names></name><x>, </x><name id="e886523e-3373-4e16-b983-08404bc6d77c"><surname id="1fd7fcce-9d78-4512-b729-b5fccaf85677">Voirin</surname> <given-names id="9502581a-0c93-4124-b6a7-3f2cb5553cec">N</given-names></name><x>, </x><etal data-class="RefEtal" id="f2d76ec5-8217-4c32-9829-fe1230f2eb11">et al</etal></person-group><x>. </x><article-title id="634eaea3-c579-48d2-a855-92131642e9b2">Safety of intravitreal dexamethasone implant (Ozurdex): the SAFODEX study. Incidence and risk factors of ocular hypertension</article-title><x>. </x><source id="51fa7a5d-6aaf-4397-9585-d5a36df13a24">Retina</source><x> </x><year id="bee65a44-2624-4b83-b4f7-65d9211e6ee1">2017</year><x>;</x><volume id="fedc30f1-8dda-4985-b42d-edbba154f963">37</volume><x>:</x><fpage id="2dd3d97f-4a70-48d0-b80d-7e4700439fca">1352</fpage><x>–</x><lpage id="2ad18f9f-b88b-4a47-9bd3-e969b8e13034">9</lpage><x>.</x><pub-id pub-id-type="doi" id="d6881aff-2cf2-4d98-a0a0-ccf8df5f5a90">10.1097/IAE.0000000000001369</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R24" data-id="R24" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R24" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/8512486" data-validated="true"><label id="bb89fdbc-0158-4cc5-8f44-d03ac561f969">24</label><element-citation publication-type="journal" id="f44c2328-49ff-4775-ba05-8198c1fc2510"><person-group person-group-type="author" id="10c35d12-42e2-44d6-aa3e-1f85b284d91d"><name id="113c0726-499f-4c27-85f1-b080bfb96292"><surname id="0dba550e-c9f6-4efa-83b7-ed2c7f7a8ed0">Chylack</surname> <given-names id="16bbdb53-d0ef-4e2f-a8eb-801d92780756">LT</given-names></name><x>, </x><name id="80b93181-8634-47bf-bfbc-069e71d3d90e"><surname id="bd47ac68-14f3-4580-9f39-ea50bff8c487">Wolfe</surname> <given-names id="cdd72765-ab1f-483d-9cc9-e9a01a648c1b">JK</given-names></name><x>, </x><name id="1f1f61d9-c82b-4b20-bd6f-0f2ec15150b1"><surname id="1ec4eb77-be9e-4569-90b6-6deeb403bbd1">Singer</surname> <given-names id="1ef46560-9b66-403a-97d7-b75d10180e83">DM</given-names></name><x>, </x><etal data-class="RefEtal" id="9e8c7779-2180-4456-9e9e-d1205d800593">et al</etal></person-group><x>. </x><article-title id="47d3296f-91c1-42ba-ad1d-547f55cecc96">The lens opacities classification system III. the longitudinal study of cataract Study Group</article-title><x>. </x><source id="29c0c158-5e6a-406b-bf32-6e1b76530d7f">Arch Ophthalmol</source><x> </x><year id="c8f7383e-c8af-4bfd-b938-09202dc0fa7e">1993</year><x>;</x><volume id="dc7ea336-f692-4aae-921a-b9395e512fba">111</volume><x>:</x><fpage id="ca6c5e49-e070-4402-8169-053088dba5ef">831</fpage><x>–</x><lpage id="6903580a-1ac7-4012-b112-775bf5207a5c">6</lpage><x>.</x></element-citation></ref><ref data-class="jrnlRefText" id="R25" data-id="R25" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R25" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/30408801" data-doi="10.1159/000492132" data-validated="true"><label id="3a899b9f-fac7-47df-be93-219fb11f8d73">25</label><element-citation publication-type="journal" id="5d74fb98-ebea-43c3-a56c-9395541e6929"><person-group person-group-type="author" id="d5cc3eeb-723b-43ff-b2ad-6c8f66dc6578"><name id="882fcc1d-ba6d-4fce-acbb-b5a26f181765"><surname id="7e4909b4-9ec3-445a-9764-ca9b94e7e0ea">Mello Filho</surname> <given-names id="fa339897-97f5-4edb-ac9c-3895fe1ff791">P</given-names></name><x>, </x><name id="4971ea67-1a6f-4643-a275-38286c378068"><surname id="1601e4e1-b73d-4e65-90cd-251701373a31">Andrade</surname> <given-names id="fee72506-47eb-4dec-ae55-1074c62b8159">G</given-names></name><x>, </x><name id="ea1aa369-6642-4b54-ad25-abf5b1efc6db"><surname id="705d07f9-f355-40df-bc72-d3ca43d1ac81">Maia</surname> <given-names id="dacaea9b-bd58-48b4-811d-5386a020202d">A</given-names></name><x>, </x><etal data-class="RefEtal" id="755c4736-e0a0-4585-9906-186ec95c4abc">et al</etal></person-group><x>. </x><article-title id="55862def-efa1-44f1-870a-0f3ea87435bd">Effectiveness and safety of intravitreal dexamethasone implant (Ozurdex) in patients with diabetic macular edema: A real-world experience</article-title><x>. </x><source id="496cbee1-96e0-41cb-abdf-339710abaf07">Ophthalmologica</source><x> </x><year id="2a75bbce-7de6-4d0f-a3d2-8c3ac611bca4">2019</year><x>;</x><volume id="764db7ec-c7b3-476b-af8c-7ceb2c407fb4">241</volume><x>:</x><fpage id="aaa0b640-b757-4bf4-bcc6-452c4517c84b">9</fpage><x>–</x><lpage id="b82c245d-e4b1-4538-a675-4b6b48d40a4f">16</lpage><x>.</x><pub-id pub-id-type="doi" id="9963d194-a3dc-4809-9c93-33c74b67a644">10.1159/000492132</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R26" data-id="R26" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R26" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/21764136" data-doi="10.1016/j.ophtha.2011.05.014" data-validated="true"><label id="8507dc06-4865-4d73-b11b-79caa1837dc6">26</label><element-citation publication-type="journal" id="a8f1a87a-d50d-4ab6-98b4-79fe3b37fe85"><person-group person-group-type="author" id="c90f641a-9955-4fc0-ad42-8f0eef9e48e5"><name id="d597b9a7-78c6-46d3-94a9-067d23a83b14"><surname id="349ed36a-5304-476a-87c8-65a4f413b026">Haller</surname> <given-names id="4de69e04-cde6-4c60-806e-87d50269a4f8">JA</given-names></name><x>, </x><name id="91ab36cc-1769-436b-88ac-47dc5d7e7cd6"><surname id="f00894d0-d70b-426d-92a9-e641f00684db">Bandello</surname> <given-names id="c7876fe8-6819-43a3-b8d6-d9862317323f">F</given-names></name><x>, </x><name id="b08fee2f-da84-46b6-a35f-9f42cddfc64f"><surname id="4eaa4ab7-04a8-4ed9-b8f7-57ff76c64a44">Belfort</surname> <given-names id="1c8f9f23-4151-4bb7-94de-c7aa18ba0a08">R</given-names></name><x>, </x><etal data-class="RefEtal" id="c52a440b-c54a-4c8b-9a7f-a0518c1ee55e">et al</etal></person-group><x>. </x><article-title id="00d1e684-5f0c-48b9-92b9-731bd7fa2788">Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results</article-title><x>. </x><source id="07461e27-8701-46ec-ac46-5fea96488842">Ophthalmology</source><x> </x><year id="001cd8f3-5109-469a-babf-01cc44667364">2011</year><x>;</x><volume id="6aa34439-8ac2-4158-86f3-f2d69473fc4c">118</volume><x>:</x><fpage id="b0076218-7174-46c0-87ba-c5f9ab203ca2">2453</fpage><x>–</x><lpage id="bd203cb3-5665-4de5-90ea-ffeb60f03dde">60</lpage><x>.</x><pub-id pub-id-type="doi" id="885e0d2b-d59f-4389-ace0-abcb6d8ea5d1">10.1016/j.ophtha.2011.05.014</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R27" data-id="R27" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R27" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/29399708" data-doi="10.1007/s00417-017-3831-6" data-validated="true" data-edited-node="true"><label id="d02792bd-2b3c-488b-bf06-e88a36b98b49">27</label><element-citation publication-type="journal" id="6bdc2c18-e78f-441d-8d04-2a39cedbae16"><person-group person-group-type="author" id="7ab27667-daec-436e-bfce-458cc4b5ce54"><name id="32a03593-6fa5-466a-b034-265b54d98863"><surname id="b9c9691a-d893-4b3e-8269-73c5332179b0">Li</surname> <given-names id="90e87de0-2bef-41e8-bfb1-5ae62040560c">X</given-names></name><x>, </x><name id="8cc83aef-0c40-4570-986e-75ac6199ff2c"><surname id="c5c0c836-830b-4e7a-84dc-0646da374bd3">Wang</surname> <given-names id="c2a31fca-e084-4e03-9fed-77a7a99f6a0f">N</given-names></name><x>, </x><name id="f26c8e5c-fa38-4626-bed2-564e3f320a08"><surname id="01923404-a8eb-4ff0-bb4d-4a4b5a57d2df">Liang</surname> <given-names id="d31a116e-f253-4275-ba1c-6e9af40587a7">X</given-names></name></person-group><x>. </x><article-title id="5d6a4811-f844-45cf-b34b-0f2368034460">Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study</article-title><x>. </x><source id="3d235f87-a794-4f1f-b6a4-3798b6741605">Graefes Arch Clin Exp Ophthalmol</source><x> </x><year id="2ff7a80c-66e3-472b-8edf-d4d30c57db1c">2018</year><x>;</x><volume id="ec14c2e6-a481-4c84-8589-709418113c76">256</volume><x>:</x><fpage id="2b2fc69a-1be5-47f5-840c-36c8ff160bdf">59</fpage><x>–</x><lpage id="e8a6ff91-7356-43f5-90bd-e61f119e4ae5">69</lpage><x>.</x><pub-id pub-id-type="doi" id="2d2cc9fc-9d1d-49b7-81f4-1dbde2d83180">10.1007/s00417-017-3831-6</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R28" data-id="R28" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R28" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/27900478" data-doi="10.1007/s00417-016-3431-x" data-validated="true" data-edited-node="true"><label id="52b5f39d-4115-4810-8e87-9b3524b40416">28</label><element-citation publication-type="journal" id="6aa56625-38b5-43da-94dc-ca552d277cab"><person-group person-group-type="author" id="86b3b32d-8a55-48d3-85a0-c54a57410ae9"><name id="eda6f71e-4333-47e7-82ce-cc8dbb6ebe7d"><surname id="1ba813cc-bfb1-44dd-b36f-49cd7c98acb1">Eter</surname> <given-names id="6571a155-f7ba-4d7b-9035-53aeb5b252f6">N</given-names></name><x>, </x><name id="8ac5c8d2-1ff1-46a4-8e94-7b877924dce8"><surname id="c1f62d85-3f76-4f62-8e0b-4b509bcb940d">Mohr</surname> <given-names id="ca4e4f50-5d20-401d-8265-a5245facbd48">A</given-names></name><x>, </x><name id="b50a5b27-5917-4180-89a0-b709f576fd41"><surname id="1617d1f6-de71-4b78-9ffb-ac001851331c">Wachtlin</surname> <given-names id="5650acdb-c3dc-4f4f-867f-30647856e68c">J</given-names></name></person-group><x>. </x><article-title id="a13a81c4-7549-4e3e-bcbb-1f608798d80e">Dexamethasone intravitreal implant in retinal vein occlusion:real-life data from a prospective, multicenter clinical trial</article-title><x>. </x><source id="c157c9f2-9bed-4d40-a5fb-c89ea1b5474b">Graefes Arch Clin Exp Ophthalmol</source><x> </x><year id="64300eaa-f88b-46f6-a535-64214140953e">2017</year><x>;</x><volume id="2b3cca90-3f53-475a-abde-7bfb662779ac">255</volume><x>:</x><fpage id="4c3f4376-004c-4417-903f-b83bd45b1c26">77</fpage><x>–</x><lpage id="75f0054a-4e14-4f90-a794-5bfcc3c84b14">87</lpage><x>.</x><pub-id pub-id-type="doi" id="a2c959a8-6a90-46aa-991c-42509fb2eaa9">10.1007/s00417-016-3431-x</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R29" data-id="R29" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R29" data-validated="true" data-doi="10.4103/tjo.tjo_62_17" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/30294527"><label id="1885db82-4996-477d-8c5a-e9bba9d0c025">29</label><element-citation publication-type="journal" id="80a48f0e-511d-4130-a54a-d25b0e8e8ba6"><person-group person-group-type="author" id="dd521eec-e528-4be5-aa7b-5ab946531285"><name id="68197c98-1cdb-418f-8aa3-b769a1ebb8db"><surname id="a58a1150-b130-478b-a09d-cee4c81f6fc7">Nagpal</surname> <given-names id="117e66b5-6f3f-4eaf-b348-7e0008b08063">M</given-names></name><x>, </x><name id="51b3d2f1-bae1-4dfc-985a-98487ba2ec6a"><surname id="54e69b8b-8e12-4af7-8fe7-585d2608c58e">Mehrotra</surname> <given-names id="04b75577-42ff-4317-b66c-56adbf34b066">N</given-names></name><x>, </x><name id="807f13d7-1b6d-48ec-8531-1e78073c26a0"><surname id="0f3dd105-1ed6-4541-b5d9-14eb80993f02">Juneja</surname> <given-names id="04152021-4e86-41d6-b407-a031f80f7dac">R</given-names></name><x>, </x><etal data-class="RefEtal" id="1b3d56b1-aaf4-4337-88f7-0bef53882ef1">et al</etal></person-group><x>. </x><article-title id="0f4882d8-08d8-4dea-9c15-280f10f003d2">Dexamethasone implant (0.7 <named-content data-cid="1553861653002" id="1b4bf502-7332-47a8-9b82-506d46f59ec7" content-type="del cts-1" specific-use="1553861653000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/03/29 17:44 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1553861653000">mg</named-content><named-content data-cid="1553861653002" id="84c9d134-3f7b-4727-acc7-eb899a177112" content-type="ins cts-1" specific-use="1553861653000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/03/29 17:44 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1553861653000">Mg</named-content>) in Indian patients with macular edema: <named-content data-cid="1553861653003" id="62c11108-6dc4-425f-a73e-9d3f8adb087d" content-type="del cts-1" specific-use="1553861653000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/03/29 17:44 pm" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1553861653000">Real</named-content><named-content data-cid="1553861653003" id="ed4b4351-aadc-4996-ac26-ddbb238bb1d7" content-type="ins cts-1" specific-use="1553861653000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/03/29 17:44 pm" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1553861653000">real</named-content>-life scenario</article-title><x>. </x><source id="2ffc9181-6ec5-4f96-9cb2-df204813fd09">Taiwan J Ophthalmol</source><x> </x><year id="ea6562c5-f512-4710-a549-771a16e94445">2018</year><x>;</x><volume id="5676d09a-915c-4c02-94f6-a46674446f9d">8</volume><x>:</x><fpage id="703f5690-5928-4c6a-885f-78ce86d09502">141</fpage><x>–</x><lpage id="8d53efb7-b9b5-4c9c-9a4e-4cb4c1dcdb45">8</lpage><x>.</x><pub-id pub-id-type="doi" id="7b4b8acb-adfe-46eb-8f15-576f3c6aa32a">10.4103/tjo.tjo_62_17</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R30" data-id="R30" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R30" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/25217856" data-doi="10.1016/j.ajo.2014.09.003" data-validated="true"><label id="eaf977d1-1932-43b2-88b2-6fd1c5cc4352">30</label><element-citation publication-type="journal" id="45115061-d84e-4763-a603-1fdb359983f4"><person-group person-group-type="author" id="7f4e6783-b31c-40bc-aa36-68a2efdb8c2a"><name id="f483f427-1c50-41f5-a427-9e2d6f915c66"><surname id="81ea4026-2392-4162-8962-76d4007d231a">Zarranz-Ventura</surname> <given-names id="5ff35ab0-34bd-4d88-bf37-092ffe07ab66">J</given-names></name><x>, </x><name id="3790c669-0da9-403f-86d5-afab3fcfcd1a"><surname id="8bc98893-8425-480a-8c27-b3aeabf61d05">Carreño</surname> <given-names id="bd3faf51-2983-4121-8497-64efebcf32ab">E</given-names></name><x>, </x><name id="b09b1b8a-3423-45f2-9c6d-56abd40378fd"><surname id="a5e2979e-0f28-4d06-a516-8422eb6ab4f2">Johnston</surname> <given-names id="673e043d-b1be-4562-802f-1a78ab3d146d">RL</given-names></name><x>, </x><etal data-class="RefEtal" id="76072bbb-e53c-4134-bec8-ed66f35e1ada">et al</etal></person-group><x>. </x><article-title id="5fffa651-1861-4de8-81ed-17e7c16d447b">Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency</article-title><x>. </x><source id="d3303b19-e59e-41af-95e3-bf444ea95913">Am J Ophthalmol</source><x> </x><year id="38bd9914-443e-44cc-853a-1242882d9afa">2014</year><x>;</x><volume id="83bb29d5-66c9-4e3d-a2bc-0e4bbf39adaa">158</volume><x>:</x><fpage id="c6202668-3631-4963-88c5-8400adec25ba">1136</fpage><x>–</x><lpage id="cb2ef58c-c8bb-4569-8b16-b7f4cc287e17">45</lpage><x>.</x><pub-id pub-id-type="doi" id="b5da58bc-2870-40b8-950a-d111bb6b42f5">10.1016/j.ajo.2014.09.003</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R31" data-id="R31" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R31" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/23598674" data-doi="10.1038/eye.2013.79" data-validated="true"><label id="e281b09c-a584-41ea-9f0b-678eaa3a451d">31</label><element-citation publication-type="journal" id="94c21a28-10a3-4bf5-9aa5-0fe77f253e88"><person-group person-group-type="author" id="3cf8a274-a18a-4c62-99d3-9478659f3e88"><name id="173a860e-9426-4437-bd1f-ac1c70bf180f"><surname id="164572ee-826d-4fcf-8659-bb9c31de597c">Mayer</surname> <given-names id="842c8edb-d071-42eb-bc1c-faa8049feec5">WJ</given-names></name><x>, </x><name id="561fda4e-2152-484b-be4b-d18670b805f1"><surname id="461e689f-c334-4655-9cc3-61892e896c1b">Wolf</surname> <given-names id="bbe79bd3-ec30-421a-9a35-b5471a01f013">A</given-names></name><x>, </x><name id="412003cc-48ab-46f1-a238-7e9eac4a9226"><surname id="d76d7463-cbc4-4e99-895a-0c310a6cc798">Kernt</surname> <given-names id="86e9a471-8bd5-40da-b370-6c1c639197bd">M</given-names></name><x>, </x><etal data-class="RefEtal" id="95a372ee-ac1e-480f-9a01-ba95e2548b6d">et al</etal></person-group><x>. </x><article-title id="61574602-898c-48d5-b6fe-07d598dde4d9">Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion</article-title><x>. </x><source id="073daaed-3b3b-4b75-8ec4-200dc14446c4">Eye</source><x> </x><year id="24e7d536-6f5b-4103-95c9-8ed051af78db">2013</year><x>;</x><volume id="a92e0ad2-6625-40f0-b4a6-24c32b605f72">27</volume><x>:</x><fpage id="31c1941c-4a94-45c2-8b65-5f0a3b3a2724">816</fpage><x>–</x><lpage id="8e99e97e-6b75-4870-9336-8baf7180445d">22</lpage><x>.</x><pub-id pub-id-type="doi" id="e5217cac-5ebd-4d18-a43e-4cbd2ace9318">10.1038/eye.2013.79</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R32" data-id="R32" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R32" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/30608950" data-doi="10.1371/journal.pone.0209997" data-validated="true"><label id="12a431eb-71f2-420b-98a0-668e21444b80">32</label><element-citation publication-type="journal" id="91dfe82a-b07c-4181-99f1-273e5612529e"><person-group person-group-type="author" id="5a64f554-3173-4052-b0fe-a05e338919d9"><name id="b94933c7-0455-43d8-a8ab-914a3ba1d92d"><surname id="35efead6-08b3-487f-8c89-ae70d47e398a">Zarranz-Ventura</surname> <given-names id="30b0600a-fa15-4489-977d-7a8283c62452">J</given-names></name><x>, </x><name id="92ee418b-cce3-44b4-ba34-b18e99a55a92"><surname id="089d54c9-94af-4022-b916-1a6b517cc663">Sala-Puigdollers</surname> <given-names id="6bcd524c-6801-4a13-84ad-e690abc350a7">A</given-names></name><x>, </x><name id="dbb398e1-4ea6-42c8-88b8-c8cbd5bfe32d"><surname id="718837d6-3b84-46aa-960e-f3f200155653">Velazquez-Villoria</surname> <given-names id="4891272a-6aef-4772-b1b5-e4c7a2a5e3f5">D</given-names></name><x>, </x><etal data-class="RefEtal" id="6e19b89b-1d1e-41a7-93f1-75d7f9a9840d">et al</etal></person-group><x>. </x><article-title id="3e456cec-2ac3-4ffe-b057-466d73873eb8">Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world</article-title><x>. </x><source id="7190813d-e2c0-42a5-ac21-e3f19c3dd6c9">PLoS One</source><x> </x><year id="5e95aba1-c9ef-466b-81cb-8aeea27cec4b">2019</year><x>;</x><volume id="ec0e8d8a-2be8-46ea-9c95-133623f901c3">14</volume><x>:</x><elocation-id id="09db0f2d-3cdb-4f4b-b4ad-07afb75fbfaa">e0209997</elocation-id><x>.</x><pub-id pub-id-type="doi" id="3d4261d5-931b-4ceb-8537-4a681e41b048">10.1371/journal.pone.0209997</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R33" data-id="R33" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R33" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/21220619" data-doi="10.1001/archophthalmol.2010.339" data-validated="true"><label id="8dbe8266-0b9e-4fee-baae-73018f9f4620">33</label><element-citation publication-type="journal" id="851b7d15-c0fe-4533-9bad-5c03a2ad6442"><person-group person-group-type="author" id="66b7e646-0dd7-4e0b-b8b5-b31bb33934d6"><name id="2835480b-e81d-4d74-bf81-aac660cb3f0d"><surname id="ad7e8c03-fa86-41f4-829d-184b28efd831">Lowder</surname> <given-names id="6544896a-2ecc-4868-948b-6c2ea166f1a0">C</given-names></name><x>, </x><name id="01f74233-f9a1-4e85-9b17-3303480760a8"><surname id="aff0e4e3-7f7c-498c-80f5-83bc57f6f5ce">Belfort</surname> <given-names id="16aa4424-bec6-416d-9a29-d58d31bef815">R</given-names></name><x>, </x><name id="e820c374-7080-4bcd-aa08-b0349417053c"><surname id="5de19cb5-2c91-4674-a0bf-6d8c1bb17243">Lightman</surname> <given-names id="42d7e427-a216-40ee-80c4-8a728b3550b6">S</given-names></name><x>, </x><etal data-class="RefEtal" id="94125e7b-cc22-4aa7-ac28-0496f3494c7d">et al</etal></person-group><x>. </x><article-title id="dda6412e-b63e-4e0a-8479-eb7714fc79c7">Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis</article-title><x>. </x><source id="e43231b2-1c03-47b3-a046-d92bc14c5343">Arch Ophthalmol</source><x> </x><year id="436e4fa1-e1ae-4a55-80f8-4af6b391d335">2011</year><x>;</x><volume id="6211c7c2-bec2-467b-9c65-b851926bae3d">129</volume><x>:</x><fpage id="7effef16-7861-45dc-aae1-423f88504f08">545</fpage><x>–</x><lpage id="7dc5b2a4-3d7e-4b28-8408-9357eef02e4a">53</lpage><x>.</x><pub-id pub-id-type="doi" id="cf7e6eda-9ce1-430b-b91a-f19967e2b857">10.1001/archophthalmol.2010.339</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R34" data-id="R34" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R34" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/25932545" data-doi="10.1097/IAE.0000000000000524" data-validated="true"><label id="66a8bcb8-2b6b-41db-8c30-3e8b7786acdf">34</label><element-citation publication-type="journal" id="b0f4ab24-b265-42a6-92ce-8adfc9f151a6"><person-group person-group-type="author" id="bff8250b-3590-4aac-a5c6-19b4b2efc0f7"><name id="a0af9447-e3ec-4b6f-9058-8590f459c048"><surname id="f01ce236-18a4-4d1f-a823-995cb91a3f57">Reid</surname> <given-names id="4c3e2241-b785-4324-8613-85b44800cb6a">GA</given-names></name><x>, </x><name id="5f73177e-b952-4538-b4d2-0930dd03d077"><surname id="f57f3477-20d3-495c-bb75-b8f5494bbf5e">Sahota</surname> <given-names id="3070c292-b833-4b73-a0df-0b772a82480d">DS</given-names></name><x>, </x><name id="e13e908e-060b-496f-826f-5ca9601a89c1"><surname id="10612572-1689-45bb-ac68-1a8f7b01dd58">Sarhan</surname> <given-names id="340c0c20-2fa4-4678-94bf-42aba751af9c">M</given-names></name></person-group><x>. </x><article-title id="9527f8ee-e3d4-4b61-b686-25d4182f9482">Observed complications from dexamethasone intravitreal implant for the treatment of macular edema in retinal vein occlusion over 3 treatment rounds</article-title><x>. </x><source id="f249e1d6-b172-40af-97e1-dd2c7ba2c185">Retina</source><x> </x><year id="8b8aa8d4-cdd6-4567-8926-adfda41ce21a">2015</year><x>;</x><volume id="bb0a6d70-3dd2-4179-a60b-709ddb1326f1">35</volume><x>:</x><fpage id="9ad0ec6b-f4a7-4b77-b952-e3ee4460c473">1647</fpage><x>–</x><lpage id="422898f6-5fb1-422e-ad39-7cfefdd5eae1">55</lpage><x>.</x><pub-id pub-id-type="doi" id="fa8e0753-5e95-4466-ab12-432b1320eaa0">10.1097/IAE.0000000000000524</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R35" data-id="R35" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R35" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/26418442" data-doi="10.1097/IAE.0000000000000750" data-validated="true"><label id="38eecdaf-d355-4090-88da-a1a4a68a09f2">35</label><element-citation publication-type="journal" id="6d1810b0-c65d-4959-9bd9-b0546399fd22"><person-group person-group-type="author" id="7c09397f-a10a-4098-a6ec-e7050537e6d4"><name id="ccc15ff8-55e2-453e-bca0-f5e52d30cb21"><surname id="0695b9ab-be6c-4145-b334-3f10ec2e473e">Bakri</surname> <given-names id="28210b8d-39c8-4fb3-a689-23a38223739e">SJ</given-names></name><x>, </x><name id="81142835-1622-4c94-9508-0408cb895770"><surname id="84d7d077-32d8-42d6-a5b1-3222e89f5136">Omar</surname> <given-names id="e4d0f138-e6f6-4a36-9fa7-eb87e46d03ed">AF</given-names></name><x>, </x><name id="9b67ff73-293b-458b-a272-8f94f6388062"><surname id="29f8568d-633f-4b24-ba70-a6b14a9793d6">Iezzi</surname> <given-names id="1bccc540-1d86-40f1-b4e6-809bcd4876f6">R</given-names></name><x>, </x><etal data-class="RefEtal" id="9a215a90-fb47-4161-8dd4-5fea74e1a874">et al</etal></person-group><x>. </x><article-title id="d1568895-9a08-49f6-9a05-a404f5617197">Evaluation of multiple dexamethasone intravitreal implants in patients with macular edema associated with retinal vein occlusion</article-title><x>. </x><source id="2d9f7755-401c-46e5-88c7-ec33dfbc9c30">Retina</source><x> </x><year id="53d3a601-bfa9-4dec-9553-007be3b30944">2016</year><x>;</x><volume id="cdc93e3f-307e-492e-ba09-6fb24090ed8d">36</volume><x>:</x><fpage id="2e0e17fe-73ed-4fec-993b-ba0d5a51b6f9">552</fpage><x>–</x><lpage id="54e2baa6-26ce-4246-8bbc-120fa32e3d08">7</lpage><x>.</x><pub-id pub-id-type="doi" id="ab74ae74-7f4f-4255-bb13-44ba7ea3bf4c">10.1097/IAE.0000000000000750</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R36" data-id="R36" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R36" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/26871523" data-doi="10.1097/IAE.0000000000001004" data-validated="true"><label id="0e03b24d-dce0-4bf6-b805-7b85b64df1d6">36</label><element-citation publication-type="journal" id="f64ae522-080f-43e5-a896-88e3fd678456"><person-group person-group-type="author" id="ddcccd1a-e55c-442d-b929-c7d0dbe128c7"><name id="565caed2-6b1d-4fd5-b063-645d14ef997b"><surname id="2b3ad652-1847-4cda-804b-f9dc58f0cf81">Maturi</surname> <given-names id="43e835aa-487c-4ee3-aa44-3e6b566308fa">RK</given-names></name><x>, </x><name id="57bed04a-8275-4c61-acdb-43d8ca3097d3"><surname id="c2c6d49a-7777-4665-af16-2a1199af9d88">Pollack</surname> <given-names id="b81d0484-1834-47fb-b063-98d27d4c80b7">A</given-names></name><x>, </x><name id="dc62ca81-7930-485a-b262-f575f81baf39"><surname id="e29dc599-2470-48b4-abea-a7c3ecf8f1f5">Uy</surname> <given-names id="f1bcda2f-2174-47d9-829f-7d52cb8f1c57">HS</given-names></name><x>, </x><etal data-class="RefEtal" id="b6936956-006c-4695-97d4-9a6f58aa4f25">et al</etal></person-group><x>. </x><article-title id="e530e0e7-8b6f-4f96-b18c-53bd733f3717">Intraocular pressure in patients with diabetic macular edema treated with dexamethasone intravitreal implant in the 3-year MEAD study</article-title><x>. </x><source id="db0419d5-003e-40bf-a70a-1a93edcf2521">Retina</source><x> </x><year id="cdbf6763-e12a-410f-b527-e2d736d33c18">2016</year><x>;</x><volume id="6d8a7af3-b592-4b33-8bf1-522150d2075e">36</volume><x>:</x><fpage id="507d7534-7f71-4d5f-ba8f-f62ed3a26dc7">1143</fpage><x>–</x><lpage id="4b9b59a7-e48b-4cbd-9bdf-4975ef1f12b6">52</lpage><x>.</x><pub-id pub-id-type="doi" id="38291cc9-5f08-455e-8ed5-d76c946a4cdb">10.1097/IAE.0000000000001004</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R37" data-id="R37" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R37" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/30451802" data-doi="10.1097/OPX.0000000000001306" data-validated="true"><label id="a65c92b1-93c4-49c7-9a69-8cb85938ef0c">37</label><element-citation publication-type="journal" id="54674c03-f835-4081-b45a-c93db30b9870"><person-group person-group-type="author" id="715845d6-bb8d-47e8-8b96-25f7f8707462"><name id="0c74389e-91fe-47a3-9734-4a6ba2e8d5df"><surname id="bf910832-d1b4-45e5-a437-6ad3c9f172fd">Ozkaya</surname> <given-names id="e8119cfa-98e2-44b2-aac2-a57634b76aa2">A</given-names></name><x>, </x><name id="36652b82-a382-4c59-b20f-1a8cf2af6751"><surname id="8e44274f-632d-4942-b84c-58a05133b2c0">Tarakcioglu</surname> <given-names id="51d18bea-9fd5-4c9a-a7f1-d50a40442ffa">HN</given-names></name><x>, </x><name id="38cf45f9-3375-4f4a-a50d-793bd0bdd04f"><surname id="b85783ff-4016-4a86-ac98-4d16d5ea90c0">Tanir</surname> <given-names id="225d4d06-5af8-4cc0-8d2c-a2809bb6b385">I</given-names></name></person-group><x>. </x><article-title id="bc943ae9-d703-48c7-85e1-e720afa044a9">Ranibizumab versus dexamethasone implant in macular edema secondary to branch retinal vein occlusion: two-year outcomes</article-title><x>. </x><source id="770c2f8a-2236-438c-bc57-3ba20f4be715">Optom Vis Sci</source><x> </x><year id="0eb5a63e-8a9d-4b3a-a217-87707b23e14b">2018</year><x>;</x><volume id="55354438-33c8-4a20-8c9c-a61beff97abe">95</volume><x>:</x><fpage id="a83f2034-911c-4a5f-af13-7096bcf8dcdb">1149</fpage><x>–</x><lpage id="51e06da3-79be-4048-a99e-0106bdaa5add">54</lpage><x>.</x><pub-id pub-id-type="doi" id="0eee436a-b2af-4173-a5d0-e1e2fdbc2f82">10.1097/OPX.0000000000001306</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R38" data-id="R38" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R38" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/28884024" data-doi="10.1155/2017/4896036" data-validated="true"><label id="e9c92d55-258e-4ac6-8472-b2330739f04f">38</label><element-citation publication-type="journal" id="5960b8b8-19fc-4fbc-9d7d-75c7bc5066e4"><person-group person-group-type="author" id="9f92478e-deee-45ad-865f-6b1ce85b694d"><name id="d30377d4-0960-4bd5-bfed-eb98a1deea5a"><surname id="8cf8a11d-f332-48e7-b0d2-eb008c367895">Furino</surname> <given-names id="2c8bf6c7-5a34-43bd-89b1-18cc72a65680">C</given-names></name><x>, </x><name id="6149d1f8-e29f-48e2-95c2-05c0a49b6627"><surname id="78491c11-b62c-43ba-abd5-7145a6fe7cd6">Boscia</surname> <given-names id="1ceb50da-e7dd-4362-8fac-78551662c6a6">F</given-names></name><x>, </x><name id="dadd5a8f-9ec0-4be0-adb2-c35bd2d25829"><surname id="65fd2c77-aa5f-4901-9916-f1f1c32de488">Niro</surname> <given-names id="c27053cc-3614-40fa-afe1-ecba06564727">A</given-names></name><x>, </x><etal data-class="RefEtal" id="c7900827-79e4-4cc1-a44d-a93b0b0e2b1b">et al</etal></person-group><x>. </x><article-title id="dd6c5981-9efa-44d8-b05f-9b78f85a695f">Combined phacoemulsification and intravitreal dexamethasone implant (Ozurdex®) in diabetic patients with coexisting cataract and diabetic macular edema</article-title><x>. </x><source id="e13f2dfd-60ef-4c1e-a715-7bd10464a031">J Ophthalmol</source><x> </x><year id="7a013910-a587-4c1b-8568-d53d11c63e2a">2017</year><x>;</x><volume id="dd572f5c-34eb-4339-a82a-214fc7b0471a">2017</volume><x>:</x><fpage id="14078179-58ca-4cc5-a303-c352508c7e9a">1</fpage><x>–</x><lpage id="14e1b943-08d7-460b-9365-969ea7f902eb">7</lpage><x>.</x><pub-id pub-id-type="doi" id="84e6a383-5274-42d6-bb9a-95c0e2820270">10.1155/2017/4896036</pub-id></element-citation></ref></ref-list></back><workflow ftp-file-name="bjophthalmol-2019-313991" data-job-id="ed10eaf2-cab4-49de-8bfc-d0491b3bf047"><priority>priority</priority><current-stage>Pre-editing</current-stage><paw-stage><previous>Corrections</previous><current>Revises</current></paw-stage><word-count/><word-count-without-ref>6979</word-count-without-ref><stage><name>addJob</name><customer-stage-name>Add Job</customer-stage-name><start-date-time/><end-date-time/><start-date>2019-03-28 06:45:00</start-date><duration>0</duration><end-word-count>19</end-word-count><end-word-count-without-ref>19</end-word-count-without-ref><end-date>2019-03-28 06:45:02</end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on/><reason/></assigned><time-log><log><start/><end/><duration/><status/></log></time-log></stage><stage><iteration>1</iteration><start-word-count>19</start-word-count><start-word-count-without-ref>19</start-word-count-without-ref><name>File download</name><customer-stage-name>Clean up</customer-stage-name><start-date>2019-03-28 06:45:02</start-date><duration>0</duration><end-word-count>19</end-word-count><end-word-count-without-ref>19</end-word-count-without-ref><end-date>2019-03-28 06:45:10</end-date><sla-start-date>2019-03-28 06:45:02</sla-start-date><sla-end-date>2019-03-29 06:45:02</sla-end-date><planned-start-date>2019-03-28 06:45:02</planned-start-date><planned-end-date>2019-03-29 06:45:02</planned-end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object></stage><stage><iteration>1</iteration><start-word-count>19</start-word-count><start-word-count-without-ref>19</start-word-count-without-ref><name>Convert Files</name><customer-stage-name>Clean up</customer-stage-name><start-date>2019-03-28 06:45:10</start-date><duration>0</duration><end-word-count>664</end-word-count><end-word-count-without-ref>664</end-word-count-without-ref><end-date>2019-03-28 06:45:21</end-date><sla-start-date>2019-03-28 06:45:02</sla-start-date><sla-end-date>2019-03-29 06:45:02</sla-end-date><planned-start-date>2019-03-28 06:45:10</planned-start-date><planned-end-date>2019-03-29 06:45:10</planned-end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object></stage><stage><iteration>1</iteration><start-word-count>664</start-word-count><start-word-count-without-ref>664</start-word-count-without-ref><name>Pre-editing</name><customer-stage-name>Clean up</customer-stage-name><start-date>2019-03-28 06:45:21</start-date><duration>105</duration><end-word-count>7024</end-word-count><end-word-count-without-ref>5710</end-word-count-without-ref><end-date>2019-03-30 09:19:06</end-date><sla-start-date>2019-03-28 06:45:02</sla-start-date><sla-end-date>2019-03-29 06:45:02</sla-end-date><planned-start-date>2019-03-28 06:45:21</planned-start-date><planned-end-date>2019-04-01 06:45:21</planned-end-date><status>in-progress</status><comments/><assigned><to>Sabari dev, sabaridev@exeterpremedia.com</to><by>System, Exeter</by><on>2019-09-19 04:32:55</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><job-logs><log><username>Sabari dev</username><useremail>sabaridev@exeterpremedia.com</useremail><start-date>2019-09-17</start-date><start-time>08:59:05</start-time><end-date>2019-09-17</end-date><end-time>09:00:25</end-time><status type="system">in-active</status></log><log data-doi="bjophthalmol-2019-313991" data-project="bjophthalmol" data-customer="bmj"><username>Sabari</username><useremail>sabaridev@exeterpremedia.com</useremail><start-date>2019-09-17</start-date><start-time>09:09:53</start-time><end-date>2019-09-17</end-date><end-time>09:09:53</end-time><status type="system">open</status></log><log data-doi="bjophthalmol-2019-313991" data-project="bjophthalmol" data-customer="bmj"><username>Sabari</username><useremail>sabaridev@exeterpremedia.com</useremail><start-date>2019-09-17</start-date><start-time>09:09:54</start-time><end-date>2019-09-17</end-date><end-time>09:11:16</end-time><status type="system">logged-off</status></log><log><username>Sabari dev</username><useremail>sabaridev@exeterpremedia.com</useremail><start-date>2019-09-19</start-date><start-time>04:32:55</start-time><end-date>2019-09-19</end-date><end-time>04:33:53</end-time><status type="system">logged-off</status></log><log><username>Sabari dev</username><useremail>sabaridev@exeterpremedia.com</useremail><start-date>2021-05-24</start-date><start-time>14:38:28</start-time><end-date>2021-05-24</end-date><end-time>14:41:12</end-time><status type="system">in-active</status></log><log data-doi="bjophthalmol-2019-313991" data-project="bjophthalmol" data-customer="bmj"><username>Sabari</username><useremail>sabaridev@exeterpremedia.com</useremail><start-date>2021-05-24</start-date><start-time>14:41:54</start-time><end-date>2021-05-24</end-date><end-time>14:41:54</end-time><status type="system">open</status></log><log data-doi="bjophthalmol-2019-313991" data-project="bjophthalmol" data-customer="bmj"><username>Sabari</username><useremail>sabaridev@exeterpremedia.com</useremail><start-date>2021-05-24</start-date><start-time>14:41:59</start-time><end-date>2021-05-24</end-date><end-time>14:42:10</end-time><status type="system">in-active</status></log><log data-doi="bjophthalmol-2019-313991" data-project="bjophthalmol" data-customer="bmj"><username>Sabari</username><useremail>sabaridev@exeterpremedia.com</useremail><start-date>2021-05-24</start-date><start-time>14:43:02</start-time><end-date>2021-05-24</end-date><end-time>14:43:02</end-time><status type="system">open</status></log><log data-doi="bjophthalmol-2019-313991" data-project="bjophthalmol" data-customer="bmj"><username>Sabari</username><useremail>sabaridev@exeterpremedia.com</useremail><start-date>2021-05-24</start-date><start-time>14:43:08</start-time><end-date>2021-05-24</end-date><end-time>14:43:26</end-time><status type="system">in-active</status></log><log data-doi="bjophthalmol-2019-313991" data-project="bjophthalmol" data-customer="bmj"><username>Sabari</username><useremail>sabaridev@exeterpremedia.com</useremail><start-date>2021-05-24</start-date><start-time>14:43:42</start-time><end-date>2021-05-24</end-date><end-time>14:43:49</end-time><status type="user">logged-off</status></log></job-logs></stage></workflow><production-notes><note type="workflow"><id>6689bf62-0c90-4889-b183-cac2aa4ebd58</id><fullname>Workflow</fullname><created>2019-03-28 06:45:00</created><content>Job created on 2019-03-28 06:45:00</content></note><note id="559e1bcc-1f0e-4941-a94b-d057c0d78a47" type="workflow"><id>559e1bcc-1f0e-4941-a94b-d057c0d78a47</id><fullname>Workflow</fullname><created>2019-03-28 06:45:02</created><content>Article signed-off from addJob to File download</content></note><note id="d6d83953-9ce1-4d22-ad39-7c35ee90ec67" type="workflow"><id>d6d83953-9ce1-4d22-ad39-7c35ee90ec67</id><fullname>Workflow</fullname><created>2019-03-28 06:45:10</created><content>Article signed-off from File download to Convert Files</content></note><note id="e19e81c2-f68d-41a5-9dc2-2f100127b10f" type="workflow"><id>e19e81c2-f68d-41a5-9dc2-2f100127b10f</id><fullname>Workflow</fullname><created>2019-03-28 06:45:14</created><content>Payment and license info has been updated {"license":"nonOA","copyrightStatement":"nonOA","paymentMethod":"No APC","paymentStatus":"no","currentStage":"Convert Files","holdType":"NoHold","holdStatus":"true","matchStage":"Convert Files"}</content></note><note id="4008a4da-f9bf-4051-92dd-8050d9a8d93c" type="workflow"><id>4008a4da-f9bf-4051-92dd-8050d9a8d93c</id><fullname>Workflow</fullname><created>2019-03-28 06:45:21</created><content>Article signed-off from Convert Files to Pre-editing</content></note><note id="8e0e2c9f-65f9-4946-b00d-e52745dd280a" type="email"><id>8e0e2c9f-65f9-4946-b00d-e52745dd280a</id><fullname>Workflow</fullname><created>2019-03-28 06:45:22</created><content><email-content><mail-id>a4c1e28a-e8e9-9aec-4a16-88814a4d323f@exeterpremedia.com</mail-id><mail-subject>Job Notification: Article 10.1136/bjophthalmol-2019-313991 loaded </mail-subject><from>bmj@exeterpremedia.com</from><to>bmj@exeterpremedia.com</to><mail-body><p>Dear typesetter</p><p>The article '<span class="article-id">10.1136/bjophthalmol-2019-313991</span>' is now ready for editing.</p><p>Thank you,</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note></production-notes></article>